data_1nyp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nyp _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.25 163.61 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.958 1.772 . . . . 0.0 108.867 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.545 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.4 119.77 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 122.059 0.933 . . . . 0.0 109.402 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 15.0 t -58.35 117.0 3.98 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.844 0.831 . . . . 0.0 109.946 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -64.85 -0.17 4.91 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.539 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -86.67 -48.55 8.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -1.095 . . . . 0.0 109.36 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.8 13.7 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.634 HH11 ' HG3' ' A' ' 12' ' ' ARG . 8.2 mmm-85 53.52 41.32 32.11 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -115.91 143.45 30.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.7 Cg_exo -56.46 113.38 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.46 1.44 . . . . 0.0 110.546 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 8' ' ' CYS . 21.5 mt -70.92 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.54 61.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.863 -1.148 . . . . 0.0 110.662 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.661 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.66 42.32 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.8 158.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.668 0.746 . . . . 0.0 111.195 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.56 116.01 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.586 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -89.85 106.09 18.24 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.11 -0.993 . . . . 0.0 109.553 -179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.53 42.63 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.9 mmt 58.09 17.19 4.31 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.2 25.28 75.85 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.8 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.741 0.781 . . . . 0.0 109.764 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.443 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.8 mt-30 -135.38 143.49 46.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.3 m95 -141.59 139.98 33.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.534 -1.354 . . . . 0.0 110.616 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.3 m80 -56.48 131.95 49.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.22 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.871 -1.143 . . . . 0.0 108.348 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 28' ' ' HIS . 12.5 tp10 -95.78 -26.97 15.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.814 -0.554 . . . . 0.0 110.62 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.13 -6.52 31.38 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.883 -1.136 . . . . 0.0 110.826 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.422 HG11 ' N ' ' A' ' 40' ' ' PRO . 26.6 m -133.57 175.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 111.158 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.82 148.68 46.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.318 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.83 28.69 1.73 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.4 tptm -138.81 -31.69 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.364 -0.835 . . . . 0.0 110.077 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.1 -15.39 4.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.305 -0.872 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.6 0.34 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.326 -0.859 . . . . 0.0 110.191 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.46 109.56 59.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.4 Cg_endo -69.06 138.28 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.713 1.609 . . . . 0.0 112.112 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.23 1.63 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.26 -0.9 . . . . 0.0 108.996 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.01 2.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.936 -1.665 . . . . 0.0 108.936 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -116.29 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.504 -0.998 . . . . 0.0 109.94 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.43 145.34 24.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 109.352 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.2 p-80 -116.3 169.47 9.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.55 137.67 47.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.28 28.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.232 -0.917 . . . . 0.0 111.201 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.34 11.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.628 0.727 . . . . 0.0 110.333 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.23 22.86 1.45 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.586 -0.696 . . . . 0.0 109.495 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.47 30.97 20.36 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.724 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.6 mt -143.29 142.74 31.44 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.535 -0.979 . . . . 0.0 108.814 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.35 152.86 36.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 110.73 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.51 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 57.7 m-85 -153.91 140.27 18.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 90.7 m -57.55 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.316 -1.353 . . . . 0.0 108.454 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 53.1 tt0 -63.63 -35.98 82.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.383 -0.823 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.4 m -86.66 -43.75 12.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 0.0 111.339 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.459 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -66.65 -43.77 83.68 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.79 -1.194 . . . . 0.0 108.141 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.2 t80 -51.74 -56.43 13.87 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -64.52 -44.89 89.47 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.093 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.463 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.5 tp60 -54.44 -34.37 61.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.534 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.8 mp -78.68 -35.24 45.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.359 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 18.0 m-85 -158.58 -81.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.517 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.9 Cg_endo -79.6 164.3 23.57 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.673 2.249 . . . . 0.0 109.327 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.6 mt -135.31 122.83 36.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.873 0.844 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 12.1 t -61.13 116.83 4.86 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.549 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.42 -1.13 4.11 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.553 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.46 -54.22 4.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -1.149 . . . . 0.0 109.524 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.33 1.97 18.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.559 -0.713 . . . . 0.0 109.148 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 57.56 41.86 25.1 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.22 -0.925 . . . . 0.0 108.57 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -116.68 142.76 30.16 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.6 Cg_exo -55.69 113.97 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.432 1.422 . . . . 0.0 110.948 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' PRO . 23.9 mt -71.89 158.77 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -161.77 62.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 0.0 110.484 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 -100.37 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -113.33 120.49 41.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 t -97.01 154.51 3.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 111.065 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.84 112.61 38.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.6 m-80 -86.98 106.81 18.08 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.67 42.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.5 mmt 58.38 16.01 3.83 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 27.5 71.71 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -133.05 -151.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.042 0.925 . . . . 0.0 110.089 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -136.82 144.53 43.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.549 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 64.4 m95 -142.51 135.44 28.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.605 -1.31 . . . . 0.0 110.368 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.451 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 17.7 m80 -53.77 135.52 41.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 t -55.54 -18.18 4.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 120.935 -1.103 . . . . 0.0 109.053 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -94.39 -25.9 16.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.438 -0.789 . . . . 0.0 110.573 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.5 m170 -98.01 -5.03 34.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 111.028 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -82.72 106.03 14.23 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 40' ' ' PRO . 26.2 m -133.01 174.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 122.314 1.054 . . . . 0.0 111.294 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.499 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.89 148.28 40.12 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.117 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.46 35.11 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.39 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -142.99 -40.23 0.32 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.8 p -122.41 -17.34 7.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.642 -0.661 . . . . 0.0 110.256 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.8 mt-10 75.1 47.89 0.1 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 110.244 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -100.42 109.59 57.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.59 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 6.1 Cg_endo -69.89 137.73 35.77 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.863 1.709 . . . . 0.0 112.15 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.21 57.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.59 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.11 -55.51 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -0.905 . . . . 0.0 109.279 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 29.79 2.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -114.68 -174.31 2.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.483 -1.01 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.56 146.85 25.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.321 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.583 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.8 p-80 -118.32 169.12 10.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.331 -0.855 . . . . 0.0 109.603 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.715 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -133.15 138.05 46.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.56 149.73 27.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 111.394 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.62 11.54 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.588 0.708 . . . . 0.0 110.259 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp 50.89 22.41 1.17 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.74 . . . . 0.0 109.376 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.75 30.77 20.15 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.6 mt -141.99 142.26 32.93 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.59 -0.947 . . . . 0.0 108.77 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.47 153.15 35.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.29 -0.882 . . . . 0.0 110.954 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.536 ' N ' ' O ' ' A' ' 47' ' ' TYR . 48.7 m-85 -154.68 139.45 17.11 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 73.7 m -57.28 175.8 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.063 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.688 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.8 tp10 -61.98 -34.92 77.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.052 -1.03 . . . . 0.0 109.285 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 61' ' ' GLN . 70.2 m -86.25 -45.1 11.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.831 . . . . 0.0 111.251 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.445 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 31.9 m170 -65.37 -42.76 92.38 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.792 -1.192 . . . . 0.0 108.358 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -54.34 -57.56 10.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 96.6 m-20 -62.72 -44.65 95.67 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.282 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.3 tp60 -55.52 -34.43 64.65 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.548 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 6.1 mp -78.77 -34.21 45.81 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.673 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 17.3 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.222 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 2.0 t . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.7 Cg_endo -79.96 164.49 22.56 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.757 2.305 . . . . 0.0 109.526 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.533 HG12 ' HA ' ' A' ' 14' ' ' PRO . 35.1 mt -133.94 119.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.126 0.965 . . . . 0.0 109.327 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.518 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 36.2 t -61.33 116.24 4.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.796 0.807 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.54 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -59.83 -4.52 3.26 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.518 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -84.37 -51.58 6.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.406 -1.055 . . . . 0.0 109.289 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.428 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -107.56 2.98 24.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.269 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' CYS . 19.3 mmm180 50.02 34.83 8.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.653 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -113.85 138.62 22.82 Favored Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.7 Cg_exo -53.64 114.82 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.268 1.312 . . . . 0.0 110.943 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 6' ' ' PRO . 14.0 mt -68.98 158.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' CD ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -159.59 62.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.913 -1.117 . . . . 0.0 110.451 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.54 -96.46 0.1 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -112.38 142.48 44.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.65 156.77 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.744 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -125.17 116.84 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.605 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.2 m120 -88.46 105.85 17.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.077 -1.014 . . . . 0.0 109.497 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.99 41.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.661 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 57.52 16.96 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.72 20.43 78.61 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -125.38 -155.37 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.742 0.782 . . . . 0.0 109.783 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.497 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.3 mt-30 -134.53 143.99 47.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.54 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.4 m95 -142.14 139.47 32.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.616 -1.303 . . . . 0.0 110.26 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.4 ' NE2' ' HA ' ' A' ' 15' ' ' ILE . 19.6 m80 -54.68 138.65 41.14 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -57.41 -16.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 120.795 -1.191 . . . . 0.0 108.987 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -96.52 -25.82 15.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.47 -0.769 . . . . 0.0 110.54 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -93.21 -9.94 37.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.916 -1.115 . . . . 0.0 110.451 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -79.61 105.82 11.19 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 m -133.97 175.26 11.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 122.246 1.022 . . . . 0.0 110.959 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -64.13 148.53 49.71 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.268 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.0 28.12 1.66 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 tptm -138.7 -32.03 0.71 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.333 -0.854 . . . . 0.0 110.223 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.7 p -129.3 -11.27 4.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.343 -0.848 . . . . 0.0 110.205 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 65.01 47.25 2.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.472 -0.768 . . . . 0.0 110.491 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.603 ' NZ ' ' SG ' ' A' ' 55' ' ' CYS . 0.0 OUTLIER -101.99 107.49 52.67 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 3.4 Cg_endo -66.0 139.48 56.48 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.678 1.585 . . . . 0.0 112.304 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.44 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.594 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.14 -55.31 1.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.947 . . . . 0.0 109.067 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.1 30.58 2.92 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.431 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.7 OUTLIER -117.7 176.61 5.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.56 -0.965 . . . . 0.0 109.905 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.627 ' CD ' ' HH ' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -90.57 150.43 21.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.438 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.6 p-80 -119.4 170.66 8.94 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.4 m-85 -138.17 129.42 27.46 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.478 ' OE2' ' CE ' ' A' ' 23' ' ' MET . 1.3 mm-40 -100.07 153.59 19.1 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.232 -0.917 . . . . 0.0 111.702 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.35 127.05 8.79 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.558 0.694 . . . . 0.0 109.877 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt 52.59 23.8 2.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 109.59 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.661 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 31.09 23.5 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.076 -1.535 . . . . 0.0 109.36 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.4 mt -142.66 139.95 31.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.603 -0.94 . . . . 0.0 108.666 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.3 151.92 39.74 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.163 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' TYR . 55.0 m-85 -154.37 139.45 17.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.603 ' SG ' ' NZ ' ' A' ' 39' ' ' LYS . 89.3 m -57.81 178.15 0.09 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.792 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.2 tt0 -62.31 -37.82 87.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.619 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 61' ' ' GLN . 52.4 m -86.92 -43.08 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 111.66 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -65.81 -43.61 88.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.722 -1.236 . . . . 0.0 108.134 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.8 t80 -51.94 -56.5 13.81 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -64.22 -44.9 90.47 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.5 tp-100 -54.38 -34.84 62.01 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.534 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.8 mp -78.12 -33.28 50.61 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.512 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 21.2 m-85 -160.13 -81.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 110.125 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.342 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.83 163.58 35.3 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.909 1.739 . . . . 0.0 108.901 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.1 mt -134.48 119.95 31.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.012 0.911 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 16.1 t -60.27 119.6 8.22 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 110.119 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.84 0.09 11.82 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.545 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.59 -38.36 18.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -1.113 . . . . 0.0 109.392 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.64 5.04 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 54.19 41.48 31.98 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -115.54 142.54 28.99 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.5 Cg_exo -56.27 112.94 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.562 1.508 . . . . 0.0 110.729 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 6' ' ' PRO . 20.7 mt -70.45 158.68 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -159.19 62.12 0.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.691 -1.256 . . . . 0.0 110.854 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.67 -100.97 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -107.82 134.35 50.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.77 158.06 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 110.731 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.9 117.32 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.633 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.9 OUTLIER -90.03 105.97 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.29 159.76 42.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.1 mmt 58.1 18.14 5.02 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.07 75.75 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -130.32 -154.67 0.65 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.717 0.77 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.472 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.6 mt-30 -134.82 145.1 48.02 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.6 m95 -142.05 139.15 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.544 -1.347 . . . . 0.0 110.788 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.439 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 18.3 m80 -55.22 132.79 48.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.0 t -52.39 -22.58 3.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 120.835 -1.165 . . . . 0.0 109.29 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -91.85 -23.74 19.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 110.734 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -96.91 -6.58 35.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.859 -1.151 . . . . 0.0 111.029 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -81.67 103.2 11.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 40' ' ' PRO . 25.1 m -128.96 178.45 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 122.321 1.058 . . . . 0.0 111.254 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.1 t -65.61 148.4 51.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.702 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.8 28.19 1.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.486 -0.759 . . . . 0.0 109.197 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.477 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 6.3 tmtt? -134.1 -39.07 0.86 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.571 -0.706 . . . . 0.0 109.74 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.6 p -126.31 -16.17 5.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.558 -0.714 . . . . 0.0 110.553 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.0 mt-10 73.7 46.94 0.18 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -100.76 110.21 60.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.611 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.1 Cg_endo -68.46 136.97 38.24 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.718 1.612 . . . . 0.0 111.754 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.4 m-85 -95.98 60.1 2.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.611 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.3 mp -40.04 -56.02 1.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.44 -0.788 . . . . 0.0 109.476 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.67 26.16 4.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -114.56 159.98 19.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.396 -1.061 . . . . 0.0 109.822 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -75.72 154.77 36.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.452 -0.78 . . . . 0.0 109.162 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.608 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.6 p-80 -118.08 170.52 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.273 -0.892 . . . . 0.0 110.017 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -135.87 137.36 41.38 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -111.65 145.27 39.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 0.0 111.387 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.556 ' NH1' ' HG3' ' A' ' 49' ' ' ARG . 11.1 ttm-85 -144.92 137.91 26.54 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.53 0.681 . . . . 0.0 110.12 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 44.73 20.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.702 0.763 . . . . 0.0 109.166 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 87.18 30.71 19.07 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ARG . 20.1 mt -138.9 143.03 38.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.678 -0.895 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.96 151.76 33.49 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.828 0.823 . . . . 0.0 111.25 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.492 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 53.4 m-85 -153.54 135.89 14.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 14.5 m -56.57 172.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.101 -1.439 . . . . 0.0 108.141 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 68.3 tt0 -57.28 -32.35 66.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.045 -1.034 . . . . 0.0 109.745 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 61' ' ' GLN . 93.7 m -87.15 -47.88 8.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.826 . . . . 0.0 111.818 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.436 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 29.1 m170 -64.67 -40.88 96.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.756 -1.215 . . . . 0.0 108.605 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -55.13 -57.49 11.55 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 42.8 m-80 -63.03 -44.1 96.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.065 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.6 tt0 -54.72 -35.96 64.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 6.6 mp -76.1 -37.25 58.35 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.7 m-85 -156.11 -83.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.722 0.773 . . . . 0.0 109.804 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -79.9 164.68 22.59 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.733 2.289 . . . . 0.0 109.349 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.534 HG12 ' HA ' ' A' ' 14' ' ' PRO . 25.8 mt -134.97 120.45 30.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-O 121.945 0.878 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 20.8 t -62.16 121.27 12.67 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.877 0.846 . . . . 0.0 110.077 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.39 -1.48 15.24 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.534 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.35 -35.31 21.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -130.49 0.25 4.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.663 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 56.83 38.56 29.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -178.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.616 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -111.01 138.3 21.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.9 Cg_exo -55.1 113.46 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.113 1.209 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' PRO . 19.9 mt -70.62 158.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -161.26 62.41 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.897 -1.127 . . . . 0.0 110.616 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.82 -101.87 0.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -111.48 126.39 54.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.0 t -105.15 158.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 111.204 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.9 t -122.36 115.65 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.551 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.0 OUTLIER -90.49 106.55 18.57 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 109.905 -178.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.97 160.16 41.78 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.62 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.5 mmt 58.31 14.46 2.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.32 18.21 79.2 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.801 -2.12 . . . . 0.0 107.801 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -120.21 -154.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.007 0.908 . . . . 0.0 109.827 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.485 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.8 mt-30 -136.6 143.56 43.64 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.4 m95 -141.66 138.88 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.513 -1.367 . . . . 0.0 110.566 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.413 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 19.6 m80 -55.46 134.73 50.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 t -54.37 -20.43 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 120.809 -1.182 . . . . 0.0 109.08 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -92.03 -27.89 17.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 110.536 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -93.81 -7.35 43.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.031 -1.043 . . . . 0.0 110.885 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -81.25 105.86 12.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.89 174.99 12.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 122.326 1.06 . . . . 0.0 111.195 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.7 t -64.03 148.41 49.8 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.059 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.71 27.81 1.68 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.702 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.2 tptp -138.09 -33.21 0.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.1 p -126.89 -11.23 6.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.261 -0.9 . . . . 0.0 110.209 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 65.08 46.87 2.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -102.56 107.02 52.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 3.5 Cg_endo -66.45 139.75 55.18 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.816 1.677 . . . . 0.0 112.358 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -96.08 56.35 1.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.03 -55.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 30.39 2.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.428 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -116.47 178.99 4.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.96 . . . . 0.0 109.958 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -95.79 147.19 23.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.432 -0.792 . . . . 0.0 109.293 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.531 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 33.6 p-80 -117.73 168.94 9.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.0 m-85 -133.66 133.16 41.56 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -111.01 155.43 22.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.075 -1.016 . . . . 0.0 111.639 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -145.47 135.77 23.99 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.55 0.691 . . . . 0.0 110.064 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.2 ptmt 42.33 21.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.467 0.651 . . . . 0.0 109.757 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.62 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.92 30.62 9.28 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.191 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.0 mt -140.53 136.83 33.28 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.491 -1.005 . . . . 0.0 108.379 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.46 150.18 45.15 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.858 0.837 . . . . 0.0 111.11 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.671 ' N ' ' O ' ' A' ' 47' ' ' TYR . 47.4 m-85 -153.14 139.3 18.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 54.1 m -56.51 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.831 -1.168 . . . . 0.0 108.857 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 75.2 tt0 -68.65 -40.46 80.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.352 -0.843 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 61' ' ' GLN . 24.2 m -86.25 -37.57 18.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 111.292 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.56 -46.77 68.55 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.798 -1.189 . . . . 0.0 108.224 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -52.36 -55.94 18.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 93.2 m-20 -62.49 -46.26 89.26 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.51 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 57' ' ' THR . 12.5 mm100 -54.68 -38.15 66.64 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -72.1 -39.69 68.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.319 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -153.79 -83.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.288 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.4 Cg_endo -74.36 163.65 35.82 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.911 1.74 . . . . 0.0 109.002 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' A' ' 14' ' ' PRO . 28.1 mt -135.14 119.75 27.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.992 0.901 . . . . 0.0 109.206 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 17.2 t -57.85 118.8 5.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.888 0.852 . . . . 0.0 110.073 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.528 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.57 -2.01 5.37 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.538 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.56 -60.9 1.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -1.069 . . . . 0.0 109.336 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.25 -7.3 26.62 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.501 -0.749 . . . . 0.0 109.163 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.473 ' O ' ' CZ ' ' A' ' 13' ' ' ARG . 23.6 mmm180 63.51 37.81 10.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -112.87 144.07 30.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.5 Cg_exo -56.07 113.25 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.466 1.444 . . . . 0.0 110.383 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 8' ' ' CYS . 22.9 mt -70.52 158.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -160.45 61.25 0.33 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.835 -1.165 . . . . 0.0 110.694 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.33 -102.48 0.16 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -112.82 121.37 44.5 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -99.45 159.39 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 111.285 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.56 116.44 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.86 106.17 18.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.02 42.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.944 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.626 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.07 16.8 4.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 25.41 75.8 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.094 -2.003 . . . . 0.0 108.094 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.72 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.812 0.815 . . . . 0.0 109.816 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.445 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.0 mt-30 -135.29 143.7 46.36 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.528 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.5 m95 -141.6 140.93 33.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.479 -1.388 . . . . 0.0 110.644 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.475 ' C ' ' N ' ' A' ' 30' ' ' GLU . 18.0 m80 -57.41 131.91 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 t -52.58 -14.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.87 -1.144 . . . . 0.0 108.402 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 28' ' ' HIS . 11.2 tp10 -95.93 -27.11 15.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.761 -0.587 . . . . 0.0 110.501 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -97.14 -6.63 34.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.93 -1.106 . . . . 0.0 110.771 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -80.76 106.09 12.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 40' ' ' PRO . 24.4 m -132.67 176.38 9.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.314 1.054 . . . . 0.0 111.19 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.6 t -65.36 148.75 51.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.454 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.49 25.53 2.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.288 -0.883 . . . . 0.0 109.78 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.6 tptp -135.43 -32.75 0.91 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.326 -0.859 . . . . 0.0 110.22 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 p -128.66 -12.47 4.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 67.9 47.2 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.228 -0.92 . . . . 0.0 109.966 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -101.17 107.47 50.44 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.598 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 4.3 Cg_endo -66.81 138.46 48.82 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.624 1.549 . . . . 0.0 112.118 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -95.72 56.81 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.12 -55.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.166 -0.959 . . . . 0.0 109.015 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.18 29.61 3.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.432 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -116.98 175.39 5.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.574 -0.957 . . . . 0.0 109.801 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.662 ' HG2' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -89.32 150.61 22.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.572 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.3 p-80 -119.5 169.8 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.695 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.5 m-85 -136.82 132.78 35.12 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.95 150.84 24.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.928 . . . . 0.0 111.892 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.535 ' NH2' ' OH ' ' A' ' 54' ' ' TYR . 10.0 ttp180 -146.19 134.23 21.5 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.101 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' CB ' ' HZ1' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 42.04 21.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.569 0.7 . . . . 0.0 109.615 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.626 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 93.08 30.69 9.1 Favored Glycine 0 C--N 1.295 -1.71 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.043 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.1 mt -141.74 139.76 32.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.456 -1.026 . . . . 0.0 108.822 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -73.8 151.87 40.46 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.865 0.84 . . . . 0.0 110.867 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.552 ' N ' ' O ' ' A' ' 47' ' ' TYR . 48.9 m-85 -154.59 138.94 16.69 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 67.4 m -56.56 178.76 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.904 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 12.2 tm-20 -63.73 -39.24 93.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.818 . . . . 0.0 109.46 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.8 m -86.25 -39.28 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.687 . . . . 0.0 111.341 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.7 m170 -67.93 -47.18 69.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.805 -1.184 . . . . 0.0 107.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.1 t80 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -64.18 -44.39 92.2 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.623 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -57.01 -36.41 70.4 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 1.7 mp -73.28 -37.39 66.28 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.5 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.9 m-85 -153.74 -81.71 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.795 0.807 . . . . 0.0 109.913 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.332 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.3 Cg_endo -75.67 163.23 34.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.983 1.789 . . . . 0.0 109.232 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.4 mt -133.78 119.6 33.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 122.103 0.954 . . . . 0.0 109.157 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.523 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 30.3 t -58.02 115.63 3.01 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.776 0.798 . . . . 0.0 109.901 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.539 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.66 -3.23 4.11 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.523 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.55 -59.94 2.17 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.471 -1.017 . . . . 0.0 109.357 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.43 -1.07 39.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.545 -0.722 . . . . 0.0 109.179 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER 56.03 39.72 30.43 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -118.37 149.48 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.0 Cg_exo -58.73 113.01 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.442 1.428 . . . . 0.0 110.793 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 6' ' ' PRO . 20.5 mt -68.52 159.92 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.428 ' O ' ' CD ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -158.38 62.4 0.44 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.613 -1.305 . . . . 0.0 111.399 -178.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.02 -95.37 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -108.27 138.56 44.34 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.9 160.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.791 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.41 117.41 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.34 105.77 18.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 109.482 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.31 16.65 4.16 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.91 26.09 74.59 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -130.83 -153.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.848 0.832 . . . . 0.0 109.954 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.478 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.1 mt-30 -137.44 142.8 41.6 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 56.9 m95 -141.38 139.3 33.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.64 -1.288 . . . . 0.0 110.6 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.476 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.7 m80 -56.0 131.44 47.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 t -53.38 -13.85 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 120.581 -1.325 . . . . 0.0 108.361 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 28' ' ' HIS . 51.1 tp10 -94.57 -27.36 15.97 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.778 -0.576 . . . . 0.0 110.433 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -98.14 -6.28 31.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.909 -1.12 . . . . 0.0 110.787 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -80.13 107.1 12.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 40' ' ' PRO . 25.6 m -133.25 175.9 10.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.229 1.014 . . . . 0.0 111.27 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.47 148.44 48.6 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.407 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.37 25.98 2.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -0.908 . . . . 0.0 109.804 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.44 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.5 tptp -136.02 -31.53 0.91 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.291 -0.88 . . . . 0.0 110.019 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.2 p -130.03 -15.16 3.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.98 47.43 0.31 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.298 -0.876 . . . . 0.0 110.461 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -102.22 109.49 60.35 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.607 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 4.9 Cg_endo -68.76 138.41 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.848 1.698 . . . . 0.0 112.018 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.5 57.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.607 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.34 -55.49 1.72 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' C ' ' HD1' ' A' ' 44' ' ' HIS . . . -135.4 31.48 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.531 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -115.64 -163.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -1.051 . . . . 0.0 110.05 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -110.6 146.23 36.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.5 p-80 -118.06 168.33 10.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.719 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.0 m-85 -131.7 136.64 47.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -107.02 149.8 27.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -147.15 133.63 19.73 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.561 0.696 . . . . 0.0 110.01 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 15.9 ptmt 41.8 22.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.594 0.712 . . . . 0.0 109.68 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.06 31.3 9.27 Favored Glycine 0 C--N 1.296 -1.68 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.203 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.8 mt -142.78 140.64 31.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.504 -0.998 . . . . 0.0 108.79 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -75.37 152.19 38.11 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 110.879 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.504 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 52.8 m-85 -154.33 139.53 17.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.7 m -56.05 179.15 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.42 -1.312 . . . . 0.0 108.546 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 9.2 tm-20 -64.78 -38.44 91.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 61' ' ' GLN . 28.8 m -86.14 -39.1 17.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.624 -0.673 . . . . 0.0 111.19 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.478 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.9 m170 -68.92 -43.89 74.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.702 -1.249 . . . . 0.0 108.037 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.467 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -54.98 -57.03 13.33 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.424 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 39.6 m-80 -62.16 -43.68 98.3 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.377 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' THR . 18.4 mm-40 -55.92 -37.26 68.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.553 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 3.7 mp -74.52 -37.99 62.92 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.996 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.0 m-85 -156.85 -83.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.411 -0.806 . . . . 0.0 110.171 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 15' ' ' ILE . 3.4 Cg_endo -70.94 163.36 39.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.616 1.544 . . . . 0.0 108.344 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 14' ' ' PRO . 33.6 mt -134.24 120.67 35.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-O 122.201 1.001 . . . . 0.0 109.244 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 12.6 t -57.39 116.03 3.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.759 0.79 . . . . 0.0 110.066 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.11 -0.67 3.32 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.553 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -87.53 -59.26 2.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -1.086 . . . . 0.0 109.399 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -102.96 -0.86 30.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.519 -0.738 . . . . 0.0 109.267 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.605 HH11 ' HG3' ' A' ' 12' ' ' ARG . 7.2 mmm-85 58.62 43.08 19.55 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -118.62 143.62 33.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.53 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.0 Cg_exo -53.9 111.72 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.663 1.575 . . . . 0.0 110.621 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' PRO . 34.6 mt -71.17 158.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.217 -0.927 . . . . 0.0 108.516 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.38 61.45 0.27 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.727 -1.233 . . . . 0.0 110.728 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.24 -102.19 0.15 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.8 mtt-85 -112.14 120.4 41.68 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.29 158.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 111.282 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.51 115.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -89.85 106.16 18.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.694 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.53 41.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.643 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.3 mmt 58.02 15.98 3.5 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 20.86 77.94 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -124.24 -154.69 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.773 0.797 . . . . 0.0 109.885 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.465 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.5 mt-30 -135.32 143.25 46.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.525 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.0 m95 -141.09 138.55 33.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.572 -1.33 . . . . 0.0 110.588 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.497 ' C ' ' N ' ' A' ' 30' ' ' GLU . 15.6 m80 -55.42 130.74 43.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 t -52.52 -14.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 120.932 -1.105 . . . . 0.0 108.068 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.497 ' N ' ' C ' ' A' ' 28' ' ' HIS . 4.1 tt0 -95.36 -27.83 15.26 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.921 -0.487 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -98.64 -6.02 30.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.827 -1.171 . . . . 0.0 110.821 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -79.87 106.14 11.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 40' ' ' PRO . 27.7 m -134.32 174.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 122.272 1.034 . . . . 0.0 111.122 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.06 148.22 36.48 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.263 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.25 34.49 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.291 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -142.79 -40.05 0.33 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.5 -0.75 . . . . 0.0 109.744 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.1 p -123.2 -17.4 6.64 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.433 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.0 mt-10 76.32 47.59 0.08 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.4 -0.812 . . . . 0.0 110.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -100.32 110.75 60.94 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 6.2 Cg_endo -70.62 137.98 34.1 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.874 1.716 . . . . 0.0 112.192 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.488 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.11 58.13 1.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.594 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.47 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.01 30.56 2.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -115.4 -179.08 3.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.437 -1.037 . . . . 0.0 110.004 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.644 ' CG ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -96.2 143.07 27.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.502 -0.749 . . . . 0.0 109.158 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.569 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.0 p-80 -114.28 171.51 7.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.306 -0.871 . . . . 0.0 109.659 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.704 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.5 m-85 -134.0 137.75 44.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -108.5 146.94 32.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 111.585 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.905 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -151.57 117.38 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.79 -0.569 . . . . 0.0 109.645 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 22.4 mmtp 61.89 30.37 18.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 109.995 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.643 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 76.97 31.09 54.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.1 mt -141.84 137.29 31.35 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.682 -0.893 . . . . 0.0 108.734 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.79 153.88 34.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.769 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 47' ' ' TYR . 47.2 m-85 -153.8 137.86 16.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 76.3 m -56.05 173.27 0.16 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.321 -1.352 . . . . 0.0 108.254 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.4 tm-20 -59.75 -34.78 73.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 109.255 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 61' ' ' GLN . 66.5 m -87.01 -44.43 11.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.68 . . . . 0.0 111.397 -178.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.45 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 30.6 m170 -65.64 -42.12 91.8 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.792 -1.193 . . . . 0.0 108.493 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.464 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.2 t80 -54.3 -57.19 12.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 36.7 m-80 -64.61 -43.94 92.17 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.289 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' THR . 37.1 tt0 -54.31 -34.38 60.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.604 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 6.5 mp -79.24 -38.28 35.98 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.604 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.2 m-85 -160.33 -80.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.573 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.453 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.364 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -75.48 163.37 34.41 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.043 1.829 . . . . 0.0 109.274 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.5 mt -135.11 119.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 122.034 0.921 . . . . 0.0 109.149 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 32.7 t -58.51 115.0 2.73 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.84 0.829 . . . . 0.0 109.779 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.536 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.46 -3.54 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.517 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -84.99 -59.18 2.41 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.329 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.39 -1.6 35.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.569 -0.707 . . . . 0.0 109.183 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 8' ' ' CYS . 17.4 mmt180 57.8 38.84 27.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.214 -0.929 . . . . 0.0 108.693 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.04 149.34 45.35 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.552 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.3 Cg_exo -59.05 113.05 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.387 1.391 . . . . 0.0 110.783 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 8' ' ' CYS . 19.3 mt -69.87 160.31 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -170.3 70.39 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.698 -1.251 . . . . 0.0 110.549 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.82 -55.06 0.3 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.608 ' HG3' HH11 ' A' ' 18' ' ' ARG . 1.1 mtm-85 -139.56 129.67 25.13 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -126.47 152.98 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.6 t -127.23 116.39 43.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.506 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.1 m-80 -86.94 105.65 17.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.064 -1.023 . . . . 0.0 109.372 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.81 159.98 42.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.472 -0.767 . . . . 0.0 109.012 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 57.65 18.4 4.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.83 22.69 77.02 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -129.37 -156.19 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.965 -0.726 . . . . 0.0 109.767 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.462 HE21 ' H ' ' A' ' 7' ' ' ILE . 1.7 mt-30 -134.29 143.43 47.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.536 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 48.6 m95 -141.96 140.05 32.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.531 -1.355 . . . . 0.0 110.289 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -55.82 140.48 42.15 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 t -58.94 -19.46 15.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.718 -1.239 . . . . 0.0 109.288 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -96.27 -12.69 24.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -105.62 -8.76 17.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.951 -1.093 . . . . 0.0 109.955 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -81.22 103.59 11.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 40' ' ' PRO . 21.3 m -126.16 177.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 122.42 1.105 . . . . 0.0 111.597 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -68.06 149.16 50.01 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.722 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.06 26.01 2.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.7 tptm -134.12 -29.79 1.24 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.364 -0.835 . . . . 0.0 109.841 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.6 p -133.18 -15.59 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.302 -0.874 . . . . 0.0 110.392 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.51 46.56 0.4 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.266 -0.896 . . . . 0.0 110.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -101.32 112.51 65.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.481 ' N ' HG11 ' A' ' 33' ' ' VAL . 10.5 Cg_endo -71.54 134.44 24.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.483 1.455 . . . . 0.0 110.897 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.1 m-85 -93.01 59.46 3.13 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.537 ' H ' HD12 ' A' ' 42' ' ' LEU . 4.6 mp -41.02 -55.95 2.42 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.409 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.33 24.02 5.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -114.69 168.73 9.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.48 -1.012 . . . . 0.0 109.95 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -84.07 156.68 22.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.553 -0.717 . . . . 0.0 109.16 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.7 p-80 -120.81 170.25 9.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 0.0 110.054 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.708 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.0 m-85 -135.47 135.23 40.33 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -110.52 141.08 44.16 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.196 -0.94 . . . . 0.0 111.188 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.728 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -145.15 136.45 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.563 0.697 . . . . 0.0 110.369 178.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt 50.12 22.45 0.93 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.52 -0.737 . . . . 0.0 109.096 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.75 30.63 31.84 Favored Glycine 0 C--N 1.295 -1.712 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 49' ' ' ARG . 22.2 mt -140.09 143.02 36.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.775 -0.838 . . . . 0.0 108.896 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.44 151.48 34.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.487 -0.758 . . . . 0.0 110.928 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.499 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 59.5 m-85 -153.27 136.63 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 64.4 m -57.4 173.92 0.23 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.277 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 26.8 tt0 -59.5 -34.51 72.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 61' ' ' GLN . 59.1 m -86.91 -44.09 11.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -0.772 . . . . 0.0 111.683 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.446 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.0 m170 -67.57 -43.03 81.6 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.708 -1.245 . . . . 0.0 108.453 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -51.86 -55.6 19.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.404 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 44.5 m-80 -65.57 -45.34 83.67 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.977 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 57' ' ' THR . 28.1 tt0 -52.87 -39.01 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.582 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -71.64 -40.33 69.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.728 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 14.6 m-85 -154.3 -85.11 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.603 0.716 . . . . 0.0 109.973 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.8 Cg_endo -74.49 163.41 36.17 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 109.024 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.543 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.8 mt -135.71 119.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.033 0.92 . . . . 0.0 109.26 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.541 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 15.3 t -57.14 117.34 3.93 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.776 0.798 . . . . 0.0 109.86 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.527 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.76 -2.2 5.9 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.541 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.21 -60.56 2.0 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -1.063 . . . . 0.0 109.364 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.28 -2.48 33.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.781 . . . . 0.0 109.151 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.609 HH11 ' HG3' ' A' ' 12' ' ' ARG . 6.6 mmm-85 59.75 40.51 19.58 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.278 -0.889 . . . . 0.0 108.768 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.66 150.14 46.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.543 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.8 Cg_exo -59.29 113.91 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.53 1.486 . . . . 0.0 110.568 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 8' ' ' CYS . 21.1 mt -70.34 158.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' CD ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -159.21 59.38 0.41 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.833 -1.167 . . . . 0.0 110.986 -178.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.06 -102.45 0.16 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' A' ' 18' ' ' ARG . 3.0 mtt-85 -111.19 121.3 44.93 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.6 t -98.72 157.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 111.038 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.1 t -120.62 115.15 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.534 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.631 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.71 160.19 41.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.671 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.1 mmt 57.52 16.39 3.29 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.8 22.44 78.2 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -125.75 -154.67 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.737 0.78 . . . . 0.0 109.753 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.428 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.7 mt-30 -136.29 142.8 43.96 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.527 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.0 m95 -141.77 140.63 33.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.569 -1.332 . . . . 0.0 110.448 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -56.44 139.44 49.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.9 t -57.64 -20.38 13.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 120.868 -1.145 . . . . 0.0 109.315 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.88 -16.69 21.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.483 -0.761 . . . . 0.0 110.627 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.4 m170 -101.43 -9.1 21.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.845 -1.159 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -80.15 104.98 11.08 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 40' ' ' PRO . 22.2 m -130.69 177.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 122.405 1.098 . . . . 0.0 111.499 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.3 t -66.96 148.56 51.8 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.661 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.5 30.48 1.3 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.243 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -139.65 -31.01 0.69 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.0 110.122 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 32.0 p -131.05 -18.59 2.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.364 -0.835 . . . . 0.0 110.192 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.2 mt-10 74.38 45.89 0.18 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 110.299 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -101.39 112.06 64.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.478 ' N ' HG13 ' A' ' 33' ' ' VAL . 10.1 Cg_endo -71.7 135.94 27.0 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.561 1.507 . . . . 0.0 111.401 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.46 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -93.28 55.69 2.33 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 41' ' ' PHE . 3.1 mp -40.64 -55.79 2.28 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.758 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.16 23.86 5.14 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -115.69 -164.52 0.96 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.285 -1.127 . . . . 0.0 109.843 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -107.7 154.11 21.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.579 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.1 p-80 -119.65 171.72 8.18 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.702 0.763 . . . . 0.0 109.265 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.0 m-85 -138.55 132.71 31.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.26 147.42 27.07 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.302 -0.874 . . . . 0.0 112.104 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.818 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -154.58 121.02 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 1.0 OUTLIER 62.5 29.15 17.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.505 -0.747 . . . . 0.0 109.902 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.671 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 74.4 31.34 59.18 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.1 mt -141.42 141.43 33.73 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.51 153.46 33.42 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 47' ' ' TYR . 54.9 m-85 -153.56 140.31 19.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 85.5 m -60.2 175.91 0.38 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.742 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 61.4 tt0 -60.96 -37.57 82.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.419 -0.801 . . . . 0.0 109.423 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.9 -43.02 12.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.581 -0.699 . . . . 0.0 111.663 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.477 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.0 m170 -67.0 -44.83 79.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.716 -1.24 . . . . 0.0 108.284 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.7 t80 -49.11 -54.92 13.98 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -67.9 -46.08 72.63 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.207 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.1 tp-100 -53.46 -33.64 54.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.27 -38.75 41.93 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.0 m-85 -160.37 -79.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.393 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.356 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -76.31 163.61 32.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.194 1.93 . . . . 0.0 109.29 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.556 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.2 mt -134.73 119.0 27.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 122.027 0.918 . . . . 0.0 109.24 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 38.2 t -60.44 118.33 6.35 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.8 0.809 . . . . 0.0 110.141 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.531 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.94 -3.61 8.85 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -83.72 -46.59 12.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.488 -1.007 . . . . 0.0 109.449 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.44 -1.51 13.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 8' ' ' CYS . 26.8 mmt180 57.07 35.55 26.5 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 143.21 29.02 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.9 Cg_exo -55.88 113.8 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.306 1.338 . . . . 0.0 110.625 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' PRO . 12.9 mt -69.1 159.73 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -167.73 69.06 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.755 -1.215 . . . . 0.0 110.373 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.87 -64.22 0.17 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.51 HH21 ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -138.9 136.62 35.7 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.55 158.74 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.938 . . . . 0.0 110.787 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.6 t -131.51 117.16 34.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.616 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.2 m120 -87.26 105.76 17.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.127 -0.983 . . . . 0.0 109.588 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.32 160.13 41.98 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.638 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 9.2 mmt 57.84 17.77 4.47 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.19 18.5 76.67 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -124.25 -156.06 0.7 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.716 0.77 . . . . 0.0 109.699 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.477 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.3 mt-30 -134.15 144.49 48.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.531 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 53.7 m95 -142.28 139.39 31.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.499 -1.375 . . . . 0.0 110.526 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -55.13 138.97 43.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.7 t -58.63 -18.23 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 109.097 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.51 ' CD ' HH21 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -94.15 -21.37 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 110.189 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -99.51 -6.2 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 110.59 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -82.97 102.46 11.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.429 HG11 ' N ' ' A' ' 40' ' ' PRO . 22.4 m -127.2 176.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 122.241 1.019 . . . . 0.0 111.266 -177.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -63.43 148.75 47.68 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.584 178.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.11 27.58 1.83 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.38 -0.825 . . . . 0.0 109.352 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 3.3 tttm -134.21 -42.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 109.96 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.9 p -121.49 -15.99 7.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.674 -0.641 . . . . 0.0 110.476 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.1 mt-10 72.68 47.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 110.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -100.72 109.85 58.91 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.609 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 4.2 Cg_endo -67.76 138.36 44.73 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.756 1.637 . . . . 0.0 111.874 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.524 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.4 m-85 -95.46 59.97 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.609 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.81 -55.55 1.94 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.63 29.56 3.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -117.08 165.61 13.18 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 109.814 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -79.64 153.98 28.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.406 -0.809 . . . . 0.0 109.281 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.8 p-80 -118.92 169.47 9.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.277 -0.89 . . . . 0.0 109.83 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.7 m-85 -134.68 137.92 43.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -110.64 149.82 29.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -0.928 . . . . 0.0 111.464 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.632 ' NE ' ' CD2' ' A' ' 63' ' ' PHE . 13.4 tpt180 -147.09 131.39 17.51 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.413 0.625 . . . . 0.0 110.192 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 42.39 24.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.696 0.76 . . . . 0.0 109.584 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.638 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.35 31.21 12.0 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.845 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ARG . 19.2 mt -140.34 139.77 35.47 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.565 -0.962 . . . . 0.0 108.961 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.83 152.6 33.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.83 0.824 . . . . 0.0 110.94 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 56.2 m-85 -154.8 139.03 16.59 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 13.0 m -59.38 174.02 0.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.638 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.5 tp10 -59.5 -31.58 69.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.878 -1.139 . . . . 0.0 109.537 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 61' ' ' GLN . 88.6 m -86.26 -49.77 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 111.632 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.3 m170 -64.94 -41.14 95.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.877 -1.139 . . . . 0.0 108.407 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -53.3 -57.64 9.87 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.79 -44.94 91.85 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.119 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.5 tp60 -54.88 -34.94 63.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.548 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 5.3 mp -77.35 -33.06 55.45 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.438 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.632 ' CD2' ' NE ' ' A' ' 49' ' ' ARG . 19.2 m-85 -160.14 -83.36 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.362 -0.836 . . . . 0.0 110.196 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.281 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.0 Cg_endo -74.78 163.77 34.98 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.143 1.896 . . . . 0.0 109.044 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.54 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.0 mt -135.72 120.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 122.056 0.931 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 17.9 t -57.14 114.43 2.14 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.839 0.828 . . . . 0.0 109.899 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.535 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.84 -2.43 2.55 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.537 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -86.2 -59.79 2.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -1.08 . . . . 0.0 109.413 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.87 4.36 37.61 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.577 -0.702 . . . . 0.0 109.293 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.656 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.33 41.49 32.12 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.495 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -116.19 144.01 32.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.1 Cg_exo -56.81 113.17 1.34 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.332 1.355 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.449 HG13 ' H ' ' A' ' 8' ' ' CYS . 22.1 mt -69.19 158.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.614 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -166.3 67.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 110.299 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.6 -73.31 0.07 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -138.48 133.59 32.9 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.02 151.62 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.896 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.1 t -119.45 115.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.9 OUTLIER -88.57 106.16 18.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.047 -1.033 . . . . 0.0 109.583 -178.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.02 160.04 42.85 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.644 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.5 mmt 58.34 16.26 3.95 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.93 25.75 75.2 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.791 -2.123 . . . . 0.0 107.791 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -130.56 -154.56 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.931 0.872 . . . . 0.0 109.88 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.472 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.5 mt-30 -136.65 142.0 43.2 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.535 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.2 m95 -141.3 139.99 33.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.484 -1.385 . . . . 0.0 110.399 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -55.73 137.25 50.0 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.71 -17.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 120.848 -1.158 . . . . 0.0 109.044 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.31 -25.16 15.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.509 -0.744 . . . . 0.0 110.689 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -94.26 -8.52 38.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.804 -1.185 . . . . 0.0 110.364 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -80.34 106.7 12.55 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 40' ' ' PRO . 27.0 m -133.46 175.26 11.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.35 1.072 . . . . 0.0 111.184 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.03 148.58 47.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.385 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.3 28.84 1.56 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 109.608 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.9 tptt -139.8 -31.29 0.67 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.345 -0.847 . . . . 0.0 110.179 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 32.0 p -130.82 -8.92 3.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.121 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 33.2 mm-40 63.89 48.38 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 110.376 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -101.74 109.31 59.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.2 Cg_endo -68.6 138.65 42.32 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.81 1.673 . . . . 0.0 112.28 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.475 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.603 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.52 -55.59 1.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.307 -0.871 . . . . 0.0 109.494 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.11 30.27 2.84 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.496 ' N ' ' CD2' ' A' ' 44' ' ' HIS . 2.5 m-70 -114.36 -158.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.394 -1.062 . . . . 0.0 109.97 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -114.88 145.99 41.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.548 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.4 p-80 -117.43 167.42 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 0.0 109.666 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.715 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.4 m-85 -131.22 137.43 48.92 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -105.89 148.88 27.1 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.226 -0.921 . . . . 0.0 111.51 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.406 ' HB3' ' CD2' ' A' ' 54' ' ' TYR . 1.3 tmt_? -153.46 126.89 8.63 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.507 0.67 . . . . 0.0 109.991 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp 53.71 26.01 5.54 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.378 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.644 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 81.1 31.37 35.01 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.3 mt -141.92 141.64 32.99 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.734 -0.862 . . . . 0.0 108.723 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.35 152.94 34.23 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' TYR . 56.4 m-85 -153.71 140.05 18.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 99.0 m -56.85 178.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.36 -1.336 . . . . 0.0 108.473 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 62.5 tt0 -64.45 -36.47 84.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.2 m -86.59 -42.32 13.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 111.382 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.44 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.47 -43.42 81.07 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.794 -1.191 . . . . 0.0 108.207 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.469 ' O ' ' N ' ' A' ' 63' ' ' PHE . 5.4 t80 -52.85 -56.02 18.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 22.6 m-80 -63.76 -45.16 91.05 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.893 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 57' ' ' THR . 32.9 tt0 -53.38 -34.63 58.4 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 2.9 mp -79.29 -36.03 40.35 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.197 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -158.6 -84.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.128 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.478 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.33 163.57 36.05 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.055 1.836 . . . . 0.0 108.858 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.54 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.5 mt -135.13 120.25 29.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 122.028 0.918 . . . . 0.0 109.33 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 15.3 t -57.81 116.64 3.58 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.768 0.794 . . . . 0.0 110.036 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.529 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.22 -1.69 4.47 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.88 -56.33 3.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -1.071 . . . . 0.0 109.474 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -107.45 4.27 26.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.254 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 53.78 42.08 31.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.667 HH11 ' CG ' ' A' ' 13' ' ' ARG . 2.3 mtt-85 -116.4 144.09 32.42 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.7 Cg_exo -56.56 113.15 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.45 1.433 . . . . 0.0 110.472 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.444 HG13 ' H ' ' A' ' 8' ' ' CYS . 23.8 mt -70.74 158.43 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -160.73 61.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 110.679 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.38 -101.8 0.15 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.11 40.43 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.0 t -98.16 157.94 3.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 111.149 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 t -122.2 115.86 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.61 106.27 18.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 109.569 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.57 43.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.65 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.74 17.02 4.82 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.31 28.44 71.36 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -133.89 -154.41 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.919 0.866 . . . . 0.0 109.945 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.445 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.9 mt-30 -135.98 142.78 44.56 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.529 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.6 m95 -141.38 139.26 33.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.508 -1.37 . . . . 0.0 110.612 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -55.63 137.95 48.13 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.5 t -57.24 -19.51 10.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.44 -18.53 20.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.41 -0.806 . . . . 0.0 110.63 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -100.67 -7.01 24.32 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.886 -1.133 . . . . 0.0 110.231 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -83.03 102.46 11.79 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 40' ' ' PRO . 23.5 m -126.27 176.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.414 1.102 . . . . 0.0 111.266 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -66.47 149.41 50.47 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.656 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.34 24.96 3.15 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.6 tptp -132.63 -30.68 1.42 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.389 -0.819 . . . . 0.0 109.725 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.2 p -133.5 -10.18 2.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.375 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 65.55 48.24 2.05 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.321 -0.862 . . . . 0.0 110.399 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -101.11 110.4 61.14 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 3.6 Cg_endo -67.16 138.51 47.47 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.723 1.616 . . . . 0.0 111.81 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.9 m-85 -95.35 60.06 2.24 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.608 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.86 -55.38 1.99 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.484 -0.76 . . . . 0.0 109.257 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.98 30.8 2.79 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.446 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -117.31 167.08 11.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.484 -1.01 . . . . 0.0 109.912 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -82.37 151.86 26.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.0 109.151 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.586 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 15.3 p-80 -117.88 169.77 9.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 109.838 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.0 m-85 -133.85 136.67 44.55 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -111.03 140.24 45.73 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.321 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.707 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -146.68 137.66 24.1 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.485 0.659 . . . . 0.0 110.17 178.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt 51.9 22.19 1.69 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.002 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.65 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 80.25 31.04 39.36 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' ARG . 25.6 mt -140.27 143.68 36.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.71 151.67 34.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.73 0.776 . . . . 0.0 110.858 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 58.8 m-85 -153.12 137.13 16.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.6 m -57.22 174.67 0.18 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.369 -1.332 . . . . 0.0 108.276 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 64.9 tt0 -60.66 -34.85 74.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.202 -0.936 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.8 -43.64 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.63 -0.669 . . . . 0.0 111.638 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.454 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.2 m170 -67.43 -44.38 78.89 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.729 -1.232 . . . . 0.0 108.377 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -50.39 -54.98 17.73 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -66.69 -45.72 77.91 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.061 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 57' ' ' THR . 3.9 tp-100 -53.49 -38.23 63.48 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.587 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.4 mp -71.07 -39.57 72.14 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.707 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.8 m-85 -154.74 -84.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.625 0.726 . . . . 0.0 109.967 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.519 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' A' ' 14' ' ' PRO . 2.1 t . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -78.39 164.42 26.43 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.664 2.243 . . . . 0.0 109.31 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.545 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.9 mt -135.52 123.17 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.866 0.841 . . . . 0.0 109.622 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 13.8 t -63.32 118.15 7.63 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.824 0.821 . . . . 0.0 109.884 -178.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.507 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.27 0.12 6.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.54 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -86.77 -36.23 18.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -1.096 . . . . 0.0 109.563 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.04 4.38 4.87 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.668 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.79 41.01 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -114.79 141.75 27.28 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.3 Cg_exo -56.76 114.39 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.41 1.407 . . . . 0.0 110.86 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 6' ' ' PRO . 21.7 mt -71.96 159.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -160.73 61.92 0.31 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.746 -1.221 . . . . 0.0 110.964 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.66 -103.31 0.17 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -110.0 121.1 44.46 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.7 t -98.52 158.0 3.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.344 -0.847 . . . . 0.0 110.98 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.6 t -120.81 112.94 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -88.98 106.61 18.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.181 -0.95 . . . . 0.0 109.801 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -143.51 158.96 43.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.641 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.6 mmt 58.74 14.52 3.22 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 72.74 21.52 79.62 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -125.08 -154.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.835 0.826 . . . . 0.0 109.749 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -135.0 145.11 47.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.507 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 66.0 m95 -142.6 135.66 28.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.672 -1.267 . . . . 0.0 110.181 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.438 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 19.0 m80 -53.55 135.61 39.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.4 t -55.0 -21.24 7.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 120.918 -1.114 . . . . 0.0 109.548 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 6.5 pm0 -95.02 -20.02 19.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 110.679 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -97.34 -9.78 26.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.813 -1.179 . . . . 0.0 110.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -78.42 105.58 9.77 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 40' ' ' PRO . 24.5 m -134.04 176.54 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.219 1.009 . . . . 0.0 111.032 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -62.63 148.01 47.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.22 32.03 1.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -140.25 -41.55 0.42 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.467 -0.77 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.5 p -119.3 -18.95 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.574 -0.704 . . . . 0.0 110.309 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.6 mt-10 75.51 48.04 0.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -100.84 106.97 47.13 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.59 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.3 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.801 1.667 . . . . 0.0 112.355 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.482 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.14 56.98 1.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.59 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.29 -55.57 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.437 ' C ' ' HD1' ' A' ' 44' ' ' HIS . . . -135.04 31.27 2.72 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -115.23 -163.27 0.87 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -1.0 . . . . 0.0 109.984 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -111.09 145.52 38.42 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.559 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 35.1 p-80 -117.69 170.03 9.11 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.019 0.914 . . . . 0.0 109.88 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.5 m-85 -134.29 135.28 42.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -112.15 150.56 30.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.076 -1.015 . . . . 0.0 111.303 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.66 132.69 19.23 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.691 0.758 . . . . 0.0 110.378 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.0 mttm 50.34 20.65 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.558 -0.714 . . . . 0.0 109.422 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.641 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.31 30.96 12.43 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.332 -1.414 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -141.73 137.95 32.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -72.59 151.72 42.2 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.05 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.664 ' N ' ' O ' ' A' ' 47' ' ' TYR . 45.4 m-85 -153.46 139.47 18.24 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.9 m -56.8 -179.82 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.516 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.5 tt0 -65.32 -36.94 85.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.9 m -86.99 -42.52 13.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 0.0 111.475 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.446 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -66.23 -43.74 85.78 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.209 . . . . 0.0 108.325 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.46 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.0 t80 -52.78 -56.73 13.54 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -63.8 -44.51 93.11 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.196 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 57' ' ' THR . 11.8 tt0 -55.1 -34.28 63.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.538 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 4.9 mp -78.76 -35.01 45.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.383 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 19.2 m-85 -158.52 -81.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.107 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.443 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 2.0 t . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.1 Cg_endo -80.19 164.66 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.796 2.33 . . . . 0.0 109.248 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.526 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.6 mt -135.8 123.03 34.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.831 0.825 . . . . 0.0 109.553 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 14.5 t -63.09 118.01 7.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.766 0.793 . . . . 0.0 109.929 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.501 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.12 0.2 6.52 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -87.1 -35.81 18.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -1.095 . . . . 0.0 109.618 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.51 4.4 4.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.666 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.87 41.33 32.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.643 HH11 ' CG ' ' A' ' 13' ' ' ARG . 2.0 mtt-85 -115.32 140.86 26.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.526 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.8 Cg_exo -55.27 114.01 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.444 1.43 . . . . 0.0 110.84 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 6' ' ' PRO . 22.4 mt -71.64 158.39 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -159.38 59.73 0.39 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.798 -1.189 . . . . 0.0 110.945 -178.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.57 -102.27 0.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -110.48 122.37 47.57 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 t -98.56 156.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 111.119 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 t -119.37 111.91 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.475 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.1 m-80 -87.02 106.51 17.89 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.42 43.3 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.61 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 58.26 16.39 3.96 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.98 28.69 70.1 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -135.86 -154.45 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.807 0.813 . . . . 0.0 109.846 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -133.77 145.47 49.83 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.501 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.3 m95 -143.0 135.94 27.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.648 -1.283 . . . . 0.0 110.18 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.433 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 19.5 m80 -53.69 135.76 40.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.9 t -54.6 -20.8 5.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.911 -1.118 . . . . 0.0 109.275 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.21 -22.76 18.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 110.674 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -96.5 -7.44 34.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.826 -1.171 . . . . 0.0 110.28 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -82.45 103.65 12.16 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 m -127.27 178.66 4.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.336 1.065 . . . . 0.0 111.057 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -69.31 148.75 49.29 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.883 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -89.9 25.55 2.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.7 tptt -135.83 -32.15 0.9 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.399 -0.813 . . . . 0.0 110.054 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.3 p -129.45 -7.6 4.69 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 110.164 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 59.1 42.61 18.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.222 -0.923 . . . . 0.0 109.483 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -99.07 108.47 49.71 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 2.6 Cg_endo -65.11 140.37 65.06 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.748 1.632 . . . . 0.0 112.343 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.7 m-85 -96.15 61.27 2.07 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.603 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 9.8 mp -40.32 -55.86 2.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 109.82 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.82 26.18 4.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -116.61 159.81 21.61 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.417 -1.049 . . . . 0.0 109.685 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.629 ' NE ' ' HH ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -77.08 159.21 30.0 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.49 ' HB3' ' CD2' ' A' ' 41' ' ' PHE . 8.9 p-80 -116.95 172.7 7.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.6 m-85 -136.02 128.71 30.83 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.46 150.72 23.6 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.95 0.881 . . . . 0.0 111.772 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.67 ' NH2' ' NZ ' ' A' ' 50' ' ' LYS . 0.8 OUTLIER -143.82 134.16 24.58 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.394 0.616 . . . . 0.0 109.548 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.67 ' NZ ' ' NH2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER 37.45 25.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.643 0.735 . . . . 0.0 109.973 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.61 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.42 30.95 9.29 Favored Glycine 0 N--CA 1.481 1.675 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.583 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.8 mt -142.17 140.26 32.33 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.335 -1.097 . . . . 0.0 108.728 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.86 150.75 39.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.899 0.856 . . . . 0.0 110.967 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 53.1 m-85 -154.04 137.22 15.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 93.2 m -56.16 178.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.393 -1.323 . . . . 0.0 108.696 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 39.7 tt0 -61.71 -39.33 91.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.371 -0.83 . . . . 0.0 109.782 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' GLN . 46.3 m -86.23 -40.9 15.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 111.804 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.45 -44.81 77.77 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.676 -1.265 . . . . 0.0 108.235 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.9 t80 -51.82 -55.85 17.46 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -64.03 -46.09 85.98 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 57' ' ' THR . 16.8 tt0 -53.23 -35.0 59.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.552 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 mp -77.51 -40.57 42.34 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.342 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.8 m-85 -152.78 -84.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.313 -0.867 . . . . 0.0 110.301 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.39 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.093 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 15' ' ' ILE . 3.9 Cg_endo -72.2 163.63 38.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.759 1.639 . . . . 0.0 108.404 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.54 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.0 mt -134.29 120.4 33.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 122.172 0.987 . . . . 0.0 109.361 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 14.2 t -58.5 117.03 4.06 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.815 0.817 . . . . 0.0 110.048 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.533 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.84 -1.39 4.99 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -86.01 -52.94 5.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -1.084 . . . . 0.0 109.395 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.45 4.66 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.582 -0.699 . . . . 0.0 109.169 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.38 42.46 32.02 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -116.75 143.23 31.02 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.7 Cg_exo -55.16 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.723 1.615 . . . . 0.0 110.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 6' ' ' PRO . 27.1 mt -72.09 158.56 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.29 61.38 0.28 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.725 -1.234 . . . . 0.0 110.766 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.34 -102.42 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -111.38 121.59 45.61 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.26 159.02 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -0.8 . . . . 0.0 111.252 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.39 115.74 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.536 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.2 m-80 -89.92 106.35 18.41 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.097 -1.002 . . . . 0.0 109.694 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.77 159.43 43.2 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.79 16.83 4.74 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.87 73.41 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -131.71 -154.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.457 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.9 mt-30 -135.97 142.96 44.61 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.533 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.0 m95 -141.3 138.41 33.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.589 -1.319 . . . . 0.0 110.504 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.4 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 18.2 m80 -54.52 138.01 41.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 t -57.26 -18.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 O-C-N 120.878 -1.139 . . . . 0.0 109.319 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -96.36 -22.29 17.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 110.667 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -96.1 -9.22 31.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.863 -1.148 . . . . 0.0 110.398 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -80.07 105.95 11.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 40' ' ' PRO . 25.4 m -133.21 175.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.266 1.032 . . . . 0.0 111.12 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.56 149.05 44.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.086 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.57 24.51 3.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 14.6 tppt? -134.19 -33.43 1.01 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.2 p -125.8 -19.74 4.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.8 mt-10 76.22 46.5 0.09 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.302 -0.874 . . . . 0.0 110.449 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.75 110.27 60.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.6 Cg_endo -68.79 138.06 40.02 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.726 1.618 . . . . 0.0 112.11 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.31 -55.36 1.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.31 29.44 3.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.86 -177.73 3.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -1.03 . . . . 0.0 109.963 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -97.05 145.63 25.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.744 . . . . 0.0 109.356 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.567 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -116.28 170.21 8.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.87 137.51 46.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -106.78 147.76 29.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.263 -0.898 . . . . 0.0 111.402 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.66 129.48 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.613 0.721 . . . . 0.0 110.208 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.626 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 51.0 mttp 51.82 23.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 30.8 24.26 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -142.77 143.21 32.11 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.623 -0.928 . . . . 0.0 108.844 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.54 152.86 35.87 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.43 -0.794 . . . . 0.0 110.797 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 58.7 m-85 -153.97 140.33 18.66 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 89.8 m -57.61 176.75 0.12 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.619 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 56.3 tt0 -63.33 -35.7 81.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.337 -0.852 . . . . 0.0 109.312 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' GLN . 52.6 m -86.52 -43.64 12.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.345 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 62' ' ' LEU . 32.6 m170 -66.8 -45.59 77.9 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.765 -1.209 . . . . 0.0 108.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.4 t80 -49.48 -55.85 11.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -65.67 -45.82 81.47 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.073 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' THR . 7.0 tp-100 -54.93 -33.25 62.03 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.546 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -78.62 -35.28 45.79 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.138 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.626 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 16.8 m-85 -158.59 -80.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.005 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.477 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 1.9 t . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ILE . 10.1 Cg_endo -80.44 164.32 21.44 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.686 2.258 . . . . 0.0 109.862 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 14' ' ' PRO . 38.9 mt -135.08 120.15 28.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.995 0.902 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 38.3 t -62.68 116.09 4.88 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.826 0.822 . . . . 0.0 110.048 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.523 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -62.59 -3.54 5.72 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -87.28 -33.02 19.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.403 -1.057 . . . . 0.0 109.266 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 0.9 7.15 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 8' ' ' CYS . 21.1 mmm180 50.92 34.35 10.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -115.24 137.32 22.94 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.53 ' HA ' HG12 ' A' ' 7' ' ' ILE . 7.1 Cg_exo -51.65 114.56 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.075 1.183 . . . . 0.0 111.056 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 6' ' ' PRO . 11.5 mt -69.31 160.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -169.25 69.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.264 . . . . 0.0 110.403 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.31 -59.06 0.24 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.5 133.13 30.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.03 157.92 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.084 -1.01 . . . . 0.0 110.74 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 t -132.43 116.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.684 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.032 -1.042 . . . . 0.0 109.389 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . . . -144.34 157.63 44.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.409 -0.807 . . . . 0.0 108.985 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.678 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 58.02 19.36 5.87 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.95 13.72 72.69 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -118.95 -156.76 0.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.7 0.762 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.525 HE21 ' H ' ' A' ' 7' ' ' ILE . 1.9 mt-30 -133.61 144.67 49.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.523 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 50.0 m95 -142.23 140.73 32.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.58 -1.325 . . . . 0.0 110.411 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -54.43 141.93 28.95 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 t -62.26 -18.4 20.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.684 -1.26 . . . . 0.0 109.496 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -20.45 20.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 110.438 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.43 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.9 m170 -101.86 -6.32 23.7 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.171 -0.955 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.429 ' CZ ' ' CB ' ' A' ' 22' ' ' ALA . 31.0 t80 -81.45 106.18 13.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 40' ' ' PRO . 24.7 m -133.19 175.11 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.296 1.046 . . . . 0.0 111.508 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -63.03 149.47 44.93 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.298 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.59 26.6 2.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.103 -0.998 . . . . 0.0 109.848 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.9 tptp -135.44 -31.34 0.97 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.382 -0.824 . . . . 0.0 109.917 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.0 p -129.82 -16.39 3.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 72.75 47.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.15 109.69 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.589 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.8 Cg_endo -69.25 137.38 36.8 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.758 1.639 . . . . 0.0 112.031 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.05 57.93 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.589 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.22 -55.4 1.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.251 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.5 3.01 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.62 -174.81 2.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.396 -1.061 . . . . 0.0 109.939 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -98.71 147.37 24.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.59 -0.693 . . . . 0.0 109.363 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.589 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-80 -119.41 169.43 10.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 109.551 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.724 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -132.51 137.24 47.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.59 143.43 41.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.242 -0.911 . . . . 0.0 111.581 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.672 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -150.22 136.59 18.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.442 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 51.47 21.33 1.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.633 -0.667 . . . . 0.0 109.282 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.678 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.1 31.28 29.0 Favored Glycine 0 C--N 1.295 -1.709 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.3 mt -142.27 142.13 32.54 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.71 -0.876 . . . . 0.0 108.84 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.28 152.63 36.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.415 -0.803 . . . . 0.0 110.671 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.522 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 55.2 m-85 -153.11 138.71 17.79 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 88.1 m -58.0 176.58 0.15 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.432 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.696 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.6 tp10 -63.46 -36.3 83.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.137 -0.977 . . . . 0.0 109.061 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 61' ' ' GLN . 32.6 m -85.73 -41.0 15.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 111.279 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.436 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -69.45 -45.35 69.28 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.723 -1.235 . . . . 0.0 108.207 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -51.17 -54.43 25.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 93.2 m-20 -65.55 -46.99 77.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.135 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 14.9 tt0 -52.31 -40.19 61.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.3 mp -68.93 -39.09 79.79 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.672 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.5 m-85 -155.34 -87.61 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.802 0.81 . . . . 0.0 110.001 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.532 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 15' ' ' ILE . 8.4 Cg_endo -79.21 164.2 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.65 2.233 . . . . 0.0 109.65 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' A' ' 14' ' ' PRO . 35.3 mt -134.86 119.69 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.035 0.921 . . . . 0.0 109.419 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 35.2 t -58.38 114.55 2.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.742 0.782 . . . . 0.0 109.828 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.545 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.63 -4.37 4.0 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.517 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -84.41 -59.47 2.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.397 -1.061 . . . . 0.0 109.393 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.29 -0.2 38.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.239 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.667 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 55.74 38.8 30.55 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.2 -0.937 . . . . 0.0 108.758 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.81 149.07 44.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.0 Cg_exo -58.63 113.69 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.3 1.334 . . . . 0.0 110.713 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.449 HG13 ' H ' ' A' ' 8' ' ' CYS . 15.3 mt -68.54 159.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -168.62 69.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.894 -1.129 . . . . 0.0 110.271 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.44 -62.99 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.31 137.15 35.57 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -126.15 151.89 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.1 -1.0 . . . . 0.0 110.376 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.48 116.35 48.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.67 105.43 17.67 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.093 -1.005 . . . . 0.0 109.703 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.41 160.22 41.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.558 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 13.1 mmt 57.5 14.71 2.39 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.1 13.78 79.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -115.24 -155.55 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.805 0.812 . . . . 0.0 109.678 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.489 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.7 mt-30 -136.28 141.94 43.91 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.545 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 51.4 m95 -141.29 139.37 33.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.554 -1.341 . . . . 0.0 110.204 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -54.8 140.58 35.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.31 -18.2 13.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.675 -1.265 . . . . 0.0 109.201 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -95.31 -24.8 16.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -94.08 -9.34 36.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.792 -1.193 . . . . 0.0 110.271 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -79.36 105.94 11.03 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.411 HG11 ' N ' ' A' ' 40' ' ' PRO . 25.3 m -134.85 176.34 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.34 1.066 . . . . 0.0 111.209 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.63 148.22 49.5 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.282 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.43 28.63 1.91 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.438 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.8 -31.07 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.452 -0.78 . . . . 0.0 109.976 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.6 p -131.66 -15.18 3.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.271 -0.893 . . . . 0.0 110.379 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.2 48.18 0.26 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.361 -0.837 . . . . 0.0 110.551 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -102.74 109.21 60.55 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.1 Cg_endo -69.05 138.26 39.62 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.9 58.07 1.88 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.602 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.23 -55.62 1.65 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.455 ' C ' ' HD1' ' A' ' 44' ' ' HIS . . . -135.76 31.8 2.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.501 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 1.1 m-70 -115.85 -163.82 0.92 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.515 -0.991 . . . . 0.0 110.1 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -109.94 147.07 34.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.543 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 29.0 p-80 -119.07 169.67 9.71 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.141 0.972 . . . . 0.0 109.889 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.724 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.4 m-85 -132.99 136.72 46.22 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.402 ' CD ' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -117.82 154.01 32.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.846 -1.159 . . . . 0.0 112.102 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -143.31 131.85 22.36 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.63 0.729 . . . . 0.0 109.727 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.4 ptpt 45.15 23.12 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.751 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 91.31 29.35 12.54 Favored Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.025 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 49' ' ' ARG . 16.6 mt -137.02 132.27 34.03 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.446 -1.032 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.81 0.814 . . . . 0.0 111.207 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' TYR . 50.6 m-85 -152.15 139.35 19.3 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.5 m -56.12 -179.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.693 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 5.9 tm-20 -66.67 -37.73 85.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.024 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 61' ' ' GLN . 38.2 m -86.83 -40.23 15.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.572 -0.705 . . . . 0.0 111.525 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.68 -44.38 74.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 108.272 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.0 t80 -51.19 -54.84 21.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -65.42 -46.07 81.44 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.121 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.4 tp-100 -53.07 -36.89 61.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 2.4 mp -74.4 -32.35 62.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.654 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 22.4 m-85 -162.59 -86.5 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.832 0.825 . . . . 0.0 109.95 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.575 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 1.8 t . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 15' ' ' ILE . 8.5 Cg_endo -80.35 164.6 21.52 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.738 2.292 . . . . 0.0 109.655 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.0 mt -134.27 119.93 32.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.977 0.894 . . . . 0.0 109.35 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 36.9 t -63.79 121.19 13.39 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.844 0.831 . . . . 0.0 110.096 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -65.3 -3.83 14.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.509 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.0 -32.58 22.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -1.04 . . . . 0.0 109.353 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 1.42 5.49 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.648 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 50.71 34.46 9.99 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.667 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -113.64 138.85 22.79 Favored Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.4 Cg_exo -53.27 114.69 1.86 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.301 1.334 . . . . 0.0 111.311 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' PRO . 13.7 mt -70.03 159.37 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -161.33 63.57 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.818 -1.177 . . . . 0.0 110.365 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.33 -98.22 0.11 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.645 ' CG ' HH11 ' A' ' 18' ' ' ARG . 3.4 mtt-85 -115.44 130.71 56.97 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -111.32 160.7 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.907 0.861 . . . . 0.0 111.472 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 t -127.13 116.82 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.1 106.15 18.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.64 158.41 43.69 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.668 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.8 mmt 58.16 17.52 4.63 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.86 76.04 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -120.37 -155.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.791 0.805 . . . . 0.0 109.724 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.499 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.3 mt-30 -135.8 144.85 45.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 58.3 m95 -142.63 140.54 31.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.594 -1.316 . . . . 0.0 110.359 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -55.83 138.46 48.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 t -58.01 -19.05 11.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 120.746 -1.221 . . . . 0.0 109.164 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -96.27 -3.14 44.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 110.418 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.59 -10.39 11.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.026 -1.046 . . . . 0.0 110.145 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -78.79 105.82 10.36 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 40' ' ' PRO . 26.4 m -133.45 174.98 12.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.252 1.025 . . . . 0.0 111.215 -177.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -61.7 149.31 40.02 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.483 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.75 27.65 2.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 35.1 tptt -138.87 -32.06 0.7 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.251 -0.906 . . . . 0.0 110.197 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.8 p -128.27 -16.5 4.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.198 -0.939 . . . . 0.0 110.298 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 73.43 47.31 0.18 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.353 -0.842 . . . . 0.0 110.192 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.49 109.96 60.44 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.9 Cg_endo -69.3 137.17 36.14 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.889 1.726 . . . . 0.0 112.242 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.34 58.83 1.82 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.588 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.11 -55.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.917 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.59 31.53 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -113.43 -178.12 3.3 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -1.033 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.409 ' O ' ' CE1' ' A' ' 47' ' ' TYR . 5.5 tpp180 -98.83 129.51 45.22 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.2 p-80 -101.3 175.82 5.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.012 . . . . 0.0 110.147 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.673 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.7 m-85 -135.88 136.47 40.57 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -108.6 148.16 30.76 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.297 -0.877 . . . . 0.0 111.428 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.729 HH22 ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -153.03 127.57 9.35 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.467 0.651 . . . . 0.0 110.411 179.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' CB ' ' NZ ' ' A' ' 50' ' ' LYS . 8.3 mtmp? 54.45 23.88 4.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.668 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.55 31.7 26.68 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.9 mt -143.76 141.9 30.66 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.663 -0.904 . . . . 0.0 108.926 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.81 153.16 33.06 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 110.651 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.705 ' CG ' ' NH2' ' A' ' 49' ' ' ARG . 59.6 m-85 -153.78 139.38 17.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 87.8 m -57.36 175.04 0.17 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.208 -1.397 . . . . 0.0 108.313 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -62.39 -34.59 77.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.042 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 61' ' ' GLN . 54.0 m -86.44 -44.09 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 111.155 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.477 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.2 m170 -67.25 -42.58 83.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.81 -1.156 . . . . 0.0 107.966 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.729 ' HA ' HH22 ' A' ' 49' ' ' ARG . 5.5 t80 -51.79 -55.63 18.65 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.411 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 49.9 m-80 -67.14 -43.99 80.97 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.425 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' THR . 34.9 tt0 -54.29 -37.82 65.19 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.576 HD22 ' NH2' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -75.58 -35.57 60.57 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.452 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.2 m-85 -155.03 -81.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 110.104 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.04 163.64 36.29 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.939 1.76 . . . . 0.0 108.916 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.22 120.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.116 0.96 . . . . 0.0 109.408 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 19.4 t -58.35 116.15 3.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.778 0.799 . . . . 0.0 109.987 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.542 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.2 -2.11 4.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.537 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.29 -53.05 5.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -1.072 . . . . 0.0 109.429 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.54 5.36 19.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.665 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.09 42.08 32.18 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -116.16 143.2 30.54 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HA ' HG12 ' A' ' 7' ' ' ILE . 4.9 Cg_exo -56.05 112.56 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.504 1.469 . . . . 0.0 110.252 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.447 HG13 ' H ' ' A' ' 8' ' ' CYS . 22.7 mt -69.65 158.02 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.684 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -160.91 62.73 0.3 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.874 -1.141 . . . . 0.0 110.441 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.0 -98.73 0.12 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 125.18 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.74 152.62 6.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.735 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -118.2 115.08 47.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.0 OUTLIER -88.69 106.16 18.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 109.747 -178.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.95 160.03 42.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.679 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.2 mmt 58.12 16.44 3.86 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.6 20.66 77.38 Favored Glycine 0 C--N 1.291 -1.925 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -123.44 -153.97 0.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.974 0.892 . . . . 0.0 109.94 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.491 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.0 mt-30 -136.9 142.45 42.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.542 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 57.0 m95 -141.45 139.75 33.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.534 -1.354 . . . . 0.0 110.503 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -55.91 137.05 51.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 t -55.98 -19.33 6.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.822 -1.174 . . . . 0.0 109.119 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.456 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -94.08 -27.2 16.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.464 -0.772 . . . . 0.0 110.497 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -93.56 -7.08 45.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.08 . . . . 0.0 110.674 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -81.69 105.7 13.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 40' ' ' PRO . 24.1 m -133.76 175.85 10.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 122.303 1.049 . . . . 0.0 111.249 -177.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.539 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.06 149.29 45.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.389 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.47 28.88 1.84 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.756 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 tptp -138.55 -31.68 0.73 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.416 -0.802 . . . . 0.0 110.057 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.6 p -129.43 -18.54 3.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.1 mt-10 75.26 47.28 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.308 -0.87 . . . . 0.0 110.064 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.98 107.67 50.84 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 4.9 Cg_endo -67.19 137.95 45.55 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.628 1.552 . . . . 0.0 112.179 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.15 58.46 1.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.01 -55.56 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 31.45 2.66 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.18 -176.29 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.418 -1.049 . . . . 0.0 110.224 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HG3' ' CZ ' ' A' ' 47' ' ' TYR . 5.8 tpp180 -99.37 136.01 39.94 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -108.23 173.2 6.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.833 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.684 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -134.59 141.48 46.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -110.75 151.46 27.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.176 -0.952 . . . . 0.0 111.788 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.732 ' HE ' ' N ' ' A' ' 50' ' ' LYS . 1.4 tpm_? -156.07 129.41 8.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.349 0.595 . . . . 0.0 109.808 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.732 ' N ' ' HE ' ' A' ' 49' ' ' ARG . 8.6 mmtp 53.17 22.96 2.84 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 178.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.679 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.03 31.39 32.04 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.6 mt -140.69 141.55 34.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.27 154.13 33.25 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.632 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.557 ' CD2' ' HB3' ' A' ' 49' ' ' ARG . 53.1 m-85 -154.33 140.25 18.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.1 m -57.34 176.7 0.11 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.156 -1.418 . . . . 0.0 108.234 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -63.83 -35.46 80.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 109.462 179.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 61' ' ' GLN . 46.3 m -86.23 -41.32 14.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 111.115 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -68.56 -43.96 75.47 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.729 -1.232 . . . . 0.0 107.863 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -53.28 -56.48 16.26 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -63.69 -44.05 94.84 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.528 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' THR . 10.2 mm100 -56.26 -37.05 69.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 3.4 mp -73.71 -32.58 63.97 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.35 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.6 m-85 -160.08 -83.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.971 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.517 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.19 28.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.134 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.8 167.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.3 46.87 0.2 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.25 130.77 5.36 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.314 -1.109 . . . . 0.0 109.372 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.25 163.61 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.958 1.772 . . . . 0.0 108.867 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.545 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.4 119.77 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 122.059 0.933 . . . . 0.0 109.402 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.539 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 15.0 t -58.35 117.0 3.98 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.844 0.831 . . . . 0.0 109.946 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -64.85 -0.17 4.91 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.539 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -86.67 -48.55 8.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -1.095 . . . . 0.0 109.36 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.8 13.7 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.634 HH11 ' HG3' ' A' ' 12' ' ' ARG . 8.2 mmm-85 53.52 41.32 32.11 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -115.91 143.45 30.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.7 Cg_exo -56.46 113.38 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.46 1.44 . . . . 0.0 110.546 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.45 HG13 ' H ' ' A' ' 8' ' ' CYS . 21.5 mt -70.92 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -160.54 61.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.863 -1.148 . . . . 0.0 110.662 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.661 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.66 42.32 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.8 t -98.8 158.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.668 0.746 . . . . 0.0 111.195 -177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 t -122.56 116.01 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.586 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -89.85 106.09 18.24 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.11 -0.993 . . . . 0.0 109.553 -179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.53 42.63 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.9 mmt 58.09 17.19 4.31 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.2 25.28 75.85 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.8 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.741 0.781 . . . . 0.0 109.764 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.443 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.8 mt-30 -135.38 143.49 46.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.3 m95 -141.59 139.98 33.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.534 -1.354 . . . . 0.0 110.616 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.3 m80 -56.48 131.95 49.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 t -53.22 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.871 -1.143 . . . . 0.0 108.348 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 28' ' ' HIS . 12.5 tp10 -95.78 -26.97 15.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.814 -0.554 . . . . 0.0 110.62 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.13 -6.52 31.38 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.883 -1.136 . . . . 0.0 110.826 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.422 HG11 ' N ' ' A' ' 40' ' ' PRO . 26.6 m -133.57 175.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 111.158 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.82 148.68 46.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.318 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.83 28.69 1.73 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.4 tptm -138.81 -31.69 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.364 -0.835 . . . . 0.0 110.077 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.1 -15.39 4.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.305 -0.872 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.6 0.34 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.326 -0.859 . . . . 0.0 110.191 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.46 109.56 59.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.4 Cg_endo -69.06 138.28 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.713 1.609 . . . . 0.0 112.112 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.23 1.63 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.26 -0.9 . . . . 0.0 108.996 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.01 2.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.936 -1.665 . . . . 0.0 108.936 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -116.29 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.504 -0.998 . . . . 0.0 109.94 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.43 145.34 24.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 109.352 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.2 p-80 -116.3 169.47 9.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.55 137.67 47.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.28 28.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.232 -0.917 . . . . 0.0 111.201 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.34 11.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.628 0.727 . . . . 0.0 110.333 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.23 22.86 1.45 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.586 -0.696 . . . . 0.0 109.495 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.47 30.97 20.36 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.724 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.6 mt -143.29 142.74 31.44 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.535 -0.979 . . . . 0.0 108.814 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.35 152.86 36.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 110.73 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.51 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 57.7 m-85 -153.91 140.27 18.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 90.7 m -57.55 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.316 -1.353 . . . . 0.0 108.454 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 53.1 tt0 -63.63 -35.98 82.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.383 -0.823 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.4 m -86.66 -43.75 12.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 0.0 111.339 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.459 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -66.65 -43.77 83.68 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.79 -1.194 . . . . 0.0 108.141 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.49 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.2 t80 -51.74 -56.43 13.87 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -64.52 -44.89 89.47 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.093 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.5 tp60 -54.44 -34.37 61.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.534 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.8 mp -78.68 -35.24 45.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.359 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 18.0 m-85 -158.58 -81.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.41 31.39 16.49 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' A' ' 59' ' ' TYR . 26.2 m-20 48.5 51.27 15.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -1.117 . . . . 0.0 109.566 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.482 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 t -50.09 158.9 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -1.123 . . . . 0.0 109.463 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 tpt -61.09 -9.18 4.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . 144.26 -72.09 0.36 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.0 t 57.16 117.7 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.436 -1.038 . . . . 0.0 109.944 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.9 Cg_endo -79.6 164.3 23.57 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.673 2.249 . . . . 0.0 109.327 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.6 mt -135.31 122.83 36.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.873 0.844 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 12.1 t -61.13 116.83 4.86 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.549 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.42 -1.13 4.11 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.553 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.46 -54.22 4.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -1.149 . . . . 0.0 109.524 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.33 1.97 18.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.559 -0.713 . . . . 0.0 109.148 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 57.56 41.86 25.1 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.22 -0.925 . . . . 0.0 108.57 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -116.68 142.76 30.16 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.6 Cg_exo -55.69 113.97 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.432 1.422 . . . . 0.0 110.948 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' PRO . 23.9 mt -71.89 158.77 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -161.77 62.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 0.0 110.484 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 -100.37 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -113.33 120.49 41.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.6 t -97.01 154.51 3.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 111.065 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.84 112.61 38.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.6 m-80 -86.98 106.81 18.08 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.67 42.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.5 mmt 58.38 16.01 3.83 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 27.5 71.71 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -133.05 -151.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.042 0.925 . . . . 0.0 110.089 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -136.82 144.53 43.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.549 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 64.4 m95 -142.51 135.44 28.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.605 -1.31 . . . . 0.0 110.368 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -53.77 135.52 41.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.3 t -55.54 -18.18 4.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 120.935 -1.103 . . . . 0.0 109.053 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -94.39 -25.9 16.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.438 -0.789 . . . . 0.0 110.573 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.5 m170 -98.01 -5.03 34.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 111.028 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -82.72 106.03 14.23 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 40' ' ' PRO . 26.2 m -133.01 174.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 122.314 1.054 . . . . 0.0 111.294 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.495 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.89 148.28 40.12 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.117 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.46 35.11 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.39 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -142.99 -40.23 0.32 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.8 p -122.41 -17.34 7.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.642 -0.661 . . . . 0.0 110.256 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.8 mt-10 75.1 47.89 0.1 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 110.244 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -100.42 109.59 57.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.59 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 6.1 Cg_endo -69.89 137.73 35.77 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.863 1.709 . . . . 0.0 112.15 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.21 57.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.59 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.11 -55.51 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -0.905 . . . . 0.0 109.279 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 29.79 2.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -114.68 -174.31 2.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.483 -1.01 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.56 146.85 25.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.321 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.583 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.8 p-80 -118.32 169.12 10.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.331 -0.855 . . . . 0.0 109.603 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.715 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -133.15 138.05 46.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.56 149.73 27.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 111.394 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.62 11.54 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.588 0.708 . . . . 0.0 110.259 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp 50.89 22.41 1.17 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.74 . . . . 0.0 109.376 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.75 30.77 20.15 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.6 mt -141.99 142.26 32.93 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.59 -0.947 . . . . 0.0 108.77 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.47 153.15 35.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.29 -0.882 . . . . 0.0 110.954 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.536 ' N ' ' O ' ' A' ' 47' ' ' TYR . 48.7 m-85 -154.68 139.45 17.11 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 73.7 m -57.28 175.8 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.063 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.688 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.8 tp10 -61.98 -34.92 77.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.052 -1.03 . . . . 0.0 109.285 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 61' ' ' GLN . 70.2 m -86.25 -45.1 11.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.831 . . . . 0.0 111.251 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.445 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 31.9 m170 -65.37 -42.76 92.38 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.792 -1.192 . . . . 0.0 108.358 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -54.34 -57.56 10.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 96.6 m-20 -62.72 -44.65 95.67 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.282 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.3 tp60 -55.52 -34.43 64.65 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.548 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 6.1 mp -78.77 -34.21 45.81 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.673 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 17.3 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.82 31.58 43.68 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 55.92 80.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -1.089 . . . . 0.0 109.397 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.476 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' N ' ' CE ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -79.47 51.55 1.25 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.106 . . . . 0.0 109.458 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -163.93 -167.53 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.454 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.495 ' O ' ' SD ' ' A' ' 3' ' ' MET . . . -79.35 -161.3 21.47 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 2.0 t -153.77 117.79 2.71 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.24 -1.153 . . . . 0.0 109.825 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.7 Cg_endo -79.96 164.49 22.56 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.757 2.305 . . . . 0.0 109.526 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.533 HG12 ' HA ' ' A' ' 14' ' ' PRO . 35.1 mt -133.94 119.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.126 0.965 . . . . 0.0 109.327 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.518 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 36.2 t -61.33 116.24 4.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.796 0.807 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.54 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -59.83 -4.52 3.26 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.518 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -84.37 -51.58 6.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.406 -1.055 . . . . 0.0 109.289 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.428 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -107.56 2.98 24.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.269 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' CYS . 19.3 mmm180 50.02 34.83 8.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.653 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -113.85 138.62 22.82 Favored Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.7 Cg_exo -53.64 114.82 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.268 1.312 . . . . 0.0 110.943 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 6' ' ' PRO . 14.0 mt -68.98 158.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' CD ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -159.59 62.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.913 -1.117 . . . . 0.0 110.451 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.54 -96.46 0.1 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -112.38 142.48 44.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.7 t -122.65 156.77 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.744 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.5 t -125.17 116.84 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.605 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.2 m120 -88.46 105.85 17.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.077 -1.014 . . . . 0.0 109.497 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.99 41.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.661 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 57.52 16.96 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.72 20.43 78.61 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -125.38 -155.37 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.742 0.782 . . . . 0.0 109.783 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.497 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.3 mt-30 -134.53 143.99 47.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.54 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.4 m95 -142.14 139.47 32.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.616 -1.303 . . . . 0.0 110.26 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.4 ' NE2' ' HA ' ' A' ' 15' ' ' ILE . 19.6 m80 -54.68 138.65 41.14 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -57.41 -16.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 120.795 -1.191 . . . . 0.0 108.987 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -96.52 -25.82 15.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.47 -0.769 . . . . 0.0 110.54 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -93.21 -9.94 37.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.916 -1.115 . . . . 0.0 110.451 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -79.61 105.82 11.19 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 m -133.97 175.26 11.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 122.246 1.022 . . . . 0.0 110.959 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -64.13 148.53 49.71 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.268 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.0 28.12 1.66 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 tptm -138.7 -32.03 0.71 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.333 -0.854 . . . . 0.0 110.223 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.7 p -129.3 -11.27 4.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.343 -0.848 . . . . 0.0 110.205 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 65.01 47.25 2.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.472 -0.768 . . . . 0.0 110.491 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.603 ' NZ ' ' SG ' ' A' ' 55' ' ' CYS . 0.0 OUTLIER -101.99 107.49 52.67 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 3.4 Cg_endo -66.0 139.48 56.48 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.678 1.585 . . . . 0.0 112.304 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.44 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.594 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.14 -55.31 1.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.947 . . . . 0.0 109.067 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.1 30.58 2.92 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.431 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.7 OUTLIER -117.7 176.61 5.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.56 -0.965 . . . . 0.0 109.905 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.627 ' CD ' ' HH ' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -90.57 150.43 21.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.438 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.6 p-80 -119.4 170.66 8.94 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.4 m-85 -138.17 129.42 27.46 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.478 ' OE2' ' CE ' ' A' ' 23' ' ' MET . 1.3 mm-40 -100.07 153.59 19.1 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.232 -0.917 . . . . 0.0 111.702 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.35 127.05 8.79 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.558 0.694 . . . . 0.0 109.877 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt 52.59 23.8 2.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 109.59 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.661 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 31.09 23.5 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.076 -1.535 . . . . 0.0 109.36 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.4 mt -142.66 139.95 31.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.603 -0.94 . . . . 0.0 108.666 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.3 151.92 39.74 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.163 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' TYR . 55.0 m-85 -154.37 139.45 17.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.603 ' SG ' ' NZ ' ' A' ' 39' ' ' LYS . 89.3 m -57.81 178.15 0.09 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.792 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.2 tt0 -62.31 -37.82 87.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.619 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 61' ' ' GLN . 52.4 m -86.92 -43.08 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 111.66 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -65.81 -43.61 88.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.722 -1.236 . . . . 0.0 108.134 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.8 t80 -51.94 -56.5 13.81 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -64.22 -44.9 90.47 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.5 tp-100 -54.38 -34.84 62.01 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.534 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.8 mp -78.12 -33.28 50.61 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.512 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 21.2 m-85 -160.13 -81.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 110.125 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.26 26.07 55.83 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -172.55 25.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -1.084 . . . . 0.0 109.493 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.473 -179.894 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.7 p -166.43 43.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -1.145 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.5 tpp 50.62 -128.48 2.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.425 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -176.73 -46.78 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.2 t 57.13 129.27 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.548 -0.972 . . . . 0.0 109.888 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.83 163.58 35.3 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.909 1.739 . . . . 0.0 108.901 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.1 mt -134.48 119.95 31.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.012 0.911 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 16.1 t -60.27 119.6 8.22 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 110.119 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.84 0.09 11.82 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.545 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.59 -38.36 18.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -1.113 . . . . 0.0 109.392 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.64 5.04 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 54.19 41.48 31.98 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -115.54 142.54 28.99 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.5 Cg_exo -56.27 112.94 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.562 1.508 . . . . 0.0 110.729 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 6' ' ' PRO . 20.7 mt -70.45 158.68 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -159.19 62.12 0.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.691 -1.256 . . . . 0.0 110.854 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.67 -100.97 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -107.82 134.35 50.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.2 t -115.77 158.06 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 110.731 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.9 117.32 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.633 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.9 OUTLIER -90.03 105.97 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.29 159.76 42.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.1 mmt 58.1 18.14 5.02 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.07 75.75 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -130.32 -154.67 0.65 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.717 0.77 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.472 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.6 mt-30 -134.82 145.1 48.02 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.6 m95 -142.05 139.15 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.544 -1.347 . . . . 0.0 110.788 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -55.22 132.79 48.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.0 t -52.39 -22.58 3.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 120.835 -1.165 . . . . 0.0 109.29 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -91.85 -23.74 19.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 110.734 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -96.91 -6.58 35.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.859 -1.151 . . . . 0.0 111.029 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -81.67 103.2 11.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 40' ' ' PRO . 25.1 m -128.96 178.45 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 122.321 1.058 . . . . 0.0 111.254 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.598 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.1 t -65.61 148.4 51.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.702 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.8 28.19 1.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.486 -0.759 . . . . 0.0 109.197 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 6.3 tmtt? -134.1 -39.07 0.86 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.571 -0.706 . . . . 0.0 109.74 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.6 p -126.31 -16.17 5.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.558 -0.714 . . . . 0.0 110.553 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.0 mt-10 73.7 46.94 0.18 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -100.76 110.21 60.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.611 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.1 Cg_endo -68.46 136.97 38.24 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.718 1.612 . . . . 0.0 111.754 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.4 m-85 -95.98 60.1 2.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.611 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.3 mp -40.04 -56.02 1.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.44 -0.788 . . . . 0.0 109.476 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.67 26.16 4.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -114.56 159.98 19.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.396 -1.061 . . . . 0.0 109.822 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -75.72 154.77 36.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.452 -0.78 . . . . 0.0 109.162 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.608 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.6 p-80 -118.08 170.52 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.273 -0.892 . . . . 0.0 110.017 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -135.87 137.36 41.38 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -111.65 145.27 39.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 0.0 111.387 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.556 ' NH1' ' HG3' ' A' ' 49' ' ' ARG . 11.1 ttm-85 -144.92 137.91 26.54 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.53 0.681 . . . . 0.0 110.12 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 44.73 20.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.702 0.763 . . . . 0.0 109.166 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 87.18 30.71 19.07 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ARG . 20.1 mt -138.9 143.03 38.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.678 -0.895 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.96 151.76 33.49 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.828 0.823 . . . . 0.0 111.25 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.492 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 53.4 m-85 -153.54 135.89 14.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 14.5 m -56.57 172.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.101 -1.439 . . . . 0.0 108.141 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 68.3 tt0 -57.28 -32.35 66.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.045 -1.034 . . . . 0.0 109.745 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 61' ' ' GLN . 93.7 m -87.15 -47.88 8.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.826 . . . . 0.0 111.818 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.436 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 29.1 m170 -64.67 -40.88 96.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.756 -1.215 . . . . 0.0 108.605 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -55.13 -57.49 11.55 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.414 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 42.8 m-80 -63.03 -44.1 96.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.065 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.6 tt0 -54.72 -35.96 64.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 6.6 mp -76.1 -37.25 58.35 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.7 m-85 -156.11 -83.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.722 0.773 . . . . 0.0 109.804 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 90.31 31.61 10.46 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.5 t70 56.38 81.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -1.104 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.563 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' MET . 15.4 m -165.9 -120.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 0.0 109.4 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 3' ' ' MET . 0.0 OUTLIER 51.63 98.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -109.51 17.35 30.99 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.0 t 56.67 116.19 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.939 . . . . 0.0 110.086 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -79.9 164.68 22.59 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.733 2.289 . . . . 0.0 109.349 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.534 HG12 ' HA ' ' A' ' 14' ' ' PRO . 25.8 mt -134.97 120.45 30.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-O 121.945 0.878 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.534 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 20.8 t -62.16 121.27 12.67 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.877 0.846 . . . . 0.0 110.077 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.39 -1.48 15.24 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.534 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.35 -35.31 21.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -130.49 0.25 4.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.663 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 56.83 38.56 29.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -178.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.616 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -111.01 138.3 21.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.9 Cg_exo -55.1 113.46 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.113 1.209 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' PRO . 19.9 mt -70.62 158.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -161.26 62.41 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.897 -1.127 . . . . 0.0 110.616 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.82 -101.87 0.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -111.48 126.39 54.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.0 t -105.15 158.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 111.204 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.9 t -122.36 115.65 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.551 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.0 OUTLIER -90.49 106.55 18.57 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 109.905 -178.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.97 160.16 41.78 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.62 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.5 mmt 58.31 14.46 2.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.32 18.21 79.2 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.801 -2.12 . . . . 0.0 107.801 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -120.21 -154.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.007 0.908 . . . . 0.0 109.827 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.485 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.8 mt-30 -136.6 143.56 43.64 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.4 m95 -141.66 138.88 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.513 -1.367 . . . . 0.0 110.566 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -55.46 134.73 50.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 t -54.37 -20.43 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 120.809 -1.182 . . . . 0.0 109.08 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -92.03 -27.89 17.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 110.536 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -93.81 -7.35 43.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.031 -1.043 . . . . 0.0 110.885 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -81.25 105.86 12.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.89 174.99 12.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 122.326 1.06 . . . . 0.0 111.195 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.7 t -64.03 148.41 49.8 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.059 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.71 27.81 1.68 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.702 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.2 tptp -138.09 -33.21 0.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.1 p -126.89 -11.23 6.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.261 -0.9 . . . . 0.0 110.209 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 65.08 46.87 2.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -102.56 107.02 52.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 3.5 Cg_endo -66.45 139.75 55.18 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.816 1.677 . . . . 0.0 112.358 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -96.08 56.35 1.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.03 -55.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 30.39 2.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.428 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -116.47 178.99 4.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.96 . . . . 0.0 109.958 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -95.79 147.19 23.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.432 -0.792 . . . . 0.0 109.293 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.531 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 33.6 p-80 -117.73 168.94 9.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.0 m-85 -133.66 133.16 41.56 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -111.01 155.43 22.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.075 -1.016 . . . . 0.0 111.639 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -145.47 135.77 23.99 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.55 0.691 . . . . 0.0 110.064 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.2 ptmt 42.33 21.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.467 0.651 . . . . 0.0 109.757 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.62 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.92 30.62 9.28 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.191 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.0 mt -140.53 136.83 33.28 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.491 -1.005 . . . . 0.0 108.379 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.46 150.18 45.15 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.858 0.837 . . . . 0.0 111.11 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.671 ' N ' ' O ' ' A' ' 47' ' ' TYR . 47.4 m-85 -153.14 139.3 18.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 54.1 m -56.51 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.831 -1.168 . . . . 0.0 108.857 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 75.2 tt0 -68.65 -40.46 80.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.352 -0.843 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 61' ' ' GLN . 24.2 m -86.25 -37.57 18.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 111.292 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.56 -46.77 68.55 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.798 -1.189 . . . . 0.0 108.224 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -52.36 -55.94 18.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 93.2 m-20 -62.49 -46.26 89.26 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.51 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 57' ' ' THR . 12.5 mm100 -54.68 -38.15 66.64 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -72.1 -39.69 68.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.319 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -153.79 -83.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.28 -10.18 29.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 170.27 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.483 -1.01 . . . . 0.0 109.397 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.425 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p -63.76 160.63 16.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -1.139 . . . . 0.0 109.45 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.3 ttt -164.36 40.31 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.361 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 48.33 -170.54 0.07 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t -155.28 130.79 5.36 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.156 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.4 Cg_endo -74.36 163.65 35.82 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.911 1.74 . . . . 0.0 109.002 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.546 HG12 ' HA ' ' A' ' 14' ' ' PRO . 28.1 mt -135.14 119.75 27.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.992 0.901 . . . . 0.0 109.206 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 17.2 t -57.85 118.8 5.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.888 0.852 . . . . 0.0 110.073 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.528 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.57 -2.01 5.37 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.538 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.56 -60.9 1.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -1.069 . . . . 0.0 109.336 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.25 -7.3 26.62 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.501 -0.749 . . . . 0.0 109.163 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.473 ' O ' ' CZ ' ' A' ' 13' ' ' ARG . 23.6 mmm180 63.51 37.81 10.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -112.87 144.07 30.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.5 Cg_exo -56.07 113.25 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.466 1.444 . . . . 0.0 110.383 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.455 HG13 ' H ' ' A' ' 8' ' ' CYS . 22.9 mt -70.52 158.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -160.45 61.25 0.33 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.835 -1.165 . . . . 0.0 110.694 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.33 -102.48 0.16 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.4 mtm180 -112.82 121.37 44.5 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -99.45 159.39 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 111.285 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.56 116.44 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.86 106.17 18.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.02 42.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.944 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.626 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.07 16.8 4.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 25.41 75.8 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.094 -2.003 . . . . 0.0 108.094 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.72 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.812 0.815 . . . . 0.0 109.816 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.445 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.0 mt-30 -135.29 143.7 46.36 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.528 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.5 m95 -141.6 140.93 33.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.479 -1.388 . . . . 0.0 110.644 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.475 ' C ' ' N ' ' A' ' 30' ' ' GLU . 18.0 m80 -57.41 131.91 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 t -52.58 -14.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.87 -1.144 . . . . 0.0 108.402 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 28' ' ' HIS . 11.2 tp10 -95.93 -27.11 15.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.761 -0.587 . . . . 0.0 110.501 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -97.14 -6.63 34.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.93 -1.106 . . . . 0.0 110.771 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -80.76 106.09 12.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 40' ' ' PRO . 24.4 m -132.67 176.38 9.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.314 1.054 . . . . 0.0 111.19 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.6 t -65.36 148.75 51.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.454 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.49 25.53 2.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.288 -0.883 . . . . 0.0 109.78 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.6 tptp -135.43 -32.75 0.91 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.326 -0.859 . . . . 0.0 110.22 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 p -128.66 -12.47 4.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 67.9 47.2 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.228 -0.92 . . . . 0.0 109.966 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -101.17 107.47 50.44 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.598 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 4.3 Cg_endo -66.81 138.46 48.82 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.624 1.549 . . . . 0.0 112.118 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -95.72 56.81 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.12 -55.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.166 -0.959 . . . . 0.0 109.015 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.18 29.61 3.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.432 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -116.98 175.39 5.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.574 -0.957 . . . . 0.0 109.801 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.662 ' HG2' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -89.32 150.61 22.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.572 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.3 p-80 -119.5 169.8 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.695 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.5 m-85 -136.82 132.78 35.12 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.95 150.84 24.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.928 . . . . 0.0 111.892 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.535 ' NH2' ' OH ' ' A' ' 54' ' ' TYR . 10.0 ttp180 -146.19 134.23 21.5 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.101 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' CB ' ' HZ1' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 42.04 21.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.569 0.7 . . . . 0.0 109.615 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.626 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 93.08 30.69 9.1 Favored Glycine 0 C--N 1.295 -1.71 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.043 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.1 mt -141.74 139.76 32.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.456 -1.026 . . . . 0.0 108.822 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -73.8 151.87 40.46 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.865 0.84 . . . . 0.0 110.867 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.552 ' N ' ' O ' ' A' ' 47' ' ' TYR . 48.9 m-85 -154.59 138.94 16.69 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 67.4 m -56.56 178.76 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.904 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 12.2 tm-20 -63.73 -39.24 93.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.818 . . . . 0.0 109.46 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.8 m -86.25 -39.28 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.687 . . . . 0.0 111.341 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.7 m170 -67.93 -47.18 69.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.805 -1.184 . . . . 0.0 107.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.433 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.1 t80 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -64.18 -44.39 92.2 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.623 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -57.01 -36.41 70.4 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 1.7 mp -73.28 -37.39 66.28 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.5 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.9 m-85 -153.74 -81.71 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.795 0.807 . . . . 0.0 109.913 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 65' ' ' ASP . . . 70.53 -11.77 2.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.4 OUTLIER 158.79 -18.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.79 -0.829 . . . . 0.0 108.859 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.487 ' OXT' ' CD2' ' A' ' 63' ' ' PHE . 48.4 t . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.521 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.521 ' C ' ' H ' ' A' ' 4' ' ' GLY . 8.2 t 55.5 102.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -1.158 . . . . 0.0 109.484 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.6 mtp -74.22 31.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 2' ' ' SER . . . 82.85 -26.02 4.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -45.26 129.22 5.89 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.517 -0.99 . . . . 0.0 109.703 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.3 Cg_endo -75.67 163.23 34.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.983 1.789 . . . . 0.0 109.232 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.548 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.4 mt -133.78 119.6 33.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 122.103 0.954 . . . . 0.0 109.157 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.523 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 30.3 t -58.02 115.63 3.01 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.776 0.798 . . . . 0.0 109.901 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.539 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.66 -3.23 4.11 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.523 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.55 -59.94 2.17 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.471 -1.017 . . . . 0.0 109.357 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.43 -1.07 39.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.545 -0.722 . . . . 0.0 109.179 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER 56.03 39.72 30.43 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -118.37 149.48 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.548 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.0 Cg_exo -58.73 113.01 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.442 1.428 . . . . 0.0 110.793 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 6' ' ' PRO . 20.5 mt -68.52 159.92 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.428 ' O ' ' CD ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -158.38 62.4 0.44 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.613 -1.305 . . . . 0.0 111.399 -178.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.02 -95.37 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -108.27 138.56 44.34 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.9 160.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.791 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.41 117.41 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.34 105.77 18.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 109.482 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.31 16.65 4.16 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.91 26.09 74.59 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -130.83 -153.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.848 0.832 . . . . 0.0 109.954 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.478 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.1 mt-30 -137.44 142.8 41.6 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 56.9 m95 -141.38 139.3 33.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.64 -1.288 . . . . 0.0 110.6 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.476 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.7 m80 -56.0 131.44 47.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 t -53.38 -13.85 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 120.581 -1.325 . . . . 0.0 108.361 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 28' ' ' HIS . 51.1 tp10 -94.57 -27.36 15.97 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.778 -0.576 . . . . 0.0 110.433 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -98.14 -6.28 31.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.909 -1.12 . . . . 0.0 110.787 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -80.13 107.1 12.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 40' ' ' PRO . 25.6 m -133.25 175.9 10.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.229 1.014 . . . . 0.0 111.27 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.47 148.44 48.6 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.407 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.37 25.98 2.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -0.908 . . . . 0.0 109.804 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.44 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.5 tptp -136.02 -31.53 0.91 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.291 -0.88 . . . . 0.0 110.019 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.2 p -130.03 -15.16 3.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.98 47.43 0.31 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.298 -0.876 . . . . 0.0 110.461 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -102.22 109.49 60.35 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.607 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 4.9 Cg_endo -68.76 138.41 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.848 1.698 . . . . 0.0 112.018 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.5 57.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.607 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.34 -55.49 1.72 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' C ' ' HD1' ' A' ' 44' ' ' HIS . . . -135.4 31.48 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.531 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -115.64 -163.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -1.051 . . . . 0.0 110.05 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -110.6 146.23 36.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.5 p-80 -118.06 168.33 10.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.719 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.0 m-85 -131.7 136.64 47.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -107.02 149.8 27.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -147.15 133.63 19.73 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.561 0.696 . . . . 0.0 110.01 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 15.9 ptmt 41.8 22.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.594 0.712 . . . . 0.0 109.68 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.06 31.3 9.27 Favored Glycine 0 C--N 1.296 -1.68 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.203 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.8 mt -142.78 140.64 31.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.504 -0.998 . . . . 0.0 108.79 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -75.37 152.19 38.11 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 110.879 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.504 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 52.8 m-85 -154.33 139.53 17.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.7 m -56.05 179.15 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.42 -1.312 . . . . 0.0 108.546 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 9.2 tm-20 -64.78 -38.44 91.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 61' ' ' GLN . 28.8 m -86.14 -39.1 17.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.624 -0.673 . . . . 0.0 111.19 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.478 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.9 m170 -68.92 -43.89 74.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.702 -1.249 . . . . 0.0 108.037 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.467 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -54.98 -57.03 13.33 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.424 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 39.6 m-80 -62.16 -43.68 98.3 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.377 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' THR . 18.4 mm-40 -55.92 -37.26 68.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.553 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 3.7 mp -74.52 -37.99 62.92 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.996 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.0 m-85 -156.85 -83.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.411 -0.806 . . . . 0.0 110.171 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 93.12 -9.25 75.24 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 49.78 71.16 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -1.066 . . . . 0.0 109.475 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.496 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 20.5 m -165.56 126.58 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -1.143 . . . . 0.0 109.478 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -51.93 129.91 28.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.279 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.602 ' N ' ' SD ' ' A' ' 3' ' ' MET . . . -144.88 84.36 0.19 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -84.39 134.23 43.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 15' ' ' ILE . 3.4 Cg_endo -70.94 163.36 39.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.616 1.544 . . . . 0.0 108.344 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 14' ' ' PRO . 33.6 mt -134.24 120.67 35.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-O 122.201 1.001 . . . . 0.0 109.244 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 12.6 t -57.39 116.03 3.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.759 0.79 . . . . 0.0 110.066 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.11 -0.67 3.32 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.553 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -87.53 -59.26 2.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -1.086 . . . . 0.0 109.399 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -102.96 -0.86 30.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.519 -0.738 . . . . 0.0 109.267 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.605 HH11 ' HG3' ' A' ' 12' ' ' ARG . 7.2 mmm-85 58.62 43.08 19.55 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -118.62 143.62 33.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.53 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.0 Cg_exo -53.9 111.72 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.663 1.575 . . . . 0.0 110.621 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' PRO . 34.6 mt -71.17 158.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.217 -0.927 . . . . 0.0 108.516 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.38 61.45 0.27 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.727 -1.233 . . . . 0.0 110.728 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.24 -102.19 0.15 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.8 mtt-85 -112.14 120.4 41.68 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.29 158.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 111.282 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.0 t -122.51 115.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -89.85 106.16 18.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.694 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.53 41.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.643 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.3 mmt 58.02 15.98 3.5 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 20.86 77.94 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -124.24 -154.69 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.773 0.797 . . . . 0.0 109.885 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.465 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.5 mt-30 -135.32 143.25 46.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.525 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.0 m95 -141.09 138.55 33.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.572 -1.33 . . . . 0.0 110.588 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.497 ' C ' ' N ' ' A' ' 30' ' ' GLU . 15.6 m80 -55.42 130.74 43.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 t -52.52 -14.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 120.932 -1.105 . . . . 0.0 108.068 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.497 ' N ' ' C ' ' A' ' 28' ' ' HIS . 4.1 tt0 -95.36 -27.83 15.26 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.921 -0.487 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -98.64 -6.02 30.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.827 -1.171 . . . . 0.0 110.821 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -79.87 106.14 11.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 40' ' ' PRO . 27.7 m -134.32 174.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 122.272 1.034 . . . . 0.0 111.122 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.515 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.06 148.22 36.48 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.263 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.25 34.49 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.291 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -142.79 -40.05 0.33 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.5 -0.75 . . . . 0.0 109.744 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.1 p -123.2 -17.4 6.64 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.433 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.0 mt-10 76.32 47.59 0.08 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.4 -0.812 . . . . 0.0 110.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -100.32 110.75 60.94 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 6.2 Cg_endo -70.62 137.98 34.1 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.874 1.716 . . . . 0.0 112.192 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.488 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.11 58.13 1.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.594 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.47 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.01 30.56 2.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -115.4 -179.08 3.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.437 -1.037 . . . . 0.0 110.004 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.644 ' CG ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -96.2 143.07 27.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.502 -0.749 . . . . 0.0 109.158 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.569 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.0 p-80 -114.28 171.51 7.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.306 -0.871 . . . . 0.0 109.659 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.704 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.5 m-85 -134.0 137.75 44.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -108.5 146.94 32.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 111.585 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.905 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -151.57 117.38 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.79 -0.569 . . . . 0.0 109.645 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 22.4 mmtp 61.89 30.37 18.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 109.995 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.643 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 76.97 31.09 54.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 26.1 mt -141.84 137.29 31.35 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.682 -0.893 . . . . 0.0 108.734 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.79 153.88 34.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.769 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 47' ' ' TYR . 47.2 m-85 -153.8 137.86 16.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 76.3 m -56.05 173.27 0.16 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.321 -1.352 . . . . 0.0 108.254 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.4 tm-20 -59.75 -34.78 73.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 109.255 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 61' ' ' GLN . 66.5 m -87.01 -44.43 11.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.68 . . . . 0.0 111.397 -178.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.45 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 30.6 m170 -65.64 -42.12 91.8 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.792 -1.193 . . . . 0.0 108.493 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.464 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.2 t80 -54.3 -57.19 12.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 36.7 m-80 -64.61 -43.94 92.17 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.289 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 57' ' ' THR . 37.1 tt0 -54.31 -34.38 60.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.604 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 6.5 mp -79.24 -38.28 35.98 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.604 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.2 m-85 -160.33 -80.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.573 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.32 -9.59 77.04 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 66' ' ' VAL . 7.1 p30 -164.4 -99.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.372 -1.075 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.507 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 32.6 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 m -159.37 -64.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -1.152 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.8 ptt? -49.9 131.37 22.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.459 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . 168.68 -111.1 0.41 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.543 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.2 t 57.25 128.98 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.542 -0.975 . . . . 0.0 109.727 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -75.48 163.37 34.41 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.043 1.829 . . . . 0.0 109.274 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.552 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.5 mt -135.11 119.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 122.034 0.921 . . . . 0.0 109.149 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 32.7 t -58.51 115.0 2.73 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.84 0.829 . . . . 0.0 109.779 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.536 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.46 -3.54 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.517 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -84.99 -59.18 2.41 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.329 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.39 -1.6 35.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.569 -0.707 . . . . 0.0 109.183 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 8' ' ' CYS . 17.4 mmt180 57.8 38.84 27.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.214 -0.929 . . . . 0.0 108.693 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.04 149.34 45.35 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.552 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.3 Cg_exo -59.05 113.05 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.387 1.391 . . . . 0.0 110.783 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 8' ' ' CYS . 19.3 mt -69.87 160.31 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -170.3 70.39 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.698 -1.251 . . . . 0.0 110.549 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.82 -55.06 0.3 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.608 ' HG3' HH11 ' A' ' 18' ' ' ARG . 1.1 mtm-85 -139.56 129.67 25.13 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.7 t -126.47 152.98 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.6 t -127.23 116.39 43.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.506 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.1 m-80 -86.94 105.65 17.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.064 -1.023 . . . . 0.0 109.372 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.81 159.98 42.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.472 -0.767 . . . . 0.0 109.012 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 57.65 18.4 4.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.83 22.69 77.02 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -129.37 -156.19 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.965 -0.726 . . . . 0.0 109.767 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.462 HE21 ' H ' ' A' ' 7' ' ' ILE . 1.7 mt-30 -134.29 143.43 47.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.536 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 48.6 m95 -141.96 140.05 32.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.531 -1.355 . . . . 0.0 110.289 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -55.82 140.48 42.15 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 t -58.94 -19.46 15.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.718 -1.239 . . . . 0.0 109.288 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -96.27 -12.69 24.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -105.62 -8.76 17.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.951 -1.093 . . . . 0.0 109.955 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -81.22 103.59 11.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 40' ' ' PRO . 21.3 m -126.16 177.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 122.42 1.105 . . . . 0.0 111.597 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.585 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -68.06 149.16 50.01 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.722 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.06 26.01 2.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.7 tptm -134.12 -29.79 1.24 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.364 -0.835 . . . . 0.0 109.841 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.6 p -133.18 -15.59 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.302 -0.874 . . . . 0.0 110.392 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.51 46.56 0.4 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.266 -0.896 . . . . 0.0 110.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -101.32 112.51 65.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.481 ' N ' HG11 ' A' ' 33' ' ' VAL . 10.5 Cg_endo -71.54 134.44 24.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.483 1.455 . . . . 0.0 110.897 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.1 m-85 -93.01 59.46 3.13 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.537 ' H ' HD12 ' A' ' 42' ' ' LEU . 4.6 mp -41.02 -55.95 2.42 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.409 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.33 24.02 5.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -114.69 168.73 9.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.48 -1.012 . . . . 0.0 109.95 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -84.07 156.68 22.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.553 -0.717 . . . . 0.0 109.16 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.7 p-80 -120.81 170.25 9.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 0.0 110.054 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.708 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.0 m-85 -135.47 135.23 40.33 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -110.52 141.08 44.16 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.196 -0.94 . . . . 0.0 111.188 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.728 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -145.15 136.45 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.563 0.697 . . . . 0.0 110.369 178.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt 50.12 22.45 0.93 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.52 -0.737 . . . . 0.0 109.096 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.75 30.63 31.84 Favored Glycine 0 C--N 1.295 -1.712 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 49' ' ' ARG . 22.2 mt -140.09 143.02 36.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.775 -0.838 . . . . 0.0 108.896 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.44 151.48 34.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.487 -0.758 . . . . 0.0 110.928 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.499 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 59.5 m-85 -153.27 136.63 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 64.4 m -57.4 173.92 0.23 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.277 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 26.8 tt0 -59.5 -34.51 72.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 61' ' ' GLN . 59.1 m -86.91 -44.09 11.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -0.772 . . . . 0.0 111.683 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.446 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.0 m170 -67.57 -43.03 81.6 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.708 -1.245 . . . . 0.0 108.453 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -51.86 -55.6 19.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 44.5 m-80 -65.57 -45.34 83.67 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.977 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 57' ' ' THR . 28.1 tt0 -52.87 -39.01 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.582 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -71.64 -40.33 69.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.728 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 14.6 m-85 -154.3 -85.11 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.603 0.716 . . . . 0.0 109.973 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 90.53 31.53 10.29 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.3 t70 52.94 39.7 29.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -1.082 . . . . 0.0 109.476 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.472 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' MET . 8.2 t 53.34 98.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.437 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 3.0 ttt -62.45 -138.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . 143.95 -75.9 0.3 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.542 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.2 t 57.28 129.8 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.611 -0.935 . . . . 0.0 109.775 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.8 Cg_endo -74.49 163.41 36.17 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 109.024 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.543 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.8 mt -135.71 119.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.033 0.92 . . . . 0.0 109.26 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.541 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 15.3 t -57.14 117.34 3.93 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.776 0.798 . . . . 0.0 109.86 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.527 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.76 -2.2 5.9 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.541 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.21 -60.56 2.0 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -1.063 . . . . 0.0 109.364 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.28 -2.48 33.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.781 . . . . 0.0 109.151 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.609 HH11 ' HG3' ' A' ' 12' ' ' ARG . 6.6 mmm-85 59.75 40.51 19.58 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.278 -0.889 . . . . 0.0 108.768 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.66 150.14 46.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.543 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.8 Cg_exo -59.29 113.91 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.53 1.486 . . . . 0.0 110.568 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 8' ' ' CYS . 21.1 mt -70.34 158.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' CD ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -159.21 59.38 0.41 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.833 -1.167 . . . . 0.0 110.986 -178.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.06 -102.45 0.16 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.663 ' CG ' HH11 ' A' ' 18' ' ' ARG . 3.0 mtt-85 -111.19 121.3 44.93 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.6 t -98.72 157.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 111.038 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.1 t -120.62 115.15 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.534 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.631 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.71 160.19 41.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.671 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.1 mmt 57.52 16.39 3.29 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.8 22.44 78.2 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -125.75 -154.67 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.737 0.78 . . . . 0.0 109.753 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.428 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.7 mt-30 -136.29 142.8 43.96 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.527 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.0 m95 -141.77 140.63 33.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.569 -1.332 . . . . 0.0 110.448 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -56.44 139.44 49.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.9 t -57.64 -20.38 13.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 120.868 -1.145 . . . . 0.0 109.315 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.88 -16.69 21.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.483 -0.761 . . . . 0.0 110.627 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.4 m170 -101.43 -9.1 21.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.845 -1.159 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -80.15 104.98 11.08 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 40' ' ' PRO . 22.2 m -130.69 177.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 122.405 1.098 . . . . 0.0 111.499 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.3 t -66.96 148.56 51.8 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.661 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.5 30.48 1.3 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.243 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -139.65 -31.01 0.69 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.0 110.122 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 32.0 p -131.05 -18.59 2.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.364 -0.835 . . . . 0.0 110.192 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.2 mt-10 74.38 45.89 0.18 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 110.299 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -101.39 112.06 64.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.478 ' N ' HG13 ' A' ' 33' ' ' VAL . 10.1 Cg_endo -71.7 135.94 27.0 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.561 1.507 . . . . 0.0 111.401 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.46 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -93.28 55.69 2.33 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 41' ' ' PHE . 3.1 mp -40.64 -55.79 2.28 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.758 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.16 23.86 5.14 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -115.69 -164.52 0.96 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.285 -1.127 . . . . 0.0 109.843 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -107.7 154.11 21.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.579 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.1 p-80 -119.65 171.72 8.18 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.702 0.763 . . . . 0.0 109.265 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.0 m-85 -138.55 132.71 31.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.26 147.42 27.07 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.302 -0.874 . . . . 0.0 112.104 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.818 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -154.58 121.02 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 1.0 OUTLIER 62.5 29.15 17.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.505 -0.747 . . . . 0.0 109.902 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.671 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 74.4 31.34 59.18 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.1 mt -141.42 141.43 33.73 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.51 153.46 33.42 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 47' ' ' TYR . 54.9 m-85 -153.56 140.31 19.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 85.5 m -60.2 175.91 0.38 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.742 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 61.4 tt0 -60.96 -37.57 82.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.419 -0.801 . . . . 0.0 109.423 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.9 -43.02 12.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.581 -0.699 . . . . 0.0 111.663 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.477 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.0 m170 -67.0 -44.83 79.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.716 -1.24 . . . . 0.0 108.284 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.7 t80 -49.11 -54.92 13.98 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -67.9 -46.08 72.63 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.207 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.1 tp-100 -53.46 -33.64 54.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.27 -38.75 41.93 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.0 m-85 -160.37 -79.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.393 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.08 -9.4 77.47 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 2.1 m-20 54.71 59.97 3.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.394 -1.062 . . . . 0.0 109.5 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.455 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t 52.12 85.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -1.155 . . . . 0.0 109.374 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.7 mtm -145.66 144.92 30.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.843 . . . . 0.0 109.334 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.7 80.81 0.06 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t -153.92 128.69 4.82 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.191 -1.182 . . . . 0.0 109.435 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -76.31 163.61 32.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.194 1.93 . . . . 0.0 109.29 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.556 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.2 mt -134.73 119.0 27.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 122.027 0.918 . . . . 0.0 109.24 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 38.2 t -60.44 118.33 6.35 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.8 0.809 . . . . 0.0 110.141 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.531 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.94 -3.61 8.85 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -83.72 -46.59 12.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.488 -1.007 . . . . 0.0 109.449 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.44 -1.51 13.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 8' ' ' CYS . 26.8 mmt180 57.07 35.55 26.5 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 143.21 29.02 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.9 Cg_exo -55.88 113.8 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.306 1.338 . . . . 0.0 110.625 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' PRO . 12.9 mt -69.1 159.73 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -167.73 69.06 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.755 -1.215 . . . . 0.0 110.373 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.87 -64.22 0.17 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.51 HH21 ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -138.9 136.62 35.7 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.6 t -126.55 158.74 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.938 . . . . 0.0 110.787 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.6 t -131.51 117.16 34.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.616 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.2 m120 -87.26 105.76 17.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.127 -0.983 . . . . 0.0 109.588 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.32 160.13 41.98 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.638 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 9.2 mmt 57.84 17.77 4.47 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.19 18.5 76.67 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -124.25 -156.06 0.7 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.716 0.77 . . . . 0.0 109.699 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.477 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.3 mt-30 -134.15 144.49 48.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.531 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 53.7 m95 -142.28 139.39 31.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.499 -1.375 . . . . 0.0 110.526 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -55.13 138.97 43.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.7 t -58.63 -18.23 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 109.097 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.51 ' CD ' HH21 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -94.15 -21.37 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 110.189 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -99.51 -6.2 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 110.59 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -82.97 102.46 11.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.429 HG11 ' N ' ' A' ' 40' ' ' PRO . 22.4 m -127.2 176.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 122.241 1.019 . . . . 0.0 111.266 -177.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.604 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -63.43 148.75 47.68 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.584 178.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.11 27.58 1.83 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.38 -0.825 . . . . 0.0 109.352 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 3.3 tttm -134.21 -42.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 109.96 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.9 p -121.49 -15.99 7.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.674 -0.641 . . . . 0.0 110.476 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.1 mt-10 72.68 47.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 110.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -100.72 109.85 58.91 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.609 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 4.2 Cg_endo -67.76 138.36 44.73 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.756 1.637 . . . . 0.0 111.874 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.524 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.4 m-85 -95.46 59.97 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.609 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.81 -55.55 1.94 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.63 29.56 3.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -117.08 165.61 13.18 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 109.814 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -79.64 153.98 28.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.406 -0.809 . . . . 0.0 109.281 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.8 p-80 -118.92 169.47 9.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.277 -0.89 . . . . 0.0 109.83 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.7 m-85 -134.68 137.92 43.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -110.64 149.82 29.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -0.928 . . . . 0.0 111.464 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.632 ' NE ' ' CD2' ' A' ' 63' ' ' PHE . 13.4 tpt180 -147.09 131.39 17.51 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.413 0.625 . . . . 0.0 110.192 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 42.39 24.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.696 0.76 . . . . 0.0 109.584 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.638 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.35 31.21 12.0 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.845 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ARG . 19.2 mt -140.34 139.77 35.47 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.565 -0.962 . . . . 0.0 108.961 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.83 152.6 33.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.83 0.824 . . . . 0.0 110.94 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 56.2 m-85 -154.8 139.03 16.59 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 13.0 m -59.38 174.02 0.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.638 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.5 tp10 -59.5 -31.58 69.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.878 -1.139 . . . . 0.0 109.537 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 61' ' ' GLN . 88.6 m -86.26 -49.77 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 111.632 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.465 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.3 m170 -64.94 -41.14 95.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.877 -1.139 . . . . 0.0 108.407 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -53.3 -57.64 9.87 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.79 -44.94 91.85 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.119 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' THR . 6.5 tp60 -54.88 -34.94 63.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.548 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 5.3 mp -77.35 -33.06 55.45 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.438 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.632 ' CD2' ' NE ' ' A' ' 49' ' ' ARG . 19.2 m-85 -160.14 -83.36 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.362 -0.836 . . . . 0.0 110.196 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.68 31.5 44.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 t70 55.75 39.62 30.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.496 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.486 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.547 ' HG ' ' H ' ' A' ' 4' ' ' GLY . 46.7 t -75.52 125.18 28.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 109.498 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.1 tpt -69.04 -5.89 24.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.33 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.547 ' H ' ' HG ' ' A' ' 2' ' ' SER . . . 71.54 49.67 23.81 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t -74.89 129.62 82.88 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.186 -1.185 . . . . 0.0 109.389 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.0 Cg_endo -74.78 163.77 34.98 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.143 1.896 . . . . 0.0 109.044 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.54 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.0 mt -135.72 120.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 122.056 0.931 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 17.9 t -57.14 114.43 2.14 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.839 0.828 . . . . 0.0 109.899 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.535 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.84 -2.43 2.55 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.537 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -86.2 -59.79 2.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -1.08 . . . . 0.0 109.413 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.87 4.36 37.61 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.577 -0.702 . . . . 0.0 109.293 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.656 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.33 41.49 32.12 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.495 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -116.19 144.01 32.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.1 Cg_exo -56.81 113.17 1.34 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.332 1.355 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.449 HG13 ' H ' ' A' ' 8' ' ' CYS . 22.1 mt -69.19 158.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.614 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -166.3 67.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 110.299 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.6 -73.31 0.07 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -138.48 133.59 32.9 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.02 151.62 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.896 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.1 t -119.45 115.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.9 OUTLIER -88.57 106.16 18.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.047 -1.033 . . . . 0.0 109.583 -178.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.02 160.04 42.85 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.644 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.5 mmt 58.34 16.26 3.95 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.93 25.75 75.2 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.791 -2.123 . . . . 0.0 107.791 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -130.56 -154.56 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.931 0.872 . . . . 0.0 109.88 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.472 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.5 mt-30 -136.65 142.0 43.2 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.535 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.2 m95 -141.3 139.99 33.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.484 -1.385 . . . . 0.0 110.399 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -55.73 137.25 50.0 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.71 -17.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 120.848 -1.158 . . . . 0.0 109.044 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.31 -25.16 15.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.509 -0.744 . . . . 0.0 110.689 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -94.26 -8.52 38.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.804 -1.185 . . . . 0.0 110.364 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -80.34 106.7 12.55 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 40' ' ' PRO . 27.0 m -133.46 175.26 11.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.35 1.072 . . . . 0.0 111.184 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.03 148.58 47.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.385 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.3 28.84 1.56 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 109.608 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.9 tptt -139.8 -31.29 0.67 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.345 -0.847 . . . . 0.0 110.179 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 32.0 p -130.82 -8.92 3.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.121 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 33.2 mm-40 63.89 48.38 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 110.376 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -101.74 109.31 59.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.2 Cg_endo -68.6 138.65 42.32 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.81 1.673 . . . . 0.0 112.28 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.475 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.603 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.52 -55.59 1.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.307 -0.871 . . . . 0.0 109.494 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.11 30.27 2.84 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.496 ' N ' ' CD2' ' A' ' 44' ' ' HIS . 2.5 m-70 -114.36 -158.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.394 -1.062 . . . . 0.0 109.97 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -114.88 145.99 41.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.548 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.4 p-80 -117.43 167.42 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 0.0 109.666 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.715 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.4 m-85 -131.22 137.43 48.92 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -105.89 148.88 27.1 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.226 -0.921 . . . . 0.0 111.51 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.406 ' HB3' ' CD2' ' A' ' 54' ' ' TYR . 1.3 tmt_? -153.46 126.89 8.63 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.507 0.67 . . . . 0.0 109.991 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp 53.71 26.01 5.54 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.378 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.644 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 81.1 31.37 35.01 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 22.3 mt -141.92 141.64 32.99 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.734 -0.862 . . . . 0.0 108.723 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.35 152.94 34.23 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 47' ' ' TYR . 56.4 m-85 -153.71 140.05 18.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 99.0 m -56.85 178.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.36 -1.336 . . . . 0.0 108.473 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 62.5 tt0 -64.45 -36.47 84.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.2 m -86.59 -42.32 13.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 111.382 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.44 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.47 -43.42 81.07 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.794 -1.191 . . . . 0.0 108.207 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.469 ' O ' ' N ' ' A' ' 63' ' ' PHE . 5.4 t80 -52.85 -56.02 18.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 22.6 m-80 -63.76 -45.16 91.05 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.893 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 57' ' ' THR . 32.9 tt0 -53.38 -34.63 58.4 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 2.9 mp -79.29 -36.03 40.35 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.197 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -158.6 -84.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.128 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.03 -9.32 77.28 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.24 57.55 6.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.43 -1.041 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.492 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' H2 ' ' H ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.427 ' H ' ' H2 ' ' A' ' 1' ' ' GLY . 13.1 p -173.94 -173.87 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.459 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.3 mtp -49.73 135.15 19.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 109.436 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.57 -46.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.67 130.29 94.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.28 -1.13 . . . . 0.0 109.487 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.33 163.57 36.05 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.055 1.836 . . . . 0.0 108.858 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.54 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.5 mt -135.13 120.25 29.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 122.028 0.918 . . . . 0.0 109.33 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.544 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 15.3 t -57.81 116.64 3.58 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.768 0.794 . . . . 0.0 110.036 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.529 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.22 -1.69 4.47 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.88 -56.33 3.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -1.071 . . . . 0.0 109.474 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -107.45 4.27 26.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.254 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 53.78 42.08 31.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.667 HH11 ' CG ' ' A' ' 13' ' ' ARG . 2.3 mtt-85 -116.4 144.09 32.42 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.7 Cg_exo -56.56 113.15 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.45 1.433 . . . . 0.0 110.472 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.444 HG13 ' H ' ' A' ' 8' ' ' CYS . 23.8 mt -70.74 158.43 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -160.73 61.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 110.679 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.38 -101.8 0.15 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.11 40.43 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.0 t -98.16 157.94 3.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 111.149 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 t -122.2 115.86 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.61 106.27 18.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 109.569 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.57 43.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.65 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.74 17.02 4.82 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.31 28.44 71.36 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -133.89 -154.41 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.919 0.866 . . . . 0.0 109.945 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.445 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.9 mt-30 -135.98 142.78 44.56 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.529 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.6 m95 -141.38 139.26 33.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.508 -1.37 . . . . 0.0 110.612 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -55.63 137.95 48.13 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.5 t -57.24 -19.51 10.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.44 -18.53 20.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.41 -0.806 . . . . 0.0 110.63 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -100.67 -7.01 24.32 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.886 -1.133 . . . . 0.0 110.231 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -83.03 102.46 11.79 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 40' ' ' PRO . 23.5 m -126.27 176.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.414 1.102 . . . . 0.0 111.266 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -66.47 149.41 50.47 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.656 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.34 24.96 3.15 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.6 tptp -132.63 -30.68 1.42 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.389 -0.819 . . . . 0.0 109.725 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.2 p -133.5 -10.18 2.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.375 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 65.55 48.24 2.05 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.321 -0.862 . . . . 0.0 110.399 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -101.11 110.4 61.14 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 3.6 Cg_endo -67.16 138.51 47.47 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.723 1.616 . . . . 0.0 111.81 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.9 m-85 -95.35 60.06 2.24 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.608 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.86 -55.38 1.99 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.484 -0.76 . . . . 0.0 109.257 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.98 30.8 2.79 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.446 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -117.31 167.08 11.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.484 -1.01 . . . . 0.0 109.912 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -82.37 151.86 26.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.0 109.151 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.586 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 15.3 p-80 -117.88 169.77 9.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 109.838 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.0 m-85 -133.85 136.67 44.55 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -111.03 140.24 45.73 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.321 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.707 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -146.68 137.66 24.1 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.485 0.659 . . . . 0.0 110.17 178.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt 51.9 22.19 1.69 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.002 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.65 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 80.25 31.04 39.36 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' ARG . 25.6 mt -140.27 143.68 36.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.71 151.67 34.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.73 0.776 . . . . 0.0 110.858 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.501 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 58.8 m-85 -153.12 137.13 16.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.6 m -57.22 174.67 0.18 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.369 -1.332 . . . . 0.0 108.276 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 64.9 tt0 -60.66 -34.85 74.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.202 -0.936 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.8 -43.64 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.63 -0.669 . . . . 0.0 111.638 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.454 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.2 m170 -67.43 -44.38 78.89 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.729 -1.232 . . . . 0.0 108.377 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -50.39 -54.98 17.73 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -66.69 -45.72 77.91 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.061 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 57' ' ' THR . 3.9 tp-100 -53.49 -38.23 63.48 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.587 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.4 mp -71.07 -39.57 72.14 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.707 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.8 m-85 -154.74 -84.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.625 0.726 . . . . 0.0 109.967 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.95 31.34 23.71 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 66' ' ' VAL . 16.2 t0 -173.11 88.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -1.053 . . . . 0.0 109.467 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.459 ' C ' ' O ' ' A' ' 65' ' ' ASP . 14.6 p . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.034 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 m -65.06 -157.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -1.182 . . . . 0.0 109.402 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.2 mmt -50.68 166.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -172.77 -143.44 4.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.1 t 57.5 122.87 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.498 -1.001 . . . . 0.0 109.974 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.43 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -78.39 164.42 26.43 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.664 2.243 . . . . 0.0 109.31 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.545 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.9 mt -135.52 123.17 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.866 0.841 . . . . 0.0 109.622 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 13.8 t -63.32 118.15 7.63 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.824 0.821 . . . . 0.0 109.884 -178.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.507 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.27 0.12 6.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.54 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -86.77 -36.23 18.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -1.096 . . . . 0.0 109.563 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.04 4.38 4.87 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.668 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.79 41.01 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -114.79 141.75 27.28 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.545 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.3 Cg_exo -56.76 114.39 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.41 1.407 . . . . 0.0 110.86 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 6' ' ' PRO . 21.7 mt -71.96 159.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -160.73 61.92 0.31 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.746 -1.221 . . . . 0.0 110.964 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.66 -103.31 0.17 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -110.0 121.1 44.46 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.7 t -98.52 158.0 3.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.344 -0.847 . . . . 0.0 110.98 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.6 t -120.81 112.94 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -88.98 106.61 18.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.181 -0.95 . . . . 0.0 109.801 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -143.51 158.96 43.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.641 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.6 mmt 58.74 14.52 3.22 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 72.74 21.52 79.62 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -125.08 -154.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.835 0.826 . . . . 0.0 109.749 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -135.0 145.11 47.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.507 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 66.0 m95 -142.6 135.66 28.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.672 -1.267 . . . . 0.0 110.181 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -53.55 135.61 39.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.4 t -55.0 -21.24 7.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 120.918 -1.114 . . . . 0.0 109.548 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 30' ' ' GLU . 6.5 pm0 -95.02 -20.02 19.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 110.679 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -97.34 -9.78 26.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.813 -1.179 . . . . 0.0 110.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -78.42 105.58 9.77 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 40' ' ' PRO . 24.5 m -134.04 176.54 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.219 1.009 . . . . 0.0 111.032 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -62.63 148.01 47.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.22 32.03 1.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -140.25 -41.55 0.42 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.467 -0.77 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.5 p -119.3 -18.95 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.574 -0.704 . . . . 0.0 110.309 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.6 mt-10 75.51 48.04 0.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -100.84 106.97 47.13 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.59 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.3 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.801 1.667 . . . . 0.0 112.355 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.482 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.14 56.98 1.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.59 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.29 -55.57 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.437 ' C ' ' HD1' ' A' ' 44' ' ' HIS . . . -135.04 31.27 2.72 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -115.23 -163.27 0.87 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -1.0 . . . . 0.0 109.984 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -111.09 145.52 38.42 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.559 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 35.1 p-80 -117.69 170.03 9.11 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.019 0.914 . . . . 0.0 109.88 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.5 m-85 -134.29 135.28 42.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -112.15 150.56 30.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.076 -1.015 . . . . 0.0 111.303 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.66 132.69 19.23 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.691 0.758 . . . . 0.0 110.378 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.0 mttm 50.34 20.65 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.558 -0.714 . . . . 0.0 109.422 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.641 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.31 30.96 12.43 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.332 -1.414 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -141.73 137.95 32.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -72.59 151.72 42.2 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.05 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.664 ' N ' ' O ' ' A' ' 47' ' ' TYR . 45.4 m-85 -153.46 139.47 18.24 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.9 m -56.8 -179.82 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.516 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.5 tt0 -65.32 -36.94 85.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.9 m -86.99 -42.52 13.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 0.0 111.475 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.446 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -66.23 -43.74 85.78 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.209 . . . . 0.0 108.325 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.46 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.0 t80 -52.78 -56.73 13.54 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -63.8 -44.51 93.11 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.196 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 57' ' ' THR . 11.8 tt0 -55.1 -34.28 63.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.538 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 4.9 mp -78.76 -35.01 45.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.383 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 19.2 m-85 -158.52 -81.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.107 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.05 31.43 14.68 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 50.4 43.6 26.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -1.124 . . . . 0.0 109.437 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.446 179.96 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 4' ' ' GLY . 31.5 m -170.22 96.71 0.26 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -1.127 . . . . 0.0 109.442 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.9 mmt -63.97 75.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 2' ' ' SER . . . -83.63 -133.09 2.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.0 t 57.09 116.22 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.423 -1.045 . . . . 0.0 110.01 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.429 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.1 Cg_endo -80.19 164.66 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.796 2.33 . . . . 0.0 109.248 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.526 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.6 mt -135.8 123.03 34.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.831 0.825 . . . . 0.0 109.553 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 14.5 t -63.09 118.01 7.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.766 0.793 . . . . 0.0 109.929 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.501 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.12 0.2 6.52 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -87.1 -35.81 18.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -1.095 . . . . 0.0 109.618 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.51 4.4 4.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.666 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.87 41.33 32.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.643 HH11 ' CG ' ' A' ' 13' ' ' ARG . 2.0 mtt-85 -115.32 140.86 26.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.526 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.8 Cg_exo -55.27 114.01 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.444 1.43 . . . . 0.0 110.84 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 6' ' ' PRO . 22.4 mt -71.64 158.39 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -159.38 59.73 0.39 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.798 -1.189 . . . . 0.0 110.945 -178.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.57 -102.27 0.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -110.48 122.37 47.57 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.5 t -98.56 156.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 111.119 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 t -119.37 111.91 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.475 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.1 m-80 -87.02 106.51 17.89 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.42 43.3 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.61 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 58.26 16.39 3.96 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.98 28.69 70.1 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -135.86 -154.45 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.807 0.813 . . . . 0.0 109.846 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -133.77 145.47 49.83 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.501 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.3 m95 -143.0 135.94 27.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.648 -1.283 . . . . 0.0 110.18 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -53.69 135.76 40.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.9 t -54.6 -20.8 5.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.911 -1.118 . . . . 0.0 109.275 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.21 -22.76 18.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 110.674 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -96.5 -7.44 34.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.826 -1.171 . . . . 0.0 110.28 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -82.45 103.65 12.16 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 m -127.27 178.66 4.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.336 1.065 . . . . 0.0 111.057 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -69.31 148.75 49.29 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.883 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -89.9 25.55 2.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.7 tptt -135.83 -32.15 0.9 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.399 -0.813 . . . . 0.0 110.054 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.3 p -129.45 -7.6 4.69 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 110.164 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 59.1 42.61 18.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.222 -0.923 . . . . 0.0 109.483 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -99.07 108.47 49.71 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 2.6 Cg_endo -65.11 140.37 65.06 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.748 1.632 . . . . 0.0 112.343 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.7 m-85 -96.15 61.27 2.07 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.603 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 9.8 mp -40.32 -55.86 2.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 109.82 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.82 26.18 4.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -116.61 159.81 21.61 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.417 -1.049 . . . . 0.0 109.685 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.629 ' NE ' ' HH ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -77.08 159.21 30.0 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.49 ' HB3' ' CD2' ' A' ' 41' ' ' PHE . 8.9 p-80 -116.95 172.7 7.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.6 m-85 -136.02 128.71 30.83 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.46 150.72 23.6 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.95 0.881 . . . . 0.0 111.772 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.67 ' NH2' ' NZ ' ' A' ' 50' ' ' LYS . 0.8 OUTLIER -143.82 134.16 24.58 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.394 0.616 . . . . 0.0 109.548 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.67 ' NZ ' ' NH2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER 37.45 25.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.643 0.735 . . . . 0.0 109.973 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.61 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.42 30.95 9.29 Favored Glycine 0 N--CA 1.481 1.675 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.583 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.8 mt -142.17 140.26 32.33 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.335 -1.097 . . . . 0.0 108.728 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.86 150.75 39.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.899 0.856 . . . . 0.0 110.967 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 53.1 m-85 -154.04 137.22 15.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 93.2 m -56.16 178.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.393 -1.323 . . . . 0.0 108.696 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 39.7 tt0 -61.71 -39.33 91.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.371 -0.83 . . . . 0.0 109.782 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' GLN . 46.3 m -86.23 -40.9 15.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 111.804 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.45 -44.81 77.77 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.676 -1.265 . . . . 0.0 108.235 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.9 t80 -51.82 -55.85 17.46 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -64.03 -46.09 85.98 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 57' ' ' THR . 16.8 tt0 -53.23 -35.0 59.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.552 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 mp -77.51 -40.57 42.34 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.342 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.8 m-85 -152.78 -84.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.313 -0.867 . . . . 0.0 110.301 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 65' ' ' ASP . . . 68.3 -11.46 1.09 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 63' ' ' PHE . 0.7 OUTLIER 168.4 -92.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -1.08 . . . . 0.0 109.312 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 66' ' ' VAL . 11.8 p . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.169 -0.92 . . . . 0.0 109.994 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 2' ' ' SER . 12.4 t -175.28 42.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 109.444 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.9 mmt -79.71 -175.91 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.429 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.78 -167.34 21.13 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t -154.93 132.92 6.69 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.215 -1.168 . . . . 0.0 109.54 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.473 ' O ' ' N ' ' A' ' 15' ' ' ILE . 3.9 Cg_endo -72.2 163.63 38.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.759 1.639 . . . . 0.0 108.404 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.54 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.0 mt -134.29 120.4 33.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 122.172 0.987 . . . . 0.0 109.361 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 14.2 t -58.5 117.03 4.06 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.815 0.817 . . . . 0.0 110.048 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.533 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.84 -1.39 4.99 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -86.01 -52.94 5.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -1.084 . . . . 0.0 109.395 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.45 4.66 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.582 -0.699 . . . . 0.0 109.169 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.38 42.46 32.02 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -116.75 143.23 31.02 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.7 Cg_exo -55.16 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.723 1.615 . . . . 0.0 110.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 6' ' ' PRO . 27.1 mt -72.09 158.56 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.29 61.38 0.28 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.725 -1.234 . . . . 0.0 110.766 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.34 -102.42 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -111.38 121.59 45.61 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.26 159.02 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -0.8 . . . . 0.0 111.252 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.39 115.74 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.536 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.2 m-80 -89.92 106.35 18.41 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.097 -1.002 . . . . 0.0 109.694 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.77 159.43 43.2 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.79 16.83 4.74 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.87 73.41 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -131.71 -154.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.457 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.9 mt-30 -135.97 142.96 44.61 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.533 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.0 m95 -141.3 138.41 33.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.589 -1.319 . . . . 0.0 110.504 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -54.52 138.01 41.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 t -57.26 -18.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 O-C-N 120.878 -1.139 . . . . 0.0 109.319 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -96.36 -22.29 17.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 110.667 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -96.1 -9.22 31.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.863 -1.148 . . . . 0.0 110.398 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -80.07 105.95 11.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 40' ' ' PRO . 25.4 m -133.21 175.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.266 1.032 . . . . 0.0 111.12 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.56 149.05 44.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.086 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.57 24.51 3.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 14.6 tppt? -134.19 -33.43 1.01 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.2 p -125.8 -19.74 4.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.8 mt-10 76.22 46.5 0.09 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.302 -0.874 . . . . 0.0 110.449 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.75 110.27 60.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.6 Cg_endo -68.79 138.06 40.02 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.726 1.618 . . . . 0.0 112.11 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.31 -55.36 1.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.31 29.44 3.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.86 -177.73 3.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -1.03 . . . . 0.0 109.963 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -97.05 145.63 25.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.744 . . . . 0.0 109.356 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.567 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -116.28 170.21 8.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.87 137.51 46.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -106.78 147.76 29.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.263 -0.898 . . . . 0.0 111.402 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.66 129.48 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.613 0.721 . . . . 0.0 110.208 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.626 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 51.0 mttp 51.82 23.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 30.8 24.26 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -142.77 143.21 32.11 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.623 -0.928 . . . . 0.0 108.844 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.54 152.86 35.87 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.43 -0.794 . . . . 0.0 110.797 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 58.7 m-85 -153.97 140.33 18.66 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 89.8 m -57.61 176.75 0.12 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.619 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 56.3 tt0 -63.33 -35.7 81.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.337 -0.852 . . . . 0.0 109.312 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' GLN . 52.6 m -86.52 -43.64 12.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.345 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.483 ' O ' ' N ' ' A' ' 62' ' ' LEU . 32.6 m170 -66.8 -45.59 77.9 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.765 -1.209 . . . . 0.0 108.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.4 t80 -49.48 -55.85 11.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -65.67 -45.82 81.47 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.073 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' THR . 7.0 tp-100 -54.93 -33.25 62.03 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.546 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -78.62 -35.28 45.79 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.138 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.626 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 16.8 m-85 -158.59 -80.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.005 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 65' ' ' ASP . . . 84.14 -9.3 64.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 64' ' ' GLY . 4.8 p-10 41.35 46.87 2.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.607 -0.937 . . . . 0.0 109.878 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.445 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 t -173.07 6.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.229 -1.159 . . . . 0.0 109.516 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.8 mtt -152.73 63.98 0.79 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.34 40.54 0.48 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 1.9 t -153.92 119.06 2.74 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.128 . . . . 0.0 109.662 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ILE . 10.1 Cg_endo -80.44 164.32 21.44 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.686 2.258 . . . . 0.0 109.862 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 14' ' ' PRO . 38.9 mt -135.08 120.15 28.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.995 0.902 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 38.3 t -62.68 116.09 4.88 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.826 0.822 . . . . 0.0 110.048 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.523 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -62.59 -3.54 5.72 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.524 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -87.28 -33.02 19.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.403 -1.057 . . . . 0.0 109.266 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 0.9 7.15 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 8' ' ' CYS . 21.1 mmm180 50.92 34.35 10.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -115.24 137.32 22.94 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.53 ' HA ' HG12 ' A' ' 7' ' ' ILE . 7.1 Cg_exo -51.65 114.56 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.075 1.183 . . . . 0.0 111.056 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 6' ' ' PRO . 11.5 mt -69.31 160.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -169.25 69.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.264 . . . . 0.0 110.403 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.31 -59.06 0.24 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.5 133.13 30.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.5 t -127.03 157.92 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.084 -1.01 . . . . 0.0 110.74 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 t -132.43 116.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.684 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.032 -1.042 . . . . 0.0 109.389 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . . . -144.34 157.63 44.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.409 -0.807 . . . . 0.0 108.985 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.678 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 58.02 19.36 5.87 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.95 13.72 72.69 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -118.95 -156.76 0.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.7 0.762 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.525 HE21 ' H ' ' A' ' 7' ' ' ILE . 1.9 mt-30 -133.61 144.67 49.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.523 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 50.0 m95 -142.23 140.73 32.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.58 -1.325 . . . . 0.0 110.411 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -54.43 141.93 28.95 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 t -62.26 -18.4 20.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.684 -1.26 . . . . 0.0 109.496 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -20.45 20.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 110.438 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.43 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.9 m170 -101.86 -6.32 23.7 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.171 -0.955 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.429 ' CZ ' ' CB ' ' A' ' 22' ' ' ALA . 31.0 t80 -81.45 106.18 13.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 40' ' ' PRO . 24.7 m -133.19 175.11 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.296 1.046 . . . . 0.0 111.508 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -63.03 149.47 44.93 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.298 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.59 26.6 2.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.103 -0.998 . . . . 0.0 109.848 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.9 tptp -135.44 -31.34 0.97 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.382 -0.824 . . . . 0.0 109.917 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.0 p -129.82 -16.39 3.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 72.75 47.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.15 109.69 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.589 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.8 Cg_endo -69.25 137.38 36.8 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.758 1.639 . . . . 0.0 112.031 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.05 57.93 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.589 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.22 -55.4 1.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.251 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.5 3.01 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.62 -174.81 2.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.396 -1.061 . . . . 0.0 109.939 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -98.71 147.37 24.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.59 -0.693 . . . . 0.0 109.363 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.589 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-80 -119.41 169.43 10.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 109.551 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.724 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -132.51 137.24 47.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.59 143.43 41.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.242 -0.911 . . . . 0.0 111.581 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.672 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -150.22 136.59 18.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.442 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 51.47 21.33 1.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.633 -0.667 . . . . 0.0 109.282 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.678 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.1 31.28 29.0 Favored Glycine 0 C--N 1.295 -1.709 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.3 mt -142.27 142.13 32.54 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.71 -0.876 . . . . 0.0 108.84 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.28 152.63 36.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.415 -0.803 . . . . 0.0 110.671 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.522 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 55.2 m-85 -153.11 138.71 17.79 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 88.1 m -58.0 176.58 0.15 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.432 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.696 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.6 tp10 -63.46 -36.3 83.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.137 -0.977 . . . . 0.0 109.061 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 61' ' ' GLN . 32.6 m -85.73 -41.0 15.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 111.279 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.436 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -69.45 -45.35 69.28 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.723 -1.235 . . . . 0.0 108.207 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -51.17 -54.43 25.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 93.2 m-20 -65.55 -46.99 77.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.135 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' THR . 14.9 tt0 -52.31 -40.19 61.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.3 mp -68.93 -39.09 79.79 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.672 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.5 m-85 -155.34 -87.61 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.802 0.81 . . . . 0.0 110.001 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.46 -9.42 55.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' O ' ' OXT' ' A' ' 66' ' ' VAL . 24.9 t70 -173.43 89.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -1.087 . . . . 0.0 109.553 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.436 ' OXT' ' O ' ' A' ' 65' ' ' ASP . 2.7 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.447 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -74.9 127.13 32.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -1.098 . . . . 0.0 109.463 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -176.17 67.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.464 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -159.43 -162.5 12.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.501 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.0 t 57.21 119.71 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.103 . . . . 0.0 109.866 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' O ' ' N ' ' A' ' 15' ' ' ILE . 8.4 Cg_endo -79.21 164.2 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.65 2.233 . . . . 0.0 109.65 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' A' ' 14' ' ' PRO . 35.3 mt -134.86 119.69 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.035 0.921 . . . . 0.0 109.419 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 35.2 t -58.38 114.55 2.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.742 0.782 . . . . 0.0 109.828 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.545 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.63 -4.37 4.0 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.517 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -84.41 -59.47 2.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.397 -1.061 . . . . 0.0 109.393 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.29 -0.2 38.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.239 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.667 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 55.74 38.8 30.55 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.2 -0.937 . . . . 0.0 108.758 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.81 149.07 44.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.0 Cg_exo -58.63 113.69 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.3 1.334 . . . . 0.0 110.713 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.449 HG13 ' H ' ' A' ' 8' ' ' CYS . 15.3 mt -68.54 159.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -168.62 69.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.894 -1.129 . . . . 0.0 110.271 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.44 -62.99 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.31 137.15 35.57 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -126.15 151.89 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.1 -1.0 . . . . 0.0 110.376 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.48 116.35 48.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.67 105.43 17.67 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.093 -1.005 . . . . 0.0 109.703 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.41 160.22 41.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.558 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 13.1 mmt 57.5 14.71 2.39 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.1 13.78 79.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -115.24 -155.55 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.805 0.812 . . . . 0.0 109.678 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.489 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.7 mt-30 -136.28 141.94 43.91 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.545 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 51.4 m95 -141.29 139.37 33.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.554 -1.341 . . . . 0.0 110.204 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -54.8 140.58 35.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.31 -18.2 13.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.675 -1.265 . . . . 0.0 109.201 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -95.31 -24.8 16.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -94.08 -9.34 36.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.792 -1.193 . . . . 0.0 110.271 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -79.36 105.94 11.03 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.411 HG11 ' N ' ' A' ' 40' ' ' PRO . 25.3 m -134.85 176.34 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.34 1.066 . . . . 0.0 111.209 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.63 148.22 49.5 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.282 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.43 28.63 1.91 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.438 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.8 -31.07 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.452 -0.78 . . . . 0.0 109.976 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 22.6 p -131.66 -15.18 3.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.271 -0.893 . . . . 0.0 110.379 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.2 48.18 0.26 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.361 -0.837 . . . . 0.0 110.551 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -102.74 109.21 60.55 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.1 Cg_endo -69.05 138.26 39.62 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.9 58.07 1.88 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.602 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.23 -55.62 1.65 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.455 ' C ' ' HD1' ' A' ' 44' ' ' HIS . . . -135.76 31.8 2.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.501 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 1.1 m-70 -115.85 -163.82 0.92 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.515 -0.991 . . . . 0.0 110.1 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -109.94 147.07 34.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.543 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 29.0 p-80 -119.07 169.67 9.71 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.141 0.972 . . . . 0.0 109.889 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.724 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.4 m-85 -132.99 136.72 46.22 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.402 ' CD ' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -117.82 154.01 32.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.846 -1.159 . . . . 0.0 112.102 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -143.31 131.85 22.36 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.63 0.729 . . . . 0.0 109.727 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.4 ptpt 45.15 23.12 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.751 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 91.31 29.35 12.54 Favored Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.025 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 49' ' ' ARG . 16.6 mt -137.02 132.27 34.03 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.446 -1.032 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.81 0.814 . . . . 0.0 111.207 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' TYR . 50.6 m-85 -152.15 139.35 19.3 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.472 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.5 m -56.12 -179.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.693 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 5.9 tm-20 -66.67 -37.73 85.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.024 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 61' ' ' GLN . 38.2 m -86.83 -40.23 15.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.572 -0.705 . . . . 0.0 111.525 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.68 -44.38 74.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 108.272 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.0 t80 -51.19 -54.84 21.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -65.42 -46.07 81.44 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.121 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.4 tp-100 -53.07 -36.89 61.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 2.4 mp -74.4 -32.35 62.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.654 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 22.4 m-85 -162.59 -86.5 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.832 0.825 . . . . 0.0 109.95 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.19 31.52 14.1 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 52.11 39.81 27.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -1.097 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.52 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 t -178.95 115.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -1.174 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.0 ttm -64.11 -128.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.49 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -179.02 -123.75 0.84 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 4' ' ' GLY . 1.8 t 57.18 117.06 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.373 -1.075 . . . . 0.0 109.964 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 15' ' ' ILE . 8.5 Cg_endo -80.35 164.6 21.52 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.738 2.292 . . . . 0.0 109.655 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.0 mt -134.27 119.93 32.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.977 0.894 . . . . 0.0 109.35 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 36.9 t -63.79 121.19 13.39 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.844 0.831 . . . . 0.0 110.096 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -65.3 -3.83 14.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.509 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.0 -32.58 22.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -1.04 . . . . 0.0 109.353 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 1.42 5.49 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.648 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 50.71 34.46 9.99 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.667 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -113.64 138.85 22.79 Favored Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.4 Cg_exo -53.27 114.69 1.86 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.301 1.334 . . . . 0.0 111.311 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' PRO . 13.7 mt -70.03 159.37 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -161.33 63.57 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.818 -1.177 . . . . 0.0 110.365 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.33 -98.22 0.11 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.645 ' CG ' HH11 ' A' ' 18' ' ' ARG . 3.4 mtt-85 -115.44 130.71 56.97 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.2 t -111.32 160.7 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.907 0.861 . . . . 0.0 111.472 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.4 t -127.13 116.82 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.1 106.15 18.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.64 158.41 43.69 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.668 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.8 mmt 58.16 17.52 4.63 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.86 76.04 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -120.37 -155.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.791 0.805 . . . . 0.0 109.724 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.499 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.3 mt-30 -135.8 144.85 45.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 58.3 m95 -142.63 140.54 31.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.594 -1.316 . . . . 0.0 110.359 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -55.83 138.46 48.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 t -58.01 -19.05 11.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 120.746 -1.221 . . . . 0.0 109.164 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -96.27 -3.14 44.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 110.418 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.59 -10.39 11.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.026 -1.046 . . . . 0.0 110.145 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -78.79 105.82 10.36 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 40' ' ' PRO . 26.4 m -133.45 174.98 12.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.252 1.025 . . . . 0.0 111.215 -177.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -61.7 149.31 40.02 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.483 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.75 27.65 2.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 35.1 tptt -138.87 -32.06 0.7 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.251 -0.906 . . . . 0.0 110.197 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.8 p -128.27 -16.5 4.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.198 -0.939 . . . . 0.0 110.298 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 73.43 47.31 0.18 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.353 -0.842 . . . . 0.0 110.192 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.49 109.96 60.44 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.588 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 5.9 Cg_endo -69.3 137.17 36.14 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.889 1.726 . . . . 0.0 112.242 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.34 58.83 1.82 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.588 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.11 -55.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.917 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.59 31.53 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -113.43 -178.12 3.3 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -1.033 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.409 ' O ' ' CE1' ' A' ' 47' ' ' TYR . 5.5 tpp180 -98.83 129.51 45.22 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.2 p-80 -101.3 175.82 5.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.012 . . . . 0.0 110.147 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.673 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.7 m-85 -135.88 136.47 40.57 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -108.6 148.16 30.76 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.297 -0.877 . . . . 0.0 111.428 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.729 HH22 ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -153.03 127.57 9.35 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.467 0.651 . . . . 0.0 110.411 179.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' CB ' ' NZ ' ' A' ' 50' ' ' LYS . 8.3 mtmp? 54.45 23.88 4.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.668 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.55 31.7 26.68 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.9 mt -143.76 141.9 30.66 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.663 -0.904 . . . . 0.0 108.926 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.81 153.16 33.06 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 110.651 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.705 ' CG ' ' NH2' ' A' ' 49' ' ' ARG . 59.6 m-85 -153.78 139.38 17.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 87.8 m -57.36 175.04 0.17 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.208 -1.397 . . . . 0.0 108.313 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -62.39 -34.59 77.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.042 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 61' ' ' GLN . 54.0 m -86.44 -44.09 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 111.155 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.477 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.2 m170 -67.25 -42.58 83.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.81 -1.156 . . . . 0.0 107.966 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.729 ' HA ' HH22 ' A' ' 49' ' ' ARG . 5.5 t80 -51.79 -55.63 18.65 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.411 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 49.9 m-80 -67.14 -43.99 80.97 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.425 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' THR . 34.9 tt0 -54.29 -37.82 65.19 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.576 HD22 ' NH2' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -75.58 -35.57 60.57 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.452 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.2 m-85 -155.03 -81.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 110.104 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 83.75 31.69 26.17 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 52.1 79.57 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -1.07 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.403 179.911 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 t -165.5 -16.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -1.155 . . . . 0.0 109.414 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.7 mtt -56.28 -176.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.29 -38.16 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t -145.22 131.32 9.64 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.04 163.64 36.29 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.939 1.76 . . . . 0.0 108.916 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.22 120.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.116 0.96 . . . . 0.0 109.408 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 10' ' ' ALA . 19.4 t -58.35 116.15 3.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.778 0.799 . . . . 0.0 109.987 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.542 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.2 -2.11 4.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.537 ' CB ' ' SG ' ' A' ' 8' ' ' CYS . . . -85.29 -53.05 5.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -1.072 . . . . 0.0 109.429 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.54 5.36 19.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.665 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.09 42.08 32.18 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -116.16 143.2 30.54 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HA ' HG12 ' A' ' 7' ' ' ILE . 4.9 Cg_exo -56.05 112.56 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.504 1.469 . . . . 0.0 110.252 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.447 HG13 ' H ' ' A' ' 8' ' ' CYS . 22.7 mt -69.65 158.02 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.684 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -160.91 62.73 0.3 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.874 -1.141 . . . . 0.0 110.441 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.0 -98.73 0.12 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 125.18 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.74 152.62 6.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.735 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -118.2 115.08 47.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 21' ' ' ASN . 1.0 OUTLIER -88.69 106.16 18.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 109.747 -178.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.95 160.03 42.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.679 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.2 mmt 58.12 16.44 3.86 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.6 20.66 77.38 Favored Glycine 0 C--N 1.291 -1.925 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -123.44 -153.97 0.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.974 0.892 . . . . 0.0 109.94 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.491 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.0 mt-30 -136.9 142.45 42.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.542 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 57.0 m95 -141.45 139.75 33.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.534 -1.354 . . . . 0.0 110.503 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -55.91 137.05 51.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 t -55.98 -19.33 6.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.822 -1.174 . . . . 0.0 109.119 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.456 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -94.08 -27.2 16.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.464 -0.772 . . . . 0.0 110.497 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -93.56 -7.08 45.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.08 . . . . 0.0 110.674 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -81.69 105.7 13.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 40' ' ' PRO . 24.1 m -133.76 175.85 10.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 122.303 1.049 . . . . 0.0 111.249 -177.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.539 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.06 149.29 45.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.389 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.47 28.88 1.84 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.756 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 tptp -138.55 -31.68 0.73 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.416 -0.802 . . . . 0.0 110.057 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.6 p -129.43 -18.54 3.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.1 mt-10 75.26 47.28 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.308 -0.87 . . . . 0.0 110.064 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.98 107.67 50.84 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.592 ' HB2' ' CD1' ' A' ' 42' ' ' LEU . 4.9 Cg_endo -67.19 137.95 45.55 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.628 1.552 . . . . 0.0 112.179 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.15 58.46 1.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.01 -55.56 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 31.45 2.66 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.18 -176.29 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.418 -1.049 . . . . 0.0 110.224 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HG3' ' CZ ' ' A' ' 47' ' ' TYR . 5.8 tpp180 -99.37 136.01 39.94 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -108.23 173.2 6.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.833 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.684 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -134.59 141.48 46.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -110.75 151.46 27.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.176 -0.952 . . . . 0.0 111.788 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.732 ' HE ' ' N ' ' A' ' 50' ' ' LYS . 1.4 tpm_? -156.07 129.41 8.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.349 0.595 . . . . 0.0 109.808 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.732 ' N ' ' HE ' ' A' ' 49' ' ' ARG . 8.6 mmtp 53.17 22.96 2.84 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 178.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.679 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.03 31.39 32.04 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.6 mt -140.69 141.55 34.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.27 154.13 33.25 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.632 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.557 ' CD2' ' HB3' ' A' ' 49' ' ' ARG . 53.1 m-85 -154.33 140.25 18.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.1 m -57.34 176.7 0.11 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.156 -1.418 . . . . 0.0 108.234 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.584 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -63.83 -35.46 80.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 109.462 179.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 61' ' ' GLN . 46.3 m -86.23 -41.32 14.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 111.115 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -68.56 -43.96 75.47 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.729 -1.232 . . . . 0.0 107.863 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -53.28 -56.48 16.26 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -63.69 -44.05 94.84 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.528 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' THR . 10.2 mm100 -56.26 -37.05 69.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 3.4 mp -73.71 -32.58 63.97 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.35 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.6 m-85 -160.08 -83.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.971 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 65' ' ' ASP . . . 78.95 -10.6 32.36 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 1.6 m-20 -179.43 -93.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 109.208 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.487 -179.945 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.25 163.61 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.958 1.772 . . . . 0.0 108.867 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.4 119.77 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 122.059 0.933 . . . . 0.0 109.402 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.0 t -58.35 117.0 3.98 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.844 0.831 . . . . 0.0 109.946 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -64.85 -0.17 4.91 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.67 -48.55 8.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -1.095 . . . . 0.0 109.36 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.8 13.7 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.649 ' HG3' HH11 ' A' ' 12' ' ' ARG . 8.2 mmm-85 53.52 41.32 32.11 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -115.91 143.45 30.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.7 Cg_exo -56.46 113.38 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.46 1.44 . . . . 0.0 110.546 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.661 HG21 HG22 ' A' ' 19' ' ' VAL . 21.5 mt -70.92 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.429 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.2 pt-20 -160.54 61.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.863 -1.148 . . . . 0.0 110.662 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.673 HH11 ' CG ' ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.66 42.32 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 15' ' ' ILE . 42.8 t -98.8 158.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.668 0.746 . . . . 0.0 111.195 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 32' ' ' PHE . 4.9 t -122.56 116.01 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.85 106.09 18.24 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.11 -0.993 . . . . 0.0 109.553 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.53 42.63 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.9 mmt 58.09 17.19 4.31 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.2 25.28 75.85 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.8 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.741 0.781 . . . . 0.0 109.764 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.466 ' HG2' HG11 ' A' ' 19' ' ' VAL . 20.6 mt-30 -135.38 143.49 46.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.3 m95 -141.59 139.98 33.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.534 -1.354 . . . . 0.0 110.616 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.3 m80 -56.48 131.95 49.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 18' ' ' ARG . 7.7 t -53.22 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.871 -1.143 . . . . 0.0 108.348 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 28' ' ' HIS . 12.5 tp10 -95.78 -26.97 15.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.814 -0.554 . . . . 0.0 110.62 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.13 -6.52 31.38 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.883 -1.136 . . . . 0.0 110.826 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 20' ' ' VAL . 25.2 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.825 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.6 m -133.57 175.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 111.158 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.82 148.68 46.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.318 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.83 28.69 1.73 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.4 tptm -138.81 -31.69 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.364 -0.835 . . . . 0.0 110.077 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.1 -15.39 4.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.305 -0.872 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.6 0.34 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.326 -0.859 . . . . 0.0 110.191 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.46 109.56 59.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.825 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.4 Cg_endo -69.06 138.28 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.713 1.609 . . . . 0.0 112.112 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.131 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.23 1.63 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.26 -0.9 . . . . 0.0 108.996 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.01 2.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.936 -1.665 . . . . 0.0 108.936 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -116.29 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.504 -0.998 . . . . 0.0 109.94 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.43 145.34 24.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 109.352 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.2 p-80 -116.3 169.47 9.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.707 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.55 137.67 47.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.28 28.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.232 -0.917 . . . . 0.0 111.201 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.34 11.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.628 0.727 . . . . 0.0 110.333 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.23 22.86 1.45 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.586 -0.696 . . . . 0.0 109.495 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.47 30.97 20.36 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.724 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 52' ' ' LEU . 18.6 mt -143.29 142.74 31.44 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.535 -0.979 . . . . 0.0 108.814 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.35 152.86 36.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 110.73 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' A' ' 62' ' ' LEU . 57.7 m-85 -153.91 140.27 18.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 90.7 m -57.55 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.316 -1.353 . . . . 0.0 108.454 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 53.1 tt0 -63.63 -35.98 82.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.383 -0.823 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.4 m -86.66 -43.75 12.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 0.0 111.339 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.459 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -66.65 -43.77 83.68 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.79 -1.194 . . . . 0.0 108.141 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.2 t80 -51.74 -56.43 13.87 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 44.0 m-80 -64.52 -44.89 89.47 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.093 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.5 tp60 -54.44 -34.37 61.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.55 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.8 mp -78.68 -35.24 45.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.359 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 18.0 m-85 -158.58 -81.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.9 Cg_endo -79.6 164.3 23.57 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.673 2.249 . . . . 0.0 109.327 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.6 mt -135.31 122.83 36.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.873 0.844 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.841 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.1 t -61.13 116.83 4.86 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.549 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.42 -1.13 4.11 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.841 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.46 -54.22 4.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -1.149 . . . . 0.0 109.524 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.33 1.97 18.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.559 -0.713 . . . . 0.0 109.148 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 57.56 41.86 25.1 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.22 -0.925 . . . . 0.0 108.57 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -116.68 142.76 30.16 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.6 Cg_exo -55.69 113.97 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.432 1.422 . . . . 0.0 110.948 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 8' ' ' CYS . 23.9 mt -71.89 158.77 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.0 pt-20 -161.77 62.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 0.0 110.484 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 -100.37 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 29' ' ' VAL . 62.6 mtm180 -113.33 120.49 41.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.517 HG13 HD13 ' A' ' 15' ' ' ILE . 30.6 t -97.01 154.51 3.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 111.065 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.7 t -118.84 112.61 38.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.98 106.81 18.08 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.67 42.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.5 mmt 58.38 16.01 3.83 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 27.5 71.71 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -133.05 -151.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.042 0.925 . . . . 0.0 110.089 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.502 ' HG2' HG11 ' A' ' 19' ' ' VAL . 26.4 mt-30 -136.82 144.53 43.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.549 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 64.4 m95 -142.51 135.44 28.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.605 -1.31 . . . . 0.0 110.368 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.451 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 17.7 m80 -53.77 135.52 41.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 18' ' ' ARG . 10.3 t -55.54 -18.18 4.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 120.935 -1.103 . . . . 0.0 109.053 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -94.39 -25.9 16.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.438 -0.789 . . . . 0.0 110.573 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.5 m170 -98.01 -5.03 34.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 111.028 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' A' ' 20' ' ' VAL . 28.5 t80 -82.72 106.03 14.23 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.833 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.2 m -133.01 174.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 122.314 1.054 . . . . 0.0 111.294 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.533 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.89 148.28 40.12 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.117 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.46 35.11 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.39 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -142.99 -40.23 0.32 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.8 p -122.41 -17.34 7.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.642 -0.661 . . . . 0.0 110.256 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.8 mt-10 75.1 47.89 0.1 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 110.244 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -100.42 109.59 57.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.833 ' CA ' HG12 ' A' ' 33' ' ' VAL . 6.1 Cg_endo -69.89 137.73 35.77 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.863 1.709 . . . . 0.0 112.15 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.21 57.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.62 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.11 -55.51 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -0.905 . . . . 0.0 109.279 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 29.79 2.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -114.68 -174.31 2.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.483 -1.01 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.56 146.85 25.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.321 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.583 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.8 p-80 -118.32 169.12 10.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.331 -0.855 . . . . 0.0 109.603 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.715 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.3 m-85 -133.15 138.05 46.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.56 149.73 27.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 111.394 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.62 11.54 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.588 0.708 . . . . 0.0 110.259 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp 50.89 22.41 1.17 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.74 . . . . 0.0 109.376 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.75 30.77 20.15 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 52' ' ' LEU . 19.6 mt -141.99 142.26 32.93 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.59 -0.947 . . . . 0.0 108.77 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.47 153.15 35.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.29 -0.882 . . . . 0.0 110.954 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.627 ' CE1' HD22 ' A' ' 62' ' ' LEU . 48.7 m-85 -154.68 139.45 17.11 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 73.7 m -57.28 175.8 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.063 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.697 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.8 tp10 -61.98 -34.92 77.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.052 -1.03 . . . . 0.0 109.285 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 61' ' ' GLN . 70.2 m -86.25 -45.1 11.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.831 . . . . 0.0 111.251 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.563 ' O ' HD13 ' A' ' 62' ' ' LEU . 31.9 m170 -65.37 -42.76 92.38 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.792 -1.192 . . . . 0.0 108.358 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -54.34 -57.56 10.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 96.6 m-20 -62.72 -44.65 95.67 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.282 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' THR . 2.9 tp-100 -55.52 -34.43 64.65 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.627 HD22 ' CE1' ' A' ' 54' ' ' TYR . 6.1 mp -78.77 -34.21 45.81 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.673 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 17.3 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.222 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.7 Cg_endo -79.96 164.49 22.56 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.757 2.305 . . . . 0.0 109.526 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 14' ' ' PRO . 35.1 mt -133.94 119.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.126 0.965 . . . . 0.0 109.327 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 36.2 t -61.33 116.24 4.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.796 0.807 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.54 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -59.83 -4.52 3.26 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.801 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.37 -51.58 6.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.406 -1.055 . . . . 0.0 109.289 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.428 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -107.56 2.98 24.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.269 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' CYS . 19.3 mmm180 50.02 34.83 8.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 13' ' ' ARG . 0.2 OUTLIER -113.85 138.62 22.82 Favored Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.7 Cg_exo -53.64 114.82 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.268 1.312 . . . . 0.0 110.943 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.729 HG21 HG22 ' A' ' 19' ' ' VAL . 14.0 mt -68.98 158.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -159.59 62.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.913 -1.117 . . . . 0.0 110.451 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.54 -96.46 0.1 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -112.38 142.48 44.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.729 HG22 HG21 ' A' ' 15' ' ' ILE . 43.7 t -122.65 156.77 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.744 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.5 t -125.17 116.84 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -88.46 105.85 17.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.077 -1.014 . . . . 0.0 109.497 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.99 41.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.661 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 57.52 16.96 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.72 20.43 78.61 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -125.38 -155.37 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.742 0.782 . . . . 0.0 109.783 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HG2' HG11 ' A' ' 19' ' ' VAL . 24.7 mt-30 -134.53 143.99 47.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.54 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.4 m95 -142.14 139.47 32.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.616 -1.303 . . . . 0.0 110.26 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.422 ' NE2' ' HA ' ' A' ' 15' ' ' ILE . 19.6 m80 -54.68 138.65 41.14 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -57.41 -16.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 120.795 -1.191 . . . . 0.0 108.987 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -96.52 -25.82 15.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.47 -0.769 . . . . 0.0 110.54 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -93.21 -9.94 37.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.916 -1.115 . . . . 0.0 110.451 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' A' ' 20' ' ' VAL . 22.4 t80 -79.61 105.82 11.19 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.811 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.9 m -133.97 175.26 11.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 122.246 1.022 . . . . 0.0 110.959 -177.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -64.13 148.53 49.71 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.268 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.0 28.12 1.66 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 tptm -138.7 -32.03 0.71 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.333 -0.854 . . . . 0.0 110.223 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.7 p -129.3 -11.27 4.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.343 -0.848 . . . . 0.0 110.205 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 65.01 47.25 2.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.472 -0.768 . . . . 0.0 110.491 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.603 ' NZ ' ' SG ' ' A' ' 55' ' ' CYS . 0.0 OUTLIER -101.99 107.49 52.67 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.811 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.4 Cg_endo -66.0 139.48 56.48 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.678 1.585 . . . . 0.0 112.304 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.44 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.14 -55.31 1.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.947 . . . . 0.0 109.067 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.1 30.58 2.92 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -117.7 176.61 5.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.56 -0.965 . . . . 0.0 109.905 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.57 150.43 21.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.438 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.6 p-80 -119.4 170.66 8.94 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.4 m-85 -138.17 129.42 27.46 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.478 ' OE2' ' CE ' ' A' ' 23' ' ' MET . 1.3 mm-40 -100.07 153.59 19.1 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.232 -0.917 . . . . 0.0 111.702 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.518 ' NH2' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -153.35 127.05 8.79 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.558 0.694 . . . . 0.0 109.877 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt 52.59 23.8 2.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 109.59 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.661 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 31.09 23.5 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.076 -1.535 . . . . 0.0 109.36 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.518 HD12 ' NH2' ' A' ' 49' ' ' ARG . 19.4 mt -142.66 139.95 31.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.603 -0.94 . . . . 0.0 108.666 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.3 151.92 39.74 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.163 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' TYR . 55.0 m-85 -154.37 139.45 17.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.603 ' SG ' ' NZ ' ' A' ' 39' ' ' LYS . 89.3 m -57.81 178.15 0.09 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.792 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.2 tt0 -62.31 -37.82 87.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.619 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 61' ' ' GLN . 52.4 m -86.92 -43.08 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 111.66 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -65.81 -43.61 88.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.722 -1.236 . . . . 0.0 108.134 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.8 t80 -51.94 -56.5 13.81 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -64.22 -44.9 90.47 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 57' ' ' THR . 14.9 tp60 -54.38 -34.84 62.01 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.561 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.8 mp -78.12 -33.28 50.61 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.512 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 21.2 m-85 -160.13 -81.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 110.125 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.342 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.627 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.83 163.58 35.3 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.909 1.739 . . . . 0.0 108.901 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.1 mt -134.48 119.95 31.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.012 0.911 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.813 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.1 t -60.27 119.6 8.22 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 110.119 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.84 0.09 11.82 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.813 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.59 -38.36 18.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -1.113 . . . . 0.0 109.392 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.64 5.04 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 54.19 41.48 31.98 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -115.54 142.54 28.99 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.627 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.5 Cg_exo -56.27 112.94 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.562 1.508 . . . . 0.0 110.729 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.694 HG21 HG22 ' A' ' 19' ' ' VAL . 20.7 mt -70.45 158.68 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.418 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.2 pt-20 -159.19 62.12 0.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.691 -1.256 . . . . 0.0 110.854 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.67 -100.97 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.511 ' HB3' HG21 ' A' ' 29' ' ' VAL . 37.5 mtt180 -107.82 134.35 50.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.694 HG22 HG21 ' A' ' 15' ' ' ILE . 46.2 t -115.77 158.06 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 110.731 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.454 HG11 ' CD2' ' A' ' 32' ' ' PHE . 3.7 t -122.9 117.32 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -90.03 105.97 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.29 159.76 42.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.1 mmt 58.1 18.14 5.02 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.07 75.75 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -130.32 -154.67 0.65 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.717 0.77 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HG2' HG11 ' A' ' 19' ' ' VAL . 19.2 mt-30 -134.82 145.1 48.02 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.6 m95 -142.05 139.15 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.544 -1.347 . . . . 0.0 110.788 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.439 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 18.3 m80 -55.22 132.79 48.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 18' ' ' ARG . 77.0 t -52.39 -22.58 3.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 120.835 -1.165 . . . . 0.0 109.29 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -91.85 -23.74 19.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 110.734 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -96.91 -6.58 35.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.859 -1.151 . . . . 0.0 111.029 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.454 ' CD2' HG11 ' A' ' 20' ' ' VAL . 29.1 t80 -81.67 103.2 11.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.819 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.1 m -128.96 178.45 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 122.321 1.058 . . . . 0.0 111.254 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.639 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.1 t -65.61 148.4 51.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.702 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.8 28.19 1.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.486 -0.759 . . . . 0.0 109.197 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.477 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 6.3 tmtt? -134.1 -39.07 0.86 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.571 -0.706 . . . . 0.0 109.74 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.6 p -126.31 -16.17 5.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.558 -0.714 . . . . 0.0 110.553 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.0 mt-10 73.7 46.94 0.18 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -100.76 110.21 60.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.819 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.1 Cg_endo -68.46 136.97 38.24 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.718 1.612 . . . . 0.0 111.754 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.4 m-85 -95.98 60.1 2.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.637 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.3 mp -40.04 -56.02 1.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.44 -0.788 . . . . 0.0 109.476 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.67 26.16 4.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -114.56 159.98 19.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.396 -1.061 . . . . 0.0 109.822 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -75.72 154.77 36.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.452 -0.78 . . . . 0.0 109.162 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.608 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.6 p-80 -118.08 170.52 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.273 -0.892 . . . . 0.0 110.017 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.707 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.8 m-85 -135.87 137.36 41.38 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -111.65 145.27 39.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 0.0 111.387 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.558 ' NH1' ' HG3' ' A' ' 49' ' ' ARG . 11.1 ttm-85 -144.92 137.91 26.54 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.53 0.681 . . . . 0.0 110.12 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 44.73 20.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.702 0.763 . . . . 0.0 109.166 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 87.18 30.71 19.07 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ARG . 20.1 mt -138.9 143.03 38.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.678 -0.895 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.96 151.76 33.49 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.828 0.823 . . . . 0.0 111.25 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.562 ' CE1' HD22 ' A' ' 62' ' ' LEU . 53.4 m-85 -153.54 135.89 14.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 14.5 m -56.57 172.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.101 -1.439 . . . . 0.0 108.141 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 68.3 tt0 -57.28 -32.35 66.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.045 -1.034 . . . . 0.0 109.745 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 93.7 m -87.15 -47.88 8.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.826 . . . . 0.0 111.818 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.594 ' O ' HD13 ' A' ' 62' ' ' LEU . 29.1 m170 -64.67 -40.88 96.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.756 -1.215 . . . . 0.0 108.605 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -55.13 -57.49 11.55 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.441 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 42.8 m-80 -63.03 -44.1 96.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.065 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.72 -35.96 64.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 6.6 mp -76.1 -37.25 58.35 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.7 m-85 -156.11 -83.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.722 0.773 . . . . 0.0 109.804 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.441 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 5' ' ' VAL . 2.0 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -79.9 164.68 22.59 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.733 2.289 . . . . 0.0 109.349 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 14' ' ' PRO . 25.8 mt -134.97 120.45 30.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-O 121.945 0.878 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 20.8 t -62.16 121.27 12.67 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.877 0.846 . . . . 0.0 110.077 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.39 -1.48 15.24 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.79 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.35 -35.31 21.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -130.49 0.25 4.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.677 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 56.83 38.56 29.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -178.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.629 ' CG ' HH11 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -111.01 138.3 21.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.9 Cg_exo -55.1 113.46 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.113 1.209 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.627 HG21 HG22 ' A' ' 19' ' ' VAL . 19.9 mt -70.62 158.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -161.26 62.41 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.897 -1.127 . . . . 0.0 110.616 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.82 -101.87 0.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -111.48 126.39 54.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.627 HG22 HG21 ' A' ' 15' ' ' ILE . 42.0 t -105.15 158.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 111.204 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.9 t -122.36 115.65 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.49 106.55 18.57 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 109.905 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.97 160.16 41.78 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.62 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.5 mmt 58.31 14.46 2.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.32 18.21 79.2 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.801 -2.12 . . . . 0.0 107.801 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -120.21 -154.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.007 0.908 . . . . 0.0 109.827 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.462 ' HG2' HG11 ' A' ' 19' ' ' VAL . 28.0 mt-30 -136.6 143.56 43.64 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.4 m95 -141.66 138.88 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.513 -1.367 . . . . 0.0 110.566 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.413 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 19.6 m80 -55.46 134.73 50.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.419 HG22 HG23 ' A' ' 20' ' ' VAL . 17.1 t -54.37 -20.43 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 120.809 -1.182 . . . . 0.0 109.08 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -92.03 -27.89 17.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 110.536 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -93.81 -7.35 43.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.031 -1.043 . . . . 0.0 110.885 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.0 t80 -81.25 105.86 12.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.809 HG12 ' CA ' ' A' ' 40' ' ' PRO . 23.2 m -133.89 174.99 12.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 122.326 1.06 . . . . 0.0 111.195 -177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.7 t -64.03 148.41 49.8 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.059 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.71 27.81 1.68 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.702 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.2 tptp -138.09 -33.21 0.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.1 p -126.89 -11.23 6.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.261 -0.9 . . . . 0.0 110.209 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 65.08 46.87 2.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -102.56 107.02 52.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.809 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.5 Cg_endo -66.45 139.75 55.18 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.816 1.677 . . . . 0.0 112.358 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -96.08 56.35 1.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.03 -55.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 30.39 2.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -116.47 178.99 4.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.96 . . . . 0.0 109.958 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -95.79 147.19 23.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.432 -0.792 . . . . 0.0 109.293 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.531 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 33.6 p-80 -117.73 168.94 9.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.0 m-85 -133.66 133.16 41.56 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -111.01 155.43 22.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.075 -1.016 . . . . 0.0 111.639 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -145.47 135.77 23.99 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.55 0.691 . . . . 0.0 110.064 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.2 ptmt 42.33 21.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.467 0.651 . . . . 0.0 109.757 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.62 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.92 30.62 9.28 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.191 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.0 mt -140.53 136.83 33.28 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.491 -1.005 . . . . 0.0 108.379 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.46 150.18 45.15 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.858 0.837 . . . . 0.0 111.11 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.671 ' N ' ' O ' ' A' ' 47' ' ' TYR . 47.4 m-85 -153.14 139.3 18.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 54.1 m -56.51 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.831 -1.168 . . . . 0.0 108.857 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 75.2 tt0 -68.65 -40.46 80.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.352 -0.843 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.2 m -86.25 -37.57 18.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 111.292 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.56 -46.77 68.55 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.798 -1.189 . . . . 0.0 108.224 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -52.36 -55.94 18.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 93.2 m-20 -62.49 -46.26 89.26 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.51 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -54.68 -38.15 66.64 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -72.1 -39.69 68.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.319 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -153.79 -83.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.288 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.622 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.53 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.4 Cg_endo -74.36 163.65 35.82 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.911 1.74 . . . . 0.0 109.002 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 14' ' ' PRO . 28.1 mt -135.14 119.75 27.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.992 0.901 . . . . 0.0 109.206 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.816 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.2 t -57.85 118.8 5.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.888 0.852 . . . . 0.0 110.073 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.528 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.57 -2.01 5.37 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.816 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.56 -60.9 1.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -1.069 . . . . 0.0 109.336 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.25 -7.3 26.62 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.501 -0.749 . . . . 0.0 109.163 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.473 ' O ' ' CZ ' ' A' ' 13' ' ' ARG . 23.6 mmm180 63.51 37.81 10.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -112.87 144.07 30.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.622 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.5 Cg_exo -56.07 113.25 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.466 1.444 . . . . 0.0 110.383 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.669 HG21 HG22 ' A' ' 19' ' ' VAL . 22.9 mt -70.52 158.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.1 pt-20 -160.45 61.25 0.33 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.835 -1.165 . . . . 0.0 110.694 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.33 -102.48 0.16 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 29' ' ' VAL . 69.4 mtm180 -112.82 121.37 44.5 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.669 HG22 HG21 ' A' ' 15' ' ' ILE . 40.8 t -99.45 159.39 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 111.285 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.47 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.8 t -123.56 116.44 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -89.86 106.17 18.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.02 42.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.944 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.626 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.07 16.8 4.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 25.41 75.8 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.094 -2.003 . . . . 0.0 108.094 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.72 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.812 0.815 . . . . 0.0 109.816 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.455 ' HG2' HG11 ' A' ' 19' ' ' VAL . 21.8 mt-30 -135.29 143.7 46.36 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.528 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.5 m95 -141.6 140.93 33.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.479 -1.388 . . . . 0.0 110.644 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.475 ' C ' ' N ' ' A' ' 30' ' ' GLU . 18.0 m80 -57.41 131.91 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 20' ' ' VAL . 7.7 t -52.58 -14.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.87 -1.144 . . . . 0.0 108.402 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 28' ' ' HIS . 11.2 tp10 -95.93 -27.11 15.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.761 -0.587 . . . . 0.0 110.501 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -97.14 -6.63 34.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.93 -1.106 . . . . 0.0 110.771 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.3 t80 -80.76 106.09 12.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.4 m -132.67 176.38 9.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.314 1.054 . . . . 0.0 111.19 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.6 t -65.36 148.75 51.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.454 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.49 25.53 2.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.288 -0.883 . . . . 0.0 109.78 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.6 tptp -135.43 -32.75 0.91 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.326 -0.859 . . . . 0.0 110.22 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 p -128.66 -12.47 4.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 67.9 47.2 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.228 -0.92 . . . . 0.0 109.966 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -101.17 107.47 50.44 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.3 Cg_endo -66.81 138.46 48.82 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.624 1.549 . . . . 0.0 112.118 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -95.72 56.81 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.632 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.12 -55.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.166 -0.959 . . . . 0.0 109.015 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.18 29.61 3.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -116.98 175.39 5.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.574 -0.957 . . . . 0.0 109.801 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.709 HH11 ' HG2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -89.32 150.61 22.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.572 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.3 p-80 -119.5 169.8 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.5 m-85 -136.82 132.78 35.12 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.95 150.84 24.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.928 . . . . 0.0 111.892 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.535 ' NH2' ' OH ' ' A' ' 54' ' ' TYR . 10.0 ttp180 -146.19 134.23 21.5 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.101 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HZ3' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 42.04 21.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.569 0.7 . . . . 0.0 109.615 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.626 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 93.08 30.69 9.1 Favored Glycine 0 C--N 1.295 -1.71 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.043 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.1 mt -141.74 139.76 32.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.456 -1.026 . . . . 0.0 108.822 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -73.8 151.87 40.46 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.865 0.84 . . . . 0.0 110.867 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 47' ' ' TYR . 48.9 m-85 -154.59 138.94 16.69 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 67.4 m -56.56 178.76 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.904 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 12.2 tm-20 -63.73 -39.24 93.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.818 . . . . 0.0 109.46 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.8 m -86.25 -39.28 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.687 . . . . 0.0 111.341 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.7 m170 -67.93 -47.18 69.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.805 -1.184 . . . . 0.0 107.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.1 t80 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -64.18 -44.39 92.2 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.623 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -57.01 -36.41 70.4 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.544 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.7 mp -73.28 -37.39 66.28 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.5 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.9 m-85 -153.74 -81.71 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.795 0.807 . . . . 0.0 109.913 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.332 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.3 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.3 Cg_endo -75.67 163.23 34.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.983 1.789 . . . . 0.0 109.232 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.4 mt -133.78 119.6 33.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 122.103 0.954 . . . . 0.0 109.157 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 30.3 t -58.02 115.63 3.01 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.776 0.798 . . . . 0.0 109.901 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.539 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.66 -3.23 4.11 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.822 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.55 -59.94 2.17 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.471 -1.017 . . . . 0.0 109.357 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.43 -1.07 39.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.545 -0.722 . . . . 0.0 109.179 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER 56.03 39.72 30.43 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -118.37 149.48 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.642 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.0 Cg_exo -58.73 113.01 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.442 1.428 . . . . 0.0 110.793 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.772 HG21 HG22 ' A' ' 19' ' ' VAL . 20.5 mt -68.52 159.92 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.432 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -158.38 62.4 0.44 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.613 -1.305 . . . . 0.0 111.399 -178.248 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.02 -95.37 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -108.27 138.56 44.34 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.772 HG22 HG21 ' A' ' 15' ' ' ILE . 46.9 t -124.9 160.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.791 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.578 HG23 HG22 ' A' ' 29' ' ' VAL . 3.4 t -126.41 117.41 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -90.34 105.77 18.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 109.482 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.31 16.65 4.16 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.91 26.09 74.59 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -130.83 -153.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.848 0.832 . . . . 0.0 109.954 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -137.44 142.8 41.6 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 56.9 m95 -141.38 139.3 33.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.64 -1.288 . . . . 0.0 110.6 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.476 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.7 m80 -56.0 131.44 47.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.578 HG22 HG23 ' A' ' 20' ' ' VAL . 6.2 t -53.38 -13.85 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 120.581 -1.325 . . . . 0.0 108.361 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 28' ' ' HIS . 51.1 tp10 -94.57 -27.36 15.97 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.778 -0.576 . . . . 0.0 110.433 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -98.14 -6.28 31.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.909 -1.12 . . . . 0.0 110.787 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CD2' HG11 ' A' ' 20' ' ' VAL . 22.8 t80 -80.13 107.1 12.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.6 m -133.25 175.9 10.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.229 1.014 . . . . 0.0 111.27 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.47 148.44 48.6 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.407 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.37 25.98 2.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -0.908 . . . . 0.0 109.804 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.44 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.5 tptp -136.02 -31.53 0.91 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.291 -0.88 . . . . 0.0 110.019 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.2 p -130.03 -15.16 3.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.98 47.43 0.31 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.298 -0.876 . . . . 0.0 110.461 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -102.22 109.49 60.35 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.9 Cg_endo -68.76 138.41 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.848 1.698 . . . . 0.0 112.018 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.5 57.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.639 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.34 -55.49 1.72 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.4 31.48 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -115.64 -163.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -1.051 . . . . 0.0 110.05 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -110.6 146.23 36.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.5 p-80 -118.06 168.33 10.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.719 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.0 m-85 -131.7 136.64 47.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -107.02 149.8 27.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -147.15 133.63 19.73 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.561 0.696 . . . . 0.0 110.01 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 15.9 ptmt 41.8 22.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.594 0.712 . . . . 0.0 109.68 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.06 31.3 9.27 Favored Glycine 0 C--N 1.296 -1.68 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.203 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.8 mt -142.78 140.64 31.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.504 -0.998 . . . . 0.0 108.79 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -75.37 152.19 38.11 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 110.879 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.571 ' CE1' HD22 ' A' ' 62' ' ' LEU . 52.8 m-85 -154.33 139.53 17.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.7 m -56.05 179.15 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.42 -1.312 . . . . 0.0 108.546 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 9.2 tm-20 -64.78 -38.44 91.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.8 m -86.14 -39.1 17.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.624 -0.673 . . . . 0.0 111.19 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.478 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.9 m170 -68.92 -43.89 74.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.702 -1.249 . . . . 0.0 108.037 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -54.98 -57.03 13.33 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.453 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 39.6 m-80 -62.16 -43.68 98.3 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.377 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -55.92 -37.26 68.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 54' ' ' TYR . 3.7 mp -74.52 -37.99 62.92 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.996 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.0 m-85 -156.85 -83.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.411 -0.806 . . . . 0.0 110.171 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.453 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.607 HG11 ' CB ' ' A' ' 14' ' ' PRO . 2.1 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' A' ' 19' ' ' VAL . 3.4 Cg_endo -70.94 163.36 39.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.616 1.544 . . . . 0.0 108.344 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 33.6 mt -134.24 120.67 35.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-O 122.201 1.001 . . . . 0.0 109.244 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.866 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.6 t -57.39 116.03 3.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.759 0.79 . . . . 0.0 110.066 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.11 -0.67 3.32 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.866 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.53 -59.26 2.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -1.086 . . . . 0.0 109.399 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -102.96 -0.86 30.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.519 -0.738 . . . . 0.0 109.267 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.621 ' HG3' HH11 ' A' ' 12' ' ' ARG . 7.2 mmm-85 58.62 43.08 19.55 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -118.62 143.62 33.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.607 ' CB ' HG11 ' A' ' 5' ' ' VAL . 3.0 Cg_exo -53.9 111.72 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.663 1.575 . . . . 0.0 110.621 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.633 HG21 HG22 ' A' ' 19' ' ' VAL . 34.6 mt -71.17 158.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.217 -0.927 . . . . 0.0 108.516 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.38 61.45 0.27 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.727 -1.233 . . . . 0.0 110.728 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.24 -102.19 0.15 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.675 HH11 ' CG ' ' A' ' 18' ' ' ARG . 2.8 mtt-85 -112.14 120.4 41.68 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 15' ' ' ILE . 40.5 t -99.29 158.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 111.282 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 32' ' ' PHE . 5.0 t -122.51 115.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -89.85 106.16 18.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.694 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.53 41.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.643 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.3 mmt 58.02 15.98 3.5 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 20.86 77.94 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -124.24 -154.69 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.773 0.797 . . . . 0.0 109.885 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.468 ' HG2' HG11 ' A' ' 19' ' ' VAL . 18.3 mt-30 -135.32 143.25 46.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.525 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.0 m95 -141.09 138.55 33.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.572 -1.33 . . . . 0.0 110.588 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.497 ' C ' ' N ' ' A' ' 30' ' ' GLU . 15.6 m80 -55.42 130.74 43.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 20' ' ' VAL . 8.7 t -52.52 -14.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 120.932 -1.105 . . . . 0.0 108.068 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.497 ' N ' ' C ' ' A' ' 28' ' ' HIS . 4.1 tt0 -95.36 -27.83 15.26 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.921 -0.487 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -98.64 -6.02 30.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.827 -1.171 . . . . 0.0 110.821 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 20' ' ' VAL . 23.0 t80 -79.87 106.14 11.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' A' ' 40' ' ' PRO . 27.7 m -134.32 174.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 122.272 1.034 . . . . 0.0 111.122 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.554 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.06 148.22 36.48 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.263 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.25 34.49 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.291 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HG3' HD11 ' A' ' 62' ' ' LEU . 6.0 tmtt? -142.79 -40.05 0.33 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.5 -0.75 . . . . 0.0 109.744 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.1 p -123.2 -17.4 6.64 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.433 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.0 mt-10 76.32 47.59 0.08 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.4 -0.812 . . . . 0.0 110.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -100.32 110.75 60.94 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' A' ' 33' ' ' VAL . 6.2 Cg_endo -70.62 137.98 34.1 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.874 1.716 . . . . 0.0 112.192 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.488 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.11 58.13 1.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.47 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.01 30.56 2.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -115.4 -179.08 3.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.437 -1.037 . . . . 0.0 110.004 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.656 ' CG ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -96.2 143.07 27.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.502 -0.749 . . . . 0.0 109.158 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.569 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.0 p-80 -114.28 171.51 7.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.306 -0.871 . . . . 0.0 109.659 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.704 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.5 m-85 -134.0 137.75 44.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -108.5 146.94 32.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 111.585 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.927 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -151.57 117.38 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.79 -0.569 . . . . 0.0 109.645 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 22.4 mmtp 61.89 30.37 18.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 109.995 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.643 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 76.97 31.09 54.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 52' ' ' LEU . 26.1 mt -141.84 137.29 31.35 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.682 -0.893 . . . . 0.0 108.734 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.79 153.88 34.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.769 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.613 ' CE1' HD22 ' A' ' 62' ' ' LEU . 47.2 m-85 -153.8 137.86 16.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 76.3 m -56.05 173.27 0.16 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.321 -1.352 . . . . 0.0 108.254 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.4 tm-20 -59.75 -34.78 73.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 109.255 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 61' ' ' GLN . 66.5 m -87.01 -44.43 11.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.68 . . . . 0.0 111.397 -178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.577 ' O ' HD13 ' A' ' 62' ' ' LEU . 30.6 m170 -65.64 -42.12 91.8 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.792 -1.193 . . . . 0.0 108.493 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.2 t80 -54.3 -57.19 12.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 36.7 m-80 -64.61 -43.94 92.17 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.289 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 57' ' ' THR . 37.1 tt0 -54.31 -34.38 60.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.613 HD22 ' CE1' ' A' ' 54' ' ' TYR . 6.5 mp -79.24 -38.28 35.98 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.604 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.2 m-85 -160.33 -80.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.573 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.453 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -75.48 163.37 34.41 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.043 1.829 . . . . 0.0 109.274 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.5 mt -135.11 119.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 122.034 0.921 . . . . 0.0 109.149 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 32.7 t -58.51 115.0 2.73 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.84 0.829 . . . . 0.0 109.779 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.536 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.46 -3.54 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.819 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.99 -59.18 2.41 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.329 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.39 -1.6 35.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.569 -0.707 . . . . 0.0 109.183 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 57.8 38.84 27.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.214 -0.929 . . . . 0.0 108.693 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.04 149.34 45.35 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.3 Cg_exo -59.05 113.05 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.387 1.391 . . . . 0.0 110.783 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.706 HG21 HG22 ' A' ' 19' ' ' VAL . 19.3 mt -69.87 160.31 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.474 ' N ' HG22 ' A' ' 15' ' ' ILE . 9.0 pt-20 -170.3 70.39 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.698 -1.251 . . . . 0.0 110.549 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.82 -55.06 0.3 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.621 ' HG3' HH11 ' A' ' 18' ' ' ARG . 1.1 mtm-85 -139.56 129.67 25.13 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.706 HG22 HG21 ' A' ' 15' ' ' ILE . 48.7 t -126.47 152.98 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.6 t -127.23 116.39 43.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.94 105.65 17.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.064 -1.023 . . . . 0.0 109.372 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.81 159.98 42.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.472 -0.767 . . . . 0.0 109.012 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 57.65 18.4 4.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.83 22.69 77.02 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -129.37 -156.19 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.965 -0.726 . . . . 0.0 109.767 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -134.29 143.43 47.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.536 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 48.6 m95 -141.96 140.05 32.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.531 -1.355 . . . . 0.0 110.289 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.426 ' CD2' HG23 ' A' ' 15' ' ' ILE . 19.7 m80 -55.82 140.48 42.15 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 t -58.94 -19.46 15.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.718 -1.239 . . . . 0.0 109.288 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -96.27 -12.69 24.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -105.62 -8.76 17.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.951 -1.093 . . . . 0.0 109.955 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.468 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.1 t80 -81.22 103.59 11.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.846 HG12 ' CA ' ' A' ' 40' ' ' PRO . 21.3 m -126.16 177.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 122.42 1.105 . . . . 0.0 111.597 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -68.06 149.16 50.01 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.722 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.06 26.01 2.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.7 tptm -134.12 -29.79 1.24 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.364 -0.835 . . . . 0.0 109.841 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.6 p -133.18 -15.59 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.302 -0.874 . . . . 0.0 110.392 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.51 46.56 0.4 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.266 -0.896 . . . . 0.0 110.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -101.32 112.51 65.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.846 ' CA ' HG12 ' A' ' 33' ' ' VAL . 10.5 Cg_endo -71.54 134.44 24.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.483 1.455 . . . . 0.0 110.897 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.588 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.1 m-85 -93.01 59.46 3.13 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 40' ' ' PRO . 4.6 mp -41.02 -55.95 2.42 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.409 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.33 24.02 5.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -114.69 168.73 9.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.48 -1.012 . . . . 0.0 109.95 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -84.07 156.68 22.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.553 -0.717 . . . . 0.0 109.16 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.7 p-80 -120.81 170.25 9.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 0.0 110.054 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.708 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.0 m-85 -135.47 135.23 40.33 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -110.52 141.08 44.16 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.196 -0.94 . . . . 0.0 111.188 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.728 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -145.15 136.45 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.563 0.697 . . . . 0.0 110.369 178.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt 50.12 22.45 0.93 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.52 -0.737 . . . . 0.0 109.096 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.75 30.63 31.84 Favored Glycine 0 C--N 1.295 -1.712 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 52' ' ' LEU . 22.2 mt -140.09 143.02 36.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.775 -0.838 . . . . 0.0 108.896 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.44 151.48 34.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.487 -0.758 . . . . 0.0 110.928 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 59.5 m-85 -153.27 136.63 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 64.4 m -57.4 173.92 0.23 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.277 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 26.8 tt0 -59.5 -34.51 72.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 61' ' ' GLN . 59.1 m -86.91 -44.09 11.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -0.772 . . . . 0.0 111.683 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.446 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.0 m170 -67.57 -43.03 81.6 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.708 -1.245 . . . . 0.0 108.453 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.512 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -51.86 -55.6 19.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.435 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 44.5 m-80 -65.57 -45.34 83.67 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.977 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 57' ' ' THR . 28.1 tt0 -52.87 -39.01 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.582 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -71.64 -40.33 69.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.728 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 14.6 m-85 -154.3 -85.11 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.603 0.716 . . . . 0.0 109.973 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.516 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.8 Cg_endo -74.49 163.41 36.17 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 109.024 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.8 mt -135.71 119.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.033 0.92 . . . . 0.0 109.26 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.831 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.3 t -57.14 117.34 3.93 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.776 0.798 . . . . 0.0 109.86 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.527 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.76 -2.2 5.9 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.831 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.21 -60.56 2.0 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -1.063 . . . . 0.0 109.364 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.28 -2.48 33.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.781 . . . . 0.0 109.151 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.624 ' HG3' HH11 ' A' ' 12' ' ' ARG . 6.6 mmm-85 59.75 40.51 19.58 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.278 -0.889 . . . . 0.0 108.768 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.66 150.14 46.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.8 Cg_exo -59.29 113.91 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.53 1.486 . . . . 0.0 110.568 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.646 HG21 HG22 ' A' ' 19' ' ' VAL . 21.1 mt -70.34 158.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.417 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -159.21 59.38 0.41 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.833 -1.167 . . . . 0.0 110.986 -178.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.06 -102.45 0.16 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.674 HH11 ' CG ' ' A' ' 18' ' ' ARG . 3.0 mtt-85 -111.19 121.3 44.93 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.646 HG22 HG21 ' A' ' 15' ' ' ILE . 45.6 t -98.72 157.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 111.038 -177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.459 HG11 ' CD2' ' A' ' 32' ' ' PHE . 7.1 t -120.62 115.15 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.631 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.71 160.19 41.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.671 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.1 mmt 57.52 16.39 3.29 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.8 22.44 78.2 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -125.75 -154.67 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.737 0.78 . . . . 0.0 109.753 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HG2' HG11 ' A' ' 19' ' ' VAL . 20.0 mt-30 -136.29 142.8 43.96 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.527 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.0 m95 -141.77 140.63 33.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.569 -1.332 . . . . 0.0 110.448 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -56.44 139.44 49.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 18' ' ' ARG . 7.9 t -57.64 -20.38 13.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 120.868 -1.145 . . . . 0.0 109.315 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.88 -16.69 21.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.483 -0.761 . . . . 0.0 110.627 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.4 m170 -101.43 -9.1 21.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.845 -1.159 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CD2' HG11 ' A' ' 20' ' ' VAL . 28.0 t80 -80.15 104.98 11.08 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.831 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.2 m -130.69 177.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 122.405 1.098 . . . . 0.0 111.499 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -66.96 148.56 51.8 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.661 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.5 30.48 1.3 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.243 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -139.65 -31.01 0.69 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.0 110.122 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 32.0 p -131.05 -18.59 2.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.364 -0.835 . . . . 0.0 110.192 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.2 mt-10 74.38 45.89 0.18 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 110.299 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -101.39 112.06 64.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.831 ' CA ' HG12 ' A' ' 33' ' ' VAL . 10.1 Cg_endo -71.7 135.94 27.0 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.561 1.507 . . . . 0.0 111.401 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.46 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -93.28 55.69 2.33 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 40' ' ' PRO . 3.1 mp -40.64 -55.79 2.28 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.758 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.16 23.86 5.14 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -115.69 -164.52 0.96 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.285 -1.127 . . . . 0.0 109.843 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.58 HH11 ' HB3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -107.7 154.11 21.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.579 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.1 p-80 -119.65 171.72 8.18 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.702 0.763 . . . . 0.0 109.265 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.0 m-85 -138.55 132.71 31.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.26 147.42 27.07 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.302 -0.874 . . . . 0.0 112.104 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.832 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -154.58 121.02 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 1.0 OUTLIER 62.5 29.15 17.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.505 -0.747 . . . . 0.0 109.902 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.671 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 74.4 31.34 59.18 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 52' ' ' LEU . 29.1 mt -141.42 141.43 33.73 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.51 153.46 33.42 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 47' ' ' TYR . 54.9 m-85 -153.56 140.31 19.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 85.5 m -60.2 175.91 0.38 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.742 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 61.4 tt0 -60.96 -37.57 82.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.419 -0.801 . . . . 0.0 109.423 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.9 -43.02 12.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.581 -0.699 . . . . 0.0 111.663 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.561 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.0 m170 -67.0 -44.83 79.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.716 -1.24 . . . . 0.0 108.284 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.7 t80 -49.11 -54.92 13.98 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 55.8 m-80 -67.9 -46.08 72.63 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.207 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 57' ' ' THR . 11.1 tp60 -53.46 -33.64 54.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.27 -38.75 41.93 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.0 m-85 -160.37 -79.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.393 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -76.31 163.61 32.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.194 1.93 . . . . 0.0 109.29 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.2 mt -134.73 119.0 27.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 122.027 0.918 . . . . 0.0 109.24 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 38.2 t -60.44 118.33 6.35 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.8 0.809 . . . . 0.0 110.141 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.531 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.94 -3.61 8.85 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.792 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -83.72 -46.59 12.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.488 -1.007 . . . . 0.0 109.449 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.44 -1.51 13.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 8' ' ' CYS . 26.8 mmt180 57.07 35.55 26.5 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 143.21 29.02 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.9 Cg_exo -55.88 113.8 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.306 1.338 . . . . 0.0 110.625 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.783 HG21 HG22 ' A' ' 19' ' ' VAL . 12.9 mt -69.1 159.73 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.47 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.5 pt-20 -167.73 69.06 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.755 -1.215 . . . . 0.0 110.373 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.87 -64.22 0.17 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.527 HH21 ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -138.9 136.62 35.7 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.783 HG22 HG21 ' A' ' 15' ' ' ILE . 45.6 t -126.55 158.74 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.938 . . . . 0.0 110.787 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.49 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.6 t -131.51 117.16 34.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -87.26 105.76 17.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.127 -0.983 . . . . 0.0 109.588 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.32 160.13 41.98 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.638 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 9.2 mmt 57.84 17.77 4.47 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.19 18.5 76.67 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -124.25 -156.06 0.7 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.716 0.77 . . . . 0.0 109.699 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -134.15 144.49 48.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.531 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 53.7 m95 -142.28 139.39 31.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.499 -1.375 . . . . 0.0 110.526 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.416 ' CD2' HG23 ' A' ' 15' ' ' ILE . 19.7 m80 -55.13 138.97 43.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 18' ' ' ARG . 6.7 t -58.63 -18.23 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 109.097 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.527 ' CD ' HH21 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -94.15 -21.37 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 110.189 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -99.51 -6.2 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 110.59 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.487 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.2 t80 -82.97 102.46 11.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.4 m -127.2 176.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 122.241 1.019 . . . . 0.0 111.266 -177.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.642 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -63.43 148.75 47.68 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.584 178.235 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.11 27.58 1.83 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.38 -0.825 . . . . 0.0 109.352 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 3.3 tttm -134.21 -42.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 109.96 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.9 p -121.49 -15.99 7.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.674 -0.641 . . . . 0.0 110.476 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.1 mt-10 72.68 47.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 110.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -100.72 109.85 58.91 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.2 Cg_endo -67.76 138.36 44.73 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.756 1.637 . . . . 0.0 111.874 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.545 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.4 m-85 -95.46 59.97 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.81 -55.55 1.94 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.63 29.56 3.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -117.08 165.61 13.18 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 109.814 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -79.64 153.98 28.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.406 -0.809 . . . . 0.0 109.281 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.8 p-80 -118.92 169.47 9.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.277 -0.89 . . . . 0.0 109.83 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.706 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.7 m-85 -134.68 137.92 43.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -110.64 149.82 29.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -0.928 . . . . 0.0 111.464 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.632 ' NE ' ' CD2' ' A' ' 63' ' ' PHE . 13.4 tpt180 -147.09 131.39 17.51 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.413 0.625 . . . . 0.0 110.192 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' NZ ' ' CB ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 42.39 24.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.696 0.76 . . . . 0.0 109.584 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.638 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.35 31.21 12.0 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.845 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ARG . 19.2 mt -140.34 139.77 35.47 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.565 -0.962 . . . . 0.0 108.961 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.83 152.6 33.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.83 0.824 . . . . 0.0 110.94 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.563 ' CE1' HD22 ' A' ' 62' ' ' LEU . 56.2 m-85 -154.8 139.03 16.59 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 13.0 m -59.38 174.02 0.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.638 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.5 tp10 -59.5 -31.58 69.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.878 -1.139 . . . . 0.0 109.537 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.6 m -86.26 -49.77 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 111.632 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' HD13 ' A' ' 62' ' ' LEU . 33.3 m170 -64.94 -41.14 95.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.877 -1.139 . . . . 0.0 108.407 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -53.3 -57.64 9.87 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.79 -44.94 91.85 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.119 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -54.88 -34.94 63.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.563 HD22 ' CE1' ' A' ' 54' ' ' TYR . 5.3 mp -77.35 -33.06 55.45 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.438 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.632 ' CD2' ' NE ' ' A' ' 49' ' ' ARG . 19.2 m-85 -160.14 -83.36 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.362 -0.836 . . . . 0.0 110.196 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.281 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.653 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 15' ' ' ILE . 6.0 Cg_endo -74.78 163.77 34.98 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.143 1.896 . . . . 0.0 109.044 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.0 mt -135.72 120.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 122.056 0.931 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.847 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.9 t -57.14 114.43 2.14 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.839 0.828 . . . . 0.0 109.899 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.535 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.84 -2.43 2.55 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.847 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.2 -59.79 2.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -1.08 . . . . 0.0 109.413 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.87 4.36 37.61 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.577 -0.702 . . . . 0.0 109.293 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.33 41.49 32.12 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.495 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -116.19 144.01 32.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.1 Cg_exo -56.81 113.17 1.34 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.332 1.355 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.628 HG21 HG22 ' A' ' 19' ' ' VAL . 22.1 mt -69.19 158.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.614 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.413 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -166.3 67.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 110.299 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.6 -73.31 0.07 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -138.48 133.59 32.9 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.628 HG22 HG21 ' A' ' 15' ' ' ILE . 41.2 t -114.02 151.62 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.896 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 32' ' ' PHE . 8.1 t -119.45 115.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -88.57 106.16 18.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.047 -1.033 . . . . 0.0 109.583 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.02 160.04 42.85 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.644 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.5 mmt 58.34 16.26 3.95 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.93 25.75 75.2 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.791 -2.123 . . . . 0.0 107.791 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -130.56 -154.56 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.931 0.872 . . . . 0.0 109.88 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HG2' HG11 ' A' ' 19' ' ' VAL . 24.9 mt-30 -136.65 142.0 43.2 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.535 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.2 m95 -141.3 139.99 33.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.484 -1.385 . . . . 0.0 110.399 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -55.73 137.25 50.0 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.71 -17.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 120.848 -1.158 . . . . 0.0 109.044 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.31 -25.16 15.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.509 -0.744 . . . . 0.0 110.689 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -94.26 -8.52 38.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.804 -1.185 . . . . 0.0 110.364 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 20' ' ' VAL . 23.1 t80 -80.34 106.7 12.55 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' A' ' 40' ' ' PRO . 27.0 m -133.46 175.26 11.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.35 1.072 . . . . 0.0 111.184 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.03 148.58 47.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.385 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.3 28.84 1.56 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 109.608 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.9 tptt -139.8 -31.29 0.67 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.345 -0.847 . . . . 0.0 110.179 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 32.0 p -130.82 -8.92 3.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.121 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 33.2 mm-40 63.89 48.38 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 110.376 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -101.74 109.31 59.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.2 Cg_endo -68.6 138.65 42.32 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.81 1.673 . . . . 0.0 112.28 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.475 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.52 -55.59 1.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.307 -0.871 . . . . 0.0 109.494 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.11 30.27 2.84 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -114.36 -158.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.394 -1.062 . . . . 0.0 109.97 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -114.88 145.99 41.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.548 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.4 p-80 -117.43 167.42 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 0.0 109.666 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.715 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.4 m-85 -131.22 137.43 48.92 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -105.89 148.88 27.1 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.226 -0.921 . . . . 0.0 111.51 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 54' ' ' TYR . 1.3 tmt_? -153.46 126.89 8.63 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.507 0.67 . . . . 0.0 109.991 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp 53.71 26.01 5.54 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.378 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.644 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 81.1 31.37 35.01 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 52' ' ' LEU . 22.3 mt -141.92 141.64 32.99 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.734 -0.862 . . . . 0.0 108.723 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.35 152.94 34.23 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.56 ' CE1' HD22 ' A' ' 62' ' ' LEU . 56.4 m-85 -153.71 140.05 18.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 99.0 m -56.85 178.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.36 -1.336 . . . . 0.0 108.473 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 62.5 tt0 -64.45 -36.47 84.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.2 m -86.59 -42.32 13.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 111.382 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.44 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.47 -43.42 81.07 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.794 -1.191 . . . . 0.0 108.207 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.4 t80 -52.85 -56.02 18.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 22.6 m-80 -63.76 -45.16 91.05 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.893 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' THR . 32.9 tt0 -53.38 -34.63 58.4 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.56 HD22 ' CE1' ' A' ' 54' ' ' TYR . 2.9 mp -79.29 -36.03 40.35 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.197 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -158.6 -84.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.128 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.516 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.33 163.57 36.05 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.055 1.836 . . . . 0.0 108.858 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.5 mt -135.13 120.25 29.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 122.028 0.918 . . . . 0.0 109.33 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.3 t -57.81 116.64 3.58 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.768 0.794 . . . . 0.0 110.036 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.529 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.22 -1.69 4.47 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.88 -56.33 3.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -1.071 . . . . 0.0 109.474 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -107.45 4.27 26.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.254 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 53.78 42.08 31.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.676 ' CG ' HH11 ' A' ' 13' ' ' ARG . 2.3 mtt-85 -116.4 144.09 32.42 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.7 Cg_exo -56.56 113.15 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.45 1.433 . . . . 0.0 110.472 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.656 HG21 HG22 ' A' ' 19' ' ' VAL . 23.8 mt -70.74 158.43 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -160.73 61.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 110.679 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.38 -101.8 0.15 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.11 40.43 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.656 HG22 HG21 ' A' ' 15' ' ' ILE . 44.0 t -98.16 157.94 3.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 111.149 -177.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.458 HG11 ' CD2' ' A' ' 32' ' ' PHE . 5.4 t -122.2 115.86 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -89.61 106.27 18.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 109.569 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.57 43.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.65 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.74 17.02 4.82 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.31 28.44 71.36 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -133.89 -154.41 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.919 0.866 . . . . 0.0 109.945 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.461 ' HG2' HG11 ' A' ' 19' ' ' VAL . 21.3 mt-30 -135.98 142.78 44.56 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.529 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.6 m95 -141.38 139.26 33.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.508 -1.37 . . . . 0.0 110.612 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -55.63 137.95 48.13 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 18' ' ' ARG . 10.5 t -57.24 -19.51 10.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.44 -18.53 20.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.41 -0.806 . . . . 0.0 110.63 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -100.67 -7.01 24.32 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.886 -1.133 . . . . 0.0 110.231 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.3 t80 -83.03 102.46 11.79 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' A' ' 40' ' ' PRO . 23.5 m -126.27 176.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.414 1.102 . . . . 0.0 111.266 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -66.47 149.41 50.47 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.656 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.34 24.96 3.15 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.6 tptp -132.63 -30.68 1.42 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.389 -0.819 . . . . 0.0 109.725 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.2 p -133.5 -10.18 2.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.375 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 65.55 48.24 2.05 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.321 -0.862 . . . . 0.0 110.399 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -101.11 110.4 61.14 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.6 Cg_endo -67.16 138.51 47.47 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.723 1.616 . . . . 0.0 111.81 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.9 m-85 -95.35 60.06 2.24 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.86 -55.38 1.99 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.484 -0.76 . . . . 0.0 109.257 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.98 30.8 2.79 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -117.31 167.08 11.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.484 -1.01 . . . . 0.0 109.912 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -82.37 151.86 26.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.0 109.151 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.586 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 15.3 p-80 -117.88 169.77 9.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 109.838 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.713 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.0 m-85 -133.85 136.67 44.55 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -111.03 140.24 45.73 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.321 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.707 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -146.68 137.66 24.1 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.485 0.659 . . . . 0.0 110.17 178.652 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt 51.9 22.19 1.69 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.002 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.65 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 80.25 31.04 39.36 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 52' ' ' LEU . 25.6 mt -140.27 143.68 36.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.71 151.67 34.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.73 0.776 . . . . 0.0 110.858 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.499 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 58.8 m-85 -153.12 137.13 16.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.6 m -57.22 174.67 0.18 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.369 -1.332 . . . . 0.0 108.276 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 64.9 tt0 -60.66 -34.85 74.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.202 -0.936 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.8 -43.64 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.63 -0.669 . . . . 0.0 111.638 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.454 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.2 m170 -67.43 -44.38 78.89 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.729 -1.232 . . . . 0.0 108.377 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -50.39 -54.98 17.73 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 49.2 m-80 -66.69 -45.72 77.91 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.061 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 57' ' ' THR . 3.9 tp-100 -53.49 -38.23 63.48 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.587 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.4 mp -71.07 -39.57 72.14 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.707 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.8 m-85 -154.74 -84.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.625 0.726 . . . . 0.0 109.967 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.1 t . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -78.39 164.42 26.43 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.664 2.243 . . . . 0.0 109.31 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.9 mt -135.52 123.17 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.866 0.841 . . . . 0.0 109.622 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.843 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 13.8 t -63.32 118.15 7.63 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.824 0.821 . . . . 0.0 109.884 -178.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.507 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.27 0.12 6.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.843 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.77 -36.23 18.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -1.096 . . . . 0.0 109.563 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.04 4.38 4.87 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.79 41.01 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -114.79 141.75 27.28 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.595 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.3 Cg_exo -56.76 114.39 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.41 1.407 . . . . 0.0 110.86 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.565 HD13 HG13 ' A' ' 19' ' ' VAL . 21.7 mt -71.96 159.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.424 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.3 pt-20 -160.73 61.92 0.31 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.746 -1.221 . . . . 0.0 110.964 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.66 -103.31 0.17 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.605 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.0 mtm180 -110.0 121.1 44.46 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 HD13 ' A' ' 15' ' ' ILE . 35.7 t -98.52 158.0 3.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.344 -0.847 . . . . 0.0 110.98 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 29' ' ' VAL . 5.6 t -120.81 112.94 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -88.98 106.61 18.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.181 -0.95 . . . . 0.0 109.801 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -143.51 158.96 43.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.641 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.6 mmt 58.74 14.52 3.22 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 72.74 21.52 79.62 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -125.08 -154.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.835 0.826 . . . . 0.0 109.749 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.495 ' HG2' HG11 ' A' ' 19' ' ' VAL . 24.4 mt-30 -135.0 145.11 47.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.507 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 66.0 m95 -142.6 135.66 28.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.672 -1.267 . . . . 0.0 110.181 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.438 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 19.0 m80 -53.55 135.61 39.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 18' ' ' ARG . 33.4 t -55.0 -21.24 7.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 120.918 -1.114 . . . . 0.0 109.548 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 30' ' ' GLU . 6.5 pm0 -95.02 -20.02 19.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 110.679 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -97.34 -9.78 26.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.813 -1.179 . . . . 0.0 110.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.0 t80 -78.42 105.58 9.77 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.5 m -134.04 176.54 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.219 1.009 . . . . 0.0 111.032 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.513 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.4 t -62.63 148.01 47.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.22 32.03 1.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -140.25 -41.55 0.42 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.467 -0.77 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.5 p -119.3 -18.95 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.574 -0.704 . . . . 0.0 110.309 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.6 mt-10 75.51 48.04 0.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -100.84 106.97 47.13 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.3 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.801 1.667 . . . . 0.0 112.355 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.482 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.14 56.98 1.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.617 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.29 -55.57 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.04 31.27 2.72 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.512 ' ND1' ' N ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -115.23 -163.27 0.87 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -1.0 . . . . 0.0 109.984 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -111.09 145.52 38.42 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.559 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 35.1 p-80 -117.69 170.03 9.11 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.019 0.914 . . . . 0.0 109.88 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.713 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.5 m-85 -134.29 135.28 42.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -112.15 150.56 30.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.076 -1.015 . . . . 0.0 111.303 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.66 132.69 19.23 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.691 0.758 . . . . 0.0 110.378 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.0 mttm 50.34 20.65 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.558 -0.714 . . . . 0.0 109.422 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.641 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.31 30.96 12.43 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.332 -1.414 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 52' ' ' LEU . 17.8 mt -141.73 137.95 32.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -72.59 151.72 42.2 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.05 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.664 ' N ' ' O ' ' A' ' 47' ' ' TYR . 45.4 m-85 -153.46 139.47 18.24 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.9 m -56.8 -179.82 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.516 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.5 tt0 -65.32 -36.94 85.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.9 m -86.99 -42.52 13.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 0.0 111.475 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.468 ' O ' HD13 ' A' ' 62' ' ' LEU . 32.6 m170 -66.23 -43.74 85.78 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.209 . . . . 0.0 108.325 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.0 t80 -52.78 -56.73 13.54 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 48.4 m-80 -63.8 -44.51 93.11 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.196 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 57' ' ' THR . 11.8 tt0 -55.1 -34.28 63.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.591 HD22 ' CE1' ' A' ' 54' ' ' TYR . 4.9 mp -78.76 -35.01 45.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.383 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 19.2 m-85 -158.52 -81.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.107 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 5' ' ' VAL . 2.0 t . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.1 Cg_endo -80.19 164.66 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.796 2.33 . . . . 0.0 109.248 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.6 mt -135.8 123.03 34.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.831 0.825 . . . . 0.0 109.553 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.5 t -63.09 118.01 7.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.766 0.793 . . . . 0.0 109.929 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.501 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.12 0.2 6.52 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.1 -35.81 18.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -1.095 . . . . 0.0 109.618 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.51 4.4 4.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.87 41.33 32.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.659 ' CG ' HH11 ' A' ' 13' ' ' ARG . 2.0 mtt-85 -115.32 140.86 26.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.507 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.8 Cg_exo -55.27 114.01 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.444 1.43 . . . . 0.0 110.84 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 8' ' ' CYS . 22.4 mt -71.64 158.39 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -159.38 59.73 0.39 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.798 -1.189 . . . . 0.0 110.945 -178.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.57 -102.27 0.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.1 mtm180 -110.48 122.37 47.57 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.523 HG13 HD13 ' A' ' 15' ' ' ILE . 29.5 t -98.56 156.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 111.119 -177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' A' ' 32' ' ' PHE . 10.6 t -119.37 111.91 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 3.3 m-20 -87.02 106.51 17.89 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.42 43.3 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.61 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 58.26 16.39 3.96 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.98 28.69 70.1 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 21' ' ' ASN . 10.5 mttp -135.86 -154.45 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.807 0.813 . . . . 0.0 109.846 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.497 ' HG2' HG11 ' A' ' 19' ' ' VAL . 27.1 mt-30 -133.77 145.47 49.83 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.501 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.3 m95 -143.0 135.94 27.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.648 -1.283 . . . . 0.0 110.18 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.433 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 19.5 m80 -53.69 135.76 40.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 18' ' ' ARG . 15.9 t -54.6 -20.8 5.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.911 -1.118 . . . . 0.0 109.275 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.21 -22.76 18.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 110.674 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -96.5 -7.44 34.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.826 -1.171 . . . . 0.0 110.28 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.481 ' CD2' HG11 ' A' ' 20' ' ' VAL . 25.1 t80 -82.45 103.65 12.16 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.79 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.9 m -127.27 178.66 4.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.336 1.065 . . . . 0.0 111.057 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -69.31 148.75 49.29 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.883 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -89.9 25.55 2.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.7 tptt -135.83 -32.15 0.9 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.399 -0.813 . . . . 0.0 110.054 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.3 p -129.45 -7.6 4.69 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 110.164 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 59.1 42.61 18.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.222 -0.923 . . . . 0.0 109.483 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -99.07 108.47 49.71 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.79 ' CA ' HG12 ' A' ' 33' ' ' VAL . 2.6 Cg_endo -65.11 140.37 65.06 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.748 1.632 . . . . 0.0 112.343 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.7 m-85 -96.15 61.27 2.07 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 9.8 mp -40.32 -55.86 2.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 109.82 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.82 26.18 4.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -116.61 159.81 21.61 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.417 -1.049 . . . . 0.0 109.685 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.642 ' CB ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.08 159.21 30.0 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.325 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.509 ' HB3' ' CD2' ' A' ' 41' ' ' PHE . 8.9 p-80 -116.95 172.7 7.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.67 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.6 m-85 -136.02 128.71 30.83 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.46 150.72 23.6 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.95 0.881 . . . . 0.0 111.772 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.726 ' CZ ' ' HZ3' ' A' ' 50' ' ' LYS . 0.8 OUTLIER -143.82 134.16 24.58 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.394 0.616 . . . . 0.0 109.548 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.726 ' HZ3' ' CZ ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER 37.45 25.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.643 0.735 . . . . 0.0 109.973 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.61 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.42 30.95 9.29 Favored Glycine 0 N--CA 1.481 1.675 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.583 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.8 mt -142.17 140.26 32.33 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.335 -1.097 . . . . 0.0 108.728 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.86 150.75 39.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.899 0.856 . . . . 0.0 110.967 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' A' ' 62' ' ' LEU . 53.1 m-85 -154.04 137.22 15.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 93.2 m -56.16 178.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.393 -1.323 . . . . 0.0 108.696 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 39.7 tt0 -61.71 -39.33 91.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.371 -0.83 . . . . 0.0 109.782 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 61' ' ' GLN . 46.3 m -86.23 -40.9 15.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 111.804 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.45 -44.81 77.77 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.676 -1.265 . . . . 0.0 108.235 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.471 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.9 t80 -51.82 -55.85 17.46 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -64.03 -46.09 85.98 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 57' ' ' THR . 16.8 tt0 -53.23 -35.0 59.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.552 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 mp -77.51 -40.57 42.34 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.342 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.8 m-85 -152.78 -84.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.313 -0.867 . . . . 0.0 110.301 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.39 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.093 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 15' ' ' ILE . 3.9 Cg_endo -72.2 163.63 38.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.759 1.639 . . . . 0.0 108.404 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.534 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.0 mt -134.29 120.4 33.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 122.172 0.987 . . . . 0.0 109.361 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.841 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.2 t -58.5 117.03 4.06 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.815 0.817 . . . . 0.0 110.048 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.533 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.84 -1.39 4.99 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.841 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.01 -52.94 5.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -1.084 . . . . 0.0 109.395 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.45 4.66 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.582 -0.699 . . . . 0.0 109.169 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.38 42.46 32.02 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -116.75 143.23 31.02 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.602 ' HB3' HG11 ' A' ' 5' ' ' VAL . 2.7 Cg_exo -55.16 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.723 1.615 . . . . 0.0 110.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.626 HG21 HG22 ' A' ' 19' ' ' VAL . 27.1 mt -72.09 158.56 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.29 61.38 0.28 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.725 -1.234 . . . . 0.0 110.766 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.34 -102.42 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 29' ' ' VAL . 66.9 mtm180 -111.38 121.59 45.61 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 15' ' ' ILE . 40.3 t -100.26 159.02 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -0.8 . . . . 0.0 111.252 -177.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.465 ' N ' HG12 ' A' ' 19' ' ' VAL . 6.1 t -122.39 115.74 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.92 106.35 18.41 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.097 -1.002 . . . . 0.0 109.694 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.77 159.43 43.2 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.79 16.83 4.74 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.87 73.41 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -131.71 -154.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HG2' HG11 ' A' ' 19' ' ' VAL . 20.8 mt-30 -135.97 142.96 44.61 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.533 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.0 m95 -141.3 138.41 33.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.589 -1.319 . . . . 0.0 110.504 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.4 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 18.2 m80 -54.52 138.01 41.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' ARG . 8.4 t -57.26 -18.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 O-C-N 120.878 -1.139 . . . . 0.0 109.319 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -96.36 -22.29 17.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 110.667 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -96.1 -9.22 31.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.863 -1.148 . . . . 0.0 110.398 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.0 t80 -80.07 105.95 11.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.4 m -133.21 175.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.266 1.032 . . . . 0.0 111.12 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.56 149.05 44.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.086 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.57 24.51 3.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -134.19 -33.43 1.01 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.2 p -125.8 -19.74 4.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.8 mt-10 76.22 46.5 0.09 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.302 -0.874 . . . . 0.0 110.449 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -100.75 110.27 60.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.6 Cg_endo -68.79 138.06 40.02 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.726 1.618 . . . . 0.0 112.11 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.05 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.31 -55.36 1.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.31 29.44 3.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.86 -177.73 3.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -1.03 . . . . 0.0 109.963 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -97.05 145.63 25.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.744 . . . . 0.0 109.356 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.567 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -116.28 170.21 8.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.707 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.87 137.51 46.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -106.78 147.76 29.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.263 -0.898 . . . . 0.0 111.402 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.66 129.48 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.613 0.721 . . . . 0.0 110.208 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.626 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 51.0 mttp 51.82 23.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 30.8 24.26 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 52' ' ' LEU . 18.1 mt -142.77 143.21 32.11 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.623 -0.928 . . . . 0.0 108.844 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.54 152.86 35.87 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.43 -0.794 . . . . 0.0 110.797 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.537 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 58.7 m-85 -153.97 140.33 18.66 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 89.8 m -57.61 176.75 0.12 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.619 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 56.3 tt0 -63.33 -35.7 81.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.337 -0.852 . . . . 0.0 109.312 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 m -86.52 -43.64 12.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.345 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.591 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.6 m170 -66.8 -45.59 77.9 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.765 -1.209 . . . . 0.0 108.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.4 t80 -49.48 -55.85 11.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 42.7 m-80 -65.67 -45.82 81.47 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.073 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -54.93 -33.25 62.03 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 58' ' ' HIS . 0.9 OUTLIER -78.62 -35.28 45.79 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.138 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.626 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 16.8 m-85 -158.59 -80.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.005 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 1.9 t . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ILE . 10.1 Cg_endo -80.44 164.32 21.44 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.686 2.258 . . . . 0.0 109.862 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 14' ' ' PRO . 38.9 mt -135.08 120.15 28.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.995 0.902 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 38.3 t -62.68 116.09 4.88 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.826 0.822 . . . . 0.0 110.048 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.523 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -62.59 -3.54 5.72 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.28 -33.02 19.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.403 -1.057 . . . . 0.0 109.266 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 0.9 7.15 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 8' ' ' CYS . 21.1 mmm180 50.92 34.35 10.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -115.24 137.32 22.94 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 7' ' ' ILE . 7.1 Cg_exo -51.65 114.56 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.075 1.183 . . . . 0.0 111.056 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 HG22 ' A' ' 19' ' ' VAL . 11.5 mt -69.31 160.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 15' ' ' ILE . 4.4 pt-20 -169.25 69.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.264 . . . . 0.0 110.403 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.31 -59.06 0.24 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.5 133.13 30.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.775 HG22 HG21 ' A' ' 15' ' ' ILE . 46.5 t -127.03 157.92 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.084 -1.01 . . . . 0.0 110.74 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.488 ' N ' HG12 ' A' ' 19' ' ' VAL . 6.7 t -132.43 116.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.032 -1.042 . . . . 0.0 109.389 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . . . -144.34 157.63 44.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.409 -0.807 . . . . 0.0 108.985 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.678 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 58.02 19.36 5.87 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.95 13.72 72.69 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -118.95 -156.76 0.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.7 0.762 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.415 ' C ' ' CD1' ' A' ' 27' ' ' TRP . 15.6 mt-30 -133.61 144.67 49.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.523 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 50.0 m95 -142.23 140.73 32.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.58 -1.325 . . . . 0.0 110.411 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -54.43 141.93 28.95 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 20' ' ' VAL . 9.0 t -62.26 -18.4 20.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.684 -1.26 . . . . 0.0 109.496 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -20.45 20.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 110.438 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.43 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.9 m170 -101.86 -6.32 23.7 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.171 -0.955 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 20' ' ' VAL . 31.0 t80 -81.45 106.18 13.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.7 m -133.19 175.11 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.296 1.046 . . . . 0.0 111.508 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -63.03 149.47 44.93 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.298 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.59 26.6 2.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.103 -0.998 . . . . 0.0 109.848 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.9 tptp -135.44 -31.34 0.97 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.382 -0.824 . . . . 0.0 109.917 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.0 p -129.82 -16.39 3.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 72.75 47.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.15 109.69 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.8 Cg_endo -69.25 137.38 36.8 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.758 1.639 . . . . 0.0 112.031 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.05 57.93 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.22 -55.4 1.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.251 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.5 3.01 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.62 -174.81 2.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.396 -1.061 . . . . 0.0 109.939 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -98.71 147.37 24.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.59 -0.693 . . . . 0.0 109.363 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.589 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-80 -119.41 169.43 10.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 109.551 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.724 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.3 m-85 -132.51 137.24 47.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.59 143.43 41.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.242 -0.911 . . . . 0.0 111.581 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.672 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -150.22 136.59 18.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.442 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 51.47 21.33 1.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.633 -0.667 . . . . 0.0 109.282 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.678 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.1 31.28 29.0 Favored Glycine 0 C--N 1.295 -1.709 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 52' ' ' LEU . 19.3 mt -142.27 142.13 32.54 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.71 -0.876 . . . . 0.0 108.84 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.28 152.63 36.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.415 -0.803 . . . . 0.0 110.671 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 55.2 m-85 -153.11 138.71 17.79 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 88.1 m -58.0 176.58 0.15 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.432 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.6 tp10 -63.46 -36.3 83.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.137 -0.977 . . . . 0.0 109.061 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' GLN . 32.6 m -85.73 -41.0 15.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 111.279 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.436 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -69.45 -45.35 69.28 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.723 -1.235 . . . . 0.0 108.207 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -51.17 -54.43 25.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 93.2 m-20 -65.55 -46.99 77.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.135 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' THR . 14.9 tt0 -52.31 -40.19 61.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.3 mp -68.93 -39.09 79.79 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.672 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.5 m-85 -155.34 -87.61 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.802 0.81 . . . . 0.0 110.001 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.532 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' ILE . 8.4 Cg_endo -79.21 164.2 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.65 2.233 . . . . 0.0 109.65 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 35.3 mt -134.86 119.69 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.035 0.921 . . . . 0.0 109.419 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.827 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 35.2 t -58.38 114.55 2.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.742 0.782 . . . . 0.0 109.828 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.545 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.63 -4.37 4.0 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.827 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.41 -59.47 2.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.397 -1.061 . . . . 0.0 109.393 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.29 -0.2 38.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.239 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 55.74 38.8 30.55 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.2 -0.937 . . . . 0.0 108.758 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.81 149.07 44.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.0 Cg_exo -58.63 113.69 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.3 1.334 . . . . 0.0 110.713 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.708 HG21 HG22 ' A' ' 19' ' ' VAL . 15.3 mt -68.54 159.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.1 pt-20 -168.62 69.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.894 -1.129 . . . . 0.0 110.271 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.44 -62.99 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.31 137.15 35.57 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.708 HG22 HG21 ' A' ' 15' ' ' ILE . 44.9 t -126.15 151.89 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.1 -1.0 . . . . 0.0 110.376 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 32' ' ' PHE . 7.9 t -123.48 116.35 48.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -88.67 105.43 17.67 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.093 -1.005 . . . . 0.0 109.703 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.41 160.22 41.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.558 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 13.1 mmt 57.5 14.71 2.39 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.1 13.78 79.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -115.24 -155.55 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.805 0.812 . . . . 0.0 109.678 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -136.28 141.94 43.91 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.545 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 51.4 m95 -141.29 139.37 33.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.554 -1.341 . . . . 0.0 110.204 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.416 ' CD2' HG23 ' A' ' 15' ' ' ILE . 18.4 m80 -54.8 140.58 35.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.31 -18.2 13.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.675 -1.265 . . . . 0.0 109.201 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -95.31 -24.8 16.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -94.08 -9.34 36.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.792 -1.193 . . . . 0.0 110.271 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.487 ' CD2' HG11 ' A' ' 20' ' ' VAL . 21.0 t80 -79.36 105.94 11.03 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.3 m -134.85 176.34 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.34 1.066 . . . . 0.0 111.209 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -63.63 148.22 49.5 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.282 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.43 28.63 1.91 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.438 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.8 -31.07 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.452 -0.78 . . . . 0.0 109.976 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.404 ' HB3' ' CE1' ' A' ' 58' ' ' HIS . 22.6 p -131.66 -15.18 3.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.271 -0.893 . . . . 0.0 110.379 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.2 48.18 0.26 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.361 -0.837 . . . . 0.0 110.551 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -102.74 109.21 60.55 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.1 Cg_endo -69.05 138.26 39.62 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.9 58.07 1.88 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.23 -55.62 1.65 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.76 31.8 2.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.501 ' ND1' ' N ' ' A' ' 44' ' ' HIS . 1.1 m-70 -115.85 -163.82 0.92 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.515 -0.991 . . . . 0.0 110.1 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -109.94 147.07 34.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.543 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 29.0 p-80 -119.07 169.67 9.71 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.141 0.972 . . . . 0.0 109.889 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.724 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.4 m-85 -132.99 136.72 46.22 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.402 ' CD ' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -117.82 154.01 32.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.846 -1.159 . . . . 0.0 112.102 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -143.31 131.85 22.36 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.63 0.729 . . . . 0.0 109.727 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.4 ptpt 45.15 23.12 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.751 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 91.31 29.35 12.54 Favored Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.025 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 52' ' ' LEU . 16.6 mt -137.02 132.27 34.03 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.446 -1.032 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.81 0.814 . . . . 0.0 111.207 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' TYR . 50.6 m-85 -152.15 139.35 19.3 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.5 m -56.12 -179.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.693 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 5.9 tm-20 -66.67 -37.73 85.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.024 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 61' ' ' GLN . 38.2 m -86.83 -40.23 15.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.572 -0.705 . . . . 0.0 111.525 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.68 -44.38 74.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 108.272 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.0 t80 -51.19 -54.84 21.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.425 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 50.4 m-80 -65.42 -46.07 81.44 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.121 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' THR . 14.2 tp60 -53.07 -36.89 61.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 2.4 mp -74.4 -32.35 62.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.654 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 22.4 m-85 -162.59 -86.5 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.832 0.825 . . . . 0.0 109.95 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 1.8 t . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.532 ' CG ' HG21 ' A' ' 19' ' ' VAL . 8.5 Cg_endo -80.35 164.6 21.52 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.738 2.292 . . . . 0.0 109.655 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.505 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.0 mt -134.27 119.93 32.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.977 0.894 . . . . 0.0 109.35 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 36.9 t -63.79 121.19 13.39 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.844 0.831 . . . . 0.0 110.096 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -65.3 -3.83 14.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.78 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.0 -32.58 22.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -1.04 . . . . 0.0 109.353 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 1.42 5.49 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.658 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 50.71 34.46 9.99 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.68 ' CG ' HH11 ' A' ' 13' ' ' ARG . 0.1 OUTLIER -113.64 138.85 22.79 Favored Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.4 Cg_exo -53.27 114.69 1.86 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.301 1.334 . . . . 0.0 111.311 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 HG22 ' A' ' 19' ' ' VAL . 13.7 mt -70.03 159.37 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.455 ' N ' HG22 ' A' ' 15' ' ' ILE . 1.9 pt-20 -161.33 63.57 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.818 -1.177 . . . . 0.0 110.365 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.33 -98.22 0.11 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.66 HH11 ' CG ' ' A' ' 18' ' ' ARG . 3.4 mtt-85 -115.44 130.71 56.97 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.775 HG22 HG21 ' A' ' 15' ' ' ILE . 41.2 t -111.32 160.7 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.907 0.861 . . . . 0.0 111.472 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.493 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.4 t -127.13 116.82 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -89.1 106.15 18.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.64 158.41 43.69 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.668 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.8 mmt 58.16 17.52 4.63 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.86 76.04 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -120.37 -155.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.791 0.805 . . . . 0.0 109.724 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.423 ' HG2' HG11 ' A' ' 19' ' ' VAL . 24.9 mt-30 -135.8 144.85 45.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 58.3 m95 -142.63 140.54 31.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.594 -1.316 . . . . 0.0 110.359 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -55.83 138.46 48.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.469 HG22 HG23 ' A' ' 20' ' ' VAL . 6.9 t -58.01 -19.05 11.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 120.746 -1.221 . . . . 0.0 109.164 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -96.27 -3.14 44.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 110.418 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.59 -10.39 11.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.026 -1.046 . . . . 0.0 110.145 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CG ' HG11 ' A' ' 20' ' ' VAL . 26.5 t80 -78.79 105.82 10.36 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.815 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.4 m -133.45 174.98 12.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.252 1.025 . . . . 0.0 111.215 -177.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -61.7 149.31 40.02 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.483 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.75 27.65 2.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 35.1 tptt -138.87 -32.06 0.7 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.251 -0.906 . . . . 0.0 110.197 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.8 p -128.27 -16.5 4.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.198 -0.939 . . . . 0.0 110.298 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 73.43 47.31 0.18 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.353 -0.842 . . . . 0.0 110.192 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.49 109.96 60.44 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.815 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.9 Cg_endo -69.3 137.17 36.14 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.889 1.726 . . . . 0.0 112.242 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.34 58.83 1.82 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.619 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.11 -55.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.917 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.59 31.53 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -113.43 -178.12 3.3 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -1.033 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.409 ' O ' ' CE1' ' A' ' 47' ' ' TYR . 5.5 tpp180 -98.83 129.51 45.22 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.2 p-80 -101.3 175.82 5.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.012 . . . . 0.0 110.147 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.673 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.7 m-85 -135.88 136.47 40.57 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -108.6 148.16 30.76 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.297 -0.877 . . . . 0.0 111.428 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.765 HH22 ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -153.03 127.57 9.35 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.467 0.651 . . . . 0.0 110.411 179.141 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 50' ' ' LYS . 8.3 mtmp? 54.45 23.88 4.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.668 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.55 31.7 26.68 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 52' ' ' LEU . 20.9 mt -143.76 141.9 30.66 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.663 -0.904 . . . . 0.0 108.926 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.81 153.16 33.06 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 110.651 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.705 ' CG ' ' NH2' ' A' ' 49' ' ' ARG . 59.6 m-85 -153.78 139.38 17.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 87.8 m -57.36 175.04 0.17 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.208 -1.397 . . . . 0.0 108.313 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -62.39 -34.59 77.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.042 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' GLN . 54.0 m -86.44 -44.09 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 111.155 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.564 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.2 m170 -67.25 -42.58 83.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.81 -1.156 . . . . 0.0 107.966 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.765 ' HA ' HH22 ' A' ' 49' ' ' ARG . 5.5 t80 -51.79 -55.63 18.65 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 49.9 m-80 -67.14 -43.99 80.97 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.425 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 57' ' ' THR . 34.9 tt0 -54.29 -37.82 65.19 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.565 HD22 ' NH2' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -75.58 -35.57 60.57 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.452 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.2 m-85 -155.03 -81.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 110.104 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.437 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.63 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.491 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.04 163.64 36.29 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.939 1.76 . . . . 0.0 108.916 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.22 120.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.116 0.96 . . . . 0.0 109.408 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.4 t -58.35 116.15 3.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.778 0.799 . . . . 0.0 109.987 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.542 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.2 -2.11 4.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.29 -53.05 5.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -1.072 . . . . 0.0 109.429 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.54 5.36 19.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.09 42.08 32.18 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -116.16 143.2 30.54 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HB3' HG11 ' A' ' 5' ' ' VAL . 4.9 Cg_exo -56.05 112.56 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.504 1.469 . . . . 0.0 110.252 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.6 HG21 HG22 ' A' ' 19' ' ' VAL . 22.7 mt -69.65 158.02 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.684 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.416 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.8 pt-20 -160.91 62.73 0.3 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.874 -1.141 . . . . 0.0 110.441 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.0 -98.73 0.12 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 125.18 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 15' ' ' ILE . 46.1 t -103.74 152.62 6.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.735 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' A' ' 32' ' ' PHE . 13.1 t -118.2 115.08 47.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -88.69 106.16 18.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 109.747 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.95 160.03 42.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.679 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.2 mmt 58.12 16.44 3.86 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.6 20.66 77.38 Favored Glycine 0 C--N 1.291 -1.925 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -123.44 -153.97 0.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.974 0.892 . . . . 0.0 109.94 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.46 ' HG2' HG11 ' A' ' 19' ' ' VAL . 22.1 mt-30 -136.9 142.45 42.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.542 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 57.0 m95 -141.45 139.75 33.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.534 -1.354 . . . . 0.0 110.503 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -55.91 137.05 51.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 t -55.98 -19.33 6.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.822 -1.174 . . . . 0.0 109.119 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.456 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -94.08 -27.2 16.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.464 -0.772 . . . . 0.0 110.497 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -93.56 -7.08 45.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.08 . . . . 0.0 110.674 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.3 t80 -81.69 105.7 13.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.1 m -133.76 175.85 10.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 122.303 1.049 . . . . 0.0 111.249 -177.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.06 149.29 45.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.389 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.47 28.88 1.84 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.756 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 tptp -138.55 -31.68 0.73 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.416 -0.802 . . . . 0.0 110.057 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.6 p -129.43 -18.54 3.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.1 mt-10 75.26 47.28 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.308 -0.87 . . . . 0.0 110.064 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -100.98 107.67 50.84 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.182 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.9 Cg_endo -67.19 137.95 45.55 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.628 1.552 . . . . 0.0 112.179 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.15 58.46 1.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.01 -55.56 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 31.45 2.66 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.18 -176.29 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.418 -1.049 . . . . 0.0 110.224 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 47' ' ' TYR . 5.8 tpp180 -99.37 136.01 39.94 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -108.23 173.2 6.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.833 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.3 m-85 -134.59 141.48 46.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -110.75 151.46 27.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.176 -0.952 . . . . 0.0 111.788 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.773 ' HE ' ' N ' ' A' ' 50' ' ' LYS . 1.4 tpm_? -156.07 129.41 8.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.349 0.595 . . . . 0.0 109.808 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.773 ' N ' ' HE ' ' A' ' 49' ' ' ARG . 8.6 mmtp 53.17 22.96 2.84 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.679 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.03 31.39 32.04 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 52' ' ' LEU . 20.6 mt -140.69 141.55 34.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.27 154.13 33.25 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.632 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 49' ' ' ARG . 53.1 m-85 -154.33 140.25 18.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.1 m -57.34 176.7 0.11 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.156 -1.418 . . . . 0.0 108.234 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -63.83 -35.46 80.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 109.462 179.175 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.3 m -86.23 -41.32 14.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 111.115 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -68.56 -43.96 75.47 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.729 -1.232 . . . . 0.0 107.863 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -53.28 -56.48 16.26 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 45.3 m-80 -63.69 -44.05 94.84 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.528 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.26 -37.05 69.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 ' CE1' ' A' ' 54' ' ' TYR . 3.4 mp -73.71 -32.58 63.97 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.35 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.6 m-85 -160.08 -83.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.971 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.19 28.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.134 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.8 167.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.3 46.87 0.2 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -155.25 130.77 5.36 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.314 -1.109 . . . . 0.0 109.372 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.25 163.61 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.958 1.772 . . . . 0.0 108.867 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.4 119.77 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 122.059 0.933 . . . . 0.0 109.402 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.0 t -58.35 117.0 3.98 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.844 0.831 . . . . 0.0 109.946 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -64.85 -0.17 4.91 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.67 -48.55 8.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -1.095 . . . . 0.0 109.36 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.8 13.7 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.649 ' HG3' HH11 ' A' ' 12' ' ' ARG . 8.2 mmm-85 53.52 41.32 32.11 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -115.91 143.45 30.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.7 Cg_exo -56.46 113.38 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.46 1.44 . . . . 0.0 110.546 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.661 HG21 HG22 ' A' ' 19' ' ' VAL . 21.5 mt -70.92 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.2 pt-20 -160.54 61.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.863 -1.148 . . . . 0.0 110.662 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.673 HH11 ' CG ' ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.66 42.32 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 15' ' ' ILE . 42.8 t -98.8 158.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.668 0.746 . . . . 0.0 111.195 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 32' ' ' PHE . 4.9 t -122.56 116.01 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -89.85 106.09 18.24 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.11 -0.993 . . . . 0.0 109.553 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.53 42.63 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.9 mmt 58.09 17.19 4.31 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.2 25.28 75.85 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.8 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.741 0.781 . . . . 0.0 109.764 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.466 ' HG2' HG11 ' A' ' 19' ' ' VAL . 20.6 mt-30 -135.38 143.49 46.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.3 m95 -141.59 139.98 33.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.534 -1.354 . . . . 0.0 110.616 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.3 m80 -56.48 131.95 49.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 18' ' ' ARG . 7.7 t -53.22 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.871 -1.143 . . . . 0.0 108.348 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 28' ' ' HIS . 12.5 tp10 -95.78 -26.97 15.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.814 -0.554 . . . . 0.0 110.62 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.13 -6.52 31.38 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.883 -1.136 . . . . 0.0 110.826 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 20' ' ' VAL . 25.2 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.825 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.6 m -133.57 175.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 111.158 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.82 148.68 46.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.318 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.83 28.69 1.73 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.4 tptm -138.81 -31.69 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.364 -0.835 . . . . 0.0 110.077 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.1 -15.39 4.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.305 -0.872 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.6 0.34 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.326 -0.859 . . . . 0.0 110.191 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.46 109.56 59.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.825 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.4 Cg_endo -69.06 138.28 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.713 1.609 . . . . 0.0 112.112 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.131 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.23 1.63 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.26 -0.9 . . . . 0.0 108.996 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.01 2.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.936 -1.665 . . . . 0.0 108.936 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -116.29 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.504 -0.998 . . . . 0.0 109.94 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.43 145.34 24.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 109.352 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.2 p-80 -116.3 169.47 9.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.707 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.55 137.67 47.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.28 28.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.232 -0.917 . . . . 0.0 111.201 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.34 11.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.628 0.727 . . . . 0.0 110.333 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.23 22.86 1.45 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.586 -0.696 . . . . 0.0 109.495 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.47 30.97 20.36 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.724 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 52' ' ' LEU . 18.6 mt -143.29 142.74 31.44 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.535 -0.979 . . . . 0.0 108.814 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.35 152.86 36.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 110.73 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' A' ' 62' ' ' LEU . 57.7 m-85 -153.91 140.27 18.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 90.7 m -57.55 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.316 -1.353 . . . . 0.0 108.454 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 53.1 tt0 -63.63 -35.98 82.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.383 -0.823 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.4 m -86.66 -43.75 12.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 0.0 111.339 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.459 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -66.65 -43.77 83.68 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.79 -1.194 . . . . 0.0 108.141 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.2 t80 -51.74 -56.43 13.87 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 44.0 m-80 -64.52 -44.89 89.47 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.093 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.5 tp60 -54.44 -34.37 61.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.55 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.8 mp -78.68 -35.24 45.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.359 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 18.0 m-85 -158.58 -81.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 87.41 31.39 16.49 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' A' ' 59' ' ' TYR . 26.2 m-20 48.5 51.27 15.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -1.117 . . . . 0.0 109.566 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.482 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 t -50.09 158.9 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -1.123 . . . . 0.0 109.463 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 tpt -61.09 -9.18 4.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . 144.26 -72.09 0.36 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.0 t 57.16 117.7 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.436 -1.038 . . . . 0.0 109.944 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.9 Cg_endo -79.6 164.3 23.57 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.673 2.249 . . . . 0.0 109.327 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.6 mt -135.31 122.83 36.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.873 0.844 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.841 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.1 t -61.13 116.83 4.86 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.549 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.42 -1.13 4.11 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.841 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.46 -54.22 4.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -1.149 . . . . 0.0 109.524 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.33 1.97 18.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.559 -0.713 . . . . 0.0 109.148 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 57.56 41.86 25.1 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.22 -0.925 . . . . 0.0 108.57 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -116.68 142.76 30.16 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.6 Cg_exo -55.69 113.97 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.432 1.422 . . . . 0.0 110.948 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 8' ' ' CYS . 23.9 mt -71.89 158.77 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.0 pt-20 -161.77 62.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 0.0 110.484 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 -100.37 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 29' ' ' VAL . 62.6 mtm180 -113.33 120.49 41.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.517 HG13 HD13 ' A' ' 15' ' ' ILE . 30.6 t -97.01 154.51 3.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 111.065 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.7 t -118.84 112.61 38.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.98 106.81 18.08 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.67 42.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.5 mmt 58.38 16.01 3.83 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 27.5 71.71 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -133.05 -151.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.042 0.925 . . . . 0.0 110.089 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.502 ' HG2' HG11 ' A' ' 19' ' ' VAL . 26.4 mt-30 -136.82 144.53 43.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.549 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 64.4 m95 -142.51 135.44 28.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.605 -1.31 . . . . 0.0 110.368 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 17.7 m80 -53.77 135.52 41.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 18' ' ' ARG . 10.3 t -55.54 -18.18 4.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 120.935 -1.103 . . . . 0.0 109.053 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -94.39 -25.9 16.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.438 -0.789 . . . . 0.0 110.573 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.5 m170 -98.01 -5.03 34.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 111.028 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' A' ' 20' ' ' VAL . 28.5 t80 -82.72 106.03 14.23 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.833 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.2 m -133.01 174.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 122.314 1.054 . . . . 0.0 111.294 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.89 148.28 40.12 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.117 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.46 35.11 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.39 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -142.99 -40.23 0.32 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.8 p -122.41 -17.34 7.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.642 -0.661 . . . . 0.0 110.256 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.8 mt-10 75.1 47.89 0.1 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 110.244 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -100.42 109.59 57.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.833 ' CA ' HG12 ' A' ' 33' ' ' VAL . 6.1 Cg_endo -69.89 137.73 35.77 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.863 1.709 . . . . 0.0 112.15 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.21 57.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.62 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.11 -55.51 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -0.905 . . . . 0.0 109.279 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 29.79 2.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -114.68 -174.31 2.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.483 -1.01 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.56 146.85 25.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.321 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.583 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.8 p-80 -118.32 169.12 10.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.331 -0.855 . . . . 0.0 109.603 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.715 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.3 m-85 -133.15 138.05 46.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.56 149.73 27.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 111.394 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.62 11.54 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.588 0.708 . . . . 0.0 110.259 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp 50.89 22.41 1.17 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.74 . . . . 0.0 109.376 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.75 30.77 20.15 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 52' ' ' LEU . 19.6 mt -141.99 142.26 32.93 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.59 -0.947 . . . . 0.0 108.77 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.47 153.15 35.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.29 -0.882 . . . . 0.0 110.954 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.627 ' CE1' HD22 ' A' ' 62' ' ' LEU . 48.7 m-85 -154.68 139.45 17.11 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 73.7 m -57.28 175.8 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.063 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.697 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.8 tp10 -61.98 -34.92 77.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.052 -1.03 . . . . 0.0 109.285 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 61' ' ' GLN . 70.2 m -86.25 -45.1 11.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.831 . . . . 0.0 111.251 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.563 ' O ' HD13 ' A' ' 62' ' ' LEU . 31.9 m170 -65.37 -42.76 92.38 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.792 -1.192 . . . . 0.0 108.358 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -54.34 -57.56 10.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 96.6 m-20 -62.72 -44.65 95.67 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.282 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' THR . 2.9 tp-100 -55.52 -34.43 64.65 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.627 HD22 ' CE1' ' A' ' 54' ' ' TYR . 6.1 mp -78.77 -34.21 45.81 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.673 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 17.3 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.82 31.58 43.68 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 55.92 80.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -1.089 . . . . 0.0 109.397 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.476 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.506 ' H2 ' ' CE ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -79.47 51.55 1.25 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.106 . . . . 0.0 109.458 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.506 ' CE ' ' H2 ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER -163.93 -167.53 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.454 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.495 ' O ' ' SD ' ' A' ' 3' ' ' MET . . . -79.35 -161.3 21.47 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t -153.77 117.79 2.71 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.24 -1.153 . . . . 0.0 109.825 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.7 Cg_endo -79.96 164.49 22.56 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.757 2.305 . . . . 0.0 109.526 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 14' ' ' PRO . 35.1 mt -133.94 119.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.126 0.965 . . . . 0.0 109.327 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 36.2 t -61.33 116.24 4.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.796 0.807 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.54 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -59.83 -4.52 3.26 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.801 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.37 -51.58 6.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.406 -1.055 . . . . 0.0 109.289 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.428 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -107.56 2.98 24.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.269 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' CYS . 19.3 mmm180 50.02 34.83 8.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 13' ' ' ARG . 0.2 OUTLIER -113.85 138.62 22.82 Favored Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.7 Cg_exo -53.64 114.82 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.268 1.312 . . . . 0.0 110.943 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.729 HG21 HG22 ' A' ' 19' ' ' VAL . 14.0 mt -68.98 158.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' CD ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -159.59 62.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.913 -1.117 . . . . 0.0 110.451 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.54 -96.46 0.1 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -112.38 142.48 44.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.729 HG22 HG21 ' A' ' 15' ' ' ILE . 43.7 t -122.65 156.77 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.744 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.5 t -125.17 116.84 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -88.46 105.85 17.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.077 -1.014 . . . . 0.0 109.497 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.99 41.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.661 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 57.52 16.96 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.72 20.43 78.61 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -125.38 -155.37 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.742 0.782 . . . . 0.0 109.783 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HG2' HG11 ' A' ' 19' ' ' VAL . 24.7 mt-30 -134.53 143.99 47.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.54 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.4 m95 -142.14 139.47 32.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.616 -1.303 . . . . 0.0 110.26 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.422 ' NE2' ' HA ' ' A' ' 15' ' ' ILE . 19.6 m80 -54.68 138.65 41.14 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -57.41 -16.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 120.795 -1.191 . . . . 0.0 108.987 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -96.52 -25.82 15.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.47 -0.769 . . . . 0.0 110.54 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -93.21 -9.94 37.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.916 -1.115 . . . . 0.0 110.451 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' A' ' 20' ' ' VAL . 22.4 t80 -79.61 105.82 11.19 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.811 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.9 m -133.97 175.26 11.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 122.246 1.022 . . . . 0.0 110.959 -177.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -64.13 148.53 49.71 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.268 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.0 28.12 1.66 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 tptm -138.7 -32.03 0.71 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.333 -0.854 . . . . 0.0 110.223 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.7 p -129.3 -11.27 4.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.343 -0.848 . . . . 0.0 110.205 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 65.01 47.25 2.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.472 -0.768 . . . . 0.0 110.491 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.603 ' NZ ' ' SG ' ' A' ' 55' ' ' CYS . 0.0 OUTLIER -101.99 107.49 52.67 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.811 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.4 Cg_endo -66.0 139.48 56.48 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.678 1.585 . . . . 0.0 112.304 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.44 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.14 -55.31 1.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.947 . . . . 0.0 109.067 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.1 30.58 2.92 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -117.7 176.61 5.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.56 -0.965 . . . . 0.0 109.905 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.57 150.43 21.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.438 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.6 p-80 -119.4 170.66 8.94 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.4 m-85 -138.17 129.42 27.46 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.478 ' OE2' ' CE ' ' A' ' 23' ' ' MET . 1.3 mm-40 -100.07 153.59 19.1 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.232 -0.917 . . . . 0.0 111.702 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.518 ' NH2' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -153.35 127.05 8.79 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.558 0.694 . . . . 0.0 109.877 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt 52.59 23.8 2.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 109.59 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.661 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 31.09 23.5 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.076 -1.535 . . . . 0.0 109.36 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.518 HD12 ' NH2' ' A' ' 49' ' ' ARG . 19.4 mt -142.66 139.95 31.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.603 -0.94 . . . . 0.0 108.666 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.3 151.92 39.74 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.163 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' TYR . 55.0 m-85 -154.37 139.45 17.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.603 ' SG ' ' NZ ' ' A' ' 39' ' ' LYS . 89.3 m -57.81 178.15 0.09 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.792 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.2 tt0 -62.31 -37.82 87.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.619 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 61' ' ' GLN . 52.4 m -86.92 -43.08 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 111.66 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -65.81 -43.61 88.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.722 -1.236 . . . . 0.0 108.134 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.8 t80 -51.94 -56.5 13.81 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -64.22 -44.9 90.47 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 57' ' ' THR . 14.9 tp60 -54.38 -34.84 62.01 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.561 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.8 mp -78.12 -33.28 50.61 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.512 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 21.2 m-85 -160.13 -81.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 110.125 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.26 26.07 55.83 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -172.55 25.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -1.084 . . . . 0.0 109.493 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.453 HG12 ' OH ' ' A' ' 59' ' ' TYR . 11.2 p . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.473 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.7 p -166.43 43.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -1.145 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.5 tpp 50.62 -128.48 2.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.425 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -176.73 -46.78 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.627 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t 57.13 129.27 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.548 -0.972 . . . . 0.0 109.888 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.83 163.58 35.3 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.909 1.739 . . . . 0.0 108.901 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.1 mt -134.48 119.95 31.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.012 0.911 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.813 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.1 t -60.27 119.6 8.22 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 110.119 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.84 0.09 11.82 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.813 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.59 -38.36 18.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -1.113 . . . . 0.0 109.392 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.64 5.04 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 54.19 41.48 31.98 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -115.54 142.54 28.99 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.627 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.5 Cg_exo -56.27 112.94 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.562 1.508 . . . . 0.0 110.729 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.694 HG21 HG22 ' A' ' 19' ' ' VAL . 20.7 mt -70.45 158.68 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.418 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.2 pt-20 -159.19 62.12 0.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.691 -1.256 . . . . 0.0 110.854 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.67 -100.97 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' HB3' HG21 ' A' ' 29' ' ' VAL . 37.5 mtt180 -107.82 134.35 50.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.694 HG22 HG21 ' A' ' 15' ' ' ILE . 46.2 t -115.77 158.06 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 110.731 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.454 HG11 ' CD2' ' A' ' 32' ' ' PHE . 3.7 t -122.9 117.32 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -90.03 105.97 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.29 159.76 42.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.1 mmt 58.1 18.14 5.02 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.07 75.75 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -130.32 -154.67 0.65 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.717 0.77 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HG2' HG11 ' A' ' 19' ' ' VAL . 19.2 mt-30 -134.82 145.1 48.02 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.6 m95 -142.05 139.15 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.544 -1.347 . . . . 0.0 110.788 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 18.3 m80 -55.22 132.79 48.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 18' ' ' ARG . 77.0 t -52.39 -22.58 3.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 120.835 -1.165 . . . . 0.0 109.29 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -91.85 -23.74 19.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 110.734 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -96.91 -6.58 35.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.859 -1.151 . . . . 0.0 111.029 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.454 ' CD2' HG11 ' A' ' 20' ' ' VAL . 29.1 t80 -81.67 103.2 11.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.819 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.1 m -128.96 178.45 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 122.321 1.058 . . . . 0.0 111.254 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.1 t -65.61 148.4 51.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.702 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.8 28.19 1.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.486 -0.759 . . . . 0.0 109.197 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 6.3 tmtt? -134.1 -39.07 0.86 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.571 -0.706 . . . . 0.0 109.74 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.6 p -126.31 -16.17 5.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.558 -0.714 . . . . 0.0 110.553 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.0 mt-10 73.7 46.94 0.18 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -100.76 110.21 60.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.819 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.1 Cg_endo -68.46 136.97 38.24 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.718 1.612 . . . . 0.0 111.754 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.4 m-85 -95.98 60.1 2.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.637 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.3 mp -40.04 -56.02 1.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.44 -0.788 . . . . 0.0 109.476 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.67 26.16 4.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -114.56 159.98 19.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.396 -1.061 . . . . 0.0 109.822 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -75.72 154.77 36.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.452 -0.78 . . . . 0.0 109.162 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.608 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.6 p-80 -118.08 170.52 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.273 -0.892 . . . . 0.0 110.017 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.707 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.8 m-85 -135.87 137.36 41.38 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -111.65 145.27 39.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 0.0 111.387 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.558 ' NH1' ' HG3' ' A' ' 49' ' ' ARG . 11.1 ttm-85 -144.92 137.91 26.54 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.53 0.681 . . . . 0.0 110.12 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 44.73 20.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.702 0.763 . . . . 0.0 109.166 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 87.18 30.71 19.07 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ARG . 20.1 mt -138.9 143.03 38.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.678 -0.895 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.96 151.76 33.49 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.828 0.823 . . . . 0.0 111.25 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.562 ' CE1' HD22 ' A' ' 62' ' ' LEU . 53.4 m-85 -153.54 135.89 14.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 14.5 m -56.57 172.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.101 -1.439 . . . . 0.0 108.141 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 68.3 tt0 -57.28 -32.35 66.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.045 -1.034 . . . . 0.0 109.745 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 93.7 m -87.15 -47.88 8.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.826 . . . . 0.0 111.818 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.594 ' O ' HD13 ' A' ' 62' ' ' LEU . 29.1 m170 -64.67 -40.88 96.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.756 -1.215 . . . . 0.0 108.605 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -55.13 -57.49 11.55 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.441 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 42.8 m-80 -63.03 -44.1 96.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.065 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.72 -35.96 64.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 6.6 mp -76.1 -37.25 58.35 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.7 m-85 -156.11 -83.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.722 0.773 . . . . 0.0 109.804 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.441 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 90.31 31.61 10.46 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.5 t70 56.38 81.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -1.104 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.563 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' MET . 15.4 m -165.9 -120.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 0.0 109.4 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 3' ' ' MET . 0.0 OUTLIER 51.63 98.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -109.51 17.35 30.99 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.0 t 56.67 116.19 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.939 . . . . 0.0 110.086 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -79.9 164.68 22.59 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.733 2.289 . . . . 0.0 109.349 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 14' ' ' PRO . 25.8 mt -134.97 120.45 30.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-O 121.945 0.878 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 20.8 t -62.16 121.27 12.67 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.877 0.846 . . . . 0.0 110.077 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.39 -1.48 15.24 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.79 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.35 -35.31 21.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -130.49 0.25 4.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.677 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 56.83 38.56 29.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -178.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.629 ' CG ' HH11 ' A' ' 13' ' ' ARG . 0.0 OUTLIER -111.01 138.3 21.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.9 Cg_exo -55.1 113.46 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.113 1.209 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.627 HG21 HG22 ' A' ' 19' ' ' VAL . 19.9 mt -70.62 158.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -161.26 62.41 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.897 -1.127 . . . . 0.0 110.616 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.82 -101.87 0.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -111.48 126.39 54.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.627 HG22 HG21 ' A' ' 15' ' ' ILE . 42.0 t -105.15 158.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 111.204 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.9 t -122.36 115.65 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.49 106.55 18.57 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 109.905 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.97 160.16 41.78 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.62 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.5 mmt 58.31 14.46 2.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.32 18.21 79.2 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.801 -2.12 . . . . 0.0 107.801 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -120.21 -154.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.007 0.908 . . . . 0.0 109.827 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.462 ' HG2' HG11 ' A' ' 19' ' ' VAL . 28.0 mt-30 -136.6 143.56 43.64 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.4 m95 -141.66 138.88 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.513 -1.367 . . . . 0.0 110.566 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 19.6 m80 -55.46 134.73 50.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.419 HG22 HG23 ' A' ' 20' ' ' VAL . 17.1 t -54.37 -20.43 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 120.809 -1.182 . . . . 0.0 109.08 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -92.03 -27.89 17.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 110.536 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -93.81 -7.35 43.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.031 -1.043 . . . . 0.0 110.885 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.0 t80 -81.25 105.86 12.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.809 HG12 ' CA ' ' A' ' 40' ' ' PRO . 23.2 m -133.89 174.99 12.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 122.326 1.06 . . . . 0.0 111.195 -177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.7 t -64.03 148.41 49.8 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.059 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.71 27.81 1.68 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.702 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.2 tptp -138.09 -33.21 0.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.1 p -126.89 -11.23 6.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.261 -0.9 . . . . 0.0 110.209 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 65.08 46.87 2.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -102.56 107.02 52.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.809 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.5 Cg_endo -66.45 139.75 55.18 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.816 1.677 . . . . 0.0 112.358 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -96.08 56.35 1.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.03 -55.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 30.39 2.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -116.47 178.99 4.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.96 . . . . 0.0 109.958 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -95.79 147.19 23.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.432 -0.792 . . . . 0.0 109.293 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.531 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 33.6 p-80 -117.73 168.94 9.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.0 m-85 -133.66 133.16 41.56 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -111.01 155.43 22.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.075 -1.016 . . . . 0.0 111.639 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -145.47 135.77 23.99 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.55 0.691 . . . . 0.0 110.064 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.2 ptmt 42.33 21.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.467 0.651 . . . . 0.0 109.757 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.62 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.92 30.62 9.28 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.191 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.0 mt -140.53 136.83 33.28 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.491 -1.005 . . . . 0.0 108.379 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.46 150.18 45.15 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.858 0.837 . . . . 0.0 111.11 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.671 ' N ' ' O ' ' A' ' 47' ' ' TYR . 47.4 m-85 -153.14 139.3 18.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 54.1 m -56.51 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.831 -1.168 . . . . 0.0 108.857 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 75.2 tt0 -68.65 -40.46 80.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.352 -0.843 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.2 m -86.25 -37.57 18.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 111.292 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.56 -46.77 68.55 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.798 -1.189 . . . . 0.0 108.224 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -52.36 -55.94 18.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 93.2 m-20 -62.49 -46.26 89.26 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.51 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -54.68 -38.15 66.64 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -72.1 -39.69 68.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.319 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -153.79 -83.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.28 -10.18 29.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 170.27 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.483 -1.01 . . . . 0.0 109.397 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.425 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p -63.76 160.63 16.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -1.139 . . . . 0.0 109.45 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.3 ttt -164.36 40.31 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.361 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 48.33 -170.54 0.07 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.622 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -155.28 130.79 5.36 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.156 . . . . 0.0 109.483 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.53 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.4 Cg_endo -74.36 163.65 35.82 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.911 1.74 . . . . 0.0 109.002 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 14' ' ' PRO . 28.1 mt -135.14 119.75 27.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.992 0.901 . . . . 0.0 109.206 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.816 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.2 t -57.85 118.8 5.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.888 0.852 . . . . 0.0 110.073 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.528 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.57 -2.01 5.37 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.816 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.56 -60.9 1.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -1.069 . . . . 0.0 109.336 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.25 -7.3 26.62 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.501 -0.749 . . . . 0.0 109.163 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.473 ' O ' ' CZ ' ' A' ' 13' ' ' ARG . 23.6 mmm180 63.51 37.81 10.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -112.87 144.07 30.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.622 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.5 Cg_exo -56.07 113.25 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.466 1.444 . . . . 0.0 110.383 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.669 HG21 HG22 ' A' ' 19' ' ' VAL . 22.9 mt -70.52 158.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.1 pt-20 -160.45 61.25 0.33 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.835 -1.165 . . . . 0.0 110.694 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.33 -102.48 0.16 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 29' ' ' VAL . 69.4 mtm180 -112.82 121.37 44.5 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.669 HG22 HG21 ' A' ' 15' ' ' ILE . 40.8 t -99.45 159.39 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 111.285 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.47 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.8 t -123.56 116.44 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -89.86 106.17 18.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.02 42.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.944 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.626 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.07 16.8 4.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 25.41 75.8 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.094 -2.003 . . . . 0.0 108.094 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.72 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.812 0.815 . . . . 0.0 109.816 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.455 ' HG2' HG11 ' A' ' 19' ' ' VAL . 21.8 mt-30 -135.29 143.7 46.36 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.528 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.5 m95 -141.6 140.93 33.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.479 -1.388 . . . . 0.0 110.644 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.475 ' C ' ' N ' ' A' ' 30' ' ' GLU . 18.0 m80 -57.41 131.91 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 20' ' ' VAL . 7.7 t -52.58 -14.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.87 -1.144 . . . . 0.0 108.402 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 28' ' ' HIS . 11.2 tp10 -95.93 -27.11 15.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.761 -0.587 . . . . 0.0 110.501 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -97.14 -6.63 34.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.93 -1.106 . . . . 0.0 110.771 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.3 t80 -80.76 106.09 12.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.4 m -132.67 176.38 9.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.314 1.054 . . . . 0.0 111.19 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.6 t -65.36 148.75 51.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.454 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.49 25.53 2.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.288 -0.883 . . . . 0.0 109.78 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.6 tptp -135.43 -32.75 0.91 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.326 -0.859 . . . . 0.0 110.22 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 p -128.66 -12.47 4.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 67.9 47.2 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.228 -0.92 . . . . 0.0 109.966 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -101.17 107.47 50.44 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.3 Cg_endo -66.81 138.46 48.82 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.624 1.549 . . . . 0.0 112.118 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -95.72 56.81 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.632 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.12 -55.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.166 -0.959 . . . . 0.0 109.015 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.18 29.61 3.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -116.98 175.39 5.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.574 -0.957 . . . . 0.0 109.801 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.709 HH11 ' HG2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -89.32 150.61 22.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.572 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.3 p-80 -119.5 169.8 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.695 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.5 m-85 -136.82 132.78 35.12 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.95 150.84 24.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.928 . . . . 0.0 111.892 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.535 ' NH2' ' OH ' ' A' ' 54' ' ' TYR . 10.0 ttp180 -146.19 134.23 21.5 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.101 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HZ3' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 42.04 21.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.569 0.7 . . . . 0.0 109.615 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.626 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 93.08 30.69 9.1 Favored Glycine 0 C--N 1.295 -1.71 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.043 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.1 mt -141.74 139.76 32.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.456 -1.026 . . . . 0.0 108.822 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -73.8 151.87 40.46 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.865 0.84 . . . . 0.0 110.867 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 47' ' ' TYR . 48.9 m-85 -154.59 138.94 16.69 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 67.4 m -56.56 178.76 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.904 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 12.2 tm-20 -63.73 -39.24 93.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.818 . . . . 0.0 109.46 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.8 m -86.25 -39.28 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.687 . . . . 0.0 111.341 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.7 m170 -67.93 -47.18 69.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.805 -1.184 . . . . 0.0 107.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.1 t80 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -64.18 -44.39 92.2 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.623 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -57.01 -36.41 70.4 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.544 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.7 mp -73.28 -37.39 66.28 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.5 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.9 m-85 -153.74 -81.71 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.795 0.807 . . . . 0.0 109.913 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 65' ' ' ASP . . . 70.53 -11.77 2.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.4 OUTLIER 158.79 -18.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.79 -0.829 . . . . 0.0 108.859 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.487 ' OXT' ' CD2' ' A' ' 63' ' ' PHE . 48.4 t . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.521 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 4' ' ' GLY . 8.2 t 55.5 102.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -1.158 . . . . 0.0 109.484 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.6 mtp -74.22 31.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 2' ' ' SER . . . 82.85 -26.02 4.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.3 t -45.26 129.22 5.89 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.517 -0.99 . . . . 0.0 109.703 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.3 Cg_endo -75.67 163.23 34.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.983 1.789 . . . . 0.0 109.232 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.4 mt -133.78 119.6 33.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 122.103 0.954 . . . . 0.0 109.157 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 30.3 t -58.02 115.63 3.01 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.776 0.798 . . . . 0.0 109.901 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.539 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.66 -3.23 4.11 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.822 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.55 -59.94 2.17 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.471 -1.017 . . . . 0.0 109.357 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.43 -1.07 39.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.545 -0.722 . . . . 0.0 109.179 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER 56.03 39.72 30.43 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -118.37 149.48 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.642 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.0 Cg_exo -58.73 113.01 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.442 1.428 . . . . 0.0 110.793 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.772 HG21 HG22 ' A' ' 19' ' ' VAL . 20.5 mt -68.52 159.92 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.432 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -158.38 62.4 0.44 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.613 -1.305 . . . . 0.0 111.399 -178.248 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.02 -95.37 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -108.27 138.56 44.34 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.772 HG22 HG21 ' A' ' 15' ' ' ILE . 46.9 t -124.9 160.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.791 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.578 HG23 HG22 ' A' ' 29' ' ' VAL . 3.4 t -126.41 117.41 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -90.34 105.77 18.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 109.482 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.31 16.65 4.16 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.91 26.09 74.59 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -130.83 -153.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.848 0.832 . . . . 0.0 109.954 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -137.44 142.8 41.6 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 56.9 m95 -141.38 139.3 33.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.64 -1.288 . . . . 0.0 110.6 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.476 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.7 m80 -56.0 131.44 47.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.578 HG22 HG23 ' A' ' 20' ' ' VAL . 6.2 t -53.38 -13.85 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 120.581 -1.325 . . . . 0.0 108.361 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 28' ' ' HIS . 51.1 tp10 -94.57 -27.36 15.97 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.778 -0.576 . . . . 0.0 110.433 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -98.14 -6.28 31.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.909 -1.12 . . . . 0.0 110.787 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CD2' HG11 ' A' ' 20' ' ' VAL . 22.8 t80 -80.13 107.1 12.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.6 m -133.25 175.9 10.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.229 1.014 . . . . 0.0 111.27 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.47 148.44 48.6 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.407 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.37 25.98 2.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -0.908 . . . . 0.0 109.804 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.44 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.5 tptp -136.02 -31.53 0.91 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.291 -0.88 . . . . 0.0 110.019 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.2 p -130.03 -15.16 3.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.98 47.43 0.31 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.298 -0.876 . . . . 0.0 110.461 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -102.22 109.49 60.35 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.9 Cg_endo -68.76 138.41 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.848 1.698 . . . . 0.0 112.018 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.5 57.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.639 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.34 -55.49 1.72 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.4 31.48 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.531 ' ND1' ' N ' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -115.64 -163.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -1.051 . . . . 0.0 110.05 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -110.6 146.23 36.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.5 p-80 -118.06 168.33 10.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.719 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.0 m-85 -131.7 136.64 47.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -107.02 149.8 27.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -147.15 133.63 19.73 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.561 0.696 . . . . 0.0 110.01 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 15.9 ptmt 41.8 22.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.594 0.712 . . . . 0.0 109.68 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.06 31.3 9.27 Favored Glycine 0 C--N 1.296 -1.68 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.203 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.8 mt -142.78 140.64 31.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.504 -0.998 . . . . 0.0 108.79 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -75.37 152.19 38.11 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 110.879 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.571 ' CE1' HD22 ' A' ' 62' ' ' LEU . 52.8 m-85 -154.33 139.53 17.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.7 m -56.05 179.15 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.42 -1.312 . . . . 0.0 108.546 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 9.2 tm-20 -64.78 -38.44 91.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.8 m -86.14 -39.1 17.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.624 -0.673 . . . . 0.0 111.19 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.478 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.9 m170 -68.92 -43.89 74.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.702 -1.249 . . . . 0.0 108.037 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -54.98 -57.03 13.33 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.453 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 39.6 m-80 -62.16 -43.68 98.3 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.377 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -55.92 -37.26 68.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 54' ' ' TYR . 3.7 mp -74.52 -37.99 62.92 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.996 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.0 m-85 -156.85 -83.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.411 -0.806 . . . . 0.0 110.171 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.453 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 93.12 -9.25 75.24 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 49.78 71.16 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -1.066 . . . . 0.0 109.475 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.496 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 20.5 m -165.56 126.58 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -1.143 . . . . 0.0 109.478 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -51.93 129.91 28.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.279 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.602 ' N ' ' SD ' ' A' ' 3' ' ' MET . . . -144.88 84.36 0.19 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.607 HG11 ' CB ' ' A' ' 14' ' ' PRO . 2.1 t -84.39 134.23 43.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.0 109.5 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' A' ' 19' ' ' VAL . 3.4 Cg_endo -70.94 163.36 39.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.616 1.544 . . . . 0.0 108.344 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 33.6 mt -134.24 120.67 35.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-O 122.201 1.001 . . . . 0.0 109.244 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.866 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.6 t -57.39 116.03 3.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.759 0.79 . . . . 0.0 110.066 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.11 -0.67 3.32 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.866 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.53 -59.26 2.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -1.086 . . . . 0.0 109.399 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -102.96 -0.86 30.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.519 -0.738 . . . . 0.0 109.267 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.621 ' HG3' HH11 ' A' ' 12' ' ' ARG . 7.2 mmm-85 58.62 43.08 19.55 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -118.62 143.62 33.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.607 ' CB ' HG11 ' A' ' 5' ' ' VAL . 3.0 Cg_exo -53.9 111.72 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.663 1.575 . . . . 0.0 110.621 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.633 HG21 HG22 ' A' ' 19' ' ' VAL . 34.6 mt -71.17 158.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.217 -0.927 . . . . 0.0 108.516 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.38 61.45 0.27 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.727 -1.233 . . . . 0.0 110.728 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.24 -102.19 0.15 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.675 HH11 ' CG ' ' A' ' 18' ' ' ARG . 2.8 mtt-85 -112.14 120.4 41.68 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 15' ' ' ILE . 40.5 t -99.29 158.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 111.282 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 32' ' ' PHE . 5.0 t -122.51 115.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -89.85 106.16 18.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.694 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.53 41.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.643 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.3 mmt 58.02 15.98 3.5 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 20.86 77.94 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -124.24 -154.69 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.773 0.797 . . . . 0.0 109.885 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.468 ' HG2' HG11 ' A' ' 19' ' ' VAL . 18.3 mt-30 -135.32 143.25 46.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.525 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.0 m95 -141.09 138.55 33.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.572 -1.33 . . . . 0.0 110.588 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.497 ' C ' ' N ' ' A' ' 30' ' ' GLU . 15.6 m80 -55.42 130.74 43.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 20' ' ' VAL . 8.7 t -52.52 -14.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 120.932 -1.105 . . . . 0.0 108.068 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.497 ' N ' ' C ' ' A' ' 28' ' ' HIS . 4.1 tt0 -95.36 -27.83 15.26 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.921 -0.487 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -98.64 -6.02 30.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.827 -1.171 . . . . 0.0 110.821 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 20' ' ' VAL . 23.0 t80 -79.87 106.14 11.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' A' ' 40' ' ' PRO . 27.7 m -134.32 174.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 122.272 1.034 . . . . 0.0 111.122 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.549 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.06 148.22 36.48 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.263 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.25 34.49 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.291 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HG3' HD11 ' A' ' 62' ' ' LEU . 6.0 tmtt? -142.79 -40.05 0.33 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.5 -0.75 . . . . 0.0 109.744 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.1 p -123.2 -17.4 6.64 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.433 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.0 mt-10 76.32 47.59 0.08 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.4 -0.812 . . . . 0.0 110.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -100.32 110.75 60.94 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' A' ' 33' ' ' VAL . 6.2 Cg_endo -70.62 137.98 34.1 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.874 1.716 . . . . 0.0 112.192 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.488 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.11 58.13 1.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.47 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.01 30.56 2.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -115.4 -179.08 3.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.437 -1.037 . . . . 0.0 110.004 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.656 ' CG ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -96.2 143.07 27.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.502 -0.749 . . . . 0.0 109.158 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.569 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.0 p-80 -114.28 171.51 7.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.306 -0.871 . . . . 0.0 109.659 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.704 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.5 m-85 -134.0 137.75 44.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -108.5 146.94 32.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 111.585 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.927 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -151.57 117.38 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.79 -0.569 . . . . 0.0 109.645 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 22.4 mmtp 61.89 30.37 18.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 109.995 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.643 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 76.97 31.09 54.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 52' ' ' LEU . 26.1 mt -141.84 137.29 31.35 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.682 -0.893 . . . . 0.0 108.734 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.79 153.88 34.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.769 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.613 ' CE1' HD22 ' A' ' 62' ' ' LEU . 47.2 m-85 -153.8 137.86 16.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 76.3 m -56.05 173.27 0.16 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.321 -1.352 . . . . 0.0 108.254 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.4 tm-20 -59.75 -34.78 73.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 109.255 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 61' ' ' GLN . 66.5 m -87.01 -44.43 11.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.68 . . . . 0.0 111.397 -178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.577 ' O ' HD13 ' A' ' 62' ' ' LEU . 30.6 m170 -65.64 -42.12 91.8 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.792 -1.193 . . . . 0.0 108.493 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.2 t80 -54.3 -57.19 12.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 36.7 m-80 -64.61 -43.94 92.17 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.289 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 57' ' ' THR . 37.1 tt0 -54.31 -34.38 60.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.613 HD22 ' CE1' ' A' ' 54' ' ' TYR . 6.5 mp -79.24 -38.28 35.98 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.604 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.2 m-85 -160.33 -80.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.573 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 91.32 -9.59 77.04 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 66' ' ' VAL . 7.1 p30 -164.4 -99.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.372 -1.075 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.485 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 32.6 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 m -159.37 -64.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -1.152 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.8 ptt? -49.9 131.37 22.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.459 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . 168.68 -111.1 0.41 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t 57.25 128.98 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.542 -0.975 . . . . 0.0 109.727 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -75.48 163.37 34.41 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.043 1.829 . . . . 0.0 109.274 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.5 mt -135.11 119.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 122.034 0.921 . . . . 0.0 109.149 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 32.7 t -58.51 115.0 2.73 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.84 0.829 . . . . 0.0 109.779 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.536 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.46 -3.54 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.819 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.99 -59.18 2.41 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.329 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.39 -1.6 35.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.569 -0.707 . . . . 0.0 109.183 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 57.8 38.84 27.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.214 -0.929 . . . . 0.0 108.693 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.04 149.34 45.35 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.3 Cg_exo -59.05 113.05 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.387 1.391 . . . . 0.0 110.783 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.706 HG21 HG22 ' A' ' 19' ' ' VAL . 19.3 mt -69.87 160.31 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.474 ' N ' HG22 ' A' ' 15' ' ' ILE . 9.0 pt-20 -170.3 70.39 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.698 -1.251 . . . . 0.0 110.549 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.82 -55.06 0.3 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.621 ' HG3' HH11 ' A' ' 18' ' ' ARG . 1.1 mtm-85 -139.56 129.67 25.13 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.706 HG22 HG21 ' A' ' 15' ' ' ILE . 48.7 t -126.47 152.98 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.6 t -127.23 116.39 43.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.94 105.65 17.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.064 -1.023 . . . . 0.0 109.372 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.81 159.98 42.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.472 -0.767 . . . . 0.0 109.012 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 57.65 18.4 4.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.83 22.69 77.02 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -129.37 -156.19 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.965 -0.726 . . . . 0.0 109.767 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -134.29 143.43 47.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.536 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 48.6 m95 -141.96 140.05 32.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.531 -1.355 . . . . 0.0 110.289 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.426 ' CD2' HG23 ' A' ' 15' ' ' ILE . 19.7 m80 -55.82 140.48 42.15 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 t -58.94 -19.46 15.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.718 -1.239 . . . . 0.0 109.288 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -96.27 -12.69 24.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -105.62 -8.76 17.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.951 -1.093 . . . . 0.0 109.955 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.468 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.1 t80 -81.22 103.59 11.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.846 HG12 ' CA ' ' A' ' 40' ' ' PRO . 21.3 m -126.16 177.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 122.42 1.105 . . . . 0.0 111.597 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.62 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -68.06 149.16 50.01 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.722 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.06 26.01 2.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.7 tptm -134.12 -29.79 1.24 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.364 -0.835 . . . . 0.0 109.841 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.6 p -133.18 -15.59 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.302 -0.874 . . . . 0.0 110.392 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.51 46.56 0.4 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.266 -0.896 . . . . 0.0 110.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -101.32 112.51 65.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.846 ' CA ' HG12 ' A' ' 33' ' ' VAL . 10.5 Cg_endo -71.54 134.44 24.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.483 1.455 . . . . 0.0 110.897 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.588 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.1 m-85 -93.01 59.46 3.13 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 40' ' ' PRO . 4.6 mp -41.02 -55.95 2.42 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.409 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.33 24.02 5.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -114.69 168.73 9.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.48 -1.012 . . . . 0.0 109.95 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -84.07 156.68 22.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.553 -0.717 . . . . 0.0 109.16 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.7 p-80 -120.81 170.25 9.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 0.0 110.054 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.708 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.0 m-85 -135.47 135.23 40.33 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -110.52 141.08 44.16 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.196 -0.94 . . . . 0.0 111.188 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.728 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -145.15 136.45 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.563 0.697 . . . . 0.0 110.369 178.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt 50.12 22.45 0.93 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.52 -0.737 . . . . 0.0 109.096 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.75 30.63 31.84 Favored Glycine 0 C--N 1.295 -1.712 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 52' ' ' LEU . 22.2 mt -140.09 143.02 36.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.775 -0.838 . . . . 0.0 108.896 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.44 151.48 34.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.487 -0.758 . . . . 0.0 110.928 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 59.5 m-85 -153.27 136.63 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 64.4 m -57.4 173.92 0.23 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.277 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 26.8 tt0 -59.5 -34.51 72.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 61' ' ' GLN . 59.1 m -86.91 -44.09 11.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -0.772 . . . . 0.0 111.683 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.446 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.0 m170 -67.57 -43.03 81.6 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.708 -1.245 . . . . 0.0 108.453 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.512 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -51.86 -55.6 19.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.435 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 44.5 m-80 -65.57 -45.34 83.67 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.977 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 57' ' ' THR . 28.1 tt0 -52.87 -39.01 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.582 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -71.64 -40.33 69.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.728 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 14.6 m-85 -154.3 -85.11 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.603 0.716 . . . . 0.0 109.973 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 90.53 31.53 10.29 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.3 t70 52.94 39.7 29.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -1.082 . . . . 0.0 109.476 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.472 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' MET . 8.2 t 53.34 98.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' SER . 3.0 ttt -62.45 -138.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . 143.95 -75.9 0.3 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t 57.28 129.8 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.611 -0.935 . . . . 0.0 109.775 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.516 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.8 Cg_endo -74.49 163.41 36.17 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 109.024 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.8 mt -135.71 119.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.033 0.92 . . . . 0.0 109.26 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.831 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.3 t -57.14 117.34 3.93 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.776 0.798 . . . . 0.0 109.86 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.527 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.76 -2.2 5.9 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.831 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.21 -60.56 2.0 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -1.063 . . . . 0.0 109.364 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.28 -2.48 33.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.781 . . . . 0.0 109.151 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.624 ' HG3' HH11 ' A' ' 12' ' ' ARG . 6.6 mmm-85 59.75 40.51 19.58 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.278 -0.889 . . . . 0.0 108.768 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.66 150.14 46.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.8 Cg_exo -59.29 113.91 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.53 1.486 . . . . 0.0 110.568 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.646 HG21 HG22 ' A' ' 19' ' ' VAL . 21.1 mt -70.34 158.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -159.21 59.38 0.41 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.833 -1.167 . . . . 0.0 110.986 -178.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.06 -102.45 0.16 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.674 HH11 ' CG ' ' A' ' 18' ' ' ARG . 3.0 mtt-85 -111.19 121.3 44.93 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.646 HG22 HG21 ' A' ' 15' ' ' ILE . 45.6 t -98.72 157.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 111.038 -177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.459 HG11 ' CD2' ' A' ' 32' ' ' PHE . 7.1 t -120.62 115.15 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.631 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.71 160.19 41.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.671 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.1 mmt 57.52 16.39 3.29 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.8 22.44 78.2 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -125.75 -154.67 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.737 0.78 . . . . 0.0 109.753 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HG2' HG11 ' A' ' 19' ' ' VAL . 20.0 mt-30 -136.29 142.8 43.96 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.527 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.0 m95 -141.77 140.63 33.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.569 -1.332 . . . . 0.0 110.448 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -56.44 139.44 49.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 18' ' ' ARG . 7.9 t -57.64 -20.38 13.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 120.868 -1.145 . . . . 0.0 109.315 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.88 -16.69 21.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.483 -0.761 . . . . 0.0 110.627 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.4 m170 -101.43 -9.1 21.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.845 -1.159 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CD2' HG11 ' A' ' 20' ' ' VAL . 28.0 t80 -80.15 104.98 11.08 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.831 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.2 m -130.69 177.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 122.405 1.098 . . . . 0.0 111.499 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -66.96 148.56 51.8 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.661 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.5 30.48 1.3 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.243 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -139.65 -31.01 0.69 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.0 110.122 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 32.0 p -131.05 -18.59 2.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.364 -0.835 . . . . 0.0 110.192 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.2 mt-10 74.38 45.89 0.18 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 110.299 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -101.39 112.06 64.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.831 ' CA ' HG12 ' A' ' 33' ' ' VAL . 10.1 Cg_endo -71.7 135.94 27.0 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.561 1.507 . . . . 0.0 111.401 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.46 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -93.28 55.69 2.33 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 40' ' ' PRO . 3.1 mp -40.64 -55.79 2.28 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.758 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.16 23.86 5.14 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -115.69 -164.52 0.96 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.285 -1.127 . . . . 0.0 109.843 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.58 HH11 ' HB3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -107.7 154.11 21.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.579 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.1 p-80 -119.65 171.72 8.18 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.702 0.763 . . . . 0.0 109.265 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.688 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.0 m-85 -138.55 132.71 31.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.26 147.42 27.07 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.302 -0.874 . . . . 0.0 112.104 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.832 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -154.58 121.02 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 1.0 OUTLIER 62.5 29.15 17.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.505 -0.747 . . . . 0.0 109.902 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.671 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 74.4 31.34 59.18 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 52' ' ' LEU . 29.1 mt -141.42 141.43 33.73 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.51 153.46 33.42 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 47' ' ' TYR . 54.9 m-85 -153.56 140.31 19.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 85.5 m -60.2 175.91 0.38 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.742 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 61.4 tt0 -60.96 -37.57 82.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.419 -0.801 . . . . 0.0 109.423 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.9 -43.02 12.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.581 -0.699 . . . . 0.0 111.663 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.561 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.0 m170 -67.0 -44.83 79.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.716 -1.24 . . . . 0.0 108.284 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.7 t80 -49.11 -54.92 13.98 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.405 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 55.8 m-80 -67.9 -46.08 72.63 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.207 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 57' ' ' THR . 11.1 tp60 -53.46 -33.64 54.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.27 -38.75 41.93 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.0 m-85 -160.37 -79.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.393 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 90.08 -9.4 77.47 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 2.1 m-20 54.71 59.97 3.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.394 -1.062 . . . . 0.0 109.5 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.455 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t 52.12 85.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -1.155 . . . . 0.0 109.374 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.7 mtm -145.66 144.92 30.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.843 . . . . 0.0 109.334 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.7 80.81 0.06 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -153.92 128.69 4.82 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.191 -1.182 . . . . 0.0 109.435 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -76.31 163.61 32.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.194 1.93 . . . . 0.0 109.29 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.2 mt -134.73 119.0 27.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 122.027 0.918 . . . . 0.0 109.24 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 38.2 t -60.44 118.33 6.35 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.8 0.809 . . . . 0.0 110.141 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.531 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.94 -3.61 8.85 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.792 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -83.72 -46.59 12.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.488 -1.007 . . . . 0.0 109.449 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.44 -1.51 13.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 8' ' ' CYS . 26.8 mmt180 57.07 35.55 26.5 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 143.21 29.02 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.9 Cg_exo -55.88 113.8 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.306 1.338 . . . . 0.0 110.625 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.783 HG21 HG22 ' A' ' 19' ' ' VAL . 12.9 mt -69.1 159.73 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.47 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.5 pt-20 -167.73 69.06 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.755 -1.215 . . . . 0.0 110.373 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.87 -64.22 0.17 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.527 HH21 ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -138.9 136.62 35.7 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.783 HG22 HG21 ' A' ' 15' ' ' ILE . 45.6 t -126.55 158.74 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.938 . . . . 0.0 110.787 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.49 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.6 t -131.51 117.16 34.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -87.26 105.76 17.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.127 -0.983 . . . . 0.0 109.588 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.32 160.13 41.98 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.638 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 9.2 mmt 57.84 17.77 4.47 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.19 18.5 76.67 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -124.25 -156.06 0.7 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.716 0.77 . . . . 0.0 109.699 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -134.15 144.49 48.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.531 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 53.7 m95 -142.28 139.39 31.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.499 -1.375 . . . . 0.0 110.526 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 19.7 m80 -55.13 138.97 43.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 18' ' ' ARG . 6.7 t -58.63 -18.23 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 109.097 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.527 ' CD ' HH21 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -94.15 -21.37 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 110.189 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -99.51 -6.2 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 110.59 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.487 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.2 t80 -82.97 102.46 11.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.4 m -127.2 176.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 122.241 1.019 . . . . 0.0 111.266 -177.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.642 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -63.43 148.75 47.68 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.584 178.235 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.11 27.58 1.83 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.38 -0.825 . . . . 0.0 109.352 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 3.3 tttm -134.21 -42.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 109.96 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.9 p -121.49 -15.99 7.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.674 -0.641 . . . . 0.0 110.476 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.1 mt-10 72.68 47.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 110.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -100.72 109.85 58.91 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.2 Cg_endo -67.76 138.36 44.73 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.756 1.637 . . . . 0.0 111.874 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.545 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.4 m-85 -95.46 59.97 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.81 -55.55 1.94 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.63 29.56 3.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -117.08 165.61 13.18 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 109.814 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -79.64 153.98 28.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.406 -0.809 . . . . 0.0 109.281 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.8 p-80 -118.92 169.47 9.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.277 -0.89 . . . . 0.0 109.83 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.706 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.7 m-85 -134.68 137.92 43.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -110.64 149.82 29.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -0.928 . . . . 0.0 111.464 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.632 ' NE ' ' CD2' ' A' ' 63' ' ' PHE . 13.4 tpt180 -147.09 131.39 17.51 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.413 0.625 . . . . 0.0 110.192 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' NZ ' ' CB ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 42.39 24.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.696 0.76 . . . . 0.0 109.584 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.638 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.35 31.21 12.0 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.845 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ARG . 19.2 mt -140.34 139.77 35.47 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.565 -0.962 . . . . 0.0 108.961 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.83 152.6 33.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.83 0.824 . . . . 0.0 110.94 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.563 ' CE1' HD22 ' A' ' 62' ' ' LEU . 56.2 m-85 -154.8 139.03 16.59 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 13.0 m -59.38 174.02 0.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.638 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.5 tp10 -59.5 -31.58 69.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.878 -1.139 . . . . 0.0 109.537 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.6 m -86.26 -49.77 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 111.632 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' HD13 ' A' ' 62' ' ' LEU . 33.3 m170 -64.94 -41.14 95.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.877 -1.139 . . . . 0.0 108.407 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -53.3 -57.64 9.87 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.79 -44.94 91.85 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.119 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -54.88 -34.94 63.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.563 HD22 ' CE1' ' A' ' 54' ' ' TYR . 5.3 mp -77.35 -33.06 55.45 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.438 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.632 ' CD2' ' NE ' ' A' ' 49' ' ' ARG . 19.2 m-85 -160.14 -83.36 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.362 -0.836 . . . . 0.0 110.196 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.68 31.5 44.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 t70 55.75 39.62 30.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.496 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.486 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -75.52 125.18 28.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 109.498 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.1 tpt -69.04 -5.89 24.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.33 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.54 49.67 23.81 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.653 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -74.89 129.62 82.88 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.186 -1.185 . . . . 0.0 109.389 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 15' ' ' ILE . 6.0 Cg_endo -74.78 163.77 34.98 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.143 1.896 . . . . 0.0 109.044 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.0 mt -135.72 120.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 122.056 0.931 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.847 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.9 t -57.14 114.43 2.14 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.839 0.828 . . . . 0.0 109.899 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.535 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.84 -2.43 2.55 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.847 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.2 -59.79 2.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -1.08 . . . . 0.0 109.413 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.87 4.36 37.61 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.577 -0.702 . . . . 0.0 109.293 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.667 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.33 41.49 32.12 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.495 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -116.19 144.01 32.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.1 Cg_exo -56.81 113.17 1.34 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.332 1.355 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.628 HG21 HG22 ' A' ' 19' ' ' VAL . 22.1 mt -69.19 158.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.614 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.413 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -166.3 67.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 110.299 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.6 -73.31 0.07 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -138.48 133.59 32.9 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.628 HG22 HG21 ' A' ' 15' ' ' ILE . 41.2 t -114.02 151.62 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.896 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 32' ' ' PHE . 8.1 t -119.45 115.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -88.57 106.16 18.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.047 -1.033 . . . . 0.0 109.583 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.02 160.04 42.85 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.644 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.5 mmt 58.34 16.26 3.95 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.93 25.75 75.2 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.791 -2.123 . . . . 0.0 107.791 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -130.56 -154.56 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.931 0.872 . . . . 0.0 109.88 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HG2' HG11 ' A' ' 19' ' ' VAL . 24.9 mt-30 -136.65 142.0 43.2 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.535 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.2 m95 -141.3 139.99 33.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.484 -1.385 . . . . 0.0 110.399 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -55.73 137.25 50.0 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.71 -17.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 120.848 -1.158 . . . . 0.0 109.044 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.31 -25.16 15.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.509 -0.744 . . . . 0.0 110.689 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -94.26 -8.52 38.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.804 -1.185 . . . . 0.0 110.364 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 20' ' ' VAL . 23.1 t80 -80.34 106.7 12.55 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' A' ' 40' ' ' PRO . 27.0 m -133.46 175.26 11.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.35 1.072 . . . . 0.0 111.184 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.03 148.58 47.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.385 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.3 28.84 1.56 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 109.608 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.9 tptt -139.8 -31.29 0.67 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.345 -0.847 . . . . 0.0 110.179 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 32.0 p -130.82 -8.92 3.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.121 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 33.2 mm-40 63.89 48.38 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 110.376 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -101.74 109.31 59.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.2 Cg_endo -68.6 138.65 42.32 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.81 1.673 . . . . 0.0 112.28 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.475 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.52 -55.59 1.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.307 -0.871 . . . . 0.0 109.494 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.11 30.27 2.84 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -114.36 -158.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.394 -1.062 . . . . 0.0 109.97 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -114.88 145.99 41.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.548 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.4 p-80 -117.43 167.42 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 0.0 109.666 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.715 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.4 m-85 -131.22 137.43 48.92 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -105.89 148.88 27.1 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.226 -0.921 . . . . 0.0 111.51 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 54' ' ' TYR . 1.3 tmt_? -153.46 126.89 8.63 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.507 0.67 . . . . 0.0 109.991 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp 53.71 26.01 5.54 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.378 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.644 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 81.1 31.37 35.01 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 52' ' ' LEU . 22.3 mt -141.92 141.64 32.99 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.734 -0.862 . . . . 0.0 108.723 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.35 152.94 34.23 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.56 ' CE1' HD22 ' A' ' 62' ' ' LEU . 56.4 m-85 -153.71 140.05 18.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 99.0 m -56.85 178.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.36 -1.336 . . . . 0.0 108.473 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 62.5 tt0 -64.45 -36.47 84.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.2 m -86.59 -42.32 13.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 111.382 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.44 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.47 -43.42 81.07 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.794 -1.191 . . . . 0.0 108.207 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.4 t80 -52.85 -56.02 18.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 22.6 m-80 -63.76 -45.16 91.05 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.893 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' THR . 32.9 tt0 -53.38 -34.63 58.4 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.56 HD22 ' CE1' ' A' ' 54' ' ' TYR . 2.9 mp -79.29 -36.03 40.35 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.197 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -158.6 -84.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.128 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 89.03 -9.32 77.28 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.24 57.55 6.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.43 -1.041 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.492 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 p -173.94 -173.87 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.459 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.3 mtp -49.73 135.15 19.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 109.436 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.57 -46.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -65.67 130.29 94.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.28 -1.13 . . . . 0.0 109.487 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.516 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.33 163.57 36.05 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.055 1.836 . . . . 0.0 108.858 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.5 mt -135.13 120.25 29.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 122.028 0.918 . . . . 0.0 109.33 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.3 t -57.81 116.64 3.58 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.768 0.794 . . . . 0.0 110.036 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.529 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.22 -1.69 4.47 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.88 -56.33 3.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -1.071 . . . . 0.0 109.474 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -107.45 4.27 26.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.254 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 53.78 42.08 31.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.676 ' CG ' HH11 ' A' ' 13' ' ' ARG . 2.3 mtt-85 -116.4 144.09 32.42 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.7 Cg_exo -56.56 113.15 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.45 1.433 . . . . 0.0 110.472 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.656 HG21 HG22 ' A' ' 19' ' ' VAL . 23.8 mt -70.74 158.43 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -160.73 61.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 110.679 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.38 -101.8 0.15 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.11 40.43 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.656 HG22 HG21 ' A' ' 15' ' ' ILE . 44.0 t -98.16 157.94 3.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 111.149 -177.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG11 ' CD2' ' A' ' 32' ' ' PHE . 5.4 t -122.2 115.86 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -89.61 106.27 18.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 109.569 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.57 43.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.65 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.74 17.02 4.82 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.31 28.44 71.36 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -133.89 -154.41 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.919 0.866 . . . . 0.0 109.945 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.461 ' HG2' HG11 ' A' ' 19' ' ' VAL . 21.3 mt-30 -135.98 142.78 44.56 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.529 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.6 m95 -141.38 139.26 33.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.508 -1.37 . . . . 0.0 110.612 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -55.63 137.95 48.13 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 18' ' ' ARG . 10.5 t -57.24 -19.51 10.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.44 -18.53 20.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.41 -0.806 . . . . 0.0 110.63 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -100.67 -7.01 24.32 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.886 -1.133 . . . . 0.0 110.231 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.3 t80 -83.03 102.46 11.79 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' A' ' 40' ' ' PRO . 23.5 m -126.27 176.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.414 1.102 . . . . 0.0 111.266 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -66.47 149.41 50.47 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.656 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.34 24.96 3.15 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.6 tptp -132.63 -30.68 1.42 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.389 -0.819 . . . . 0.0 109.725 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.2 p -133.5 -10.18 2.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.375 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 65.55 48.24 2.05 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.321 -0.862 . . . . 0.0 110.399 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -101.11 110.4 61.14 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.6 Cg_endo -67.16 138.51 47.47 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.723 1.616 . . . . 0.0 111.81 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.9 m-85 -95.35 60.06 2.24 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.86 -55.38 1.99 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.484 -0.76 . . . . 0.0 109.257 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.98 30.8 2.79 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -117.31 167.08 11.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.484 -1.01 . . . . 0.0 109.912 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -82.37 151.86 26.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.0 109.151 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.586 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 15.3 p-80 -117.88 169.77 9.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 109.838 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.713 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.0 m-85 -133.85 136.67 44.55 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -111.03 140.24 45.73 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.321 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.707 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -146.68 137.66 24.1 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.485 0.659 . . . . 0.0 110.17 178.652 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt 51.9 22.19 1.69 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.002 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.65 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 80.25 31.04 39.36 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 52' ' ' LEU . 25.6 mt -140.27 143.68 36.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.71 151.67 34.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.73 0.776 . . . . 0.0 110.858 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.499 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 58.8 m-85 -153.12 137.13 16.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.6 m -57.22 174.67 0.18 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.369 -1.332 . . . . 0.0 108.276 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 64.9 tt0 -60.66 -34.85 74.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.202 -0.936 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.8 -43.64 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.63 -0.669 . . . . 0.0 111.638 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.454 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.2 m170 -67.43 -44.38 78.89 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.729 -1.232 . . . . 0.0 108.377 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -50.39 -54.98 17.73 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 49.2 m-80 -66.69 -45.72 77.91 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.061 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 57' ' ' THR . 3.9 tp-100 -53.49 -38.23 63.48 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.587 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.4 mp -71.07 -39.57 72.14 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.707 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.8 m-85 -154.74 -84.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.625 0.726 . . . . 0.0 109.967 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 84.95 31.34 23.71 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 66' ' ' VAL . 16.2 t0 -173.11 88.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -1.053 . . . . 0.0 109.467 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.704 HG22 ' OXT' ' A' ' 66' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.034 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 m -65.06 -157.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -1.182 . . . . 0.0 109.402 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.2 mmt -50.68 166.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -172.77 -143.44 4.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.1 t 57.5 122.87 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.498 -1.001 . . . . 0.0 109.974 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -78.39 164.42 26.43 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.664 2.243 . . . . 0.0 109.31 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.9 mt -135.52 123.17 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.866 0.841 . . . . 0.0 109.622 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.843 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 13.8 t -63.32 118.15 7.63 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.824 0.821 . . . . 0.0 109.884 -178.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.507 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.27 0.12 6.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.843 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.77 -36.23 18.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -1.096 . . . . 0.0 109.563 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.04 4.38 4.87 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.682 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.79 41.01 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -114.79 141.75 27.28 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.595 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.3 Cg_exo -56.76 114.39 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.41 1.407 . . . . 0.0 110.86 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.565 HD13 HG13 ' A' ' 19' ' ' VAL . 21.7 mt -71.96 159.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.424 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.3 pt-20 -160.73 61.92 0.31 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.746 -1.221 . . . . 0.0 110.964 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.66 -103.31 0.17 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.605 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.0 mtm180 -110.0 121.1 44.46 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 HD13 ' A' ' 15' ' ' ILE . 35.7 t -98.52 158.0 3.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.344 -0.847 . . . . 0.0 110.98 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 29' ' ' VAL . 5.6 t -120.81 112.94 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -88.98 106.61 18.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.181 -0.95 . . . . 0.0 109.801 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -143.51 158.96 43.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.641 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.6 mmt 58.74 14.52 3.22 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 72.74 21.52 79.62 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -125.08 -154.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.835 0.826 . . . . 0.0 109.749 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.495 ' HG2' HG11 ' A' ' 19' ' ' VAL . 24.4 mt-30 -135.0 145.11 47.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.507 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 66.0 m95 -142.6 135.66 28.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.672 -1.267 . . . . 0.0 110.181 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.4 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 19.0 m80 -53.55 135.61 39.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 18' ' ' ARG . 33.4 t -55.0 -21.24 7.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 120.918 -1.114 . . . . 0.0 109.548 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 30' ' ' GLU . 6.5 pm0 -95.02 -20.02 19.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 110.679 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -97.34 -9.78 26.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.813 -1.179 . . . . 0.0 110.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.0 t80 -78.42 105.58 9.77 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.5 m -134.04 176.54 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.219 1.009 . . . . 0.0 111.032 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.4 t -62.63 148.01 47.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.22 32.03 1.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -140.25 -41.55 0.42 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.467 -0.77 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.5 p -119.3 -18.95 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.574 -0.704 . . . . 0.0 110.309 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.6 mt-10 75.51 48.04 0.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -100.84 106.97 47.13 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.3 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.801 1.667 . . . . 0.0 112.355 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.482 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.14 56.98 1.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.617 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.29 -55.57 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.04 31.27 2.72 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.512 ' ND1' ' N ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -115.23 -163.27 0.87 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -1.0 . . . . 0.0 109.984 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -111.09 145.52 38.42 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.559 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 35.1 p-80 -117.69 170.03 9.11 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.019 0.914 . . . . 0.0 109.88 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.713 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.5 m-85 -134.29 135.28 42.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -112.15 150.56 30.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.076 -1.015 . . . . 0.0 111.303 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.66 132.69 19.23 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.691 0.758 . . . . 0.0 110.378 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.0 mttm 50.34 20.65 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.558 -0.714 . . . . 0.0 109.422 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.641 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.31 30.96 12.43 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.332 -1.414 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 52' ' ' LEU . 17.8 mt -141.73 137.95 32.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -72.59 151.72 42.2 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.05 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.664 ' N ' ' O ' ' A' ' 47' ' ' TYR . 45.4 m-85 -153.46 139.47 18.24 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.9 m -56.8 -179.82 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.516 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.5 tt0 -65.32 -36.94 85.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.9 m -86.99 -42.52 13.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 0.0 111.475 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.468 ' O ' HD13 ' A' ' 62' ' ' LEU . 32.6 m170 -66.23 -43.74 85.78 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.209 . . . . 0.0 108.325 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.0 t80 -52.78 -56.73 13.54 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 48.4 m-80 -63.8 -44.51 93.11 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.196 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 57' ' ' THR . 11.8 tt0 -55.1 -34.28 63.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.591 HD22 ' CE1' ' A' ' 54' ' ' TYR . 4.9 mp -78.76 -35.01 45.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.383 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 19.2 m-85 -158.52 -81.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.107 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 88.05 31.43 14.68 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 50.4 43.6 26.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -1.124 . . . . 0.0 109.437 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.446 179.96 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 4' ' ' GLY . 31.5 m -170.22 96.71 0.26 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -1.127 . . . . 0.0 109.442 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.9 mmt -63.97 75.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 2' ' ' SER . . . -83.63 -133.09 2.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.0 t 57.09 116.22 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.423 -1.045 . . . . 0.0 110.01 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.1 Cg_endo -80.19 164.66 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.796 2.33 . . . . 0.0 109.248 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.6 mt -135.8 123.03 34.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.831 0.825 . . . . 0.0 109.553 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.5 t -63.09 118.01 7.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.766 0.793 . . . . 0.0 109.929 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.501 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.12 0.2 6.52 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.1 -35.81 18.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -1.095 . . . . 0.0 109.618 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.51 4.4 4.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.87 41.33 32.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.659 ' CG ' HH11 ' A' ' 13' ' ' ARG . 2.0 mtt-85 -115.32 140.86 26.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.507 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.8 Cg_exo -55.27 114.01 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.444 1.43 . . . . 0.0 110.84 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 8' ' ' CYS . 22.4 mt -71.64 158.39 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -159.38 59.73 0.39 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.798 -1.189 . . . . 0.0 110.945 -178.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.57 -102.27 0.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.1 mtm180 -110.48 122.37 47.57 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.523 HG13 HD13 ' A' ' 15' ' ' ILE . 29.5 t -98.56 156.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 111.119 -177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' A' ' 32' ' ' PHE . 10.6 t -119.37 111.91 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 3.3 m-20 -87.02 106.51 17.89 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.42 43.3 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.61 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 58.26 16.39 3.96 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.98 28.69 70.1 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 21' ' ' ASN . 10.5 mttp -135.86 -154.45 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.807 0.813 . . . . 0.0 109.846 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.497 ' HG2' HG11 ' A' ' 19' ' ' VAL . 27.1 mt-30 -133.77 145.47 49.83 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.501 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.3 m95 -143.0 135.94 27.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.648 -1.283 . . . . 0.0 110.18 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -53.69 135.76 40.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 18' ' ' ARG . 15.9 t -54.6 -20.8 5.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.911 -1.118 . . . . 0.0 109.275 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.21 -22.76 18.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 110.674 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -96.5 -7.44 34.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.826 -1.171 . . . . 0.0 110.28 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.481 ' CD2' HG11 ' A' ' 20' ' ' VAL . 25.1 t80 -82.45 103.65 12.16 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.79 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.9 m -127.27 178.66 4.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.336 1.065 . . . . 0.0 111.057 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -69.31 148.75 49.29 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.883 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -89.9 25.55 2.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.7 tptt -135.83 -32.15 0.9 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.399 -0.813 . . . . 0.0 110.054 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.3 p -129.45 -7.6 4.69 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 110.164 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 59.1 42.61 18.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.222 -0.923 . . . . 0.0 109.483 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -99.07 108.47 49.71 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.79 ' CA ' HG12 ' A' ' 33' ' ' VAL . 2.6 Cg_endo -65.11 140.37 65.06 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.748 1.632 . . . . 0.0 112.343 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.7 m-85 -96.15 61.27 2.07 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 9.8 mp -40.32 -55.86 2.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 109.82 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.82 26.18 4.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -116.61 159.81 21.61 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.417 -1.049 . . . . 0.0 109.685 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.642 ' CB ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.08 159.21 30.0 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.325 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.509 ' HB3' ' CD2' ' A' ' 41' ' ' PHE . 8.9 p-80 -116.95 172.7 7.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.67 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.6 m-85 -136.02 128.71 30.83 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.46 150.72 23.6 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.95 0.881 . . . . 0.0 111.772 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.726 ' CZ ' ' HZ3' ' A' ' 50' ' ' LYS . 0.8 OUTLIER -143.82 134.16 24.58 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.394 0.616 . . . . 0.0 109.548 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.726 ' HZ3' ' CZ ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER 37.45 25.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.643 0.735 . . . . 0.0 109.973 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.61 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.42 30.95 9.29 Favored Glycine 0 N--CA 1.481 1.675 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.583 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.8 mt -142.17 140.26 32.33 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.335 -1.097 . . . . 0.0 108.728 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.86 150.75 39.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.899 0.856 . . . . 0.0 110.967 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' A' ' 62' ' ' LEU . 53.1 m-85 -154.04 137.22 15.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 93.2 m -56.16 178.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.393 -1.323 . . . . 0.0 108.696 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 39.7 tt0 -61.71 -39.33 91.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.371 -0.83 . . . . 0.0 109.782 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 61' ' ' GLN . 46.3 m -86.23 -40.9 15.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 111.804 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.45 -44.81 77.77 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.676 -1.265 . . . . 0.0 108.235 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.471 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.9 t80 -51.82 -55.85 17.46 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -64.03 -46.09 85.98 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 57' ' ' THR . 16.8 tt0 -53.23 -35.0 59.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.552 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 mp -77.51 -40.57 42.34 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.342 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.8 m-85 -152.78 -84.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.313 -0.867 . . . . 0.0 110.301 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 65' ' ' ASP . . . 68.3 -11.46 1.09 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 63' ' ' PHE . 0.7 OUTLIER 168.4 -92.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -1.08 . . . . 0.0 109.312 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 66' ' ' VAL . 11.8 p . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.169 -0.92 . . . . 0.0 109.994 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.4 t -175.28 42.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 109.444 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.9 mmt -79.71 -175.91 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.429 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.78 -167.34 21.13 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -154.93 132.92 6.69 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.215 -1.168 . . . . 0.0 109.54 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 15' ' ' ILE . 3.9 Cg_endo -72.2 163.63 38.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.759 1.639 . . . . 0.0 108.404 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.534 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.0 mt -134.29 120.4 33.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 122.172 0.987 . . . . 0.0 109.361 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.841 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.2 t -58.5 117.03 4.06 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.815 0.817 . . . . 0.0 110.048 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.533 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.84 -1.39 4.99 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.841 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.01 -52.94 5.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -1.084 . . . . 0.0 109.395 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.45 4.66 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.582 -0.699 . . . . 0.0 109.169 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.38 42.46 32.02 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -116.75 143.23 31.02 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.602 ' HB3' HG11 ' A' ' 5' ' ' VAL . 2.7 Cg_exo -55.16 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.723 1.615 . . . . 0.0 110.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.626 HG21 HG22 ' A' ' 19' ' ' VAL . 27.1 mt -72.09 158.56 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.29 61.38 0.28 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.725 -1.234 . . . . 0.0 110.766 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.34 -102.42 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 29' ' ' VAL . 66.9 mtm180 -111.38 121.59 45.61 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 15' ' ' ILE . 40.3 t -100.26 159.02 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -0.8 . . . . 0.0 111.252 -177.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.465 ' N ' HG12 ' A' ' 19' ' ' VAL . 6.1 t -122.39 115.74 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.92 106.35 18.41 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.097 -1.002 . . . . 0.0 109.694 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.77 159.43 43.2 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.79 16.83 4.74 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.87 73.41 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -131.71 -154.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HG2' HG11 ' A' ' 19' ' ' VAL . 20.8 mt-30 -135.97 142.96 44.61 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.533 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.0 m95 -141.3 138.41 33.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.589 -1.319 . . . . 0.0 110.504 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -54.52 138.01 41.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' ARG . 8.4 t -57.26 -18.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 O-C-N 120.878 -1.139 . . . . 0.0 109.319 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -96.36 -22.29 17.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 110.667 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -96.1 -9.22 31.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.863 -1.148 . . . . 0.0 110.398 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.0 t80 -80.07 105.95 11.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.4 m -133.21 175.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.266 1.032 . . . . 0.0 111.12 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.56 149.05 44.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.086 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.57 24.51 3.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -134.19 -33.43 1.01 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.2 p -125.8 -19.74 4.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.8 mt-10 76.22 46.5 0.09 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.302 -0.874 . . . . 0.0 110.449 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -100.75 110.27 60.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.6 Cg_endo -68.79 138.06 40.02 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.726 1.618 . . . . 0.0 112.11 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.05 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.31 -55.36 1.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.31 29.44 3.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.86 -177.73 3.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -1.03 . . . . 0.0 109.963 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -97.05 145.63 25.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.744 . . . . 0.0 109.356 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.567 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -116.28 170.21 8.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.707 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.87 137.51 46.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -106.78 147.76 29.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.263 -0.898 . . . . 0.0 111.402 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.66 129.48 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.613 0.721 . . . . 0.0 110.208 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.626 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 51.0 mttp 51.82 23.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 30.8 24.26 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 52' ' ' LEU . 18.1 mt -142.77 143.21 32.11 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.623 -0.928 . . . . 0.0 108.844 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.54 152.86 35.87 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.43 -0.794 . . . . 0.0 110.797 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.537 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 58.7 m-85 -153.97 140.33 18.66 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 89.8 m -57.61 176.75 0.12 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.619 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 56.3 tt0 -63.33 -35.7 81.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.337 -0.852 . . . . 0.0 109.312 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 m -86.52 -43.64 12.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.345 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.591 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.6 m170 -66.8 -45.59 77.9 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.765 -1.209 . . . . 0.0 108.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.4 t80 -49.48 -55.85 11.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 42.7 m-80 -65.67 -45.82 81.47 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.073 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 -54.93 -33.25 62.03 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 58' ' ' HIS . 0.9 OUTLIER -78.62 -35.28 45.79 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.138 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.626 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 16.8 m-85 -158.59 -80.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.005 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 65' ' ' ASP . . . 84.14 -9.3 64.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 64' ' ' GLY . 4.8 p-10 41.35 46.87 2.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.607 -0.937 . . . . 0.0 109.878 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.445 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 t -173.07 6.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.229 -1.159 . . . . 0.0 109.516 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.8 mtt -152.73 63.98 0.79 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.34 40.54 0.48 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 1.9 t -153.92 119.06 2.74 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.128 . . . . 0.0 109.662 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ILE . 10.1 Cg_endo -80.44 164.32 21.44 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.686 2.258 . . . . 0.0 109.862 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 14' ' ' PRO . 38.9 mt -135.08 120.15 28.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.995 0.902 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 38.3 t -62.68 116.09 4.88 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.826 0.822 . . . . 0.0 110.048 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.523 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -62.59 -3.54 5.72 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.28 -33.02 19.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.403 -1.057 . . . . 0.0 109.266 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 0.9 7.15 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 8' ' ' CYS . 21.1 mmm180 50.92 34.35 10.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -115.24 137.32 22.94 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 7' ' ' ILE . 7.1 Cg_exo -51.65 114.56 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.075 1.183 . . . . 0.0 111.056 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 HG22 ' A' ' 19' ' ' VAL . 11.5 mt -69.31 160.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 15' ' ' ILE . 4.4 pt-20 -169.25 69.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.264 . . . . 0.0 110.403 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.31 -59.06 0.24 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.5 133.13 30.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.775 HG22 HG21 ' A' ' 15' ' ' ILE . 46.5 t -127.03 157.92 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.084 -1.01 . . . . 0.0 110.74 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.488 ' N ' HG12 ' A' ' 19' ' ' VAL . 6.7 t -132.43 116.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.032 -1.042 . . . . 0.0 109.389 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . . . -144.34 157.63 44.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.409 -0.807 . . . . 0.0 108.985 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.678 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 58.02 19.36 5.87 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.95 13.72 72.69 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -118.95 -156.76 0.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.7 0.762 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.415 ' C ' ' CD1' ' A' ' 27' ' ' TRP . 15.6 mt-30 -133.61 144.67 49.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.523 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 50.0 m95 -142.23 140.73 32.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.58 -1.325 . . . . 0.0 110.411 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -54.43 141.93 28.95 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 20' ' ' VAL . 9.0 t -62.26 -18.4 20.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.684 -1.26 . . . . 0.0 109.496 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -20.45 20.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 110.438 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.43 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.9 m170 -101.86 -6.32 23.7 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.171 -0.955 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 20' ' ' VAL . 31.0 t80 -81.45 106.18 13.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.7 m -133.19 175.11 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.296 1.046 . . . . 0.0 111.508 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -63.03 149.47 44.93 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.298 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.59 26.6 2.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.103 -0.998 . . . . 0.0 109.848 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.9 tptp -135.44 -31.34 0.97 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.382 -0.824 . . . . 0.0 109.917 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.0 p -129.82 -16.39 3.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 72.75 47.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.15 109.69 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.8 Cg_endo -69.25 137.38 36.8 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.758 1.639 . . . . 0.0 112.031 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.05 57.93 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.22 -55.4 1.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.251 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.5 3.01 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.62 -174.81 2.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.396 -1.061 . . . . 0.0 109.939 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -98.71 147.37 24.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.59 -0.693 . . . . 0.0 109.363 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.589 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-80 -119.41 169.43 10.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 109.551 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.724 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.3 m-85 -132.51 137.24 47.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.59 143.43 41.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.242 -0.911 . . . . 0.0 111.581 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.672 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -150.22 136.59 18.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.442 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 51.47 21.33 1.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.633 -0.667 . . . . 0.0 109.282 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.678 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.1 31.28 29.0 Favored Glycine 0 C--N 1.295 -1.709 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 52' ' ' LEU . 19.3 mt -142.27 142.13 32.54 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.71 -0.876 . . . . 0.0 108.84 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.28 152.63 36.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.415 -0.803 . . . . 0.0 110.671 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 55.2 m-85 -153.11 138.71 17.79 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 88.1 m -58.0 176.58 0.15 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.432 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.6 tp10 -63.46 -36.3 83.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.137 -0.977 . . . . 0.0 109.061 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' GLN . 32.6 m -85.73 -41.0 15.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 111.279 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.436 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -69.45 -45.35 69.28 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.723 -1.235 . . . . 0.0 108.207 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -51.17 -54.43 25.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 93.2 m-20 -65.55 -46.99 77.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.135 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' THR . 14.9 tt0 -52.31 -40.19 61.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.3 mp -68.93 -39.09 79.79 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.672 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.5 m-85 -155.34 -87.61 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.802 0.81 . . . . 0.0 110.001 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.46 -9.42 55.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' O ' ' OXT' ' A' ' 66' ' ' VAL . 24.9 t70 -173.43 89.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -1.087 . . . . 0.0 109.553 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.436 ' OXT' ' O ' ' A' ' 65' ' ' ASP . 2.7 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.447 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -74.9 127.13 32.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -1.098 . . . . 0.0 109.463 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -176.17 67.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.464 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -159.43 -162.5 12.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t 57.21 119.71 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.103 . . . . 0.0 109.866 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' ILE . 8.4 Cg_endo -79.21 164.2 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.65 2.233 . . . . 0.0 109.65 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 35.3 mt -134.86 119.69 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.035 0.921 . . . . 0.0 109.419 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.827 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 35.2 t -58.38 114.55 2.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.742 0.782 . . . . 0.0 109.828 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.545 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.63 -4.37 4.0 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.827 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.41 -59.47 2.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.397 -1.061 . . . . 0.0 109.393 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.29 -0.2 38.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.239 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 55.74 38.8 30.55 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.2 -0.937 . . . . 0.0 108.758 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.81 149.07 44.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.0 Cg_exo -58.63 113.69 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.3 1.334 . . . . 0.0 110.713 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.708 HG21 HG22 ' A' ' 19' ' ' VAL . 15.3 mt -68.54 159.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.1 pt-20 -168.62 69.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.894 -1.129 . . . . 0.0 110.271 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.44 -62.99 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.31 137.15 35.57 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.708 HG22 HG21 ' A' ' 15' ' ' ILE . 44.9 t -126.15 151.89 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.1 -1.0 . . . . 0.0 110.376 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 32' ' ' PHE . 7.9 t -123.48 116.35 48.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -88.67 105.43 17.67 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.093 -1.005 . . . . 0.0 109.703 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.41 160.22 41.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.558 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 13.1 mmt 57.5 14.71 2.39 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.1 13.78 79.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -115.24 -155.55 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.805 0.812 . . . . 0.0 109.678 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -136.28 141.94 43.91 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.545 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 51.4 m95 -141.29 139.37 33.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.554 -1.341 . . . . 0.0 110.204 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.416 ' CD2' HG23 ' A' ' 15' ' ' ILE . 18.4 m80 -54.8 140.58 35.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.31 -18.2 13.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.675 -1.265 . . . . 0.0 109.201 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -95.31 -24.8 16.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -94.08 -9.34 36.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.792 -1.193 . . . . 0.0 110.271 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.487 ' CD2' HG11 ' A' ' 20' ' ' VAL . 21.0 t80 -79.36 105.94 11.03 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.3 m -134.85 176.34 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.34 1.066 . . . . 0.0 111.209 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -63.63 148.22 49.5 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.282 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.43 28.63 1.91 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.438 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.8 -31.07 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.452 -0.78 . . . . 0.0 109.976 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.404 ' HB3' ' CE1' ' A' ' 58' ' ' HIS . 22.6 p -131.66 -15.18 3.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.271 -0.893 . . . . 0.0 110.379 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.2 48.18 0.26 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.361 -0.837 . . . . 0.0 110.551 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -102.74 109.21 60.55 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.1 Cg_endo -69.05 138.26 39.62 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.9 58.07 1.88 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.23 -55.62 1.65 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.76 31.8 2.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.501 ' ND1' ' N ' ' A' ' 44' ' ' HIS . 1.1 m-70 -115.85 -163.82 0.92 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.515 -0.991 . . . . 0.0 110.1 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -109.94 147.07 34.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.543 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 29.0 p-80 -119.07 169.67 9.71 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.141 0.972 . . . . 0.0 109.889 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.724 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 2.4 m-85 -132.99 136.72 46.22 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.402 ' CD ' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -117.82 154.01 32.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.846 -1.159 . . . . 0.0 112.102 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -143.31 131.85 22.36 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.63 0.729 . . . . 0.0 109.727 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.4 ptpt 45.15 23.12 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.751 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 91.31 29.35 12.54 Favored Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.025 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' A' ' 52' ' ' LEU . 16.6 mt -137.02 132.27 34.03 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.446 -1.032 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.81 0.814 . . . . 0.0 111.207 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' TYR . 50.6 m-85 -152.15 139.35 19.3 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.5 m -56.12 -179.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.693 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 5.9 tm-20 -66.67 -37.73 85.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.024 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 61' ' ' GLN . 38.2 m -86.83 -40.23 15.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.572 -0.705 . . . . 0.0 111.525 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.68 -44.38 74.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 108.272 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.0 t80 -51.19 -54.84 21.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.425 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 50.4 m-80 -65.42 -46.07 81.44 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.121 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' THR . 14.2 tp60 -53.07 -36.89 61.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 2.4 mp -74.4 -32.35 62.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.654 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 22.4 m-85 -162.59 -86.5 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.832 0.825 . . . . 0.0 109.95 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 88.19 31.52 14.1 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 52.11 39.81 27.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -1.097 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.52 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 t -178.95 115.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -1.174 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.0 ttm -64.11 -128.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.49 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -179.02 -123.75 0.84 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 4' ' ' GLY . 1.8 t 57.18 117.06 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.373 -1.075 . . . . 0.0 109.964 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.532 ' CG ' HG21 ' A' ' 19' ' ' VAL . 8.5 Cg_endo -80.35 164.6 21.52 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.738 2.292 . . . . 0.0 109.655 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.505 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.0 mt -134.27 119.93 32.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.977 0.894 . . . . 0.0 109.35 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 36.9 t -63.79 121.19 13.39 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.844 0.831 . . . . 0.0 110.096 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -65.3 -3.83 14.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.78 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.0 -32.58 22.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -1.04 . . . . 0.0 109.353 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 1.42 5.49 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.658 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 50.71 34.46 9.99 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.68 ' CG ' HH11 ' A' ' 13' ' ' ARG . 0.1 OUTLIER -113.64 138.85 22.79 Favored Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.4 Cg_exo -53.27 114.69 1.86 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.301 1.334 . . . . 0.0 111.311 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 HG22 ' A' ' 19' ' ' VAL . 13.7 mt -70.03 159.37 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.455 ' N ' HG22 ' A' ' 15' ' ' ILE . 1.9 pt-20 -161.33 63.57 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.818 -1.177 . . . . 0.0 110.365 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.33 -98.22 0.11 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.66 HH11 ' CG ' ' A' ' 18' ' ' ARG . 3.4 mtt-85 -115.44 130.71 56.97 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.775 HG22 HG21 ' A' ' 15' ' ' ILE . 41.2 t -111.32 160.7 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.907 0.861 . . . . 0.0 111.472 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.493 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.4 t -127.13 116.82 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -89.1 106.15 18.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.64 158.41 43.69 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.668 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.8 mmt 58.16 17.52 4.63 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.86 76.04 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -120.37 -155.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.791 0.805 . . . . 0.0 109.724 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.423 ' HG2' HG11 ' A' ' 19' ' ' VAL . 24.9 mt-30 -135.8 144.85 45.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 58.3 m95 -142.63 140.54 31.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.594 -1.316 . . . . 0.0 110.359 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 25.7 m80 -55.83 138.46 48.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.469 HG22 HG23 ' A' ' 20' ' ' VAL . 6.9 t -58.01 -19.05 11.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 120.746 -1.221 . . . . 0.0 109.164 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -96.27 -3.14 44.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 110.418 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.59 -10.39 11.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.026 -1.046 . . . . 0.0 110.145 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CG ' HG11 ' A' ' 20' ' ' VAL . 26.5 t80 -78.79 105.82 10.36 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.815 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.4 m -133.45 174.98 12.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.252 1.025 . . . . 0.0 111.215 -177.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -61.7 149.31 40.02 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.483 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.75 27.65 2.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 35.1 tptt -138.87 -32.06 0.7 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.251 -0.906 . . . . 0.0 110.197 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.8 p -128.27 -16.5 4.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.198 -0.939 . . . . 0.0 110.298 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 73.43 47.31 0.18 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.353 -0.842 . . . . 0.0 110.192 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.49 109.96 60.44 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.815 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.9 Cg_endo -69.3 137.17 36.14 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.889 1.726 . . . . 0.0 112.242 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.34 58.83 1.82 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.619 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.11 -55.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.917 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.59 31.53 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -113.43 -178.12 3.3 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -1.033 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.409 ' O ' ' CE1' ' A' ' 47' ' ' TYR . 5.5 tpp180 -98.83 129.51 45.22 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.2 p-80 -101.3 175.82 5.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.012 . . . . 0.0 110.147 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.673 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.7 m-85 -135.88 136.47 40.57 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -108.6 148.16 30.76 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.297 -0.877 . . . . 0.0 111.428 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.765 HH22 ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -153.03 127.57 9.35 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.467 0.651 . . . . 0.0 110.411 179.141 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 50' ' ' LYS . 8.3 mtmp? 54.45 23.88 4.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.668 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.55 31.7 26.68 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 52' ' ' LEU . 20.9 mt -143.76 141.9 30.66 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.663 -0.904 . . . . 0.0 108.926 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.81 153.16 33.06 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 110.651 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.705 ' CG ' ' NH2' ' A' ' 49' ' ' ARG . 59.6 m-85 -153.78 139.38 17.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 87.8 m -57.36 175.04 0.17 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.208 -1.397 . . . . 0.0 108.313 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -62.39 -34.59 77.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.042 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' GLN . 54.0 m -86.44 -44.09 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 111.155 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.564 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.2 m170 -67.25 -42.58 83.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.81 -1.156 . . . . 0.0 107.966 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.765 ' HA ' HH22 ' A' ' 49' ' ' ARG . 5.5 t80 -51.79 -55.63 18.65 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 49.9 m-80 -67.14 -43.99 80.97 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.425 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 57' ' ' THR . 34.9 tt0 -54.29 -37.82 65.19 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.565 HD22 ' NH2' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -75.58 -35.57 60.57 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.452 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.2 m-85 -155.03 -81.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 110.104 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.437 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 83.75 31.69 26.17 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 52.1 79.57 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -1.07 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.403 179.911 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 3' ' ' MET . 11.6 t -165.5 -16.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -1.155 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.416 ' H ' ' H ' ' A' ' 2' ' ' SER . 38.7 mtt -56.28 -176.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.29 -38.16 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.63 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -145.22 131.32 9.64 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.491 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.04 163.64 36.29 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.939 1.76 . . . . 0.0 108.916 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.22 120.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.116 0.96 . . . . 0.0 109.408 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.4 t -58.35 116.15 3.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.778 0.799 . . . . 0.0 109.987 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.542 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.2 -2.11 4.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.29 -53.05 5.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -1.072 . . . . 0.0 109.429 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.54 5.36 19.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.09 42.08 32.18 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -116.16 143.2 30.54 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HB3' HG11 ' A' ' 5' ' ' VAL . 4.9 Cg_exo -56.05 112.56 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.504 1.469 . . . . 0.0 110.252 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.6 HG21 HG22 ' A' ' 19' ' ' VAL . 22.7 mt -69.65 158.02 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.684 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.416 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.8 pt-20 -160.91 62.73 0.3 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.874 -1.141 . . . . 0.0 110.441 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.0 -98.73 0.12 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 125.18 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 15' ' ' ILE . 46.1 t -103.74 152.62 6.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.735 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' A' ' 32' ' ' PHE . 13.1 t -118.2 115.08 47.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -88.69 106.16 18.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 109.747 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.95 160.03 42.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.679 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.2 mmt 58.12 16.44 3.86 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.6 20.66 77.38 Favored Glycine 0 C--N 1.291 -1.925 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -123.44 -153.97 0.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.974 0.892 . . . . 0.0 109.94 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.46 ' HG2' HG11 ' A' ' 19' ' ' VAL . 22.1 mt-30 -136.9 142.45 42.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.542 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 57.0 m95 -141.45 139.75 33.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.534 -1.354 . . . . 0.0 110.503 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -55.91 137.05 51.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 t -55.98 -19.33 6.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.822 -1.174 . . . . 0.0 109.119 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.456 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -94.08 -27.2 16.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.464 -0.772 . . . . 0.0 110.497 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -93.56 -7.08 45.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.08 . . . . 0.0 110.674 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.3 t80 -81.69 105.7 13.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.1 m -133.76 175.85 10.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 122.303 1.049 . . . . 0.0 111.249 -177.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.06 149.29 45.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.389 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.47 28.88 1.84 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.756 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 tptp -138.55 -31.68 0.73 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.416 -0.802 . . . . 0.0 110.057 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.6 p -129.43 -18.54 3.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.1 mt-10 75.26 47.28 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.308 -0.87 . . . . 0.0 110.064 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -100.98 107.67 50.84 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.182 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.9 Cg_endo -67.19 137.95 45.55 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.628 1.552 . . . . 0.0 112.179 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.15 58.46 1.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.01 -55.56 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 31.45 2.66 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.18 -176.29 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.418 -1.049 . . . . 0.0 110.224 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 47' ' ' TYR . 5.8 tpp180 -99.37 136.01 39.94 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -108.23 173.2 6.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.833 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.684 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 3.3 m-85 -134.59 141.48 46.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -110.75 151.46 27.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.176 -0.952 . . . . 0.0 111.788 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.773 ' HE ' ' N ' ' A' ' 50' ' ' LYS . 1.4 tpm_? -156.07 129.41 8.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.349 0.595 . . . . 0.0 109.808 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.773 ' N ' ' HE ' ' A' ' 49' ' ' ARG . 8.6 mmtp 53.17 22.96 2.84 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.679 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.03 31.39 32.04 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 52' ' ' LEU . 20.6 mt -140.69 141.55 34.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.27 154.13 33.25 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.632 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 49' ' ' ARG . 53.1 m-85 -154.33 140.25 18.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.1 m -57.34 176.7 0.11 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.156 -1.418 . . . . 0.0 108.234 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -63.83 -35.46 80.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 109.462 179.175 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.3 m -86.23 -41.32 14.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 111.115 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -68.56 -43.96 75.47 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.729 -1.232 . . . . 0.0 107.863 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -53.28 -56.48 16.26 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 45.3 m-80 -63.69 -44.05 94.84 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.528 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.26 -37.05 69.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 ' CE1' ' A' ' 54' ' ' TYR . 3.4 mp -73.71 -32.58 63.97 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.35 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.6 m-85 -160.08 -83.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.971 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 65' ' ' ASP . . . 78.95 -10.6 32.36 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 1.6 m-20 -179.43 -93.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 109.208 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.487 -179.945 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.25 163.61 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.958 1.772 . . . . 0.0 108.867 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.4 119.77 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 122.059 0.933 . . . . 0.0 109.402 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.0 t -58.35 117.0 3.98 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.844 0.831 . . . . 0.0 109.946 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -64.85 -0.17 4.91 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.67 -48.55 8.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -1.095 . . . . 0.0 109.36 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.8 13.7 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.649 HH11 ' HG3' ' A' ' 12' ' ' ARG . 8.2 mmm-85 53.52 41.32 32.11 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -115.91 143.45 30.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.7 Cg_exo -56.46 113.38 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.46 1.44 . . . . 0.0 110.546 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.661 HG21 HG22 ' A' ' 19' ' ' VAL . 21.5 mt -70.92 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.429 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.2 pt-20 -160.54 61.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.863 -1.148 . . . . 0.0 110.662 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.673 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.66 42.32 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 15' ' ' ILE . 42.8 t -98.8 158.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.668 0.746 . . . . 0.0 111.195 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 32' ' ' PHE . 4.9 t -122.56 116.01 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.608 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -89.85 106.09 18.24 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.11 -0.993 . . . . 0.0 109.553 -179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.53 42.63 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.9 mmt 58.09 17.19 4.31 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.2 25.28 75.85 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.8 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.741 0.781 . . . . 0.0 109.764 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.483 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.8 mt-30 -135.38 143.49 46.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.3 m95 -141.59 139.98 33.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.534 -1.354 . . . . 0.0 110.616 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.3 m80 -56.48 131.95 49.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 18' ' ' ARG . 7.7 t -53.22 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.871 -1.143 . . . . 0.0 108.348 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 28' ' ' HIS . 12.5 tp10 -95.78 -26.97 15.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.814 -0.554 . . . . 0.0 110.62 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.13 -6.52 31.38 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.883 -1.136 . . . . 0.0 110.826 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 20' ' ' VAL . 25.2 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.825 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.6 m -133.57 175.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 111.158 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.82 148.68 46.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.318 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.83 28.69 1.73 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.4 tptm -138.81 -31.69 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.364 -0.835 . . . . 0.0 110.077 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.1 -15.39 4.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.305 -0.872 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.6 0.34 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.326 -0.859 . . . . 0.0 110.191 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.46 109.56 59.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.825 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.4 Cg_endo -69.06 138.28 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.713 1.609 . . . . 0.0 112.112 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.23 1.63 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.26 -0.9 . . . . 0.0 108.996 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.01 2.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.936 -1.665 . . . . 0.0 108.936 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -116.29 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.504 -0.998 . . . . 0.0 109.94 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.43 145.34 24.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 109.352 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.2 p-80 -116.3 169.47 9.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.55 137.67 47.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.28 28.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.232 -0.917 . . . . 0.0 111.201 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.34 11.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.628 0.727 . . . . 0.0 110.333 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.23 22.86 1.45 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.586 -0.696 . . . . 0.0 109.495 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.47 30.97 20.36 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.724 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 52' ' ' LEU . 18.6 mt -143.29 142.74 31.44 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.535 -0.979 . . . . 0.0 108.814 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.35 152.86 36.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 110.73 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' A' ' 62' ' ' LEU . 57.7 m-85 -153.91 140.27 18.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 90.7 m -57.55 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.316 -1.353 . . . . 0.0 108.454 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 53.1 tt0 -63.63 -35.98 82.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.383 -0.823 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.4 m -86.66 -43.75 12.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 0.0 111.339 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.459 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -66.65 -43.77 83.68 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.79 -1.194 . . . . 0.0 108.141 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.2 t80 -51.74 -56.43 13.87 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 44.0 m-80 -64.52 -44.89 89.47 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.093 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.5 tp60 -54.44 -34.37 61.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.55 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.8 mp -78.68 -35.24 45.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.359 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 18.0 m-85 -158.58 -81.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.397 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.9 Cg_endo -79.6 164.3 23.57 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.673 2.249 . . . . 0.0 109.327 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.6 mt -135.31 122.83 36.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.873 0.844 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.841 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.1 t -61.13 116.83 4.86 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.549 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.42 -1.13 4.11 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.841 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.46 -54.22 4.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -1.149 . . . . 0.0 109.524 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.33 1.97 18.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.559 -0.713 . . . . 0.0 109.148 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 57.56 41.86 25.1 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.22 -0.925 . . . . 0.0 108.57 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -116.68 142.76 30.16 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.6 Cg_exo -55.69 113.97 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.432 1.422 . . . . 0.0 110.948 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 8' ' ' CYS . 23.9 mt -71.89 158.77 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.0 pt-20 -161.77 62.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 0.0 110.484 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 -100.37 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 29' ' ' VAL . 62.6 mtm180 -113.33 120.49 41.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.517 HG13 HD13 ' A' ' 15' ' ' ILE . 30.6 t -97.01 154.51 3.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 111.065 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.7 t -118.84 112.61 38.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.432 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.6 m-80 -86.98 106.81 18.08 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.67 42.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.5 mmt 58.38 16.01 3.83 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 27.5 71.71 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -133.05 -151.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.042 0.925 . . . . 0.0 110.089 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.502 ' HG2' HG11 ' A' ' 19' ' ' VAL . 26.4 mt-30 -136.82 144.53 43.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.549 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 64.4 m95 -142.51 135.44 28.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.605 -1.31 . . . . 0.0 110.368 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.451 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 17.7 m80 -53.77 135.52 41.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 18' ' ' ARG . 10.3 t -55.54 -18.18 4.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 120.935 -1.103 . . . . 0.0 109.053 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -94.39 -25.9 16.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.438 -0.789 . . . . 0.0 110.573 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.5 m170 -98.01 -5.03 34.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 111.028 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' A' ' 20' ' ' VAL . 28.5 t80 -82.72 106.03 14.23 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.833 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.2 m -133.01 174.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 122.314 1.054 . . . . 0.0 111.294 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.533 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.89 148.28 40.12 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.117 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.46 35.11 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.39 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -142.99 -40.23 0.32 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.8 p -122.41 -17.34 7.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.642 -0.661 . . . . 0.0 110.256 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.8 mt-10 75.1 47.89 0.1 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 110.244 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -100.42 109.59 57.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.833 ' CA ' HG12 ' A' ' 33' ' ' VAL . 6.1 Cg_endo -69.89 137.73 35.77 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.863 1.709 . . . . 0.0 112.15 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.21 57.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.62 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.11 -55.51 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -0.905 . . . . 0.0 109.279 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 29.79 2.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -114.68 -174.31 2.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.483 -1.01 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.56 146.85 25.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.321 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.583 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.8 p-80 -118.32 169.12 10.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.331 -0.855 . . . . 0.0 109.603 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.715 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -133.15 138.05 46.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.56 149.73 27.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 111.394 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.62 11.54 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.588 0.708 . . . . 0.0 110.259 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp 50.89 22.41 1.17 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.74 . . . . 0.0 109.376 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.75 30.77 20.15 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 52' ' ' LEU . 19.6 mt -141.99 142.26 32.93 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.59 -0.947 . . . . 0.0 108.77 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.47 153.15 35.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.29 -0.882 . . . . 0.0 110.954 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.627 ' CE1' HD22 ' A' ' 62' ' ' LEU . 48.7 m-85 -154.68 139.45 17.11 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 73.7 m -57.28 175.8 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.063 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.697 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.8 tp10 -61.98 -34.92 77.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.052 -1.03 . . . . 0.0 109.285 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 61' ' ' GLN . 70.2 m -86.25 -45.1 11.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.831 . . . . 0.0 111.251 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.563 ' O ' HD13 ' A' ' 62' ' ' LEU . 31.9 m170 -65.37 -42.76 92.38 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.792 -1.192 . . . . 0.0 108.358 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -54.34 -57.56 10.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 96.6 m-20 -62.72 -44.65 95.67 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.282 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.3 tp60 -55.52 -34.43 64.65 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.627 HD22 ' CE1' ' A' ' 54' ' ' TYR . 6.1 mp -78.77 -34.21 45.81 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.673 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 17.3 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.222 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.7 Cg_endo -79.96 164.49 22.56 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.757 2.305 . . . . 0.0 109.526 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.535 ' H ' HE21 ' A' ' 26' ' ' GLN . 35.1 mt -133.94 119.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.126 0.965 . . . . 0.0 109.327 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 36.2 t -61.33 116.24 4.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.796 0.807 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.54 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -59.83 -4.52 3.26 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.801 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.37 -51.58 6.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.406 -1.055 . . . . 0.0 109.289 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.428 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -107.56 2.98 24.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.269 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' CYS . 19.3 mmm180 50.02 34.83 8.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.66 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -113.85 138.62 22.82 Favored Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.7 Cg_exo -53.64 114.82 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.268 1.312 . . . . 0.0 110.943 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.729 HG21 HG22 ' A' ' 19' ' ' VAL . 14.0 mt -68.98 158.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' CD ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -159.59 62.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.913 -1.117 . . . . 0.0 110.451 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.54 -96.46 0.1 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -112.38 142.48 44.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.729 HG22 HG21 ' A' ' 15' ' ' ILE . 43.7 t -122.65 156.77 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.744 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.5 t -125.17 116.84 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.627 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.2 m120 -88.46 105.85 17.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.077 -1.014 . . . . 0.0 109.497 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.99 41.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.661 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 57.52 16.96 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.72 20.43 78.61 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -125.38 -155.37 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.742 0.782 . . . . 0.0 109.783 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.535 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.3 mt-30 -134.53 143.99 47.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.54 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.4 m95 -142.14 139.47 32.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.616 -1.303 . . . . 0.0 110.26 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.422 ' NE2' ' HA ' ' A' ' 15' ' ' ILE . 19.6 m80 -54.68 138.65 41.14 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -57.41 -16.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 120.795 -1.191 . . . . 0.0 108.987 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -96.52 -25.82 15.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.47 -0.769 . . . . 0.0 110.54 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -93.21 -9.94 37.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.916 -1.115 . . . . 0.0 110.451 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' A' ' 20' ' ' VAL . 22.4 t80 -79.61 105.82 11.19 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.811 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.9 m -133.97 175.26 11.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 122.246 1.022 . . . . 0.0 110.959 -177.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -64.13 148.53 49.71 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.268 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.0 28.12 1.66 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 tptm -138.7 -32.03 0.71 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.333 -0.854 . . . . 0.0 110.223 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.7 p -129.3 -11.27 4.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.343 -0.848 . . . . 0.0 110.205 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 65.01 47.25 2.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.472 -0.768 . . . . 0.0 110.491 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.603 ' NZ ' ' SG ' ' A' ' 55' ' ' CYS . 0.0 OUTLIER -101.99 107.49 52.67 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.811 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.4 Cg_endo -66.0 139.48 56.48 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.678 1.585 . . . . 0.0 112.304 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.44 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.14 -55.31 1.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.947 . . . . 0.0 109.067 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.1 30.58 2.92 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.431 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.7 OUTLIER -117.7 176.61 5.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.56 -0.965 . . . . 0.0 109.905 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.57 150.43 21.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.438 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.6 p-80 -119.4 170.66 8.94 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.4 m-85 -138.17 129.42 27.46 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.478 ' OE2' ' CE ' ' A' ' 23' ' ' MET . 1.3 mm-40 -100.07 153.59 19.1 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.232 -0.917 . . . . 0.0 111.702 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.518 ' NH2' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -153.35 127.05 8.79 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.558 0.694 . . . . 0.0 109.877 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt 52.59 23.8 2.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 109.59 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.661 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 31.09 23.5 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.076 -1.535 . . . . 0.0 109.36 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.518 HD12 ' NH2' ' A' ' 49' ' ' ARG . 19.4 mt -142.66 139.95 31.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.603 -0.94 . . . . 0.0 108.666 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.3 151.92 39.74 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.163 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' TYR . 55.0 m-85 -154.37 139.45 17.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.603 ' SG ' ' NZ ' ' A' ' 39' ' ' LYS . 89.3 m -57.81 178.15 0.09 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.792 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.2 tt0 -62.31 -37.82 87.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.619 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 61' ' ' GLN . 52.4 m -86.92 -43.08 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 111.66 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -65.81 -43.61 88.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.722 -1.236 . . . . 0.0 108.134 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.8 t80 -51.94 -56.5 13.81 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -64.22 -44.9 90.47 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.5 tp-100 -54.38 -34.84 62.01 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.561 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.8 mp -78.12 -33.28 50.61 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.512 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 21.2 m-85 -160.13 -81.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 110.125 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.342 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.627 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.83 163.58 35.3 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.909 1.739 . . . . 0.0 108.901 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.1 mt -134.48 119.95 31.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.012 0.911 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.813 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.1 t -60.27 119.6 8.22 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 110.119 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.84 0.09 11.82 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.813 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.59 -38.36 18.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -1.113 . . . . 0.0 109.392 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.64 5.04 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 54.19 41.48 31.98 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -115.54 142.54 28.99 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.627 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.5 Cg_exo -56.27 112.94 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.562 1.508 . . . . 0.0 110.729 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.694 HG21 HG22 ' A' ' 19' ' ' VAL . 20.7 mt -70.45 158.68 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.418 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.2 pt-20 -159.19 62.12 0.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.691 -1.256 . . . . 0.0 110.854 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.67 -100.97 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.511 ' HB3' HG21 ' A' ' 29' ' ' VAL . 37.5 mtt180 -107.82 134.35 50.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.694 HG22 HG21 ' A' ' 15' ' ' ILE . 46.2 t -115.77 158.06 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 110.731 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.454 HG11 ' CD2' ' A' ' 32' ' ' PHE . 3.7 t -122.9 117.32 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.655 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.9 OUTLIER -90.03 105.97 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.29 159.76 42.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.1 mmt 58.1 18.14 5.02 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.07 75.75 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -130.32 -154.67 0.65 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.717 0.77 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.513 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.6 mt-30 -134.82 145.1 48.02 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.6 m95 -142.05 139.15 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.544 -1.347 . . . . 0.0 110.788 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.439 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 18.3 m80 -55.22 132.79 48.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 18' ' ' ARG . 77.0 t -52.39 -22.58 3.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 120.835 -1.165 . . . . 0.0 109.29 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -91.85 -23.74 19.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 110.734 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -96.91 -6.58 35.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.859 -1.151 . . . . 0.0 111.029 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.454 ' CD2' HG11 ' A' ' 20' ' ' VAL . 29.1 t80 -81.67 103.2 11.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.819 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.1 m -128.96 178.45 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 122.321 1.058 . . . . 0.0 111.254 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.639 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.1 t -65.61 148.4 51.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.702 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.8 28.19 1.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.486 -0.759 . . . . 0.0 109.197 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.477 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 6.3 tmtt? -134.1 -39.07 0.86 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.571 -0.706 . . . . 0.0 109.74 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.6 p -126.31 -16.17 5.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.558 -0.714 . . . . 0.0 110.553 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.0 mt-10 73.7 46.94 0.18 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -100.76 110.21 60.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.819 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.1 Cg_endo -68.46 136.97 38.24 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.718 1.612 . . . . 0.0 111.754 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.4 m-85 -95.98 60.1 2.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.637 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.3 mp -40.04 -56.02 1.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.44 -0.788 . . . . 0.0 109.476 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.67 26.16 4.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -114.56 159.98 19.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.396 -1.061 . . . . 0.0 109.822 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -75.72 154.77 36.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.452 -0.78 . . . . 0.0 109.162 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.608 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.6 p-80 -118.08 170.52 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.273 -0.892 . . . . 0.0 110.017 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -135.87 137.36 41.38 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -111.65 145.27 39.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 0.0 111.387 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.558 ' NH1' ' HG3' ' A' ' 49' ' ' ARG . 11.1 ttm-85 -144.92 137.91 26.54 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.53 0.681 . . . . 0.0 110.12 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 44.73 20.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.702 0.763 . . . . 0.0 109.166 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 87.18 30.71 19.07 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ARG . 20.1 mt -138.9 143.03 38.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.678 -0.895 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.96 151.76 33.49 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.828 0.823 . . . . 0.0 111.25 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.562 ' CE1' HD22 ' A' ' 62' ' ' LEU . 53.4 m-85 -153.54 135.89 14.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 14.5 m -56.57 172.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.101 -1.439 . . . . 0.0 108.141 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 68.3 tt0 -57.28 -32.35 66.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.045 -1.034 . . . . 0.0 109.745 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 93.7 m -87.15 -47.88 8.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.826 . . . . 0.0 111.818 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.594 ' O ' HD13 ' A' ' 62' ' ' LEU . 29.1 m170 -64.67 -40.88 96.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.756 -1.215 . . . . 0.0 108.605 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -55.13 -57.49 11.55 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.441 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 42.8 m-80 -63.03 -44.1 96.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.065 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.72 -35.96 64.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 6.6 mp -76.1 -37.25 58.35 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.7 m-85 -156.11 -83.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.722 0.773 . . . . 0.0 109.804 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.441 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 5' ' ' VAL . 2.0 t . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -79.9 164.68 22.59 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.733 2.289 . . . . 0.0 109.349 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.528 ' H ' HE21 ' A' ' 26' ' ' GLN . 25.8 mt -134.97 120.45 30.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-O 121.945 0.878 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 20.8 t -62.16 121.27 12.67 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.877 0.846 . . . . 0.0 110.077 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.39 -1.48 15.24 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.79 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.35 -35.31 21.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -130.49 0.25 4.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.677 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 56.83 38.56 29.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -178.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.629 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -111.01 138.3 21.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.9 Cg_exo -55.1 113.46 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.113 1.209 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.627 HG21 HG22 ' A' ' 19' ' ' VAL . 19.9 mt -70.62 158.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -161.26 62.41 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.897 -1.127 . . . . 0.0 110.616 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.82 -101.87 0.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -111.48 126.39 54.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.627 HG22 HG21 ' A' ' 15' ' ' ILE . 42.0 t -105.15 158.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 111.204 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.9 t -122.36 115.65 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.577 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -90.49 106.55 18.57 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 109.905 -178.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.97 160.16 41.78 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.62 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.5 mmt 58.31 14.46 2.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.32 18.21 79.2 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.801 -2.12 . . . . 0.0 107.801 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -120.21 -154.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.007 0.908 . . . . 0.0 109.827 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.528 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.8 mt-30 -136.6 143.56 43.64 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.4 m95 -141.66 138.88 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.513 -1.367 . . . . 0.0 110.566 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.413 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 19.6 m80 -55.46 134.73 50.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.419 HG22 HG23 ' A' ' 20' ' ' VAL . 17.1 t -54.37 -20.43 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 120.809 -1.182 . . . . 0.0 109.08 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -92.03 -27.89 17.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 110.536 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -93.81 -7.35 43.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.031 -1.043 . . . . 0.0 110.885 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.0 t80 -81.25 105.86 12.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.809 HG12 ' CA ' ' A' ' 40' ' ' PRO . 23.2 m -133.89 174.99 12.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 122.326 1.06 . . . . 0.0 111.195 -177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.7 t -64.03 148.41 49.8 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.059 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.71 27.81 1.68 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.702 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.2 tptp -138.09 -33.21 0.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.1 p -126.89 -11.23 6.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.261 -0.9 . . . . 0.0 110.209 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 65.08 46.87 2.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -102.56 107.02 52.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.809 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.5 Cg_endo -66.45 139.75 55.18 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.816 1.677 . . . . 0.0 112.358 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -96.08 56.35 1.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.03 -55.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 30.39 2.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.428 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -116.47 178.99 4.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.96 . . . . 0.0 109.958 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -95.79 147.19 23.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.432 -0.792 . . . . 0.0 109.293 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.531 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 33.6 p-80 -117.73 168.94 9.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.0 m-85 -133.66 133.16 41.56 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -111.01 155.43 22.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.075 -1.016 . . . . 0.0 111.639 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -145.47 135.77 23.99 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.55 0.691 . . . . 0.0 110.064 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.2 ptmt 42.33 21.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.467 0.651 . . . . 0.0 109.757 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.62 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.92 30.62 9.28 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.191 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.0 mt -140.53 136.83 33.28 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.491 -1.005 . . . . 0.0 108.379 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.46 150.18 45.15 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.858 0.837 . . . . 0.0 111.11 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.671 ' N ' ' O ' ' A' ' 47' ' ' TYR . 47.4 m-85 -153.14 139.3 18.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 54.1 m -56.51 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.831 -1.168 . . . . 0.0 108.857 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 75.2 tt0 -68.65 -40.46 80.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.352 -0.843 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.2 m -86.25 -37.57 18.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 111.292 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.56 -46.77 68.55 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.798 -1.189 . . . . 0.0 108.224 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -52.36 -55.94 18.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 93.2 m-20 -62.49 -46.26 89.26 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.51 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -54.68 -38.15 66.64 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -72.1 -39.69 68.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.319 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -153.79 -83.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.288 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.622 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.53 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.4 Cg_endo -74.36 163.65 35.82 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.911 1.74 . . . . 0.0 109.002 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 14' ' ' PRO . 28.1 mt -135.14 119.75 27.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.992 0.901 . . . . 0.0 109.206 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.816 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.2 t -57.85 118.8 5.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.888 0.852 . . . . 0.0 110.073 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.528 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.57 -2.01 5.37 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.816 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.56 -60.9 1.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -1.069 . . . . 0.0 109.336 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.25 -7.3 26.62 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.501 -0.749 . . . . 0.0 109.163 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.473 ' O ' ' CZ ' ' A' ' 13' ' ' ARG . 23.6 mmm180 63.51 37.81 10.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -112.87 144.07 30.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.622 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.5 Cg_exo -56.07 113.25 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.466 1.444 . . . . 0.0 110.383 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.669 HG21 HG22 ' A' ' 19' ' ' VAL . 22.9 mt -70.52 158.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.1 pt-20 -160.45 61.25 0.33 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.835 -1.165 . . . . 0.0 110.694 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.33 -102.48 0.16 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 29' ' ' VAL . 69.4 mtm180 -112.82 121.37 44.5 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.669 HG22 HG21 ' A' ' 15' ' ' ILE . 40.8 t -99.45 159.39 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 111.285 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.47 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.8 t -123.56 116.44 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.86 106.17 18.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.02 42.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.944 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.626 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.07 16.8 4.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 25.41 75.8 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.094 -2.003 . . . . 0.0 108.094 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.72 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.812 0.815 . . . . 0.0 109.816 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.488 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.0 mt-30 -135.29 143.7 46.36 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.528 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.5 m95 -141.6 140.93 33.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.479 -1.388 . . . . 0.0 110.644 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.475 ' C ' ' N ' ' A' ' 30' ' ' GLU . 18.0 m80 -57.41 131.91 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 20' ' ' VAL . 7.7 t -52.58 -14.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.87 -1.144 . . . . 0.0 108.402 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 28' ' ' HIS . 11.2 tp10 -95.93 -27.11 15.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.761 -0.587 . . . . 0.0 110.501 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -97.14 -6.63 34.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.93 -1.106 . . . . 0.0 110.771 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.3 t80 -80.76 106.09 12.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.4 m -132.67 176.38 9.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.314 1.054 . . . . 0.0 111.19 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.6 t -65.36 148.75 51.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.454 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.49 25.53 2.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.288 -0.883 . . . . 0.0 109.78 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.6 tptp -135.43 -32.75 0.91 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.326 -0.859 . . . . 0.0 110.22 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 p -128.66 -12.47 4.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 67.9 47.2 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.228 -0.92 . . . . 0.0 109.966 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -101.17 107.47 50.44 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.3 Cg_endo -66.81 138.46 48.82 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.624 1.549 . . . . 0.0 112.118 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -95.72 56.81 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.632 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.12 -55.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.166 -0.959 . . . . 0.0 109.015 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.18 29.61 3.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.432 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -116.98 175.39 5.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.574 -0.957 . . . . 0.0 109.801 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.709 ' HG2' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -89.32 150.61 22.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.572 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.3 p-80 -119.5 169.8 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.695 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.5 m-85 -136.82 132.78 35.12 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.95 150.84 24.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.928 . . . . 0.0 111.892 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.535 ' NH2' ' OH ' ' A' ' 54' ' ' TYR . 10.0 ttp180 -146.19 134.23 21.5 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.101 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HZ3' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 42.04 21.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.569 0.7 . . . . 0.0 109.615 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.626 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 93.08 30.69 9.1 Favored Glycine 0 C--N 1.295 -1.71 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.043 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.1 mt -141.74 139.76 32.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.456 -1.026 . . . . 0.0 108.822 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -73.8 151.87 40.46 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.865 0.84 . . . . 0.0 110.867 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 47' ' ' TYR . 48.9 m-85 -154.59 138.94 16.69 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 67.4 m -56.56 178.76 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.904 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 12.2 tm-20 -63.73 -39.24 93.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.818 . . . . 0.0 109.46 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.8 m -86.25 -39.28 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.687 . . . . 0.0 111.341 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.7 m170 -67.93 -47.18 69.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.805 -1.184 . . . . 0.0 107.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.1 t80 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -64.18 -44.39 92.2 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.623 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -57.01 -36.41 70.4 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.544 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.7 mp -73.28 -37.39 66.28 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.5 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.9 m-85 -153.74 -81.71 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.795 0.807 . . . . 0.0 109.913 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.332 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.3 t . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.3 Cg_endo -75.67 163.23 34.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.983 1.789 . . . . 0.0 109.232 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.4 mt -133.78 119.6 33.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 122.103 0.954 . . . . 0.0 109.157 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 30.3 t -58.02 115.63 3.01 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.776 0.798 . . . . 0.0 109.901 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.539 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.66 -3.23 4.11 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.822 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.55 -59.94 2.17 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.471 -1.017 . . . . 0.0 109.357 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.43 -1.07 39.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.545 -0.722 . . . . 0.0 109.179 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER 56.03 39.72 30.43 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -118.37 149.48 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.642 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.0 Cg_exo -58.73 113.01 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.442 1.428 . . . . 0.0 110.793 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.772 HG21 HG22 ' A' ' 19' ' ' VAL . 20.5 mt -68.52 159.92 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.432 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -158.38 62.4 0.44 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.613 -1.305 . . . . 0.0 111.399 -178.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.02 -95.37 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -108.27 138.56 44.34 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.772 HG22 HG21 ' A' ' 15' ' ' ILE . 46.9 t -124.9 160.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.791 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.578 HG23 HG22 ' A' ' 29' ' ' VAL . 3.4 t -126.41 117.41 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.34 105.77 18.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 109.482 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.31 16.65 4.16 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.91 26.09 74.59 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -130.83 -153.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.848 0.832 . . . . 0.0 109.954 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.508 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.1 mt-30 -137.44 142.8 41.6 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 56.9 m95 -141.38 139.3 33.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.64 -1.288 . . . . 0.0 110.6 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.476 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.7 m80 -56.0 131.44 47.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.578 HG22 HG23 ' A' ' 20' ' ' VAL . 6.2 t -53.38 -13.85 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 120.581 -1.325 . . . . 0.0 108.361 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 28' ' ' HIS . 51.1 tp10 -94.57 -27.36 15.97 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.778 -0.576 . . . . 0.0 110.433 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -98.14 -6.28 31.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.909 -1.12 . . . . 0.0 110.787 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CD2' HG11 ' A' ' 20' ' ' VAL . 22.8 t80 -80.13 107.1 12.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.6 m -133.25 175.9 10.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.229 1.014 . . . . 0.0 111.27 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.47 148.44 48.6 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.407 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.37 25.98 2.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -0.908 . . . . 0.0 109.804 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.44 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.5 tptp -136.02 -31.53 0.91 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.291 -0.88 . . . . 0.0 110.019 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.2 p -130.03 -15.16 3.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.98 47.43 0.31 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.298 -0.876 . . . . 0.0 110.461 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -102.22 109.49 60.35 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.9 Cg_endo -68.76 138.41 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.848 1.698 . . . . 0.0 112.018 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.5 57.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.639 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.34 -55.49 1.72 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.4 31.48 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.531 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -115.64 -163.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -1.051 . . . . 0.0 110.05 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -110.6 146.23 36.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.5 p-80 -118.06 168.33 10.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.719 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.0 m-85 -131.7 136.64 47.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -107.02 149.8 27.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -147.15 133.63 19.73 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.561 0.696 . . . . 0.0 110.01 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 15.9 ptmt 41.8 22.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.594 0.712 . . . . 0.0 109.68 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.06 31.3 9.27 Favored Glycine 0 C--N 1.296 -1.68 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.203 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.8 mt -142.78 140.64 31.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.504 -0.998 . . . . 0.0 108.79 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -75.37 152.19 38.11 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 110.879 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.571 ' CE1' HD22 ' A' ' 62' ' ' LEU . 52.8 m-85 -154.33 139.53 17.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.7 m -56.05 179.15 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.42 -1.312 . . . . 0.0 108.546 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 9.2 tm-20 -64.78 -38.44 91.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.8 m -86.14 -39.1 17.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.624 -0.673 . . . . 0.0 111.19 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.478 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.9 m170 -68.92 -43.89 74.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.702 -1.249 . . . . 0.0 108.037 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -54.98 -57.03 13.33 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.453 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 39.6 m-80 -62.16 -43.68 98.3 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.377 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -55.92 -37.26 68.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 54' ' ' TYR . 3.7 mp -74.52 -37.99 62.92 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.996 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.0 m-85 -156.85 -83.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.411 -0.806 . . . . 0.0 110.171 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.453 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.607 HG11 ' CB ' ' A' ' 14' ' ' PRO . 2.1 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' A' ' 19' ' ' VAL . 3.4 Cg_endo -70.94 163.36 39.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.616 1.544 . . . . 0.0 108.344 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 33.6 mt -134.24 120.67 35.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-O 122.201 1.001 . . . . 0.0 109.244 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.866 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.6 t -57.39 116.03 3.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.759 0.79 . . . . 0.0 110.066 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.11 -0.67 3.32 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.866 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.53 -59.26 2.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -1.086 . . . . 0.0 109.399 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -102.96 -0.86 30.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.519 -0.738 . . . . 0.0 109.267 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.621 HH11 ' HG3' ' A' ' 12' ' ' ARG . 7.2 mmm-85 58.62 43.08 19.55 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -118.62 143.62 33.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.607 ' CB ' HG11 ' A' ' 5' ' ' VAL . 3.0 Cg_exo -53.9 111.72 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.663 1.575 . . . . 0.0 110.621 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.633 HG21 HG22 ' A' ' 19' ' ' VAL . 34.6 mt -71.17 158.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.217 -0.927 . . . . 0.0 108.516 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.38 61.45 0.27 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.727 -1.233 . . . . 0.0 110.728 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.24 -102.19 0.15 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.675 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.8 mtt-85 -112.14 120.4 41.68 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 15' ' ' ILE . 40.5 t -99.29 158.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 111.282 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 32' ' ' PHE . 5.0 t -122.51 115.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.647 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -89.85 106.16 18.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.694 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.53 41.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.643 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.3 mmt 58.02 15.98 3.5 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 20.86 77.94 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -124.24 -154.69 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.773 0.797 . . . . 0.0 109.885 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.502 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.5 mt-30 -135.32 143.25 46.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.525 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.0 m95 -141.09 138.55 33.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.572 -1.33 . . . . 0.0 110.588 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.497 ' C ' ' N ' ' A' ' 30' ' ' GLU . 15.6 m80 -55.42 130.74 43.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 20' ' ' VAL . 8.7 t -52.52 -14.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 120.932 -1.105 . . . . 0.0 108.068 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.497 ' N ' ' C ' ' A' ' 28' ' ' HIS . 4.1 tt0 -95.36 -27.83 15.26 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.921 -0.487 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -98.64 -6.02 30.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.827 -1.171 . . . . 0.0 110.821 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 20' ' ' VAL . 23.0 t80 -79.87 106.14 11.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' A' ' 40' ' ' PRO . 27.7 m -134.32 174.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 122.272 1.034 . . . . 0.0 111.122 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.554 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.06 148.22 36.48 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.263 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.25 34.49 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.291 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HG3' HD11 ' A' ' 62' ' ' LEU . 6.0 tmtt? -142.79 -40.05 0.33 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.5 -0.75 . . . . 0.0 109.744 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.1 p -123.2 -17.4 6.64 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.433 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.0 mt-10 76.32 47.59 0.08 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.4 -0.812 . . . . 0.0 110.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -100.32 110.75 60.94 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' A' ' 33' ' ' VAL . 6.2 Cg_endo -70.62 137.98 34.1 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.874 1.716 . . . . 0.0 112.192 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.488 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.11 58.13 1.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.47 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.01 30.56 2.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -115.4 -179.08 3.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.437 -1.037 . . . . 0.0 110.004 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.656 ' CG ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -96.2 143.07 27.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.502 -0.749 . . . . 0.0 109.158 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.569 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.0 p-80 -114.28 171.51 7.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.306 -0.871 . . . . 0.0 109.659 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.704 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.5 m-85 -134.0 137.75 44.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -108.5 146.94 32.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 111.585 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.927 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -151.57 117.38 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.79 -0.569 . . . . 0.0 109.645 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 22.4 mmtp 61.89 30.37 18.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 109.995 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.643 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 76.97 31.09 54.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 52' ' ' LEU . 26.1 mt -141.84 137.29 31.35 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.682 -0.893 . . . . 0.0 108.734 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.79 153.88 34.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.769 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.613 ' CE1' HD22 ' A' ' 62' ' ' LEU . 47.2 m-85 -153.8 137.86 16.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 76.3 m -56.05 173.27 0.16 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.321 -1.352 . . . . 0.0 108.254 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.4 tm-20 -59.75 -34.78 73.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 109.255 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 61' ' ' GLN . 66.5 m -87.01 -44.43 11.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.68 . . . . 0.0 111.397 -178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.577 ' O ' HD13 ' A' ' 62' ' ' LEU . 30.6 m170 -65.64 -42.12 91.8 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.792 -1.193 . . . . 0.0 108.493 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.2 t80 -54.3 -57.19 12.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 36.7 m-80 -64.61 -43.94 92.17 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.289 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 57' ' ' THR . 37.1 tt0 -54.31 -34.38 60.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.613 HD22 ' CE1' ' A' ' 54' ' ' TYR . 6.5 mp -79.24 -38.28 35.98 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.604 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.2 m-85 -160.33 -80.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.573 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.453 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -75.48 163.37 34.41 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.043 1.829 . . . . 0.0 109.274 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.5 mt -135.11 119.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 122.034 0.921 . . . . 0.0 109.149 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 32.7 t -58.51 115.0 2.73 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.84 0.829 . . . . 0.0 109.779 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.536 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.46 -3.54 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.819 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.99 -59.18 2.41 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.329 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.39 -1.6 35.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.569 -0.707 . . . . 0.0 109.183 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 57.8 38.84 27.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.214 -0.929 . . . . 0.0 108.693 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.04 149.34 45.35 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.3 Cg_exo -59.05 113.05 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.387 1.391 . . . . 0.0 110.783 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.706 HG21 HG22 ' A' ' 19' ' ' VAL . 19.3 mt -69.87 160.31 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.474 ' N ' HG22 ' A' ' 15' ' ' ILE . 9.0 pt-20 -170.3 70.39 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.698 -1.251 . . . . 0.0 110.549 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.82 -55.06 0.3 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.621 ' HG3' HH11 ' A' ' 18' ' ' ARG . 1.1 mtm-85 -139.56 129.67 25.13 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.706 HG22 HG21 ' A' ' 15' ' ' ILE . 48.7 t -126.47 152.98 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.6 t -127.23 116.39 43.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.533 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.1 m-80 -86.94 105.65 17.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.064 -1.023 . . . . 0.0 109.372 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.81 159.98 42.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.472 -0.767 . . . . 0.0 109.012 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 57.65 18.4 4.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.83 22.69 77.02 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -129.37 -156.19 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.965 -0.726 . . . . 0.0 109.767 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.497 HE21 ' H ' ' A' ' 7' ' ' ILE . 1.7 mt-30 -134.29 143.43 47.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.536 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 48.6 m95 -141.96 140.05 32.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.531 -1.355 . . . . 0.0 110.289 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.426 ' CD2' HG23 ' A' ' 15' ' ' ILE . 19.7 m80 -55.82 140.48 42.15 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 t -58.94 -19.46 15.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.718 -1.239 . . . . 0.0 109.288 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -96.27 -12.69 24.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -105.62 -8.76 17.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.951 -1.093 . . . . 0.0 109.955 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.468 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.1 t80 -81.22 103.59 11.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.846 HG12 ' CA ' ' A' ' 40' ' ' PRO . 21.3 m -126.16 177.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 122.42 1.105 . . . . 0.0 111.597 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -68.06 149.16 50.01 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.722 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.06 26.01 2.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.7 tptm -134.12 -29.79 1.24 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.364 -0.835 . . . . 0.0 109.841 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.6 p -133.18 -15.59 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.302 -0.874 . . . . 0.0 110.392 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.51 46.56 0.4 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.266 -0.896 . . . . 0.0 110.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -101.32 112.51 65.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.846 ' CA ' HG12 ' A' ' 33' ' ' VAL . 10.5 Cg_endo -71.54 134.44 24.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.483 1.455 . . . . 0.0 110.897 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.588 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.1 m-85 -93.01 59.46 3.13 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 40' ' ' PRO . 4.6 mp -41.02 -55.95 2.42 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.409 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.33 24.02 5.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -114.69 168.73 9.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.48 -1.012 . . . . 0.0 109.95 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -84.07 156.68 22.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.553 -0.717 . . . . 0.0 109.16 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.7 p-80 -120.81 170.25 9.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 0.0 110.054 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.708 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.0 m-85 -135.47 135.23 40.33 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -110.52 141.08 44.16 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.196 -0.94 . . . . 0.0 111.188 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.728 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -145.15 136.45 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.563 0.697 . . . . 0.0 110.369 178.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt 50.12 22.45 0.93 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.52 -0.737 . . . . 0.0 109.096 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.75 30.63 31.84 Favored Glycine 0 C--N 1.295 -1.712 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 52' ' ' LEU . 22.2 mt -140.09 143.02 36.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.775 -0.838 . . . . 0.0 108.896 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.44 151.48 34.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.487 -0.758 . . . . 0.0 110.928 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 59.5 m-85 -153.27 136.63 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 64.4 m -57.4 173.92 0.23 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.277 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 26.8 tt0 -59.5 -34.51 72.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 61' ' ' GLN . 59.1 m -86.91 -44.09 11.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -0.772 . . . . 0.0 111.683 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.446 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.0 m170 -67.57 -43.03 81.6 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.708 -1.245 . . . . 0.0 108.453 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.512 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -51.86 -55.6 19.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.435 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 44.5 m-80 -65.57 -45.34 83.67 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.977 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 57' ' ' THR . 28.1 tt0 -52.87 -39.01 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.582 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -71.64 -40.33 69.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.728 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 14.6 m-85 -154.3 -85.11 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.603 0.716 . . . . 0.0 109.973 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.516 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.8 Cg_endo -74.49 163.41 36.17 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 109.024 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.8 mt -135.71 119.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.033 0.92 . . . . 0.0 109.26 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.831 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.3 t -57.14 117.34 3.93 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.776 0.798 . . . . 0.0 109.86 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.527 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.76 -2.2 5.9 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.831 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.21 -60.56 2.0 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -1.063 . . . . 0.0 109.364 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.28 -2.48 33.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.781 . . . . 0.0 109.151 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.624 HH11 ' HG3' ' A' ' 12' ' ' ARG . 6.6 mmm-85 59.75 40.51 19.58 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.278 -0.889 . . . . 0.0 108.768 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.66 150.14 46.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.8 Cg_exo -59.29 113.91 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.53 1.486 . . . . 0.0 110.568 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.646 HG21 HG22 ' A' ' 19' ' ' VAL . 21.1 mt -70.34 158.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.417 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -159.21 59.38 0.41 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.833 -1.167 . . . . 0.0 110.986 -178.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.06 -102.45 0.16 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.674 ' CG ' HH11 ' A' ' 18' ' ' ARG . 3.0 mtt-85 -111.19 121.3 44.93 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.646 HG22 HG21 ' A' ' 15' ' ' ILE . 45.6 t -98.72 157.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 111.038 -177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.459 HG11 ' CD2' ' A' ' 32' ' ' PHE . 7.1 t -120.62 115.15 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.631 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.71 160.19 41.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.671 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.1 mmt 57.52 16.39 3.29 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.8 22.44 78.2 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -125.75 -154.67 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.737 0.78 . . . . 0.0 109.753 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HG2' HG11 ' A' ' 19' ' ' VAL . 2.7 mt-30 -136.29 142.8 43.96 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.527 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.0 m95 -141.77 140.63 33.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.569 -1.332 . . . . 0.0 110.448 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -56.44 139.44 49.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 18' ' ' ARG . 7.9 t -57.64 -20.38 13.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 120.868 -1.145 . . . . 0.0 109.315 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.88 -16.69 21.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.483 -0.761 . . . . 0.0 110.627 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.4 m170 -101.43 -9.1 21.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.845 -1.159 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CD2' HG11 ' A' ' 20' ' ' VAL . 28.0 t80 -80.15 104.98 11.08 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.831 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.2 m -130.69 177.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 122.405 1.098 . . . . 0.0 111.499 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -66.96 148.56 51.8 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.661 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.5 30.48 1.3 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.243 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -139.65 -31.01 0.69 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.0 110.122 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 32.0 p -131.05 -18.59 2.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.364 -0.835 . . . . 0.0 110.192 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.2 mt-10 74.38 45.89 0.18 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 110.299 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -101.39 112.06 64.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.831 ' CA ' HG12 ' A' ' 33' ' ' VAL . 10.1 Cg_endo -71.7 135.94 27.0 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.561 1.507 . . . . 0.0 111.401 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.46 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -93.28 55.69 2.33 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 40' ' ' PRO . 3.1 mp -40.64 -55.79 2.28 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.758 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.427 ' H ' ' CD2' ' A' ' 44' ' ' HIS . . . -128.16 23.86 5.14 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -115.69 -164.52 0.96 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.285 -1.127 . . . . 0.0 109.843 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.58 HH11 ' HB3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -107.7 154.11 21.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.579 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.1 p-80 -119.65 171.72 8.18 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.702 0.763 . . . . 0.0 109.265 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.0 m-85 -138.55 132.71 31.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.26 147.42 27.07 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.302 -0.874 . . . . 0.0 112.104 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.832 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -154.58 121.02 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 1.0 OUTLIER 62.5 29.15 17.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.505 -0.747 . . . . 0.0 109.902 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.671 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 74.4 31.34 59.18 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 52' ' ' LEU . 29.1 mt -141.42 141.43 33.73 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.51 153.46 33.42 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 47' ' ' TYR . 54.9 m-85 -153.56 140.31 19.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 85.5 m -60.2 175.91 0.38 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.742 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 61.4 tt0 -60.96 -37.57 82.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.419 -0.801 . . . . 0.0 109.423 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.9 -43.02 12.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.581 -0.699 . . . . 0.0 111.663 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.561 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.0 m170 -67.0 -44.83 79.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.716 -1.24 . . . . 0.0 108.284 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.7 t80 -49.11 -54.92 13.98 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 55.8 m-80 -67.9 -46.08 72.63 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.207 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.1 tp-100 -53.46 -33.64 54.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.27 -38.75 41.93 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.0 m-85 -160.37 -79.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.393 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -76.31 163.61 32.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.194 1.93 . . . . 0.0 109.29 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.2 mt -134.73 119.0 27.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 122.027 0.918 . . . . 0.0 109.24 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 38.2 t -60.44 118.33 6.35 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.8 0.809 . . . . 0.0 110.141 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.531 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.94 -3.61 8.85 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.792 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -83.72 -46.59 12.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.488 -1.007 . . . . 0.0 109.449 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.44 -1.51 13.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 8' ' ' CYS . 26.8 mmt180 57.07 35.55 26.5 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 143.21 29.02 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.9 Cg_exo -55.88 113.8 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.306 1.338 . . . . 0.0 110.625 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.783 HG21 HG22 ' A' ' 19' ' ' VAL . 12.9 mt -69.1 159.73 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.47 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.5 pt-20 -167.73 69.06 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.755 -1.215 . . . . 0.0 110.373 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.87 -64.22 0.17 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.527 HH21 ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -138.9 136.62 35.7 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.783 HG22 HG21 ' A' ' 15' ' ' ILE . 45.6 t -126.55 158.74 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.938 . . . . 0.0 110.787 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.49 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.6 t -131.51 117.16 34.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.2 m120 -87.26 105.76 17.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.127 -0.983 . . . . 0.0 109.588 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.32 160.13 41.98 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.638 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 9.2 mmt 57.84 17.77 4.47 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.19 18.5 76.67 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -124.25 -156.06 0.7 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.716 0.77 . . . . 0.0 109.699 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.517 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.3 mt-30 -134.15 144.49 48.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.531 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 53.7 m95 -142.28 139.39 31.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.499 -1.375 . . . . 0.0 110.526 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.416 ' CD2' HG23 ' A' ' 15' ' ' ILE . 19.7 m80 -55.13 138.97 43.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 18' ' ' ARG . 6.7 t -58.63 -18.23 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 109.097 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.527 ' CD ' HH21 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -94.15 -21.37 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 110.189 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -99.51 -6.2 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 110.59 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.487 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.2 t80 -82.97 102.46 11.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.4 m -127.2 176.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 122.241 1.019 . . . . 0.0 111.266 -177.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.642 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -63.43 148.75 47.68 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.584 178.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.11 27.58 1.83 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.38 -0.825 . . . . 0.0 109.352 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 3.3 tttm -134.21 -42.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 109.96 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.9 p -121.49 -15.99 7.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.674 -0.641 . . . . 0.0 110.476 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.1 mt-10 72.68 47.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 110.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -100.72 109.85 58.91 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.2 Cg_endo -67.76 138.36 44.73 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.756 1.637 . . . . 0.0 111.874 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.545 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.4 m-85 -95.46 59.97 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.81 -55.55 1.94 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.63 29.56 3.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -117.08 165.61 13.18 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 109.814 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -79.64 153.98 28.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.406 -0.809 . . . . 0.0 109.281 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.8 p-80 -118.92 169.47 9.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.277 -0.89 . . . . 0.0 109.83 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.7 m-85 -134.68 137.92 43.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -110.64 149.82 29.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -0.928 . . . . 0.0 111.464 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.632 ' NE ' ' CD2' ' A' ' 63' ' ' PHE . 13.4 tpt180 -147.09 131.39 17.51 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.413 0.625 . . . . 0.0 110.192 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 42.39 24.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.696 0.76 . . . . 0.0 109.584 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.638 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.35 31.21 12.0 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.845 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ARG . 19.2 mt -140.34 139.77 35.47 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.565 -0.962 . . . . 0.0 108.961 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.83 152.6 33.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.83 0.824 . . . . 0.0 110.94 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.563 ' CE1' HD22 ' A' ' 62' ' ' LEU . 56.2 m-85 -154.8 139.03 16.59 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 13.0 m -59.38 174.02 0.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.638 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.5 tp10 -59.5 -31.58 69.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.878 -1.139 . . . . 0.0 109.537 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.6 m -86.26 -49.77 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 111.632 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' HD13 ' A' ' 62' ' ' LEU . 33.3 m170 -64.94 -41.14 95.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.877 -1.139 . . . . 0.0 108.407 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -53.3 -57.64 9.87 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.79 -44.94 91.85 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.119 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -54.88 -34.94 63.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.563 HD22 ' CE1' ' A' ' 54' ' ' TYR . 5.3 mp -77.35 -33.06 55.45 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.438 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.632 ' CD2' ' NE ' ' A' ' 49' ' ' ARG . 19.2 m-85 -160.14 -83.36 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.362 -0.836 . . . . 0.0 110.196 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.281 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.653 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 15' ' ' ILE . 6.0 Cg_endo -74.78 163.77 34.98 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.143 1.896 . . . . 0.0 109.044 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.0 mt -135.72 120.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 122.056 0.931 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.847 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.9 t -57.14 114.43 2.14 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.839 0.828 . . . . 0.0 109.899 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.535 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.84 -2.43 2.55 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.847 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.2 -59.79 2.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -1.08 . . . . 0.0 109.413 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.87 4.36 37.61 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.577 -0.702 . . . . 0.0 109.293 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.667 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.33 41.49 32.12 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.495 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -116.19 144.01 32.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.1 Cg_exo -56.81 113.17 1.34 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.332 1.355 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.628 HG21 HG22 ' A' ' 19' ' ' VAL . 22.1 mt -69.19 158.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.614 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.413 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -166.3 67.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 110.299 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.6 -73.31 0.07 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -138.48 133.59 32.9 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.628 HG22 HG21 ' A' ' 15' ' ' ILE . 41.2 t -114.02 151.62 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.896 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 32' ' ' PHE . 8.1 t -119.45 115.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.513 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.9 OUTLIER -88.57 106.16 18.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.047 -1.033 . . . . 0.0 109.583 -178.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.02 160.04 42.85 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.644 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.5 mmt 58.34 16.26 3.95 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.93 25.75 75.2 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.791 -2.123 . . . . 0.0 107.791 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -130.56 -154.56 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.931 0.872 . . . . 0.0 109.88 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.514 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.5 mt-30 -136.65 142.0 43.2 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.535 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.2 m95 -141.3 139.99 33.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.484 -1.385 . . . . 0.0 110.399 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -55.73 137.25 50.0 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.71 -17.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 120.848 -1.158 . . . . 0.0 109.044 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.31 -25.16 15.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.509 -0.744 . . . . 0.0 110.689 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -94.26 -8.52 38.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.804 -1.185 . . . . 0.0 110.364 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 20' ' ' VAL . 23.1 t80 -80.34 106.7 12.55 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' A' ' 40' ' ' PRO . 27.0 m -133.46 175.26 11.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.35 1.072 . . . . 0.0 111.184 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.03 148.58 47.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.385 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.3 28.84 1.56 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 109.608 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.9 tptt -139.8 -31.29 0.67 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.345 -0.847 . . . . 0.0 110.179 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 32.0 p -130.82 -8.92 3.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.121 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 33.2 mm-40 63.89 48.38 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 110.376 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -101.74 109.31 59.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.2 Cg_endo -68.6 138.65 42.32 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.81 1.673 . . . . 0.0 112.28 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.475 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.52 -55.59 1.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.307 -0.871 . . . . 0.0 109.494 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.429 ' H ' ' CD2' ' A' ' 44' ' ' HIS . . . -135.11 30.27 2.84 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.496 ' N ' ' CD2' ' A' ' 44' ' ' HIS . 2.5 m-70 -114.36 -158.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.394 -1.062 . . . . 0.0 109.97 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -114.88 145.99 41.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.548 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.4 p-80 -117.43 167.42 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 0.0 109.666 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.715 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.4 m-85 -131.22 137.43 48.92 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -105.89 148.88 27.1 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.226 -0.921 . . . . 0.0 111.51 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 54' ' ' TYR . 1.3 tmt_? -153.46 126.89 8.63 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.507 0.67 . . . . 0.0 109.991 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp 53.71 26.01 5.54 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.378 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.644 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 81.1 31.37 35.01 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 52' ' ' LEU . 22.3 mt -141.92 141.64 32.99 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.734 -0.862 . . . . 0.0 108.723 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.35 152.94 34.23 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.56 ' CE1' HD22 ' A' ' 62' ' ' LEU . 56.4 m-85 -153.71 140.05 18.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 99.0 m -56.85 178.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.36 -1.336 . . . . 0.0 108.473 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 62.5 tt0 -64.45 -36.47 84.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.2 m -86.59 -42.32 13.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 111.382 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.44 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.47 -43.42 81.07 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.794 -1.191 . . . . 0.0 108.207 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.4 t80 -52.85 -56.02 18.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 22.6 m-80 -63.76 -45.16 91.05 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.893 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' THR . 32.9 tt0 -53.38 -34.63 58.4 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.56 HD22 ' CE1' ' A' ' 54' ' ' TYR . 2.9 mp -79.29 -36.03 40.35 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.197 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -158.6 -84.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.128 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.493 2.454 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.516 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.33 163.57 36.05 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.055 1.836 . . . . 0.0 108.858 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.5 mt -135.13 120.25 29.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 122.028 0.918 . . . . 0.0 109.33 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.3 t -57.81 116.64 3.58 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.768 0.794 . . . . 0.0 110.036 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.529 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.22 -1.69 4.47 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.88 -56.33 3.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -1.071 . . . . 0.0 109.474 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -107.45 4.27 26.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.254 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 53.78 42.08 31.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.676 HH11 ' CG ' ' A' ' 13' ' ' ARG . 2.3 mtt-85 -116.4 144.09 32.42 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.7 Cg_exo -56.56 113.15 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.45 1.433 . . . . 0.0 110.472 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.656 HG21 HG22 ' A' ' 19' ' ' VAL . 23.8 mt -70.74 158.43 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -160.73 61.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 110.679 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.38 -101.8 0.15 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.11 40.43 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.656 HG22 HG21 ' A' ' 15' ' ' ILE . 44.0 t -98.16 157.94 3.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 111.149 -177.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.458 HG11 ' CD2' ' A' ' 32' ' ' PHE . 5.4 t -122.2 115.86 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.61 106.27 18.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 109.569 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.57 43.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.65 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.74 17.02 4.82 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.31 28.44 71.36 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -133.89 -154.41 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.919 0.866 . . . . 0.0 109.945 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.49 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.9 mt-30 -135.98 142.78 44.56 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.529 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.6 m95 -141.38 139.26 33.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.508 -1.37 . . . . 0.0 110.612 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -55.63 137.95 48.13 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 18' ' ' ARG . 10.5 t -57.24 -19.51 10.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.44 -18.53 20.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.41 -0.806 . . . . 0.0 110.63 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -100.67 -7.01 24.32 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.886 -1.133 . . . . 0.0 110.231 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.3 t80 -83.03 102.46 11.79 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' A' ' 40' ' ' PRO . 23.5 m -126.27 176.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.414 1.102 . . . . 0.0 111.266 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -66.47 149.41 50.47 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.656 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.34 24.96 3.15 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.6 tptp -132.63 -30.68 1.42 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.389 -0.819 . . . . 0.0 109.725 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.2 p -133.5 -10.18 2.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.375 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 65.55 48.24 2.05 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.321 -0.862 . . . . 0.0 110.399 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -101.11 110.4 61.14 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.6 Cg_endo -67.16 138.51 47.47 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.723 1.616 . . . . 0.0 111.81 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.9 m-85 -95.35 60.06 2.24 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.86 -55.38 1.99 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.484 -0.76 . . . . 0.0 109.257 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.98 30.8 2.79 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.446 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -117.31 167.08 11.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.484 -1.01 . . . . 0.0 109.912 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -82.37 151.86 26.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.0 109.151 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.586 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 15.3 p-80 -117.88 169.77 9.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 109.838 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.0 m-85 -133.85 136.67 44.55 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -111.03 140.24 45.73 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.321 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.707 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -146.68 137.66 24.1 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.485 0.659 . . . . 0.0 110.17 178.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt 51.9 22.19 1.69 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.002 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.65 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 80.25 31.04 39.36 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 52' ' ' LEU . 25.6 mt -140.27 143.68 36.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.71 151.67 34.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.73 0.776 . . . . 0.0 110.858 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.499 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 58.8 m-85 -153.12 137.13 16.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.6 m -57.22 174.67 0.18 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.369 -1.332 . . . . 0.0 108.276 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 64.9 tt0 -60.66 -34.85 74.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.202 -0.936 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.8 -43.64 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.63 -0.669 . . . . 0.0 111.638 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.454 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.2 m170 -67.43 -44.38 78.89 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.729 -1.232 . . . . 0.0 108.377 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -50.39 -54.98 17.73 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 49.2 m-80 -66.69 -45.72 77.91 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.061 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 57' ' ' THR . 3.9 tp-100 -53.49 -38.23 63.48 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.587 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.4 mp -71.07 -39.57 72.14 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.707 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.8 m-85 -154.74 -84.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.625 0.726 . . . . 0.0 109.967 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.1 t . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -78.39 164.42 26.43 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.664 2.243 . . . . 0.0 109.31 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.9 mt -135.52 123.17 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.866 0.841 . . . . 0.0 109.622 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.843 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 13.8 t -63.32 118.15 7.63 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.824 0.821 . . . . 0.0 109.884 -178.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.507 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.27 0.12 6.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.843 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.77 -36.23 18.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -1.096 . . . . 0.0 109.563 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.04 4.38 4.87 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.682 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.79 41.01 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -114.79 141.75 27.28 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.595 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.3 Cg_exo -56.76 114.39 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.41 1.407 . . . . 0.0 110.86 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.565 HD13 HG13 ' A' ' 19' ' ' VAL . 21.7 mt -71.96 159.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.424 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.3 pt-20 -160.73 61.92 0.31 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.746 -1.221 . . . . 0.0 110.964 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.66 -103.31 0.17 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.605 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.0 mtm180 -110.0 121.1 44.46 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 HD13 ' A' ' 15' ' ' ILE . 35.7 t -98.52 158.0 3.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.344 -0.847 . . . . 0.0 110.98 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 29' ' ' VAL . 5.6 t -120.81 112.94 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -88.98 106.61 18.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.181 -0.95 . . . . 0.0 109.801 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -143.51 158.96 43.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.641 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.6 mmt 58.74 14.52 3.22 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 72.74 21.52 79.62 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -125.08 -154.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.835 0.826 . . . . 0.0 109.749 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.495 ' HG2' HG11 ' A' ' 19' ' ' VAL . 24.4 mt-30 -135.0 145.11 47.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.507 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 66.0 m95 -142.6 135.66 28.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.672 -1.267 . . . . 0.0 110.181 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.438 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 19.0 m80 -53.55 135.61 39.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 18' ' ' ARG . 33.4 t -55.0 -21.24 7.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 120.918 -1.114 . . . . 0.0 109.548 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 6.5 pm0 -95.02 -20.02 19.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 110.679 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -97.34 -9.78 26.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.813 -1.179 . . . . 0.0 110.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.0 t80 -78.42 105.58 9.77 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.5 m -134.04 176.54 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.219 1.009 . . . . 0.0 111.032 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.513 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.4 t -62.63 148.01 47.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.22 32.03 1.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -140.25 -41.55 0.42 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.467 -0.77 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.5 p -119.3 -18.95 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.574 -0.704 . . . . 0.0 110.309 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.6 mt-10 75.51 48.04 0.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -100.84 106.97 47.13 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.3 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.801 1.667 . . . . 0.0 112.355 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.482 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.14 56.98 1.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.617 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.29 -55.57 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.04 31.27 2.72 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -115.23 -163.27 0.87 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -1.0 . . . . 0.0 109.984 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -111.09 145.52 38.42 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.559 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 35.1 p-80 -117.69 170.03 9.11 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.019 0.914 . . . . 0.0 109.88 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.5 m-85 -134.29 135.28 42.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -112.15 150.56 30.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.076 -1.015 . . . . 0.0 111.303 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.66 132.69 19.23 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.691 0.758 . . . . 0.0 110.378 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.0 mttm 50.34 20.65 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.558 -0.714 . . . . 0.0 109.422 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.641 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.31 30.96 12.43 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.332 -1.414 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 52' ' ' LEU . 17.8 mt -141.73 137.95 32.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -72.59 151.72 42.2 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.05 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.664 ' N ' ' O ' ' A' ' 47' ' ' TYR . 45.4 m-85 -153.46 139.47 18.24 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.9 m -56.8 -179.82 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.516 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.5 tt0 -65.32 -36.94 85.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.9 m -86.99 -42.52 13.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 0.0 111.475 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.468 ' O ' HD13 ' A' ' 62' ' ' LEU . 32.6 m170 -66.23 -43.74 85.78 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.209 . . . . 0.0 108.325 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.0 t80 -52.78 -56.73 13.54 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 48.4 m-80 -63.8 -44.51 93.11 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.196 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 57' ' ' THR . 11.8 tt0 -55.1 -34.28 63.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.591 HD22 ' CE1' ' A' ' 54' ' ' TYR . 4.9 mp -78.76 -35.01 45.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.383 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 19.2 m-85 -158.52 -81.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.107 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 5' ' ' VAL . 2.0 t . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.1 Cg_endo -80.19 164.66 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.796 2.33 . . . . 0.0 109.248 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.6 mt -135.8 123.03 34.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.831 0.825 . . . . 0.0 109.553 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.5 t -63.09 118.01 7.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.766 0.793 . . . . 0.0 109.929 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.501 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.12 0.2 6.52 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.1 -35.81 18.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -1.095 . . . . 0.0 109.618 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.51 4.4 4.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.87 41.33 32.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.659 HH11 ' CG ' ' A' ' 13' ' ' ARG . 2.0 mtt-85 -115.32 140.86 26.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.507 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.8 Cg_exo -55.27 114.01 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.444 1.43 . . . . 0.0 110.84 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 8' ' ' CYS . 22.4 mt -71.64 158.39 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -159.38 59.73 0.39 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.798 -1.189 . . . . 0.0 110.945 -178.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.57 -102.27 0.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.1 mtm180 -110.48 122.37 47.57 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.523 HG13 HD13 ' A' ' 15' ' ' ILE . 29.5 t -98.56 156.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 111.119 -177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' A' ' 32' ' ' PHE . 10.6 t -119.37 111.91 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.502 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.1 m-80 -87.02 106.51 17.89 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.42 43.3 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.61 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 58.26 16.39 3.96 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.98 28.69 70.1 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 21' ' ' ASN . 10.5 mttp -135.86 -154.45 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.807 0.813 . . . . 0.0 109.846 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.497 ' HG2' HG11 ' A' ' 19' ' ' VAL . 27.1 mt-30 -133.77 145.47 49.83 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.501 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.3 m95 -143.0 135.94 27.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.648 -1.283 . . . . 0.0 110.18 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.433 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 19.5 m80 -53.69 135.76 40.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 18' ' ' ARG . 15.9 t -54.6 -20.8 5.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.911 -1.118 . . . . 0.0 109.275 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.21 -22.76 18.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 110.674 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -96.5 -7.44 34.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.826 -1.171 . . . . 0.0 110.28 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.481 ' CD2' HG11 ' A' ' 20' ' ' VAL . 25.1 t80 -82.45 103.65 12.16 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.79 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.9 m -127.27 178.66 4.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.336 1.065 . . . . 0.0 111.057 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -69.31 148.75 49.29 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.883 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -89.9 25.55 2.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.7 tptt -135.83 -32.15 0.9 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.399 -0.813 . . . . 0.0 110.054 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.3 p -129.45 -7.6 4.69 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 110.164 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 59.1 42.61 18.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.222 -0.923 . . . . 0.0 109.483 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -99.07 108.47 49.71 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.79 ' CA ' HG12 ' A' ' 33' ' ' VAL . 2.6 Cg_endo -65.11 140.37 65.06 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.748 1.632 . . . . 0.0 112.343 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.7 m-85 -96.15 61.27 2.07 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 9.8 mp -40.32 -55.86 2.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 109.82 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.82 26.18 4.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -116.61 159.81 21.61 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.417 -1.049 . . . . 0.0 109.685 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.642 ' CB ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.08 159.21 30.0 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.509 ' HB3' ' CD2' ' A' ' 41' ' ' PHE . 8.9 p-80 -116.95 172.7 7.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.6 m-85 -136.02 128.71 30.83 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.46 150.72 23.6 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.95 0.881 . . . . 0.0 111.772 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.726 ' CZ ' ' HZ3' ' A' ' 50' ' ' LYS . 0.8 OUTLIER -143.82 134.16 24.58 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.394 0.616 . . . . 0.0 109.548 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.726 ' HZ3' ' CZ ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER 37.45 25.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.643 0.735 . . . . 0.0 109.973 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.61 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.42 30.95 9.29 Favored Glycine 0 N--CA 1.481 1.675 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.583 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.8 mt -142.17 140.26 32.33 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.335 -1.097 . . . . 0.0 108.728 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.86 150.75 39.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.899 0.856 . . . . 0.0 110.967 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' A' ' 62' ' ' LEU . 53.1 m-85 -154.04 137.22 15.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 93.2 m -56.16 178.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.393 -1.323 . . . . 0.0 108.696 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 39.7 tt0 -61.71 -39.33 91.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.371 -0.83 . . . . 0.0 109.782 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 61' ' ' GLN . 46.3 m -86.23 -40.9 15.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 111.804 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.45 -44.81 77.77 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.676 -1.265 . . . . 0.0 108.235 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.471 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.9 t80 -51.82 -55.85 17.46 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -64.03 -46.09 85.98 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 57' ' ' THR . 16.8 tt0 -53.23 -35.0 59.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.552 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 mp -77.51 -40.57 42.34 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.342 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.8 m-85 -152.78 -84.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.313 -0.867 . . . . 0.0 110.301 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.39 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.093 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 15' ' ' ILE . 3.9 Cg_endo -72.2 163.63 38.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.759 1.639 . . . . 0.0 108.404 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.534 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.0 mt -134.29 120.4 33.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 122.172 0.987 . . . . 0.0 109.361 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.841 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.2 t -58.5 117.03 4.06 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.815 0.817 . . . . 0.0 110.048 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.533 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.84 -1.39 4.99 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.841 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.01 -52.94 5.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -1.084 . . . . 0.0 109.395 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.45 4.66 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.582 -0.699 . . . . 0.0 109.169 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.38 42.46 32.02 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -116.75 143.23 31.02 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.602 ' HB3' HG11 ' A' ' 5' ' ' VAL . 2.7 Cg_exo -55.16 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.723 1.615 . . . . 0.0 110.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.626 HG21 HG22 ' A' ' 19' ' ' VAL . 27.1 mt -72.09 158.56 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.29 61.38 0.28 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.725 -1.234 . . . . 0.0 110.766 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.34 -102.42 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 29' ' ' VAL . 66.9 mtm180 -111.38 121.59 45.61 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 15' ' ' ILE . 40.3 t -100.26 159.02 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -0.8 . . . . 0.0 111.252 -177.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.465 ' N ' HG12 ' A' ' 19' ' ' VAL . 6.1 t -122.39 115.74 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.2 m-80 -89.92 106.35 18.41 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.097 -1.002 . . . . 0.0 109.694 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.77 159.43 43.2 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.79 16.83 4.74 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.87 73.41 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -131.71 -154.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.496 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.9 mt-30 -135.97 142.96 44.61 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.533 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.0 m95 -141.3 138.41 33.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.589 -1.319 . . . . 0.0 110.504 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.4 ' ND1' ' CB ' ' A' ' 8' ' ' CYS . 18.2 m80 -54.52 138.01 41.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' ARG . 8.4 t -57.26 -18.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 O-C-N 120.878 -1.139 . . . . 0.0 109.319 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -96.36 -22.29 17.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 110.667 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -96.1 -9.22 31.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.863 -1.148 . . . . 0.0 110.398 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.0 t80 -80.07 105.95 11.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.4 m -133.21 175.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.266 1.032 . . . . 0.0 111.12 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.56 149.05 44.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.086 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.57 24.51 3.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -134.19 -33.43 1.01 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.2 p -125.8 -19.74 4.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.8 mt-10 76.22 46.5 0.09 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.302 -0.874 . . . . 0.0 110.449 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -100.75 110.27 60.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.6 Cg_endo -68.79 138.06 40.02 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.726 1.618 . . . . 0.0 112.11 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.31 -55.36 1.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.31 29.44 3.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.86 -177.73 3.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -1.03 . . . . 0.0 109.963 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -97.05 145.63 25.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.744 . . . . 0.0 109.356 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.567 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -116.28 170.21 8.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.87 137.51 46.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -106.78 147.76 29.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.263 -0.898 . . . . 0.0 111.402 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.66 129.48 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.613 0.721 . . . . 0.0 110.208 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.626 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 51.0 mttp 51.82 23.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 30.8 24.26 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 52' ' ' LEU . 18.1 mt -142.77 143.21 32.11 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.623 -0.928 . . . . 0.0 108.844 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.54 152.86 35.87 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.43 -0.794 . . . . 0.0 110.797 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.537 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 58.7 m-85 -153.97 140.33 18.66 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 89.8 m -57.61 176.75 0.12 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.619 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 56.3 tt0 -63.33 -35.7 81.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.337 -0.852 . . . . 0.0 109.312 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 m -86.52 -43.64 12.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.345 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.591 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.6 m170 -66.8 -45.59 77.9 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.765 -1.209 . . . . 0.0 108.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.4 t80 -49.48 -55.85 11.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 42.7 m-80 -65.67 -45.82 81.47 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.073 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -54.93 -33.25 62.03 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 58' ' ' HIS . 0.9 OUTLIER -78.62 -35.28 45.79 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.138 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.626 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 16.8 m-85 -158.59 -80.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.005 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.395 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 1.9 t . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ILE . 10.1 Cg_endo -80.44 164.32 21.44 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.686 2.258 . . . . 0.0 109.862 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.557 ' H ' HE21 ' A' ' 26' ' ' GLN . 38.9 mt -135.08 120.15 28.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.995 0.902 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 38.3 t -62.68 116.09 4.88 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.826 0.822 . . . . 0.0 110.048 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.523 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -62.59 -3.54 5.72 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.28 -33.02 19.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.403 -1.057 . . . . 0.0 109.266 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 0.9 7.15 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 8' ' ' CYS . 21.1 mmm180 50.92 34.35 10.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -115.24 137.32 22.94 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 7' ' ' ILE . 7.1 Cg_exo -51.65 114.56 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.075 1.183 . . . . 0.0 111.056 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 HG22 ' A' ' 19' ' ' VAL . 11.5 mt -69.31 160.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 15' ' ' ILE . 4.4 pt-20 -169.25 69.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.264 . . . . 0.0 110.403 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.31 -59.06 0.24 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.5 133.13 30.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.775 HG22 HG21 ' A' ' 15' ' ' ILE . 46.5 t -127.03 157.92 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.084 -1.01 . . . . 0.0 110.74 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.488 ' N ' HG12 ' A' ' 19' ' ' VAL . 6.7 t -132.43 116.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.706 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.032 -1.042 . . . . 0.0 109.389 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . . . -144.34 157.63 44.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.409 -0.807 . . . . 0.0 108.985 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.678 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 58.02 19.36 5.87 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.95 13.72 72.69 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -118.95 -156.76 0.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.7 0.762 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.557 HE21 ' H ' ' A' ' 7' ' ' ILE . 1.9 mt-30 -133.61 144.67 49.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.523 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 50.0 m95 -142.23 140.73 32.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.58 -1.325 . . . . 0.0 110.411 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -54.43 141.93 28.95 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 20' ' ' VAL . 9.0 t -62.26 -18.4 20.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.684 -1.26 . . . . 0.0 109.496 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -20.45 20.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 110.438 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.43 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.9 m170 -101.86 -6.32 23.7 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.171 -0.955 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 20' ' ' VAL . 31.0 t80 -81.45 106.18 13.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.7 m -133.19 175.11 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.296 1.046 . . . . 0.0 111.508 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -63.03 149.47 44.93 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.298 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.59 26.6 2.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.103 -0.998 . . . . 0.0 109.848 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.9 tptp -135.44 -31.34 0.97 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.382 -0.824 . . . . 0.0 109.917 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.0 p -129.82 -16.39 3.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 72.75 47.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.15 109.69 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.8 Cg_endo -69.25 137.38 36.8 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.758 1.639 . . . . 0.0 112.031 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.05 57.93 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.22 -55.4 1.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.251 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.5 3.01 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.62 -174.81 2.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.396 -1.061 . . . . 0.0 109.939 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -98.71 147.37 24.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.59 -0.693 . . . . 0.0 109.363 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.589 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-80 -119.41 169.43 10.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 109.551 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.724 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -132.51 137.24 47.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.59 143.43 41.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.242 -0.911 . . . . 0.0 111.581 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.672 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -150.22 136.59 18.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.442 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 51.47 21.33 1.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.633 -0.667 . . . . 0.0 109.282 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.678 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.1 31.28 29.0 Favored Glycine 0 C--N 1.295 -1.709 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 52' ' ' LEU . 19.3 mt -142.27 142.13 32.54 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.71 -0.876 . . . . 0.0 108.84 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.28 152.63 36.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.415 -0.803 . . . . 0.0 110.671 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 55.2 m-85 -153.11 138.71 17.79 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 88.1 m -58.0 176.58 0.15 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.432 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.6 tp10 -63.46 -36.3 83.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.137 -0.977 . . . . 0.0 109.061 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' GLN . 32.6 m -85.73 -41.0 15.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 111.279 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.436 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -69.45 -45.35 69.28 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.723 -1.235 . . . . 0.0 108.207 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -51.17 -54.43 25.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 93.2 m-20 -65.55 -46.99 77.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.135 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' THR . 14.9 tt0 -52.31 -40.19 61.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.3 mp -68.93 -39.09 79.79 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.672 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.5 m-85 -155.34 -87.61 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.802 0.81 . . . . 0.0 110.001 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.532 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' ILE . 8.4 Cg_endo -79.21 164.2 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.65 2.233 . . . . 0.0 109.65 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 35.3 mt -134.86 119.69 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.035 0.921 . . . . 0.0 109.419 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.827 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 35.2 t -58.38 114.55 2.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.742 0.782 . . . . 0.0 109.828 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.545 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.63 -4.37 4.0 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.827 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.41 -59.47 2.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.397 -1.061 . . . . 0.0 109.393 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.29 -0.2 38.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.239 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 55.74 38.8 30.55 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.2 -0.937 . . . . 0.0 108.758 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.81 149.07 44.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.0 Cg_exo -58.63 113.69 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.3 1.334 . . . . 0.0 110.713 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.708 HG21 HG22 ' A' ' 19' ' ' VAL . 15.3 mt -68.54 159.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.1 pt-20 -168.62 69.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.894 -1.129 . . . . 0.0 110.271 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.44 -62.99 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.31 137.15 35.57 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.708 HG22 HG21 ' A' ' 15' ' ' ILE . 44.9 t -126.15 151.89 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.1 -1.0 . . . . 0.0 110.376 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 32' ' ' PHE . 7.9 t -123.48 116.35 48.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.67 105.43 17.67 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.093 -1.005 . . . . 0.0 109.703 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.41 160.22 41.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.558 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 13.1 mmt 57.5 14.71 2.39 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.1 13.78 79.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -115.24 -155.55 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.805 0.812 . . . . 0.0 109.678 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.514 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.7 mt-30 -136.28 141.94 43.91 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.545 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 51.4 m95 -141.29 139.37 33.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.554 -1.341 . . . . 0.0 110.204 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.416 ' CD2' HG23 ' A' ' 15' ' ' ILE . 18.4 m80 -54.8 140.58 35.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.31 -18.2 13.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.675 -1.265 . . . . 0.0 109.201 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -95.31 -24.8 16.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -94.08 -9.34 36.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.792 -1.193 . . . . 0.0 110.271 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.487 ' CD2' HG11 ' A' ' 20' ' ' VAL . 21.0 t80 -79.36 105.94 11.03 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.3 m -134.85 176.34 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.34 1.066 . . . . 0.0 111.209 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.508 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -63.63 148.22 49.5 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.282 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.43 28.63 1.91 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.438 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.8 -31.07 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.452 -0.78 . . . . 0.0 109.976 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.404 ' HB3' ' CE1' ' A' ' 58' ' ' HIS . 22.6 p -131.66 -15.18 3.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.271 -0.893 . . . . 0.0 110.379 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.2 48.18 0.26 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.361 -0.837 . . . . 0.0 110.551 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -102.74 109.21 60.55 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.1 Cg_endo -69.05 138.26 39.62 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.9 58.07 1.88 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.23 -55.62 1.65 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.76 31.8 2.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.501 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 1.1 m-70 -115.85 -163.82 0.92 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.515 -0.991 . . . . 0.0 110.1 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -109.94 147.07 34.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.543 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 29.0 p-80 -119.07 169.67 9.71 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.141 0.972 . . . . 0.0 109.889 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.724 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.4 m-85 -132.99 136.72 46.22 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.402 ' CD ' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -117.82 154.01 32.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.846 -1.159 . . . . 0.0 112.102 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -143.31 131.85 22.36 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.63 0.729 . . . . 0.0 109.727 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.4 ptpt 45.15 23.12 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.751 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 91.31 29.35 12.54 Favored Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.025 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 52' ' ' LEU . 16.6 mt -137.02 132.27 34.03 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.446 -1.032 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.81 0.814 . . . . 0.0 111.207 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' TYR . 50.6 m-85 -152.15 139.35 19.3 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.5 m -56.12 -179.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.693 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 5.9 tm-20 -66.67 -37.73 85.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.024 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 61' ' ' GLN . 38.2 m -86.83 -40.23 15.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.572 -0.705 . . . . 0.0 111.525 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.68 -44.38 74.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 108.272 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.443 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.0 t80 -51.19 -54.84 21.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.425 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 50.4 m-80 -65.42 -46.07 81.44 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.121 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.4 tp-100 -53.07 -36.89 61.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 2.4 mp -74.4 -32.35 62.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.654 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 22.4 m-85 -162.59 -86.5 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.832 0.825 . . . . 0.0 109.95 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 1.8 t . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.532 ' CG ' HG21 ' A' ' 19' ' ' VAL . 8.5 Cg_endo -80.35 164.6 21.52 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.738 2.292 . . . . 0.0 109.655 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.537 ' H ' HE21 ' A' ' 26' ' ' GLN . 34.0 mt -134.27 119.93 32.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.977 0.894 . . . . 0.0 109.35 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 36.9 t -63.79 121.19 13.39 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.844 0.831 . . . . 0.0 110.096 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -65.3 -3.83 14.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.78 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.0 -32.58 22.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -1.04 . . . . 0.0 109.353 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 1.42 5.49 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.658 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 50.71 34.46 9.99 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.68 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -113.64 138.85 22.79 Favored Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.4 Cg_exo -53.27 114.69 1.86 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.301 1.334 . . . . 0.0 111.311 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 HG22 ' A' ' 19' ' ' VAL . 13.7 mt -70.03 159.37 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.455 ' N ' HG22 ' A' ' 15' ' ' ILE . 1.9 pt-20 -161.33 63.57 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.818 -1.177 . . . . 0.0 110.365 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.33 -98.22 0.11 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 18' ' ' ARG . 3.4 mtt-85 -115.44 130.71 56.97 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.775 HG22 HG21 ' A' ' 15' ' ' ILE . 41.2 t -111.32 160.7 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.907 0.861 . . . . 0.0 111.472 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.493 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.4 t -127.13 116.82 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.422 ' N ' HD22 ' A' ' 21' ' ' ASN . 2.8 m120 -89.1 106.15 18.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.64 158.41 43.69 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.668 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.8 mmt 58.16 17.52 4.63 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.86 76.04 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -120.37 -155.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.791 0.805 . . . . 0.0 109.724 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.537 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.3 mt-30 -135.8 144.85 45.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 58.3 m95 -142.63 140.54 31.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.594 -1.316 . . . . 0.0 110.359 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -55.83 138.46 48.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.469 HG22 HG23 ' A' ' 20' ' ' VAL . 6.9 t -58.01 -19.05 11.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 120.746 -1.221 . . . . 0.0 109.164 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -96.27 -3.14 44.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 110.418 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.59 -10.39 11.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.026 -1.046 . . . . 0.0 110.145 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CG ' HG11 ' A' ' 20' ' ' VAL . 26.5 t80 -78.79 105.82 10.36 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.815 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.4 m -133.45 174.98 12.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.252 1.025 . . . . 0.0 111.215 -177.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -61.7 149.31 40.02 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.483 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.75 27.65 2.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 35.1 tptt -138.87 -32.06 0.7 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.251 -0.906 . . . . 0.0 110.197 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.8 p -128.27 -16.5 4.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.198 -0.939 . . . . 0.0 110.298 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 73.43 47.31 0.18 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.353 -0.842 . . . . 0.0 110.192 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.49 109.96 60.44 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.815 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.9 Cg_endo -69.3 137.17 36.14 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.889 1.726 . . . . 0.0 112.242 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.34 58.83 1.82 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.619 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.11 -55.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.917 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.59 31.53 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -113.43 -178.12 3.3 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -1.033 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.409 ' O ' ' CE1' ' A' ' 47' ' ' TYR . 5.5 tpp180 -98.83 129.51 45.22 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.2 p-80 -101.3 175.82 5.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.012 . . . . 0.0 110.147 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.673 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.7 m-85 -135.88 136.47 40.57 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -108.6 148.16 30.76 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.297 -0.877 . . . . 0.0 111.428 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.765 HH22 ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -153.03 127.57 9.35 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.467 0.651 . . . . 0.0 110.411 179.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' CB ' ' NZ ' ' A' ' 50' ' ' LYS . 8.3 mtmp? 54.45 23.88 4.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.668 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.55 31.7 26.68 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 52' ' ' LEU . 20.9 mt -143.76 141.9 30.66 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.663 -0.904 . . . . 0.0 108.926 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.81 153.16 33.06 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 110.651 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.705 ' CG ' ' NH2' ' A' ' 49' ' ' ARG . 59.6 m-85 -153.78 139.38 17.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 87.8 m -57.36 175.04 0.17 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.208 -1.397 . . . . 0.0 108.313 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -62.39 -34.59 77.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.042 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' GLN . 54.0 m -86.44 -44.09 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 111.155 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.564 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.2 m170 -67.25 -42.58 83.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.81 -1.156 . . . . 0.0 107.966 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.765 ' HA ' HH22 ' A' ' 49' ' ' ARG . 5.5 t80 -51.79 -55.63 18.65 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 49.9 m-80 -67.14 -43.99 80.97 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.425 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 57' ' ' THR . 34.9 tt0 -54.29 -37.82 65.19 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.565 HD22 ' NH2' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -75.58 -35.57 60.57 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.452 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.2 m-85 -155.03 -81.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 110.104 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.437 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.404 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.63 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.491 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.04 163.64 36.29 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.939 1.76 . . . . 0.0 108.916 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.22 120.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.116 0.96 . . . . 0.0 109.408 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.4 t -58.35 116.15 3.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.778 0.799 . . . . 0.0 109.987 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.542 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.2 -2.11 4.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.29 -53.05 5.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -1.072 . . . . 0.0 109.429 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.54 5.36 19.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.09 42.08 32.18 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -116.16 143.2 30.54 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HB3' HG11 ' A' ' 5' ' ' VAL . 4.9 Cg_exo -56.05 112.56 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.504 1.469 . . . . 0.0 110.252 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.6 HG21 HG22 ' A' ' 19' ' ' VAL . 22.7 mt -69.65 158.02 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.684 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.416 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.8 pt-20 -160.91 62.73 0.3 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.874 -1.141 . . . . 0.0 110.441 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.0 -98.73 0.12 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 125.18 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 15' ' ' ILE . 46.1 t -103.74 152.62 6.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.735 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' A' ' 32' ' ' PHE . 13.1 t -118.2 115.08 47.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.542 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -88.69 106.16 18.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 109.747 -178.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.95 160.03 42.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.679 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.2 mmt 58.12 16.44 3.86 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.6 20.66 77.38 Favored Glycine 0 C--N 1.291 -1.925 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -123.44 -153.97 0.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.974 0.892 . . . . 0.0 109.94 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.528 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.0 mt-30 -136.9 142.45 42.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.542 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 57.0 m95 -141.45 139.75 33.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.534 -1.354 . . . . 0.0 110.503 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -55.91 137.05 51.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 t -55.98 -19.33 6.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.822 -1.174 . . . . 0.0 109.119 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.456 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -94.08 -27.2 16.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.464 -0.772 . . . . 0.0 110.497 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -93.56 -7.08 45.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.08 . . . . 0.0 110.674 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.3 t80 -81.69 105.7 13.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.1 m -133.76 175.85 10.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 122.303 1.049 . . . . 0.0 111.249 -177.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.06 149.29 45.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.389 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.47 28.88 1.84 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.756 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 tptp -138.55 -31.68 0.73 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.416 -0.802 . . . . 0.0 110.057 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.6 p -129.43 -18.54 3.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.1 mt-10 75.26 47.28 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.308 -0.87 . . . . 0.0 110.064 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -100.98 107.67 50.84 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.9 Cg_endo -67.19 137.95 45.55 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.628 1.552 . . . . 0.0 112.179 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.15 58.46 1.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.01 -55.56 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 31.45 2.66 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.18 -176.29 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.418 -1.049 . . . . 0.0 110.224 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 47' ' ' TYR . 5.8 tpp180 -99.37 136.01 39.94 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -108.23 173.2 6.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.833 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.684 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -134.59 141.48 46.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -110.75 151.46 27.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.176 -0.952 . . . . 0.0 111.788 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.773 ' HE ' ' N ' ' A' ' 50' ' ' LYS . 1.4 tpm_? -156.07 129.41 8.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.349 0.595 . . . . 0.0 109.808 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.773 ' N ' ' HE ' ' A' ' 49' ' ' ARG . 8.6 mmtp 53.17 22.96 2.84 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.679 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.03 31.39 32.04 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 52' ' ' LEU . 20.6 mt -140.69 141.55 34.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.27 154.13 33.25 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.632 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 49' ' ' ARG . 53.1 m-85 -154.33 140.25 18.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.1 m -57.34 176.7 0.11 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.156 -1.418 . . . . 0.0 108.234 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -63.83 -35.46 80.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 109.462 179.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.3 m -86.23 -41.32 14.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 111.115 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -68.56 -43.96 75.47 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.729 -1.232 . . . . 0.0 107.863 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -53.28 -56.48 16.26 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 45.3 m-80 -63.69 -44.05 94.84 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.528 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.26 -37.05 69.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 ' CE1' ' A' ' 54' ' ' TYR . 3.4 mp -73.71 -32.58 63.97 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.35 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.6 m-85 -160.08 -83.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.971 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -78.77 156.19 28.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -1.134 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.6 mtt -49.8 167.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.0 109.46 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.3 46.87 0.2 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -155.25 130.77 5.36 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.314 -1.109 . . . . 0.0 109.372 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.527 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.25 163.61 36.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.958 1.772 . . . . 0.0 108.867 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.53 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.4 119.77 26.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 122.059 0.933 . . . . 0.0 109.402 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.0 t -58.35 117.0 3.98 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.844 0.831 . . . . 0.0 109.946 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -64.85 -0.17 4.91 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.67 -48.55 8.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -1.095 . . . . 0.0 109.36 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -116.11 4.8 13.7 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.649 HH11 ' HG3' ' A' ' 12' ' ' ARG . 8.2 mmm-85 53.52 41.32 32.11 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -115.91 143.45 30.83 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.7 Cg_exo -56.46 113.38 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.46 1.44 . . . . 0.0 110.546 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.661 HG21 HG22 ' A' ' 19' ' ' VAL . 21.5 mt -70.92 158.45 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.2 pt-20 -160.54 61.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.863 -1.148 . . . . 0.0 110.662 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.01 -101.95 0.15 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.673 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.66 42.32 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 15' ' ' ILE . 42.8 t -98.8 158.67 3.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 121.668 0.746 . . . . 0.0 111.195 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 32' ' ' PHE . 4.9 t -122.56 116.01 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.608 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -89.85 106.09 18.24 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.11 -0.993 . . . . 0.0 109.553 -179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.53 42.63 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.9 mmt 58.09 17.19 4.31 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.2 25.28 75.85 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 mttm -130.23 -154.8 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.741 0.781 . . . . 0.0 109.764 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.483 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.8 mt-30 -135.38 143.49 46.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.3 m95 -141.59 139.98 33.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.534 -1.354 . . . . 0.0 110.616 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.466 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.3 m80 -56.48 131.95 49.98 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 18' ' ' ARG . 7.7 t -53.22 -14.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.871 -1.143 . . . . 0.0 108.348 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 28' ' ' HIS . 12.5 tp10 -95.78 -26.97 15.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.814 -0.554 . . . . 0.0 110.62 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -98.13 -6.52 31.38 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.883 -1.136 . . . . 0.0 110.826 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 20' ' ' VAL . 25.2 t80 -80.2 106.28 12.1 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.825 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.6 m -133.57 175.3 11.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.262 1.03 . . . . 0.0 111.158 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.518 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.82 148.68 46.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.318 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.83 28.69 1.73 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.177 -0.952 . . . . 0.0 109.727 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 13.4 tptm -138.81 -31.69 0.71 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.364 -0.835 . . . . 0.0 110.077 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.6 p -129.1 -15.39 4.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.305 -0.872 . . . . 0.0 110.153 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 71.7 47.6 0.34 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.326 -0.859 . . . . 0.0 110.191 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.46 109.56 59.33 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.825 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.4 Cg_endo -69.06 138.28 39.65 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.713 1.609 . . . . 0.0 112.112 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.626 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.23 1.63 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.26 -0.9 . . . . 0.0 108.996 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.18 31.01 2.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.936 -1.665 . . . . 0.0 108.936 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -116.29 178.94 4.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.504 -0.998 . . . . 0.0 109.94 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -94.43 145.34 24.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.483 -0.761 . . . . 0.0 109.352 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.56 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.2 p-80 -116.3 169.47 9.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.351 -0.843 . . . . 0.0 109.556 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.55 137.67 47.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -107.02 148.28 28.9 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.232 -0.917 . . . . 0.0 111.201 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.34 11.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.628 0.727 . . . . 0.0 110.333 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.3 mttm 51.23 22.86 1.45 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.586 -0.696 . . . . 0.0 109.495 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.628 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.47 30.97 20.36 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.427 -1.368 . . . . 0.0 109.724 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 52' ' ' LEU . 18.6 mt -143.29 142.74 31.44 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.535 -0.979 . . . . 0.0 108.814 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.35 152.86 36.21 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.388 -0.82 . . . . 0.0 110.73 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' A' ' 62' ' ' LEU . 57.7 m-85 -153.91 140.27 18.65 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 90.7 m -57.55 177.47 0.1 Allowed 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.316 -1.353 . . . . 0.0 108.454 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 53.1 tt0 -63.63 -35.98 82.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.383 -0.823 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.4 m -86.66 -43.75 12.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.503 -0.748 . . . . 0.0 111.339 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.459 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -66.65 -43.77 83.68 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.79 -1.194 . . . . 0.0 108.141 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.2 t80 -51.74 -56.43 13.87 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.42 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 44.0 m-80 -64.52 -44.89 89.47 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.093 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.5 tp60 -54.44 -34.37 61.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.55 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.8 mp -78.68 -35.24 45.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.359 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 18.0 m-85 -158.58 -81.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 110.075 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 87.41 31.39 16.49 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' OH ' ' A' ' 59' ' ' TYR . 26.2 m-20 48.5 51.27 15.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -1.117 . . . . 0.0 109.566 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.482 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 t -50.09 158.9 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -1.123 . . . . 0.0 109.463 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 tpt -61.09 -9.18 4.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . 144.26 -72.09 0.36 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.0 t 57.16 117.7 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.436 -1.038 . . . . 0.0 109.944 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.9 Cg_endo -79.6 164.3 23.57 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.673 2.249 . . . . 0.0 109.327 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.6 mt -135.31 122.83 36.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.873 0.844 . . . . 0.0 109.506 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.841 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.1 t -61.13 116.83 4.86 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.818 0.818 . . . . 0.0 109.964 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.549 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.42 -1.13 4.11 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.841 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.46 -54.22 4.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.247 -1.149 . . . . 0.0 109.524 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.33 1.97 18.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.559 -0.713 . . . . 0.0 109.148 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 57.56 41.86 25.1 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.22 -0.925 . . . . 0.0 108.57 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -116.68 142.76 30.16 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.6 Cg_exo -55.69 113.97 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.432 1.422 . . . . 0.0 110.948 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 8' ' ' CYS . 23.9 mt -71.89 158.77 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.0 pt-20 -161.77 62.84 0.25 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.868 -1.145 . . . . 0.0 110.484 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.49 -100.37 0.13 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 29' ' ' VAL . 62.6 mtm180 -113.33 120.49 41.32 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.517 HG13 HD13 ' A' ' 15' ' ' ILE . 30.6 t -97.01 154.51 3.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.328 -0.857 . . . . 0.0 111.065 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.7 t -118.84 112.61 38.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.432 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.6 m-80 -86.98 106.81 18.08 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.222 -0.924 . . . . 0.0 109.656 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.67 42.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.5 mmt 58.38 16.01 3.83 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 27.5 71.71 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -133.05 -151.11 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.042 0.925 . . . . 0.0 110.089 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.502 ' HG2' HG11 ' A' ' 19' ' ' VAL . 26.4 mt-30 -136.82 144.53 43.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.549 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 64.4 m95 -142.51 135.44 28.35 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.605 -1.31 . . . . 0.0 110.368 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 17.7 m80 -53.77 135.52 41.35 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 18' ' ' ARG . 10.3 t -55.54 -18.18 4.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 120.935 -1.103 . . . . 0.0 109.053 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -94.39 -25.9 16.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.438 -0.789 . . . . 0.0 110.573 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.5 m170 -98.01 -5.03 34.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 111.028 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' A' ' 20' ' ' VAL . 28.5 t80 -82.72 106.03 14.23 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.833 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.2 m -133.01 174.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 122.314 1.054 . . . . 0.0 111.294 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.89 148.28 40.12 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.117 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.46 35.11 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.39 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -142.99 -40.23 0.32 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.8 p -122.41 -17.34 7.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.642 -0.661 . . . . 0.0 110.256 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.8 mt-10 75.1 47.89 0.1 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.303 -0.873 . . . . 0.0 110.244 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -100.42 109.59 57.49 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.833 ' CA ' HG12 ' A' ' 33' ' ' VAL . 6.1 Cg_endo -69.89 137.73 35.77 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.863 1.709 . . . . 0.0 112.15 -177.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.21 57.82 1.76 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.62 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.11 -55.51 1.61 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -0.905 . . . . 0.0 109.279 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 29.79 2.96 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -114.68 -174.31 2.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.483 -1.01 . . . . 0.0 109.918 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -99.56 146.85 25.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.596 -0.69 . . . . 0.0 109.321 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.583 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.8 p-80 -118.32 169.12 10.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.331 -0.855 . . . . 0.0 109.603 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.715 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -133.15 138.05 46.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -107.56 149.73 27.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 111.394 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.97 129.62 11.54 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.588 0.708 . . . . 0.0 110.259 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp 50.89 22.41 1.17 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.74 . . . . 0.0 109.376 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 86.75 30.77 20.15 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 52' ' ' LEU . 19.6 mt -141.99 142.26 32.93 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.59 -0.947 . . . . 0.0 108.77 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.47 153.15 35.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.29 -0.882 . . . . 0.0 110.954 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.627 ' CE1' HD22 ' A' ' 62' ' ' LEU . 48.7 m-85 -154.68 139.45 17.11 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 73.7 m -57.28 175.8 0.14 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.265 -1.374 . . . . 0.0 108.063 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.697 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.8 tp10 -61.98 -34.92 77.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.052 -1.03 . . . . 0.0 109.285 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 61' ' ' GLN . 70.2 m -86.25 -45.1 11.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.37 -0.831 . . . . 0.0 111.251 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.563 ' O ' HD13 ' A' ' 62' ' ' LEU . 31.9 m170 -65.37 -42.76 92.38 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.792 -1.192 . . . . 0.0 108.358 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -54.34 -57.56 10.8 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 96.6 m-20 -62.72 -44.65 95.67 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.282 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' THR . 8.3 tp60 -55.52 -34.43 64.65 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.627 HD22 ' CE1' ' A' ' 54' ' ' TYR . 6.1 mp -78.77 -34.21 45.81 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.673 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 17.3 m-85 -158.49 -81.54 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.82 31.58 43.68 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 55.92 80.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -1.089 . . . . 0.0 109.397 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.476 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.506 ' H2 ' ' CE ' ' A' ' 3' ' ' MET . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -79.47 51.55 1.25 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.106 . . . . 0.0 109.458 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.506 ' CE ' ' H2 ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER -163.93 -167.53 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.454 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.495 ' O ' ' SD ' ' A' ' 3' ' ' MET . . . -79.35 -161.3 21.47 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.463 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t -153.77 117.79 2.71 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.24 -1.153 . . . . 0.0 109.825 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.7 Cg_endo -79.96 164.49 22.56 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.757 2.305 . . . . 0.0 109.526 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.535 ' H ' HE21 ' A' ' 26' ' ' GLN . 35.1 mt -133.94 119.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-O 122.126 0.965 . . . . 0.0 109.327 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 36.2 t -61.33 116.24 4.48 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.796 0.807 . . . . 0.0 109.897 -178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.54 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -59.83 -4.52 3.26 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.801 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.37 -51.58 6.85 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.406 -1.055 . . . . 0.0 109.289 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.428 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -107.56 2.98 24.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.521 -0.737 . . . . 0.0 109.269 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' CYS . 19.3 mmm180 50.02 34.83 8.69 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.66 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -113.85 138.62 22.82 Favored Pre-proline 0 N--CA 1.486 1.345 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -178.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 7' ' ' ILE . 3.7 Cg_exo -53.64 114.82 1.94 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.268 1.312 . . . . 0.0 110.943 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.729 HG21 HG22 ' A' ' 19' ' ' VAL . 14.0 mt -68.98 158.61 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' O ' ' CD ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -159.59 62.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.913 -1.117 . . . . 0.0 110.451 -178.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.54 -96.46 0.1 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -112.38 142.48 44.85 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.729 HG22 HG21 ' A' ' 15' ' ' ILE . 43.7 t -122.65 156.77 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 0.0 110.744 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.5 t -125.17 116.84 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.627 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.2 m120 -88.46 105.85 17.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.077 -1.014 . . . . 0.0 109.497 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.45 159.99 41.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.661 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 57.52 16.96 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.72 20.43 78.61 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -125.38 -155.37 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.742 0.782 . . . . 0.0 109.783 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.535 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.3 mt-30 -134.53 143.99 47.74 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.54 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.4 m95 -142.14 139.47 32.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.616 -1.303 . . . . 0.0 110.26 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.422 ' NE2' ' HA ' ' A' ' 15' ' ' ILE . 19.6 m80 -54.68 138.65 41.14 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 t -57.41 -16.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 O-C-N 120.795 -1.191 . . . . 0.0 108.987 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -96.52 -25.82 15.5 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.47 -0.769 . . . . 0.0 110.54 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -93.21 -9.94 37.47 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.916 -1.115 . . . . 0.0 110.451 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' CD2' HG11 ' A' ' 20' ' ' VAL . 22.4 t80 -79.61 105.82 11.19 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.811 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.9 m -133.97 175.26 11.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 122.246 1.022 . . . . 0.0 110.959 -177.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -64.13 148.53 49.71 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.268 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.0 28.12 1.66 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 109.561 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.9 tptm -138.7 -32.03 0.71 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.333 -0.854 . . . . 0.0 110.223 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.7 p -129.3 -11.27 4.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.343 -0.848 . . . . 0.0 110.205 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 65.01 47.25 2.58 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.472 -0.768 . . . . 0.0 110.491 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.603 ' NZ ' ' SG ' ' A' ' 55' ' ' CYS . 0.0 OUTLIER -101.99 107.49 52.67 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.811 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.4 Cg_endo -66.0 139.48 56.48 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 121.678 1.585 . . . . 0.0 112.304 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.78 56.44 1.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.628 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.14 -55.31 1.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.184 -0.947 . . . . 0.0 109.067 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.1 30.58 2.92 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.431 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.7 OUTLIER -117.7 176.61 5.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.56 -0.965 . . . . 0.0 109.905 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.57 150.43 21.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.438 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.571 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.6 p-80 -119.4 170.66 8.94 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.4 m-85 -138.17 129.42 27.46 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.478 ' OE2' ' CE ' ' A' ' 23' ' ' MET . 1.3 mm-40 -100.07 153.59 19.1 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.232 -0.917 . . . . 0.0 111.702 -177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.518 ' NH2' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -153.35 127.05 8.79 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.558 0.694 . . . . 0.0 109.877 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt 52.59 23.8 2.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.651 -0.656 . . . . 0.0 109.59 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.661 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 31.09 23.5 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 119.076 -1.535 . . . . 0.0 109.36 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.518 HD12 ' NH2' ' A' ' 49' ' ' ARG . 19.4 mt -142.66 139.95 31.4 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.603 -0.94 . . . . 0.0 108.666 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.3 151.92 39.74 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.163 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 47' ' ' TYR . 55.0 m-85 -154.37 139.45 17.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.603 ' SG ' ' NZ ' ' A' ' 39' ' ' LYS . 89.3 m -57.81 178.15 0.09 Allowed 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.411 -1.316 . . . . 0.0 108.792 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.2 tt0 -62.31 -37.82 87.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.619 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 61' ' ' GLN . 52.4 m -86.92 -43.08 12.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 111.66 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.451 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -65.81 -43.61 88.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.722 -1.236 . . . . 0.0 108.134 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.8 t80 -51.94 -56.5 13.81 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -64.22 -44.9 90.47 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.08 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.5 tp-100 -54.38 -34.84 62.01 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.561 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.8 mp -78.12 -33.28 50.61 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.512 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 21.2 m-85 -160.13 -81.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 110.125 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.26 26.07 55.83 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -172.55 25.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -1.084 . . . . 0.0 109.493 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.453 HG12 ' OH ' ' A' ' 59' ' ' TYR . 11.2 p . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.473 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.7 p -166.43 43.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -1.145 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 39.5 tpp 50.62 -128.48 2.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.425 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -176.73 -46.78 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.627 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t 57.13 129.27 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.548 -0.972 . . . . 0.0 109.888 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' ILE . 5.5 Cg_endo -74.83 163.58 35.3 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.909 1.739 . . . . 0.0 108.901 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.1 mt -134.48 119.95 31.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.012 0.911 . . . . 0.0 109.365 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.813 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.1 t -60.27 119.6 8.22 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.731 0.777 . . . . 0.0 110.119 -178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.509 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.84 0.09 11.82 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.813 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.59 -38.36 18.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -1.113 . . . . 0.0 109.392 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.64 5.04 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 54.19 41.48 31.98 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -115.54 142.54 28.99 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.627 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.5 Cg_exo -56.27 112.94 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.562 1.508 . . . . 0.0 110.729 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.694 HG21 HG22 ' A' ' 19' ' ' VAL . 20.7 mt -70.45 158.68 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.418 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.2 pt-20 -159.19 62.12 0.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.691 -1.256 . . . . 0.0 110.854 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 179.67 -100.97 0.15 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' HB3' HG21 ' A' ' 29' ' ' VAL . 37.5 mtt180 -107.82 134.35 50.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.694 HG22 HG21 ' A' ' 15' ' ' ILE . 46.2 t -115.77 158.06 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.091 -1.006 . . . . 0.0 110.731 -177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.454 HG11 ' CD2' ' A' ' 32' ' ' PHE . 3.7 t -122.9 117.32 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.655 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.9 OUTLIER -90.03 105.97 18.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.176 -0.953 . . . . 0.0 109.472 -179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.29 159.76 42.15 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.624 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.1 mmt 58.1 18.14 5.02 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.07 75.75 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -130.32 -154.67 0.65 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.717 0.77 . . . . 0.0 109.797 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.513 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.6 mt-30 -134.82 145.1 48.02 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.509 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.6 m95 -142.05 139.15 32.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.544 -1.347 . . . . 0.0 110.788 -177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 18.3 m80 -55.22 132.79 48.51 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 18' ' ' ARG . 77.0 t -52.39 -22.58 3.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 120.835 -1.165 . . . . 0.0 109.29 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -91.85 -23.74 19.57 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 110.734 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -96.91 -6.58 35.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.859 -1.151 . . . . 0.0 111.029 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.454 ' CD2' HG11 ' A' ' 20' ' ' VAL . 29.1 t80 -81.67 103.2 11.2 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.819 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.1 m -128.96 178.45 5.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 122.321 1.058 . . . . 0.0 111.254 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.636 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.1 t -65.61 148.4 51.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.702 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.8 28.19 1.87 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.486 -0.759 . . . . 0.0 109.197 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 6.3 tmtt? -134.1 -39.07 0.86 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.571 -0.706 . . . . 0.0 109.74 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.434 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.6 p -126.31 -16.17 5.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.558 -0.714 . . . . 0.0 110.553 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.0 mt-10 73.7 46.94 0.18 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -100.76 110.21 60.02 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.819 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.1 Cg_endo -68.46 136.97 38.24 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.718 1.612 . . . . 0.0 111.754 -177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.571 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.4 m-85 -95.98 60.1 2.04 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.637 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.3 mp -40.04 -56.02 1.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.44 -0.788 . . . . 0.0 109.476 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.67 26.16 4.35 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -114.56 159.98 19.79 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.396 -1.061 . . . . 0.0 109.822 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -75.72 154.77 36.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.452 -0.78 . . . . 0.0 109.162 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.608 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.6 p-80 -118.08 170.52 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.273 -0.892 . . . . 0.0 110.017 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -135.87 137.36 41.38 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -111.65 145.27 39.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.204 -0.935 . . . . 0.0 111.387 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.558 ' NH1' ' HG3' ' A' ' 49' ' ' ARG . 11.1 ttm-85 -144.92 137.91 26.54 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.53 0.681 . . . . 0.0 110.12 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt 44.73 20.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.702 0.763 . . . . 0.0 109.166 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.624 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 87.18 30.71 19.07 Favored Glycine 0 C--N 1.296 -1.673 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ARG . 20.1 mt -138.9 143.03 38.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.678 -0.895 . . . . 0.0 108.85 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.96 151.76 33.49 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.828 0.823 . . . . 0.0 111.25 -178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.562 ' CE1' HD22 ' A' ' 62' ' ' LEU . 53.4 m-85 -153.54 135.89 14.97 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 14.5 m -56.57 172.03 0.27 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.101 -1.439 . . . . 0.0 108.141 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 68.3 tt0 -57.28 -32.35 66.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.045 -1.034 . . . . 0.0 109.745 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 93.7 m -87.15 -47.88 8.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.379 -0.826 . . . . 0.0 111.818 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.594 ' O ' HD13 ' A' ' 62' ' ' LEU . 29.1 m170 -64.67 -40.88 96.19 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.756 -1.215 . . . . 0.0 108.605 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.529 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -55.13 -57.49 11.55 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.441 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 42.8 m-80 -63.03 -44.1 96.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.065 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.72 -35.96 64.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.598 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 6.6 mp -76.1 -37.25 58.35 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.7 m-85 -156.11 -83.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.722 0.773 . . . . 0.0 109.804 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.441 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 90.31 31.61 10.46 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.5 t70 56.38 81.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -1.104 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.563 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' MET . 15.4 m -165.9 -120.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 0.0 109.4 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 3' ' ' MET . 0.0 OUTLIER 51.63 98.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.498 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -109.51 17.35 30.99 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.0 t 56.67 116.19 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.603 -0.939 . . . . 0.0 110.086 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -79.9 164.68 22.59 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.733 2.289 . . . . 0.0 109.349 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.528 ' H ' HE21 ' A' ' 26' ' ' GLN . 25.8 mt -134.97 120.45 30.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-O 121.945 0.878 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 20.8 t -62.16 121.27 12.67 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.877 0.846 . . . . 0.0 110.077 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.514 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -67.39 -1.48 15.24 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.79 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.35 -35.31 21.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.313 -1.11 . . . . 0.0 109.68 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -130.49 0.25 4.48 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.677 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 56.83 38.56 29.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -178.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.629 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -111.01 138.3 21.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.9 Cg_exo -55.1 113.46 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.113 1.209 . . . . 0.0 110.613 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.627 HG21 HG22 ' A' ' 19' ' ' VAL . 19.9 mt -70.62 158.97 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -161.26 62.41 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.897 -1.127 . . . . 0.0 110.616 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.82 -101.87 0.15 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -111.48 126.39 54.91 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.627 HG22 HG21 ' A' ' 15' ' ' ILE . 42.0 t -105.15 158.68 5.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 111.204 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.9 t -122.36 115.65 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 178.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.577 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -90.49 106.55 18.57 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 109.905 -178.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.97 160.16 41.78 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.62 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.5 mmt 58.31 14.46 2.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.32 18.21 79.2 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.801 -2.12 . . . . 0.0 107.801 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -120.21 -154.83 0.6 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.007 0.908 . . . . 0.0 109.827 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.528 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.8 mt-30 -136.6 143.56 43.64 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.514 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.4 m95 -141.66 138.88 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.513 -1.367 . . . . 0.0 110.566 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 19.6 m80 -55.46 134.73 50.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.419 HG22 HG23 ' A' ' 20' ' ' VAL . 17.1 t -54.37 -20.43 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 120.809 -1.182 . . . . 0.0 109.08 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -92.03 -27.89 17.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.419 -0.801 . . . . 0.0 110.536 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -93.81 -7.35 43.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.031 -1.043 . . . . 0.0 110.885 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.0 t80 -81.25 105.86 12.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.809 HG12 ' CA ' ' A' ' 40' ' ' PRO . 23.2 m -133.89 174.99 12.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 122.326 1.06 . . . . 0.0 111.195 -177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.7 t -64.03 148.41 49.8 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.059 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.71 27.81 1.68 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.702 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.412 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.2 tptp -138.09 -33.21 0.7 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.327 -0.858 . . . . 0.0 110.105 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 27.1 p -126.89 -11.23 6.02 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.261 -0.9 . . . . 0.0 110.209 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 65.08 46.87 2.64 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.244 -0.91 . . . . 0.0 109.693 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -102.56 107.02 52.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.809 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.5 Cg_endo -66.45 139.75 55.18 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.816 1.677 . . . . 0.0 112.358 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.493 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -96.08 56.35 1.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.03 -55.18 1.62 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.221 -0.924 . . . . 0.0 109.036 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.57 30.39 2.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.428 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -116.47 178.99 4.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.96 . . . . 0.0 109.958 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -95.79 147.19 23.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.432 -0.792 . . . . 0.0 109.293 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.531 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 33.6 p-80 -117.73 168.94 9.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.256 -0.902 . . . . 0.0 109.778 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.718 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.0 m-85 -133.66 133.16 41.56 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' O ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -111.01 155.43 22.74 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.075 -1.016 . . . . 0.0 111.639 -177.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -145.47 135.77 23.99 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.55 0.691 . . . . 0.0 110.064 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.2 ptmt 42.33 21.66 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.467 0.651 . . . . 0.0 109.757 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.62 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.92 30.62 9.28 Favored Glycine 0 N--CA 1.481 1.69 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.191 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.0 mt -140.53 136.83 33.28 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.491 -1.005 . . . . 0.0 108.379 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.46 150.18 45.15 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.858 0.837 . . . . 0.0 111.11 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.671 ' N ' ' O ' ' A' ' 47' ' ' TYR . 47.4 m-85 -153.14 139.3 18.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 54.1 m -56.51 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.831 -1.168 . . . . 0.0 108.857 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 75.2 tt0 -68.65 -40.46 80.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.352 -0.843 . . . . 0.0 109.538 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.2 m -86.25 -37.57 18.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 111.292 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.452 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.56 -46.77 68.55 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.798 -1.189 . . . . 0.0 108.224 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -52.36 -55.94 18.22 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 93.2 m-20 -62.49 -46.26 89.26 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.51 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -54.68 -38.15 66.64 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.557 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -72.1 -39.69 68.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.319 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -153.79 -83.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.28 -10.18 29.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 170.27 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.483 -1.01 . . . . 0.0 109.397 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.425 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p -63.76 160.63 16.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -1.139 . . . . 0.0 109.45 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.3 ttt -164.36 40.31 0.08 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.361 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 48.33 -170.54 0.07 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.622 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -155.28 130.79 5.36 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.156 . . . . 0.0 109.483 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.53 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.4 Cg_endo -74.36 163.65 35.82 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.911 1.74 . . . . 0.0 109.002 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 14' ' ' PRO . 28.1 mt -135.14 119.75 27.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.992 0.901 . . . . 0.0 109.206 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.816 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.2 t -57.85 118.8 5.71 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.888 0.852 . . . . 0.0 110.073 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.528 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.57 -2.01 5.37 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.816 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.56 -60.9 1.89 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.382 -1.069 . . . . 0.0 109.336 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -99.25 -7.3 26.62 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.501 -0.749 . . . . 0.0 109.163 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.473 ' O ' ' CZ ' ' A' ' 13' ' ' ARG . 23.6 mmm180 63.51 37.81 10.25 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.473 ' CZ ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -112.87 144.07 30.31 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.622 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.5 Cg_exo -56.07 113.25 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.466 1.444 . . . . 0.0 110.383 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.669 HG21 HG22 ' A' ' 19' ' ' VAL . 22.9 mt -70.52 158.73 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.1 pt-20 -160.45 61.25 0.33 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.835 -1.165 . . . . 0.0 110.694 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.33 -102.48 0.16 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.69 -2.164 . . . . 0.0 107.69 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 29' ' ' VAL . 69.4 mtm180 -112.82 121.37 44.5 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.669 HG22 HG21 ' A' ' 15' ' ' ILE . 40.8 t -99.45 159.39 3.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.394 -0.816 . . . . 0.0 111.285 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.47 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.8 t -123.56 116.44 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.86 106.17 18.29 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.147 -0.971 . . . . 0.0 109.529 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.17 160.02 42.1 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.437 -0.789 . . . . 0.0 108.944 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.626 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.07 16.8 4.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 25.41 75.8 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.094 -2.003 . . . . 0.0 108.094 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.72 -154.78 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.812 0.815 . . . . 0.0 109.816 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.488 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.0 mt-30 -135.29 143.7 46.36 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.528 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.5 m95 -141.6 140.93 33.46 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.479 -1.388 . . . . 0.0 110.644 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.475 ' C ' ' N ' ' A' ' 30' ' ' GLU . 18.0 m80 -57.41 131.91 51.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 20' ' ' VAL . 7.7 t -52.58 -14.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 120.87 -1.144 . . . . 0.0 108.402 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 28' ' ' HIS . 11.2 tp10 -95.93 -27.11 15.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.761 -0.587 . . . . 0.0 110.501 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -97.14 -6.63 34.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.93 -1.106 . . . . 0.0 110.771 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.3 t80 -80.76 106.09 12.49 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.4 m -132.67 176.38 9.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 122.314 1.054 . . . . 0.0 111.19 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.6 t -65.36 148.75 51.17 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.454 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -90.49 25.53 2.25 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.288 -0.883 . . . . 0.0 109.78 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.6 tptp -135.43 -32.75 0.91 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.326 -0.859 . . . . 0.0 110.22 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 28.0 p -128.66 -12.47 4.87 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.277 -0.889 . . . . 0.0 110.362 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 67.9 47.2 1.13 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.228 -0.92 . . . . 0.0 109.966 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -101.17 107.47 50.44 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.3 Cg_endo -66.81 138.46 48.82 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.624 1.549 . . . . 0.0 112.118 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -95.72 56.81 1.8 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.632 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.12 -55.32 1.64 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.166 -0.959 . . . . 0.0 109.015 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.18 29.61 3.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.432 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -116.98 175.39 5.61 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.574 -0.957 . . . . 0.0 109.801 -179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.709 ' HG2' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -89.32 150.61 22.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.497 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.572 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.3 p-80 -119.5 169.8 9.72 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.695 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.5 m-85 -136.82 132.78 35.12 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.95 150.84 24.57 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.214 -0.928 . . . . 0.0 111.892 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.535 ' NH2' ' OH ' ' A' ' 54' ' ' TYR . 10.0 ttp180 -146.19 134.23 21.5 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.101 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HZ3' ' HB2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER 42.04 21.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.569 0.7 . . . . 0.0 109.615 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.626 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 93.08 30.69 9.1 Favored Glycine 0 C--N 1.295 -1.71 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.043 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.1 mt -141.74 139.76 32.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.456 -1.026 . . . . 0.0 108.822 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -73.8 151.87 40.46 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.865 0.84 . . . . 0.0 110.867 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 47' ' ' TYR . 48.9 m-85 -154.59 138.94 16.69 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 67.4 m -56.56 178.76 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.904 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 12.2 tm-20 -63.73 -39.24 93.8 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.392 -0.818 . . . . 0.0 109.46 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.8 m -86.25 -39.28 16.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.687 . . . . 0.0 111.341 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.7 m170 -67.93 -47.18 69.44 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.805 -1.184 . . . . 0.0 107.977 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.461 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.1 t80 -50.78 -56.63 11.19 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -64.18 -44.39 92.2 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.623 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -57.01 -36.41 70.4 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.544 HD22 ' CE1' ' A' ' 54' ' ' TYR . 1.7 mp -73.28 -37.39 66.28 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.5 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.9 m-85 -153.74 -81.71 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.795 0.807 . . . . 0.0 109.913 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 65' ' ' ASP . . . 70.53 -11.77 2.19 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.4 OUTLIER 158.79 -18.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.79 -0.829 . . . . 0.0 108.859 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.487 ' OXT' ' CD2' ' A' ' 63' ' ' PHE . 48.4 t . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.521 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 4' ' ' GLY . 8.2 t 55.5 102.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.231 -1.158 . . . . 0.0 109.484 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.6 mtp -74.22 31.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 2' ' ' SER . . . 82.85 -26.02 4.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.642 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.3 t -45.26 129.22 5.89 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.517 -0.99 . . . . 0.0 109.703 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' ILE . 6.3 Cg_endo -75.67 163.23 34.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.983 1.789 . . . . 0.0 109.232 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.4 mt -133.78 119.6 33.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 122.103 0.954 . . . . 0.0 109.157 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 30.3 t -58.02 115.63 3.01 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.776 0.798 . . . . 0.0 109.901 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.539 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.66 -3.23 4.11 Favored Glycine 0 N--CA 1.484 1.842 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.822 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.55 -59.94 2.17 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.471 -1.017 . . . . 0.0 109.357 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.4 p -99.43 -1.07 39.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.545 -0.722 . . . . 0.0 109.179 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER 56.03 39.72 30.43 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -118.37 149.48 46.03 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.642 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.0 Cg_exo -58.73 113.01 1.38 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.442 1.428 . . . . 0.0 110.793 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.772 HG21 HG22 ' A' ' 19' ' ' VAL . 20.5 mt -68.52 159.92 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.432 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -158.38 62.4 0.44 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.613 -1.305 . . . . 0.0 111.399 -178.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 174.02 -95.37 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -108.27 138.56 44.34 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.772 HG22 HG21 ' A' ' 15' ' ' ILE . 46.9 t -124.9 160.97 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.172 -0.955 . . . . 0.0 110.791 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.578 HG23 HG22 ' A' ' 29' ' ' VAL . 3.4 t -126.41 117.41 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -90.34 105.77 18.04 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.216 -0.927 . . . . 0.0 109.482 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.635 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.31 16.65 4.16 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.91 26.09 74.59 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -130.83 -153.83 0.59 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.848 0.832 . . . . 0.0 109.954 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.508 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.1 mt-30 -137.44 142.8 41.6 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.539 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 56.9 m95 -141.38 139.3 33.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.64 -1.288 . . . . 0.0 110.6 -177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.476 ' C ' ' N ' ' A' ' 30' ' ' GLU . 17.7 m80 -56.0 131.44 47.32 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.578 HG22 HG23 ' A' ' 20' ' ' VAL . 6.2 t -53.38 -13.85 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 120.581 -1.325 . . . . 0.0 108.361 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 28' ' ' HIS . 51.1 tp10 -94.57 -27.36 15.97 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.778 -0.576 . . . . 0.0 110.433 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -98.14 -6.28 31.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.909 -1.12 . . . . 0.0 110.787 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CD2' HG11 ' A' ' 20' ' ' VAL . 22.8 t80 -80.13 107.1 12.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.823 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.6 m -133.25 175.9 10.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.229 1.014 . . . . 0.0 111.27 -177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.47 148.44 48.6 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.407 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.37 25.98 2.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.247 -0.908 . . . . 0.0 109.804 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.44 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.5 tptp -136.02 -31.53 0.91 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.291 -0.88 . . . . 0.0 110.019 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.2 p -130.03 -15.16 3.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.241 -0.912 . . . . 0.0 110.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 71.98 47.43 0.31 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.298 -0.876 . . . . 0.0 110.461 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -102.22 109.49 60.35 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.823 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.9 Cg_endo -68.76 138.41 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.848 1.698 . . . . 0.0 112.018 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.479 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.5 57.82 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.639 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.34 -55.49 1.72 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.4 31.48 2.67 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.531 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -115.64 -163.61 0.9 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -1.051 . . . . 0.0 110.05 -179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -110.6 146.23 36.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.646 -0.659 . . . . 0.0 109.231 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.5 p-80 -118.06 168.33 10.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.315 -0.866 . . . . 0.0 109.785 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.719 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.0 m-85 -131.7 136.64 47.81 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -107.02 149.8 27.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -147.15 133.63 19.73 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.561 0.696 . . . . 0.0 110.01 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 15.9 ptmt 41.8 22.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.594 0.712 . . . . 0.0 109.68 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.635 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.06 31.3 9.27 Favored Glycine 0 C--N 1.296 -1.68 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.203 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 49' ' ' ARG . 17.8 mt -142.78 140.64 31.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.504 -0.998 . . . . 0.0 108.79 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -75.37 152.19 38.11 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.422 -0.799 . . . . 0.0 110.879 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.571 ' CE1' HD22 ' A' ' 62' ' ' LEU . 52.8 m-85 -154.33 139.53 17.51 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.7 m -56.05 179.15 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 118.42 -1.312 . . . . 0.0 108.546 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 9.2 tm-20 -64.78 -38.44 91.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.8 m -86.14 -39.1 17.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.624 -0.673 . . . . 0.0 111.19 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.478 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.9 m170 -68.92 -43.89 74.22 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.702 -1.249 . . . . 0.0 108.037 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 6.4 t80 -54.98 -57.03 13.33 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.453 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 39.6 m-80 -62.16 -43.68 98.3 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.377 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -55.92 -37.26 68.68 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 54' ' ' TYR . 3.7 mp -74.52 -37.99 62.92 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.513 -0.767 . . . . 0.0 108.996 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.553 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.0 m-85 -156.85 -83.48 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.411 -0.806 . . . . 0.0 110.171 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.453 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 93.12 -9.25 75.24 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 49.78 71.16 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.387 -1.066 . . . . 0.0 109.475 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.496 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 20.5 m -165.56 126.58 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -1.143 . . . . 0.0 109.478 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.602 ' SD ' ' N ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -51.93 129.91 28.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.279 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.602 ' N ' ' SD ' ' A' ' 3' ' ' MET . . . -144.88 84.36 0.19 Allowed Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.607 HG11 ' CB ' ' A' ' 14' ' ' PRO . 2.1 t -84.39 134.23 43.24 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.0 109.5 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' A' ' 19' ' ' VAL . 3.4 Cg_endo -70.94 163.36 39.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.616 1.544 . . . . 0.0 108.344 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 33.6 mt -134.24 120.67 35.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-O 122.201 1.001 . . . . 0.0 109.244 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.866 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.6 t -57.39 116.03 3.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.759 0.79 . . . . 0.0 110.066 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.11 -0.67 3.32 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.866 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.53 -59.26 2.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.354 -1.086 . . . . 0.0 109.399 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.0 p -102.96 -0.86 30.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.519 -0.738 . . . . 0.0 109.267 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.621 HH11 ' HG3' ' A' ' 12' ' ' ARG . 7.2 mmm-85 58.62 43.08 19.55 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -118.62 143.62 33.79 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.607 ' CB ' HG11 ' A' ' 5' ' ' VAL . 3.0 Cg_exo -53.9 111.72 0.78 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.663 1.575 . . . . 0.0 110.621 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.633 HG21 HG22 ' A' ' 19' ' ' VAL . 34.6 mt -71.17 158.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.217 -0.927 . . . . 0.0 108.516 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.38 61.45 0.27 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.727 -1.233 . . . . 0.0 110.728 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.24 -102.19 0.15 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 107.626 -2.19 . . . . 0.0 107.626 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.675 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.8 mtt-85 -112.14 120.4 41.68 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 15' ' ' ILE . 40.5 t -99.29 158.87 3.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 111.282 -177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 32' ' ' PHE . 5.0 t -122.51 115.75 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.647 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -89.85 106.16 18.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 109.694 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.53 41.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.643 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 11.3 mmt 58.02 15.98 3.5 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.86 20.86 77.94 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -124.24 -154.69 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.773 0.797 . . . . 0.0 109.885 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.502 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.5 mt-30 -135.32 143.25 46.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.525 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.0 m95 -141.09 138.55 33.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.572 -1.33 . . . . 0.0 110.588 -177.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.497 ' C ' ' N ' ' A' ' 30' ' ' GLU . 15.6 m80 -55.42 130.74 43.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 20' ' ' VAL . 8.7 t -52.52 -14.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 O-C-N 120.932 -1.105 . . . . 0.0 108.068 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.497 ' N ' ' C ' ' A' ' 28' ' ' HIS . 4.1 tt0 -95.36 -27.83 15.26 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.921 -0.487 . . . . 0.0 110.54 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -98.64 -6.02 30.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.827 -1.171 . . . . 0.0 110.821 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 20' ' ' VAL . 23.0 t80 -79.87 106.14 11.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' A' ' 40' ' ' PRO . 27.7 m -134.32 174.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 122.272 1.034 . . . . 0.0 111.122 -177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.549 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -60.06 148.22 36.48 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.263 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.25 34.49 1.03 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.291 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HG3' HD11 ' A' ' 62' ' ' LEU . 6.0 tmtt? -142.79 -40.05 0.33 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.5 -0.75 . . . . 0.0 109.744 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 30.1 p -123.2 -17.4 6.64 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.433 -178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.0 mt-10 76.32 47.59 0.08 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.4 -0.812 . . . . 0.0 110.532 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -100.32 110.75 60.94 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' A' ' 33' ' ' VAL . 6.2 Cg_endo -70.62 137.98 34.1 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.874 1.716 . . . . 0.0 112.192 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.488 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.11 58.13 1.82 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.08 -55.47 1.59 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 109.204 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.01 30.56 2.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -115.4 -179.08 3.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.437 -1.037 . . . . 0.0 110.004 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.656 ' CG ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -96.2 143.07 27.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.502 -0.749 . . . . 0.0 109.158 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.569 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.0 p-80 -114.28 171.51 7.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.306 -0.871 . . . . 0.0 109.659 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.704 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.5 m-85 -134.0 137.75 44.96 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -108.5 146.94 32.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 111.585 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.927 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -151.57 117.38 5.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.79 -0.569 . . . . 0.0 109.645 178.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 22.4 mmtp 61.89 30.37 18.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 109.995 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.643 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 76.97 31.09 54.56 Favored Glycine 0 N--CA 1.48 1.623 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 52' ' ' LEU . 26.1 mt -141.84 137.29 31.35 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.682 -0.893 . . . . 0.0 108.734 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.79 153.88 34.51 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.769 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.613 ' CE1' HD22 ' A' ' 62' ' ' LEU . 47.2 m-85 -153.8 137.86 16.41 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 76.3 m -56.05 173.27 0.16 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.321 -1.352 . . . . 0.0 108.254 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.4 tm-20 -59.75 -34.78 73.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.119 -0.988 . . . . 0.0 109.255 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.496 ' O ' ' N ' ' A' ' 61' ' ' GLN . 66.5 m -87.01 -44.43 11.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.613 -0.68 . . . . 0.0 111.397 -178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.577 ' O ' HD13 ' A' ' 62' ' ' LEU . 30.6 m170 -65.64 -42.12 91.8 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.792 -1.193 . . . . 0.0 108.493 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.2 t80 -54.3 -57.19 12.16 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 36.7 m-80 -64.61 -43.94 92.17 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.289 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 57' ' ' THR . 37.1 tt0 -54.31 -34.38 60.87 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.613 HD22 ' CE1' ' A' ' 54' ' ' TYR . 6.5 mp -79.24 -38.28 35.98 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.604 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.2 m-85 -160.33 -80.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.573 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 91.32 -9.59 77.04 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 66' ' ' VAL . 7.1 p30 -164.4 -99.18 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.372 -1.075 . . . . 0.0 109.419 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.485 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 32.6 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 m -159.37 -64.27 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -1.152 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.8 ptt? -49.9 131.37 22.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.92 . . . . 0.0 109.459 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . 168.68 -111.1 0.41 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t 57.25 128.98 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.542 -0.975 . . . . 0.0 109.727 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -75.48 163.37 34.41 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.043 1.829 . . . . 0.0 109.274 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.537 HG12 ' HA ' ' A' ' 14' ' ' PRO . 34.5 mt -135.11 119.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-O 122.034 0.921 . . . . 0.0 109.149 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.819 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 32.7 t -58.51 115.0 2.73 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.84 0.829 . . . . 0.0 109.779 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.536 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -61.46 -3.54 4.2 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.819 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.99 -59.18 2.41 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.439 -1.036 . . . . 0.0 109.329 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.39 -1.6 35.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.569 -0.707 . . . . 0.0 109.183 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 57.8 38.84 27.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.214 -0.929 . . . . 0.0 108.693 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -118.04 149.34 45.35 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.3 Cg_exo -59.05 113.05 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.387 1.391 . . . . 0.0 110.783 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.706 HG21 HG22 ' A' ' 19' ' ' VAL . 19.3 mt -69.87 160.31 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.474 ' N ' HG22 ' A' ' 15' ' ' ILE . 9.0 pt-20 -170.3 70.39 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.698 -1.251 . . . . 0.0 110.549 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.82 -55.06 0.3 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.621 ' HG3' HH11 ' A' ' 18' ' ' ARG . 1.1 mtm-85 -139.56 129.67 25.13 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.706 HG22 HG21 ' A' ' 15' ' ' ILE . 48.7 t -126.47 152.98 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.358 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 32' ' ' PHE . 6.6 t -127.23 116.39 43.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.533 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.1 m-80 -86.94 105.65 17.25 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.064 -1.023 . . . . 0.0 109.372 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.81 159.98 42.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.472 -0.767 . . . . 0.0 109.012 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.631 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 57.65 18.4 4.69 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.83 22.69 77.02 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 108.056 -2.018 . . . . 0.0 108.056 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -129.37 -156.19 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.965 -0.726 . . . . 0.0 109.767 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.497 HE21 ' H ' ' A' ' 7' ' ' ILE . 1.7 mt-30 -134.29 143.43 47.73 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.536 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 48.6 m95 -141.96 140.05 32.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.531 -1.355 . . . . 0.0 110.289 -178.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.426 ' CD2' HG23 ' A' ' 15' ' ' ILE . 19.7 m80 -55.82 140.48 42.15 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 t -58.94 -19.46 15.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 O-C-N 120.718 -1.239 . . . . 0.0 109.288 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -96.27 -12.69 24.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -105.62 -8.76 17.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.951 -1.093 . . . . 0.0 109.955 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.468 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.1 t80 -81.22 103.59 11.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.846 HG12 ' CA ' ' A' ' 40' ' ' PRO . 21.3 m -126.16 177.55 5.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 122.42 1.105 . . . . 0.0 111.597 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.62 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -68.06 149.16 50.01 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.722 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.06 26.01 2.64 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.466 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.475 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 12.7 tptm -134.12 -29.79 1.24 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.364 -0.835 . . . . 0.0 109.841 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.6 p -133.18 -15.59 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.302 -0.874 . . . . 0.0 110.392 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 71.51 46.56 0.4 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.266 -0.896 . . . . 0.0 110.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -101.32 112.51 65.17 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.846 ' CA ' HG12 ' A' ' 33' ' ' VAL . 10.5 Cg_endo -71.54 134.44 24.31 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.483 1.455 . . . . 0.0 110.897 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.588 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.1 m-85 -93.01 59.46 3.13 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 40' ' ' PRO . 4.6 mp -41.02 -55.95 2.42 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.409 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.33 24.02 5.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -114.69 168.73 9.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.48 -1.012 . . . . 0.0 109.95 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -84.07 156.68 22.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.553 -0.717 . . . . 0.0 109.16 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.7 p-80 -120.81 170.25 9.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 0.0 110.054 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.708 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.0 m-85 -135.47 135.23 40.33 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -110.52 141.08 44.16 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.196 -0.94 . . . . 0.0 111.188 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.728 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -145.15 136.45 25.04 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.563 0.697 . . . . 0.0 110.369 178.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt 50.12 22.45 0.93 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.52 -0.737 . . . . 0.0 109.096 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.631 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.75 30.63 31.84 Favored Glycine 0 C--N 1.295 -1.712 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 52' ' ' LEU . 22.2 mt -140.09 143.02 36.07 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.775 -0.838 . . . . 0.0 108.896 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.44 151.48 34.7 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.487 -0.758 . . . . 0.0 110.928 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' TYR . 59.5 m-85 -153.27 136.63 15.78 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.62 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 64.4 m -57.4 173.92 0.23 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.277 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 26.8 tt0 -59.5 -34.51 72.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 61' ' ' GLN . 59.1 m -86.91 -44.09 11.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -0.772 . . . . 0.0 111.683 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.446 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.0 m170 -67.57 -43.03 81.6 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.708 -1.245 . . . . 0.0 108.453 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.512 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -51.86 -55.6 19.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.435 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 44.5 m-80 -65.57 -45.34 83.67 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.977 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 57' ' ' THR . 28.1 tt0 -52.87 -39.01 62.26 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.582 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.2 mp -71.64 -40.33 69.78 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.728 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 14.6 m-85 -154.3 -85.11 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.603 0.716 . . . . 0.0 109.973 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 90.53 31.53 10.29 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.3 t70 52.94 39.7 29.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -1.082 . . . . 0.0 109.476 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.472 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' MET . 8.2 t 53.34 98.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' SER . 3.0 ttt -62.45 -138.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.887 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . 143.95 -75.9 0.3 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.651 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t 57.28 129.8 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.611 -0.935 . . . . 0.0 109.775 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.516 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.8 Cg_endo -74.49 163.41 36.17 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 109.024 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.8 mt -135.71 119.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.033 0.92 . . . . 0.0 109.26 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.831 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.3 t -57.14 117.34 3.93 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.776 0.798 . . . . 0.0 109.86 -178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.527 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.76 -2.2 5.9 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.831 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.21 -60.56 2.0 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.393 -1.063 . . . . 0.0 109.364 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.28 -2.48 33.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.781 . . . . 0.0 109.151 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.624 HH11 ' HG3' ' A' ' 12' ' ' ARG . 6.6 mmm-85 59.75 40.51 19.58 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.278 -0.889 . . . . 0.0 108.768 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.66 150.14 46.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.8 Cg_exo -59.29 113.91 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.53 1.486 . . . . 0.0 110.568 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.646 HG21 HG22 ' A' ' 19' ' ' VAL . 21.1 mt -70.34 158.29 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -159.21 59.38 0.41 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.833 -1.167 . . . . 0.0 110.986 -178.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.06 -102.45 0.16 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 107.681 -2.167 . . . . 0.0 107.681 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.674 ' CG ' HH11 ' A' ' 18' ' ' ARG . 3.0 mtt-85 -111.19 121.3 44.93 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 177.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.646 HG22 HG21 ' A' ' 15' ' ' ILE . 45.6 t -98.72 157.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 111.038 -177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.459 HG11 ' CD2' ' A' ' 32' ' ' PHE . 7.1 t -120.62 115.15 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -90.07 106.12 18.27 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.1 -1.0 . . . . 0.0 109.631 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.71 160.19 41.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.671 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.1 mmt 57.52 16.39 3.29 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.8 22.44 78.2 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -125.75 -154.67 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.737 0.78 . . . . 0.0 109.753 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HG2' HG11 ' A' ' 19' ' ' VAL . 2.7 mt-30 -136.29 142.8 43.96 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.527 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 61.0 m95 -141.77 140.63 33.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.569 -1.332 . . . . 0.0 110.448 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -56.44 139.44 49.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 18' ' ' ARG . 7.9 t -57.64 -20.38 13.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 O-C-N 120.868 -1.145 . . . . 0.0 109.315 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.88 -16.69 21.64 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.483 -0.761 . . . . 0.0 110.627 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.4 m170 -101.43 -9.1 21.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.845 -1.159 . . . . 0.0 110.221 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.459 ' CD2' HG11 ' A' ' 20' ' ' VAL . 28.0 t80 -80.15 104.98 11.08 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.831 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.2 m -130.69 177.79 6.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 122.405 1.098 . . . . 0.0 111.499 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -66.96 148.56 51.8 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.661 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.5 30.48 1.3 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.34 -0.85 . . . . 0.0 109.243 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -139.65 -31.01 0.69 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.502 -0.749 . . . . 0.0 110.122 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.43 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 32.0 p -131.05 -18.59 2.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.364 -0.835 . . . . 0.0 110.192 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.2 mt-10 74.38 45.89 0.18 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.367 -0.833 . . . . 0.0 110.299 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -101.39 112.06 64.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.831 ' CA ' HG12 ' A' ' 33' ' ' VAL . 10.1 Cg_endo -71.7 135.94 27.0 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.561 1.507 . . . . 0.0 111.401 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.46 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -93.28 55.69 2.33 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.473 HD12 ' HB2' ' A' ' 40' ' ' PRO . 3.1 mp -40.64 -55.79 2.28 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.521 -0.737 . . . . 0.0 109.758 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.427 ' H ' ' CD2' ' A' ' 44' ' ' HIS . . . -128.16 23.86 5.14 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.591 ' N ' ' CD2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -115.69 -164.52 0.96 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.285 -1.127 . . . . 0.0 109.843 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.58 HH11 ' HB3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -107.7 154.11 21.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.661 -0.649 . . . . 0.0 109.437 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.579 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 13.1 p-80 -119.65 171.72 8.18 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.702 0.763 . . . . 0.0 109.265 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.688 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.0 m-85 -138.55 132.71 31.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -103.26 147.42 27.07 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.302 -0.874 . . . . 0.0 112.104 -177.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.832 HH11 ' HG2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -154.58 121.02 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HG2' ' NH1' ' A' ' 49' ' ' ARG . 1.0 OUTLIER 62.5 29.15 17.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.505 -0.747 . . . . 0.0 109.902 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.671 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 74.4 31.34 59.18 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 52' ' ' LEU . 29.1 mt -141.42 141.43 33.73 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.51 153.46 33.42 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.67 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 47' ' ' TYR . 54.9 m-85 -153.56 140.31 19.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 85.5 m -60.2 175.91 0.38 Allowed 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.742 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 61.4 tt0 -60.96 -37.57 82.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.419 -0.801 . . . . 0.0 109.423 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.9 -43.02 12.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.581 -0.699 . . . . 0.0 111.663 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.561 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.0 m170 -67.0 -44.83 79.35 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.716 -1.24 . . . . 0.0 108.284 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 4.7 t80 -49.11 -54.92 13.98 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.405 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 55.8 m-80 -67.9 -46.08 72.63 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.207 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.1 tp-100 -53.46 -33.64 54.9 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.592 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -78.27 -38.75 41.93 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 32.0 m-85 -160.37 -79.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.48 -0.762 . . . . 0.0 110.393 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 90.08 -9.4 77.47 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 2.1 m-20 54.71 59.97 3.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.394 -1.062 . . . . 0.0 109.5 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.455 -179.935 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t 52.12 85.19 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -1.155 . . . . 0.0 109.374 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.7 mtm -145.66 144.92 30.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.843 . . . . 0.0 109.334 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.7 80.81 0.06 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -153.92 128.69 4.82 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.191 -1.182 . . . . 0.0 109.435 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.2 Cg_endo -76.31 163.61 32.19 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.194 1.93 . . . . 0.0 109.29 178.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 14' ' ' PRO . 30.2 mt -134.73 119.0 27.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 122.027 0.918 . . . . 0.0 109.24 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 38.2 t -60.44 118.33 6.35 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.8 0.809 . . . . 0.0 110.141 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.531 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.94 -3.61 8.85 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.792 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -83.72 -46.59 12.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.488 -1.007 . . . . 0.0 109.449 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.44 -1.51 13.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.48 -0.763 . . . . 0.0 109.138 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 8' ' ' CYS . 26.8 mmt180 57.07 35.55 26.5 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.63 143.21 29.02 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.9 Cg_exo -55.88 113.8 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.306 1.338 . . . . 0.0 110.625 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.783 HG21 HG22 ' A' ' 19' ' ' VAL . 12.9 mt -69.1 159.73 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.47 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.5 pt-20 -167.73 69.06 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.755 -1.215 . . . . 0.0 110.373 -178.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.87 -64.22 0.17 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.527 HH21 ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -138.9 136.62 35.7 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.783 HG22 HG21 ' A' ' 15' ' ' ILE . 45.6 t -126.55 158.74 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.2 -0.938 . . . . 0.0 110.787 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.49 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.6 t -131.51 117.16 34.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.2 m120 -87.26 105.76 17.44 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.127 -0.983 . . . . 0.0 109.588 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.32 160.13 41.98 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.638 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 9.2 mmt 57.84 17.77 4.47 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.19 18.5 76.67 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -124.25 -156.06 0.7 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.716 0.77 . . . . 0.0 109.699 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.517 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.3 mt-30 -134.15 144.49 48.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.531 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 53.7 m95 -142.28 139.39 31.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.499 -1.375 . . . . 0.0 110.526 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.427 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 19.7 m80 -55.13 138.97 43.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 18' ' ' ARG . 6.7 t -58.63 -18.23 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 O-C-N 120.674 -1.266 . . . . 0.0 109.097 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.527 ' CD ' HH21 ' A' ' 18' ' ' ARG . 0.3 OUTLIER -94.15 -21.37 19.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.418 -0.801 . . . . 0.0 110.189 -179.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -99.51 -6.2 27.94 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.008 -1.058 . . . . 0.0 110.59 -179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.487 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.2 t80 -82.97 102.46 11.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' A' ' 40' ' ' PRO . 22.4 m -127.2 176.26 7.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-O 122.241 1.019 . . . . 0.0 111.266 -177.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.642 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -63.43 148.75 47.68 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.584 178.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.11 27.58 1.83 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.38 -0.825 . . . . 0.0 109.352 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 3.3 tttm -134.21 -42.04 0.8 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.497 -0.752 . . . . 0.0 109.96 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.9 p -121.49 -15.99 7.91 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.674 -0.641 . . . . 0.0 110.476 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 4.1 mt-10 72.68 47.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.41 -0.806 . . . . 0.0 110.141 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -100.72 109.85 58.91 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.2 Cg_endo -67.76 138.36 44.73 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.756 1.637 . . . . 0.0 111.874 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.545 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.4 m-85 -95.46 59.97 2.2 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.81 -55.55 1.94 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.63 29.56 3.11 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.457 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -117.08 165.61 13.18 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.995 . . . . 0.0 109.814 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -79.64 153.98 28.99 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.406 -0.809 . . . . 0.0 109.281 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.604 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 16.8 p-80 -118.92 169.47 9.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.277 -0.89 . . . . 0.0 109.83 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.706 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.7 m-85 -134.68 137.92 43.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -110.64 149.82 29.88 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.216 -0.928 . . . . 0.0 111.464 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.632 ' NE ' ' CD2' ' A' ' 63' ' ' PHE . 13.4 tpt180 -147.09 131.39 17.51 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.413 0.625 . . . . 0.0 110.192 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 42.39 24.75 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.696 0.76 . . . . 0.0 109.584 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.638 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.35 31.21 12.0 Favored Glycine 0 C--N 1.296 -1.677 0 C-N-CA 119.475 -1.345 . . . . 0.0 109.845 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ARG . 19.2 mt -140.34 139.77 35.47 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.565 -0.962 . . . . 0.0 108.961 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.83 152.6 33.35 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.83 0.824 . . . . 0.0 110.94 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.563 ' CE1' HD22 ' A' ' 62' ' ' LEU . 56.2 m-85 -154.8 139.03 16.59 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 13.0 m -59.38 174.02 0.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.638 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.5 tp10 -59.5 -31.58 69.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.878 -1.139 . . . . 0.0 109.537 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.6 m -86.26 -49.77 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 111.632 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' HD13 ' A' ' 62' ' ' LEU . 33.3 m170 -64.94 -41.14 95.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.877 -1.139 . . . . 0.0 108.407 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.6 t80 -53.3 -57.64 9.87 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -63.79 -44.94 91.85 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.119 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -54.88 -34.94 63.54 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.563 HD22 ' CE1' ' A' ' 54' ' ' TYR . 5.3 mp -77.35 -33.06 55.45 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.438 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.632 ' CD2' ' NE ' ' A' ' 49' ' ' ARG . 19.2 m-85 -160.14 -83.36 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.362 -0.836 . . . . 0.0 110.196 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.68 31.5 44.64 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 t70 55.75 39.62 30.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.496 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.486 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -75.52 125.18 28.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 109.498 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.1 tpt -69.04 -5.89 24.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.33 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.54 49.67 23.81 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.653 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -74.89 129.62 82.88 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.186 -1.185 . . . . 0.0 109.389 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.494 ' HB2' HD12 ' A' ' 15' ' ' ILE . 6.0 Cg_endo -74.78 163.77 34.98 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.143 1.896 . . . . 0.0 109.044 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.0 mt -135.72 120.17 26.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 122.056 0.931 . . . . 0.0 109.349 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.847 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.9 t -57.14 114.43 2.14 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.839 0.828 . . . . 0.0 109.899 -178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.535 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.84 -2.43 2.55 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.847 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.2 -59.79 2.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -1.08 . . . . 0.0 109.413 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.7 p -102.87 4.36 37.61 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.577 -0.702 . . . . 0.0 109.293 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.667 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.33 41.49 32.12 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -179.495 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -116.19 144.01 32.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.653 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.1 Cg_exo -56.81 113.17 1.34 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.332 1.355 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.628 HG21 HG22 ' A' ' 19' ' ' VAL . 22.1 mt -69.19 158.17 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.614 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.413 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -166.3 67.96 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 110.299 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.6 -73.31 0.07 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.584 -2.207 . . . . 0.0 107.584 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -138.48 133.59 32.9 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.628 HG22 HG21 ' A' ' 15' ' ' ILE . 41.2 t -114.02 151.62 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.297 -0.877 . . . . 0.0 110.896 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 32' ' ' PHE . 8.1 t -119.45 115.41 47.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.513 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.9 OUTLIER -88.57 106.16 18.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.047 -1.033 . . . . 0.0 109.583 -178.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.02 160.04 42.85 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.644 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.5 mmt 58.34 16.26 3.95 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.93 25.75 75.2 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.791 -2.123 . . . . 0.0 107.791 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.9 mtpp -130.56 -154.56 0.64 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.931 0.872 . . . . 0.0 109.88 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.514 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.5 mt-30 -136.65 142.0 43.2 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.535 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 55.2 m95 -141.3 139.99 33.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.484 -1.385 . . . . 0.0 110.399 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -55.73 137.25 50.0 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.71 -17.56 3.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 120.848 -1.158 . . . . 0.0 109.044 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.31 -25.16 15.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.509 -0.744 . . . . 0.0 110.689 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -94.26 -8.52 38.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.804 -1.185 . . . . 0.0 110.364 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CD2' HG11 ' A' ' 20' ' ' VAL . 23.1 t80 -80.34 106.7 12.55 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.817 HG12 ' CA ' ' A' ' 40' ' ' PRO . 27.0 m -133.46 175.26 11.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 122.35 1.072 . . . . 0.0 111.184 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.03 148.58 47.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.385 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.3 28.84 1.56 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 109.608 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.9 tptt -139.8 -31.29 0.67 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.345 -0.847 . . . . 0.0 110.179 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 32.0 p -130.82 -8.92 3.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.262 -0.899 . . . . 0.0 110.121 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 37' ' ' CYS . 33.2 mm-40 63.89 48.38 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.382 -0.824 . . . . 0.0 110.376 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -101.74 109.31 59.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.817 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.2 Cg_endo -68.6 138.65 42.32 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.81 1.673 . . . . 0.0 112.28 -177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.475 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.52 -55.59 1.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.307 -0.871 . . . . 0.0 109.494 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.429 ' H ' ' CD2' ' A' ' 44' ' ' HIS . . . -135.11 30.27 2.84 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.496 ' N ' ' CD2' ' A' ' 44' ' ' HIS . 2.5 m-70 -114.36 -158.51 0.67 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.394 -1.062 . . . . 0.0 109.97 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -114.88 145.99 41.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.674 -0.641 . . . . 0.0 109.35 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.548 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 12.4 p-80 -117.43 167.42 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 0.0 109.666 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.715 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.4 m-85 -131.22 137.43 48.92 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -105.89 148.88 27.1 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.226 -0.921 . . . . 0.0 111.51 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.431 ' HB3' ' CD2' ' A' ' 54' ' ' TYR . 1.3 tmt_? -153.46 126.89 8.63 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.507 0.67 . . . . 0.0 109.991 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.6 mmtp 53.71 26.01 5.54 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.448 -0.783 . . . . 0.0 109.378 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.644 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 81.1 31.37 35.01 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 52' ' ' LEU . 22.3 mt -141.92 141.64 32.99 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.734 -0.862 . . . . 0.0 108.723 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.35 152.94 34.23 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.56 ' CE1' HD22 ' A' ' 62' ' ' LEU . 56.4 m-85 -153.71 140.05 18.62 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 99.0 m -56.85 178.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 118.36 -1.336 . . . . 0.0 108.473 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 62.5 tt0 -64.45 -36.47 84.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.197 -0.939 . . . . 0.0 109.347 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 61' ' ' GLN . 55.2 m -86.59 -42.32 13.57 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.535 -0.728 . . . . 0.0 111.382 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.44 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.47 -43.42 81.07 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.794 -1.191 . . . . 0.0 108.207 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.4 t80 -52.85 -56.02 18.81 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 56' ' ' GLU . 22.6 m-80 -63.76 -45.16 91.05 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.893 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' THR . 32.9 tt0 -53.38 -34.63 58.4 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.56 HD22 ' CE1' ' A' ' 54' ' ' TYR . 2.9 mp -79.29 -36.03 40.35 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.197 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 15.6 m-85 -158.6 -84.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 110.128 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 89.03 -9.32 77.28 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.1 t70 52.24 57.55 6.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.43 -1.041 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.492 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 p -173.94 -173.87 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.459 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.3 mtp -49.73 135.15 19.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 109.436 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.57 -46.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -65.67 130.29 94.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.28 -1.13 . . . . 0.0 109.487 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.516 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.33 163.57 36.05 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.055 1.836 . . . . 0.0 108.858 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.5 mt -135.13 120.25 29.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-O 122.028 0.918 . . . . 0.0 109.33 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.3 t -57.81 116.64 3.58 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.768 0.794 . . . . 0.0 110.036 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.529 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.22 -1.69 4.47 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.835 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.88 -56.33 3.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -1.071 . . . . 0.0 109.474 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -107.45 4.27 26.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.528 -0.732 . . . . 0.0 109.254 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 53.78 42.08 31.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.676 HH11 ' CG ' ' A' ' 13' ' ' ARG . 2.3 mtt-85 -116.4 144.09 32.42 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HB3' HG11 ' A' ' 5' ' ' VAL . 5.7 Cg_exo -56.56 113.15 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.45 1.433 . . . . 0.0 110.472 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.656 HG21 HG22 ' A' ' 19' ' ' VAL . 23.8 mt -70.74 158.43 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.6 pt-20 -160.73 61.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.857 -1.152 . . . . 0.0 110.679 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.38 -101.8 0.15 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.669 -2.172 . . . . 0.0 107.669 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.678 ' CG ' HH11 ' A' ' 18' ' ' ARG . 2.9 mtt-85 -112.64 120.11 40.43 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.656 HG22 HG21 ' A' ' 15' ' ' ILE . 44.0 t -98.16 157.94 3.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.511 -0.743 . . . . 0.0 111.149 -177.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG11 ' CD2' ' A' ' 32' ' ' PHE . 5.4 t -122.2 115.86 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.61 106.27 18.35 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.232 -0.917 . . . . 0.0 109.569 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.57 43.09 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.65 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.7 mmt 58.74 17.02 4.82 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.31 28.44 71.36 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.834 -2.107 . . . . 0.0 107.834 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -133.89 -154.41 0.6 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.919 0.866 . . . . 0.0 109.945 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.49 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.9 mt-30 -135.98 142.78 44.56 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.529 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.6 m95 -141.38 139.26 33.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.508 -1.37 . . . . 0.0 110.612 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -55.63 137.95 48.13 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 18' ' ' ARG . 10.5 t -57.24 -19.51 10.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -95.44 -18.53 20.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.41 -0.806 . . . . 0.0 110.63 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.3 m170 -100.67 -7.01 24.32 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.886 -1.133 . . . . 0.0 110.231 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.3 t80 -83.03 102.46 11.79 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.82 HG12 ' CA ' ' A' ' 40' ' ' PRO . 23.5 m -126.27 176.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.414 1.102 . . . . 0.0 111.266 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.3 t -66.47 149.41 50.47 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.656 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.34 24.96 3.15 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.327 -0.858 . . . . 0.0 109.829 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.6 tptp -132.63 -30.68 1.42 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.389 -0.819 . . . . 0.0 109.725 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 26.2 p -133.5 -10.18 2.83 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.326 -0.859 . . . . 0.0 110.375 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 65.55 48.24 2.05 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.321 -0.862 . . . . 0.0 110.399 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -101.11 110.4 61.14 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.82 ' CA ' HG12 ' A' ' 33' ' ' VAL . 3.6 Cg_endo -67.16 138.51 47.47 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.723 1.616 . . . . 0.0 111.81 -177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 2.9 m-85 -95.35 60.06 2.24 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.2 mp -39.86 -55.38 1.99 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.484 -0.76 . . . . 0.0 109.257 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.98 30.8 2.79 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.446 ' CD2' ' N ' ' A' ' 44' ' ' HIS . 0.8 OUTLIER -117.31 167.08 11.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.484 -1.01 . . . . 0.0 109.912 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -82.37 151.86 26.47 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.553 -0.717 . . . . 0.0 109.151 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.586 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 15.3 p-80 -117.88 169.77 9.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.0 109.838 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.0 m-85 -133.85 136.67 44.55 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -111.03 140.24 45.73 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.321 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.707 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -146.68 137.66 24.1 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.485 0.659 . . . . 0.0 110.17 178.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt 51.9 22.19 1.69 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.002 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.65 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 80.25 31.04 39.36 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 52' ' ' LEU . 25.6 mt -140.27 143.68 36.04 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.71 151.67 34.07 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.73 0.776 . . . . 0.0 110.858 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.499 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 58.8 m-85 -153.12 137.13 16.33 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.6 m -57.22 174.67 0.18 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.369 -1.332 . . . . 0.0 108.276 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 64.9 tt0 -60.66 -34.85 74.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.202 -0.936 . . . . 0.0 109.385 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.2 m -86.8 -43.64 12.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.63 -0.669 . . . . 0.0 111.638 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.454 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 33.2 m170 -67.43 -44.38 78.89 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.729 -1.232 . . . . 0.0 108.377 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -50.39 -54.98 17.73 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.417 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 49.2 m-80 -66.69 -45.72 77.91 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.061 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 57' ' ' THR . 3.9 tp-100 -53.49 -38.23 63.48 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.587 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.4 mp -71.07 -39.57 72.14 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.707 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.8 m-85 -154.74 -84.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.625 0.726 . . . . 0.0 109.967 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 84.95 31.34 23.71 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 66' ' ' VAL . 16.2 t0 -173.11 88.65 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -1.053 . . . . 0.0 109.467 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.704 ' OXT' HG22 ' A' ' 66' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.034 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 m -65.06 -157.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.191 -1.182 . . . . 0.0 109.402 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.2 mmt -50.68 166.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -172.77 -143.44 4.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.595 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.1 t 57.5 122.87 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.498 -1.001 . . . . 0.0 109.974 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.0 Cg_endo -78.39 164.42 26.43 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.664 2.243 . . . . 0.0 109.31 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.9 mt -135.52 123.17 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 CA-C-O 121.866 0.841 . . . . 0.0 109.622 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.843 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 13.8 t -63.32 118.15 7.63 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.824 0.821 . . . . 0.0 109.884 -178.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.507 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.27 0.12 6.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.843 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.77 -36.23 18.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -1.096 . . . . 0.0 109.563 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.04 4.38 4.87 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.682 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.79 41.01 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -114.79 141.75 27.28 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.595 ' HB3' HG11 ' A' ' 5' ' ' VAL . 6.3 Cg_exo -56.76 114.39 1.89 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 121.41 1.407 . . . . 0.0 110.86 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.565 HD13 HG13 ' A' ' 19' ' ' VAL . 21.7 mt -71.96 159.39 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.424 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.3 pt-20 -160.73 61.92 0.31 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.746 -1.221 . . . . 0.0 110.964 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.66 -103.31 0.17 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 107.609 -2.196 . . . . 0.0 107.609 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.605 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.0 mtm180 -110.0 121.1 44.46 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 HD13 ' A' ' 15' ' ' ILE . 35.7 t -98.52 158.0 3.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.344 -0.847 . . . . 0.0 110.98 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 29' ' ' VAL . 5.6 t -120.81 112.94 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -88.98 106.61 18.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.181 -0.95 . . . . 0.0 109.801 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -143.51 158.96 43.25 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.641 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.6 mmt 58.74 14.52 3.22 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 72.74 21.52 79.62 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 107.979 -2.048 . . . . 0.0 107.979 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -125.08 -154.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.835 0.826 . . . . 0.0 109.749 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.495 ' HG2' HG11 ' A' ' 19' ' ' VAL . 24.4 mt-30 -135.0 145.11 47.78 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.507 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 66.0 m95 -142.6 135.66 28.41 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.672 -1.267 . . . . 0.0 110.181 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.4 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 19.0 m80 -53.55 135.61 39.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 18' ' ' ARG . 33.4 t -55.0 -21.24 7.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 120.918 -1.114 . . . . 0.0 109.548 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 6.5 pm0 -95.02 -20.02 19.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.858 . . . . 0.0 110.679 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 50.2 m170 -97.34 -9.78 26.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.813 -1.179 . . . . 0.0 110.191 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CD2' HG11 ' A' ' 20' ' ' VAL . 24.0 t80 -78.42 105.58 9.77 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.822 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.5 m -134.04 176.54 8.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-O 122.219 1.009 . . . . 0.0 111.032 -177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.4 t -62.63 148.01 47.57 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.22 32.03 1.07 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.605 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -140.25 -41.55 0.42 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.467 -0.77 . . . . 0.0 109.842 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.5 p -119.3 -18.95 8.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.574 -0.704 . . . . 0.0 110.309 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.6 mt-10 75.51 48.04 0.09 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -100.84 106.97 47.13 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.822 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.3 Cg_endo -67.83 137.92 43.13 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.801 1.667 . . . . 0.0 112.355 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.482 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.14 56.98 1.7 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.617 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.29 -55.57 1.68 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.21 -0.931 . . . . 0.0 109.374 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.04 31.27 2.72 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -115.23 -163.27 0.87 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.5 -1.0 . . . . 0.0 109.984 -179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -111.09 145.52 38.42 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.559 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 35.1 p-80 -117.69 170.03 9.11 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.019 0.914 . . . . 0.0 109.88 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.5 m-85 -134.29 135.28 42.72 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -112.15 150.56 30.63 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.076 -1.015 . . . . 0.0 111.303 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.66 132.69 19.23 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.691 0.758 . . . . 0.0 110.378 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.0 mttm 50.34 20.65 0.69 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.558 -0.714 . . . . 0.0 109.422 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.641 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 89.31 30.96 12.43 Favored Glycine 0 N--CA 1.483 1.826 0 C-N-CA 119.332 -1.414 . . . . 0.0 109.648 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 52' ' ' LEU . 17.8 mt -141.73 137.95 32.01 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -72.59 151.72 42.2 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.05 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.664 ' N ' ' O ' ' A' ' 47' ' ' TYR . 45.4 m-85 -153.46 139.47 18.24 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.9 m -56.8 -179.82 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.516 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 28.5 tt0 -65.32 -36.94 85.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 61' ' ' GLN . 53.9 m -86.99 -42.52 13.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 0.0 111.475 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.468 ' O ' HD13 ' A' ' 62' ' ' LEU . 32.6 m170 -66.23 -43.74 85.78 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.766 -1.209 . . . . 0.0 108.325 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.0 t80 -52.78 -56.73 13.54 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 48.4 m-80 -63.8 -44.51 93.11 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.196 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 57' ' ' THR . 11.8 tt0 -55.1 -34.28 63.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.591 HD22 ' CE1' ' A' ' 54' ' ' TYR . 4.9 mp -78.76 -35.01 45.22 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.383 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 19.2 m-85 -158.52 -81.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.107 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 88.05 31.43 14.68 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 50.4 43.6 26.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -1.124 . . . . 0.0 109.437 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.446 179.96 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 4' ' ' GLY . 31.5 m -170.22 96.71 0.26 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -1.127 . . . . 0.0 109.442 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.9 mmt -63.97 75.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 2' ' ' SER . . . -83.63 -133.09 2.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.0 t 57.09 116.22 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.423 -1.045 . . . . 0.0 110.01 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 15' ' ' ILE . 7.1 Cg_endo -80.19 164.66 21.87 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.796 2.33 . . . . 0.0 109.248 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.6 mt -135.8 123.03 34.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.831 0.825 . . . . 0.0 109.553 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.5 t -63.09 118.01 7.28 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.766 0.793 . . . . 0.0 109.929 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.501 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -66.12 0.2 6.52 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.1 -35.81 18.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.338 -1.095 . . . . 0.0 109.618 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -130.51 4.4 4.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.87 41.33 32.08 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.659 HH11 ' CG ' ' A' ' 13' ' ' ARG . 2.0 mtt-85 -115.32 140.86 26.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.507 ' HA ' HG12 ' A' ' 7' ' ' ILE . 2.8 Cg_exo -55.27 114.01 1.68 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 121.444 1.43 . . . . 0.0 110.84 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 8' ' ' CYS . 22.4 mt -71.64 158.39 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' N ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -159.38 59.73 0.39 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.798 -1.189 . . . . 0.0 110.945 -178.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.57 -102.27 0.15 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 107.629 -2.189 . . . . 0.0 107.629 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 29' ' ' VAL . 63.1 mtm180 -110.48 122.37 47.57 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.523 HG13 HD13 ' A' ' 15' ' ' ILE . 29.5 t -98.56 156.0 3.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 111.119 -177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' A' ' 32' ' ' PHE . 10.6 t -119.37 111.91 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.502 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.1 m-80 -87.02 106.51 17.89 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.177 -0.952 . . . . 0.0 109.529 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.07 159.42 43.3 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.61 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.1 mmt 58.26 16.39 3.96 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.98 28.69 70.1 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 21' ' ' ASN . 10.5 mttp -135.86 -154.45 0.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.807 0.813 . . . . 0.0 109.846 -178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.497 ' HG2' HG11 ' A' ' 19' ' ' VAL . 27.1 mt-30 -133.77 145.47 49.83 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.501 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 63.3 m95 -143.0 135.94 27.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.648 -1.283 . . . . 0.0 110.18 -178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -53.69 135.76 40.5 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 18' ' ' ARG . 15.9 t -54.6 -20.8 5.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 O-C-N 120.911 -1.118 . . . . 0.0 109.275 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.21 -22.76 18.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 110.674 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -96.5 -7.44 34.69 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.826 -1.171 . . . . 0.0 110.28 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.481 ' CD2' HG11 ' A' ' 20' ' ' VAL . 25.1 t80 -82.45 103.65 12.16 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.79 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.9 m -127.27 178.66 4.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 122.336 1.065 . . . . 0.0 111.057 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -69.31 148.75 49.29 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.883 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -89.9 25.55 2.07 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.476 -0.765 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 25.7 tptt -135.83 -32.15 0.9 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.399 -0.813 . . . . 0.0 110.054 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 30.3 p -129.45 -7.6 4.69 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.294 -0.879 . . . . 0.0 110.164 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 59.1 42.61 18.66 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.222 -0.923 . . . . 0.0 109.483 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -99.07 108.47 49.71 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.79 ' CA ' HG12 ' A' ' 33' ' ' VAL . 2.6 Cg_endo -65.11 140.37 65.06 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 C-N-CA 121.748 1.632 . . . . 0.0 112.343 -177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CD2' ' HB3' ' A' ' 46' ' ' HIS . 1.7 m-85 -96.15 61.27 2.07 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.627 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 9.8 mp -40.32 -55.86 2.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 109.82 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.82 26.18 4.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -116.61 159.81 21.61 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.417 -1.049 . . . . 0.0 109.685 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.642 ' CB ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.08 159.21 30.0 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.509 ' HB3' ' CD2' ' A' ' 41' ' ' PHE . 8.9 p-80 -116.95 172.7 7.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 0.0 109.739 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.6 m-85 -136.02 128.71 30.83 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -103.46 150.72 23.6 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.95 0.881 . . . . 0.0 111.772 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.726 ' CZ ' ' HZ3' ' A' ' 50' ' ' LYS . 0.8 OUTLIER -143.82 134.16 24.58 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.394 0.616 . . . . 0.0 109.548 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.726 ' HZ3' ' CZ ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER 37.45 25.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.643 0.735 . . . . 0.0 109.973 -179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.61 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 92.42 30.95 9.29 Favored Glycine 0 N--CA 1.481 1.675 0 C-N-CA 119.555 -1.307 . . . . 0.0 110.583 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 49' ' ' ARG . 18.8 mt -142.17 140.26 32.33 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.335 -1.097 . . . . 0.0 108.728 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -74.86 150.75 39.12 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.899 0.856 . . . . 0.0 110.967 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.55 ' CE1' HD22 ' A' ' 62' ' ' LEU . 53.1 m-85 -154.04 137.22 15.63 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.54 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 93.2 m -56.16 178.43 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 118.393 -1.323 . . . . 0.0 108.696 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 39.7 tt0 -61.71 -39.33 91.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.371 -0.83 . . . . 0.0 109.782 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 61' ' ' GLN . 46.3 m -86.23 -40.9 15.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 111.804 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.461 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.5 m170 -67.45 -44.81 77.77 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.676 -1.265 . . . . 0.0 108.235 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.471 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.9 t80 -51.82 -55.85 17.46 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -64.03 -46.09 85.98 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.079 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 57' ' ' THR . 16.8 tt0 -53.23 -35.0 59.48 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.552 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 2.2 mp -77.51 -40.57 42.34 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.342 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 62' ' ' LEU . 12.8 m-85 -152.78 -84.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.313 -0.867 . . . . 0.0 110.301 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 65' ' ' ASP . . . 68.3 -11.46 1.09 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 63' ' ' PHE . 0.7 OUTLIER 168.4 -92.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.364 -1.08 . . . . 0.0 109.312 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.723 ' O ' HG22 ' A' ' 66' ' ' VAL . 11.8 p . . . . . 0 N--CA 1.495 1.811 0 CA-C-O 118.169 -0.92 . . . . 0.0 109.994 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.4 t -175.28 42.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 109.444 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.9 mmt -79.71 -175.91 5.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.897 . . . . 0.0 109.429 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.78 -167.34 21.13 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -154.93 132.92 6.69 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.215 -1.168 . . . . 0.0 109.54 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.535 ' O ' ' N ' ' A' ' 15' ' ' ILE . 3.9 Cg_endo -72.2 163.63 38.12 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.759 1.639 . . . . 0.0 108.404 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.534 HG12 ' HA ' ' A' ' 14' ' ' PRO . 31.0 mt -134.29 120.4 33.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 122.172 0.987 . . . . 0.0 109.361 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.841 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.2 t -58.5 117.03 4.06 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.815 0.817 . . . . 0.0 110.048 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.533 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.84 -1.39 4.99 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.841 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -86.01 -52.94 5.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -1.084 . . . . 0.0 109.395 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.45 4.66 19.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.582 -0.699 . . . . 0.0 109.169 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.38 42.46 32.02 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -116.75 143.23 31.02 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.602 ' HB3' HG11 ' A' ' 5' ' ' VAL . 2.7 Cg_exo -55.16 112.5 1.06 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 121.723 1.615 . . . . 0.0 110.723 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.626 HG21 HG22 ' A' ' 19' ' ' VAL . 27.1 mt -72.09 158.56 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 14' ' ' PRO . 1.4 pm0 -161.29 61.38 0.28 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.725 -1.234 . . . . 0.0 110.766 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -175.34 -102.42 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 29' ' ' VAL . 66.9 mtm180 -111.38 121.59 45.61 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 15' ' ' ILE . 40.3 t -100.26 159.02 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -0.8 . . . . 0.0 111.252 -177.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.465 ' N ' HG12 ' A' ' 19' ' ' VAL . 6.1 t -122.39 115.74 46.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.2 m-80 -89.92 106.35 18.41 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.097 -1.002 . . . . 0.0 109.694 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.77 159.43 43.2 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.619 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 7.6 mmt 58.79 16.83 4.74 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.87 73.41 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -131.71 -154.47 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.933 0.873 . . . . 0.0 109.881 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.496 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.9 mt-30 -135.97 142.96 44.61 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.533 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 62.0 m95 -141.3 138.41 33.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.589 -1.319 . . . . 0.0 110.504 -177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -54.52 138.01 41.6 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' ARG . 8.4 t -57.26 -18.74 9.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 O-C-N 120.878 -1.139 . . . . 0.0 109.319 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -96.36 -22.29 17.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 110.667 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -96.1 -9.22 31.31 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.863 -1.148 . . . . 0.0 110.398 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.0 t80 -80.07 105.95 11.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.4 m -133.21 175.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 122.266 1.032 . . . . 0.0 111.12 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -62.56 149.05 44.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.086 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.57 24.51 3.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.201 -0.937 . . . . 0.0 110.037 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -134.19 -33.43 1.01 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 29.2 p -125.8 -19.74 4.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.266 -0.896 . . . . 0.0 110.305 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 5.8 mt-10 76.22 46.5 0.09 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.302 -0.874 . . . . 0.0 110.449 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -100.75 110.27 60.19 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.827 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.6 Cg_endo -68.79 138.06 40.02 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.726 1.618 . . . . 0.0 112.11 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.487 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.93 57.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.624 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.31 -55.36 1.72 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.31 29.44 3.04 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.86 -177.73 3.2 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -1.03 . . . . 0.0 109.963 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.8 ttt180 -97.05 145.63 25.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.744 . . . . 0.0 109.356 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.567 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -116.28 170.21 8.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.707 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.8 m-85 -132.87 137.51 46.7 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -106.78 147.76 29.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.263 -0.898 . . . . 0.0 111.402 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.66 129.48 11.66 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.613 0.721 . . . . 0.0 110.208 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.626 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 51.0 mttp 51.82 23.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.548 -0.72 . . . . 0.0 109.509 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.619 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 85.24 30.8 24.26 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 52' ' ' LEU . 18.1 mt -142.77 143.21 32.11 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.623 -0.928 . . . . 0.0 108.844 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.54 152.86 35.87 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.43 -0.794 . . . . 0.0 110.797 -178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.537 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 58.7 m-85 -153.97 140.33 18.66 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 89.8 m -57.61 176.75 0.12 Allowed 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.619 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 56.3 tt0 -63.33 -35.7 81.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.337 -0.852 . . . . 0.0 109.312 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.6 m -86.52 -43.64 12.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.618 -0.676 . . . . 0.0 111.345 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.591 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.6 m170 -66.8 -45.59 77.9 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.765 -1.209 . . . . 0.0 108.095 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.4 t80 -49.48 -55.85 11.82 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 42.7 m-80 -65.67 -45.82 81.47 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.073 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -54.93 -33.25 62.03 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 58' ' ' HIS . 0.9 OUTLIER -78.62 -35.28 45.79 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.138 179.082 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.626 ' CZ ' ' NZ ' ' A' ' 50' ' ' LYS . 16.8 m-85 -158.59 -80.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.005 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 65' ' ' ASP . . . 84.14 -9.3 64.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 64' ' ' GLY . 4.8 p-10 41.35 46.87 2.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.607 -0.937 . . . . 0.0 109.878 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.445 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 t -173.07 6.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.229 -1.159 . . . . 0.0 109.516 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 35.8 mtt -152.73 63.98 0.79 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.34 40.54 0.48 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 1.9 t -153.92 119.06 2.74 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.128 . . . . 0.0 109.662 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ILE . 10.1 Cg_endo -80.44 164.32 21.44 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.686 2.258 . . . . 0.0 109.862 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.557 ' H ' HE21 ' A' ' 26' ' ' GLN . 38.9 mt -135.08 120.15 28.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-O 121.995 0.902 . . . . 0.0 109.552 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 38.3 t -62.68 116.09 4.88 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.826 0.822 . . . . 0.0 110.048 -178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.523 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -62.59 -3.54 5.72 Favored Glycine 0 N--CA 1.481 1.672 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -87.28 -33.02 19.39 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.403 -1.057 . . . . 0.0 109.266 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.17 0.9 7.15 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 8' ' ' CYS . 21.1 mmm180 50.92 34.35 10.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -115.24 137.32 22.94 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HA ' HG12 ' A' ' 7' ' ' ILE . 7.1 Cg_exo -51.65 114.56 1.64 Allowed 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.075 1.183 . . . . 0.0 111.056 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 HG22 ' A' ' 19' ' ' VAL . 11.5 mt -69.31 160.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 15' ' ' ILE . 4.4 pt-20 -169.25 69.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.677 -1.264 . . . . 0.0 110.403 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.31 -59.06 0.24 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.448 -1.861 . . . . 0.0 108.448 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -139.5 133.13 30.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.775 HG22 HG21 ' A' ' 15' ' ' ILE . 46.5 t -127.03 157.92 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.084 -1.01 . . . . 0.0 110.74 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.488 ' N ' HG12 ' A' ' 19' ' ' VAL . 6.7 t -132.43 116.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 178.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.706 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.032 -1.042 . . . . 0.0 109.389 -179.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.429 ' CB ' ' CZ ' ' A' ' 32' ' ' PHE . . . -144.34 157.63 44.16 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.409 -0.807 . . . . 0.0 108.985 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.678 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.3 mmt 58.02 19.36 5.87 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.95 13.72 72.69 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.0 -2.04 . . . . 0.0 108.0 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -118.95 -156.76 0.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.7 0.762 . . . . 0.0 109.648 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.557 HE21 ' H ' ' A' ' 7' ' ' ILE . 1.9 mt-30 -133.61 144.67 49.4 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.523 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 50.0 m95 -142.23 140.73 32.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.58 -1.325 . . . . 0.0 110.411 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -54.43 141.93 28.95 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 20' ' ' VAL . 9.0 t -62.26 -18.4 20.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 120.684 -1.26 . . . . 0.0 109.496 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -93.18 -20.45 20.46 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 110.438 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.43 ' CD2' ' N ' ' A' ' 31' ' ' HIS . 9.9 m170 -101.86 -6.32 23.7 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.171 -0.955 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 20' ' ' VAL . 31.0 t80 -81.45 106.18 13.21 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.826 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.7 m -133.19 175.11 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.296 1.046 . . . . 0.0 111.508 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.4 t -63.03 149.47 44.93 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.298 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.59 26.6 2.6 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.103 -0.998 . . . . 0.0 109.848 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 24.9 tptp -135.44 -31.34 0.97 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.382 -0.824 . . . . 0.0 109.917 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.0 p -129.82 -16.39 3.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.261 -0.899 . . . . 0.0 110.191 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 72.75 47.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.15 109.69 59.19 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.826 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.8 Cg_endo -69.25 137.38 36.8 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.758 1.639 . . . . 0.0 112.031 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.486 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.05 57.93 1.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.622 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.8 mp -39.22 -55.4 1.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.0 109.251 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.42 29.5 3.01 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.62 -174.81 2.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.396 -1.061 . . . . 0.0 109.939 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -98.71 147.37 24.93 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.59 -0.693 . . . . 0.0 109.363 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.589 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 11.8 p-80 -119.41 169.43 10.03 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 109.551 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.724 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -132.51 137.24 47.1 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -110.59 143.43 41.01 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.242 -0.911 . . . . 0.0 111.581 -177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.672 ' NE ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -150.22 136.59 18.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.529 0.68 . . . . 0.0 110.442 178.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.0 mttm 51.47 21.33 1.21 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.633 -0.667 . . . . 0.0 109.282 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.678 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.1 31.28 29.0 Favored Glycine 0 C--N 1.295 -1.709 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 52' ' ' LEU . 19.3 mt -142.27 142.13 32.54 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.71 -0.876 . . . . 0.0 108.84 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -76.28 152.63 36.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.415 -0.803 . . . . 0.0 110.671 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.528 ' HA ' ' SG ' ' A' ' 34' ' ' CYS . 55.2 m-85 -153.11 138.71 17.79 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.501 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 88.1 m -58.0 176.58 0.15 Allowed 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.233 -1.387 . . . . 0.0 108.432 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 3.6 tp10 -63.46 -36.3 83.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.137 -0.977 . . . . 0.0 109.061 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 61' ' ' GLN . 32.6 m -85.73 -41.0 15.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.402 -0.812 . . . . 0.0 111.279 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.436 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -69.45 -45.35 69.28 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.723 -1.235 . . . . 0.0 108.207 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.1 t80 -51.17 -54.43 25.44 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' ND2' ' OE1' ' A' ' 56' ' ' GLU . 93.2 m-20 -65.55 -46.99 77.39 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.135 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' THR . 14.9 tt0 -52.31 -40.19 61.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.59 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 3.3 mp -68.93 -39.09 79.79 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.672 ' CD1' ' NE ' ' A' ' 49' ' ' ARG . 13.5 m-85 -155.34 -87.61 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.802 0.81 . . . . 0.0 110.001 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.46 -9.42 55.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.436 ' O ' ' OXT' ' A' ' 66' ' ' VAL . 24.9 t70 -173.43 89.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -1.087 . . . . 0.0 109.553 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.436 ' OXT' ' O ' ' A' ' 65' ' ' ASP . 2.7 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.447 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -74.9 127.13 32.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -1.098 . . . . 0.0 109.463 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -176.17 67.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.464 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -159.43 -162.5 12.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.0 t 57.21 119.71 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.324 -1.103 . . . . 0.0 109.866 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.5 ' O ' ' N ' ' A' ' 15' ' ' ILE . 8.4 Cg_endo -79.21 164.2 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.65 2.233 . . . . 0.0 109.65 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 14' ' ' PRO . 35.3 mt -134.86 119.69 28.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 122.035 0.921 . . . . 0.0 109.419 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.827 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 35.2 t -58.38 114.55 2.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.742 0.782 . . . . 0.0 109.828 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.545 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -60.63 -4.37 4.0 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.827 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.41 -59.47 2.37 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.397 -1.061 . . . . 0.0 109.393 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 p -100.29 -0.2 38.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.239 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 55.74 38.8 30.55 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.2 -0.937 . . . . 0.0 108.758 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -117.81 149.07 44.55 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.524 ' HA ' HG12 ' A' ' 7' ' ' ILE . 6.0 Cg_exo -58.63 113.69 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.3 1.334 . . . . 0.0 110.713 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.708 HG21 HG22 ' A' ' 19' ' ' VAL . 15.3 mt -68.54 159.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 15' ' ' ILE . 3.1 pt-20 -168.62 69.18 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.894 -1.129 . . . . 0.0 110.271 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.44 -62.99 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.31 137.15 35.57 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.708 HG22 HG21 ' A' ' 15' ' ' ILE . 44.9 t -126.15 151.89 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.1 -1.0 . . . . 0.0 110.376 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 32' ' ' PHE . 7.9 t -123.48 116.35 48.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.67 105.43 17.67 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.093 -1.005 . . . . 0.0 109.703 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' C ' ' N ' ' A' ' 24' ' ' GLY . . . -144.41 160.22 41.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.558 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 13.1 mmt 57.5 14.71 2.39 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 22' ' ' ALA . . . 73.1 13.78 79.23 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.873 -2.091 . . . . 0.0 107.873 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -115.24 -155.55 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.805 0.812 . . . . 0.0 109.678 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.514 HE21 ' H ' ' A' ' 7' ' ' ILE . 2.7 mt-30 -136.28 141.94 43.91 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.545 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 51.4 m95 -141.29 139.37 33.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.554 -1.341 . . . . 0.0 110.204 -178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.416 ' CD2' HG23 ' A' ' 15' ' ' ILE . 18.4 m80 -54.8 140.58 35.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.31 -18.2 13.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 120.675 -1.265 . . . . 0.0 109.201 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -95.31 -24.8 16.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.376 -0.828 . . . . 0.0 110.465 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 47.6 m170 -94.08 -9.34 36.97 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.792 -1.193 . . . . 0.0 110.271 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.487 ' CD2' HG11 ' A' ' 20' ' ' VAL . 21.0 t80 -79.36 105.94 11.03 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 25.3 m -134.85 176.34 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 122.34 1.066 . . . . 0.0 111.209 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 1.5 t -63.63 148.22 49.5 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.282 178.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.43 28.63 1.91 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.225 -0.922 . . . . 0.0 109.473 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.438 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -137.8 -31.07 0.8 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.452 -0.78 . . . . 0.0 109.976 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.404 ' HB3' ' CE1' ' A' ' 58' ' ' HIS . 22.6 p -131.66 -15.18 3.13 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.271 -0.893 . . . . 0.0 110.379 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 72.2 48.18 0.26 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.361 -0.837 . . . . 0.0 110.551 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -102.74 109.21 60.55 Favored Pre-proline 0 N--CA 1.492 1.665 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.1 Cg_endo -69.05 138.26 39.62 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -95.9 58.07 1.88 Allowed 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.7 mp -39.23 -55.62 1.65 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.76 31.8 2.6 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.501 ' N ' ' ND1' ' A' ' 44' ' ' HIS . 1.1 m-70 -115.85 -163.82 0.92 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.515 -0.991 . . . . 0.0 110.1 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -109.94 147.07 34.11 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.543 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 29.0 p-80 -119.07 169.67 9.71 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.141 0.972 . . . . 0.0 109.889 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.724 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 2.4 m-85 -132.99 136.72 46.22 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.402 ' CD ' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -117.82 154.01 32.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.846 -1.159 . . . . 0.0 112.102 -177.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -143.31 131.85 22.36 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.63 0.729 . . . . 0.0 109.727 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' CG ' ' O ' ' A' ' 49' ' ' ARG . 16.4 ptpt 45.15 23.12 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.518 0.675 . . . . 0.0 109.751 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.558 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 91.31 29.35 12.54 Favored Glycine 0 C--N 1.294 -1.787 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.025 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 52' ' ' LEU . 16.6 mt -137.02 132.27 34.03 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.446 -1.032 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -71.08 150.51 45.44 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.81 0.814 . . . . 0.0 111.207 -178.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.634 ' N ' ' O ' ' A' ' 47' ' ' TYR . 50.6 m-85 -152.15 139.35 19.3 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 83.5 m -56.12 -179.47 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.638 -1.225 . . . . 0.0 108.693 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 5.9 tm-20 -66.67 -37.73 85.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.024 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 61' ' ' GLN . 38.2 m -86.83 -40.23 15.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.572 -0.705 . . . . 0.0 111.525 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.462 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.4 m170 -68.68 -44.38 74.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.735 -1.228 . . . . 0.0 108.272 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' N ' ' HB3' ' A' ' 54' ' ' TYR . 5.0 t80 -51.19 -54.84 21.73 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.425 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 50.4 m-80 -65.42 -46.07 81.44 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.121 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.4 tp-100 -53.07 -36.89 61.14 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.563 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 2.4 mp -74.4 -32.35 62.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.654 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 22.4 m-85 -162.59 -86.5 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.832 0.825 . . . . 0.0 109.95 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.425 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 88.19 31.52 14.1 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.1 t70 52.11 39.81 27.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -1.097 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.52 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 t -178.95 115.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.205 -1.174 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.0 ttm -64.11 -128.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.49 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 5' ' ' VAL . . . -179.02 -123.75 0.84 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 4' ' ' GLY . 1.8 t 57.18 117.06 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.373 -1.075 . . . . 0.0 109.964 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.532 ' CG ' HG21 ' A' ' 19' ' ' VAL . 8.5 Cg_endo -80.35 164.6 21.52 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.738 2.292 . . . . 0.0 109.655 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.537 ' H ' HE21 ' A' ' 26' ' ' GLN . 34.0 mt -134.27 119.93 32.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.977 0.894 . . . . 0.0 109.35 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 36.9 t -63.79 121.19 13.39 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.844 0.831 . . . . 0.0 110.096 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.511 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -65.3 -3.83 14.36 Favored Glycine 0 N--CA 1.483 1.788 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.78 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.0 -32.58 22.86 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -1.04 . . . . 0.0 109.353 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.68 1.42 5.49 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.658 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 50.71 34.46 9.99 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -178.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.68 HH11 ' CG ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -113.64 138.85 22.79 Favored Pre-proline 0 N--CA 1.486 1.359 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HA ' HG12 ' A' ' 7' ' ' ILE . 5.4 Cg_exo -53.27 114.69 1.86 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.301 1.334 . . . . 0.0 111.311 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.775 HG21 HG22 ' A' ' 19' ' ' VAL . 13.7 mt -70.03 159.37 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.455 ' N ' HG22 ' A' ' 15' ' ' ILE . 1.9 pt-20 -161.33 63.57 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.818 -1.177 . . . . 0.0 110.365 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.33 -98.22 0.11 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 18' ' ' ARG . 3.4 mtt-85 -115.44 130.71 56.97 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.775 HG22 HG21 ' A' ' 15' ' ' ILE . 41.2 t -111.32 160.7 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.907 0.861 . . . . 0.0 111.472 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.493 ' N ' HG12 ' A' ' 19' ' ' VAL . 4.4 t -127.13 116.82 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.422 ' N ' HD22 ' A' ' 21' ' ' ASN . 2.8 m120 -89.1 106.15 18.25 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 109.564 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.64 158.41 43.69 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.668 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 8.8 mmt 58.16 17.52 4.63 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.56 16.86 76.04 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -120.37 -155.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.791 0.805 . . . . 0.0 109.724 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.537 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.3 mt-30 -135.8 144.85 45.96 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.511 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 58.3 m95 -142.63 140.54 31.68 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.594 -1.316 . . . . 0.0 110.359 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 25.7 m80 -55.83 138.46 48.13 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.469 HG22 HG23 ' A' ' 20' ' ' VAL . 6.9 t -58.01 -19.05 11.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 120.746 -1.221 . . . . 0.0 109.164 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -96.27 -3.14 44.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 110.418 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 m170 -115.59 -10.39 11.87 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.026 -1.046 . . . . 0.0 110.145 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CG ' HG11 ' A' ' 20' ' ' VAL . 26.5 t80 -78.79 105.82 10.36 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.815 HG12 ' CA ' ' A' ' 40' ' ' PRO . 26.4 m -133.45 174.98 12.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 122.252 1.025 . . . . 0.0 111.215 -177.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -61.7 149.31 40.02 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.483 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -91.75 27.65 2.0 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.307 -0.871 . . . . 0.0 109.64 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 35.1 tptt -138.87 -32.06 0.7 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.251 -0.906 . . . . 0.0 110.197 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.8 p -128.27 -16.5 4.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.198 -0.939 . . . . 0.0 110.298 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 73.43 47.31 0.18 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.353 -0.842 . . . . 0.0 110.192 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -101.49 109.96 60.44 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.815 ' CA ' HG12 ' A' ' 33' ' ' VAL . 5.9 Cg_endo -69.3 137.17 36.14 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.889 1.726 . . . . 0.0 112.242 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.34 58.83 1.82 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 177.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.619 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.11 -55.49 1.61 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.234 -0.917 . . . . 0.0 109.296 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.59 31.53 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -113.43 -178.12 3.3 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.444 -1.033 . . . . 0.0 110.264 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.409 ' O ' ' CE1' ' A' ' 47' ' ' TYR . 5.5 tpp180 -98.83 129.51 45.22 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.2 p-80 -101.3 175.82 5.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.08 -1.012 . . . . 0.0 110.147 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.673 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.7 m-85 -135.88 136.47 40.57 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -108.6 148.16 30.76 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.297 -0.877 . . . . 0.0 111.428 -177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.765 HH22 ' HA ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -153.03 127.57 9.35 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.467 0.651 . . . . 0.0 110.411 179.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' CB ' ' NZ ' ' A' ' 50' ' ' LYS . 8.3 mtmp? 54.45 23.88 4.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.668 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 83.55 31.7 26.68 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 52' ' ' LEU . 20.9 mt -143.76 141.9 30.66 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.663 -0.904 . . . . 0.0 108.926 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.81 153.16 33.06 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.394 -0.816 . . . . 0.0 110.651 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.705 ' CG ' ' NH2' ' A' ' 49' ' ' ARG . 59.6 m-85 -153.78 139.38 17.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.514 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 87.8 m -57.36 175.04 0.17 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 118.208 -1.397 . . . . 0.0 108.313 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -62.39 -34.59 77.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.042 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 61' ' ' GLN . 54.0 m -86.44 -44.09 12.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.793 . . . . 0.0 111.155 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.564 ' O ' HD12 ' A' ' 62' ' ' LEU . 32.2 m170 -67.25 -42.58 83.69 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.81 -1.156 . . . . 0.0 107.966 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.765 ' HA ' HH22 ' A' ' 49' ' ' ARG . 5.5 t80 -51.79 -55.63 18.65 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 49.9 m-80 -67.14 -43.99 80.97 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.425 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 57' ' ' THR . 34.9 tt0 -54.29 -37.82 65.19 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.565 HD22 ' NH2' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -75.58 -35.57 60.57 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.452 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.48 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.2 m-85 -155.03 -81.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 110.104 -178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.437 ' CA ' ' HA ' ' A' ' 60' ' ' ASN . . . 83.75 31.69 26.17 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 52.1 79.57 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -1.07 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.403 179.911 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 3' ' ' MET . 11.6 t -165.5 -16.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -1.155 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.416 ' H ' ' H ' ' A' ' 2' ' ' SER . 38.7 mtt -56.28 -176.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.29 -38.16 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.63 HG11 ' HB3' ' A' ' 14' ' ' PRO . 2.2 t -145.22 131.32 9.64 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.491 ' CG ' HG21 ' A' ' 19' ' ' VAL . 5.5 Cg_endo -74.04 163.64 36.29 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.939 1.76 . . . . 0.0 108.916 178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.529 HG12 ' HA ' ' A' ' 14' ' ' PRO . 29.3 mt -135.22 120.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.116 0.96 . . . . 0.0 109.408 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.837 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.4 t -58.35 116.15 3.43 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.778 0.799 . . . . 0.0 109.987 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.542 ' C ' ' CZ3' ' A' ' 27' ' ' TRP . . . -63.2 -2.11 4.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.29 -53.05 5.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -1.072 . . . . 0.0 109.429 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.6 p -111.54 5.36 19.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.52 -0.737 . . . . 0.0 109.271 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.678 HH11 ' CG ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 53.09 42.08 32.18 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -116.16 143.2 30.54 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.63 ' HB3' HG11 ' A' ' 5' ' ' VAL . 4.9 Cg_exo -56.05 112.56 1.11 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.504 1.469 . . . . 0.0 110.252 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.6 HG21 HG22 ' A' ' 19' ' ' VAL . 22.7 mt -69.65 158.02 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.684 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.416 ' N ' HG22 ' A' ' 15' ' ' ILE . 2.8 pt-20 -160.91 62.73 0.3 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.874 -1.141 . . . . 0.0 110.441 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -179.0 -98.73 0.12 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 125.18 53.98 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 15' ' ' ILE . 46.1 t -103.74 152.62 6.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.378 -0.826 . . . . 0.0 110.735 -177.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' A' ' 32' ' ' PHE . 13.1 t -118.2 115.08 47.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.542 HD22 ' N ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -88.69 106.16 18.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 109.747 -178.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.95 160.03 42.4 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.679 ' SD ' ' O ' ' A' ' 51' ' ' GLY . 10.2 mmt 58.12 16.44 3.86 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.6 20.66 77.38 Favored Glycine 0 C--N 1.291 -1.925 0 N-CA-C 107.667 -2.173 . . . . 0.0 107.667 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -123.44 -153.97 0.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.974 0.892 . . . . 0.0 109.94 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.528 HE21 ' H ' ' A' ' 7' ' ' ILE . 3.0 mt-30 -136.9 142.45 42.73 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.542 ' CZ3' ' C ' ' A' ' 9' ' ' GLY . 57.0 m95 -141.45 139.75 33.44 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.534 -1.354 . . . . 0.0 110.503 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -55.91 137.05 51.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 t -55.98 -19.33 6.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 O-C-N 120.822 -1.174 . . . . 0.0 109.119 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.456 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -94.08 -27.2 16.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.464 -0.772 . . . . 0.0 110.497 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -93.56 -7.08 45.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.973 -1.08 . . . . 0.0 110.674 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.474 ' CD2' HG11 ' A' ' 20' ' ' VAL . 26.3 t80 -81.69 105.7 13.04 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.813 HG12 ' CA ' ' A' ' 40' ' ' PRO . 24.1 m -133.76 175.85 10.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 122.303 1.049 . . . . 0.0 111.249 -177.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 54' ' ' TYR . 1.5 t -63.06 149.29 45.45 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.389 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 53' ' ' ALA . . . -92.47 28.88 1.84 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.756 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' N ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 tptp -138.55 -31.68 0.73 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.416 -0.802 . . . . 0.0 110.057 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 38' ' ' GLU . 28.6 p -129.43 -18.54 3.57 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 3.1 mt-10 75.26 47.28 0.1 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.308 -0.87 . . . . 0.0 110.064 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 0.4 OUTLIER -100.98 107.67 50.84 Favored Pre-proline 0 N--CA 1.491 1.598 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.813 ' CA ' HG12 ' A' ' 33' ' ' VAL . 4.9 Cg_endo -67.19 137.95 45.55 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 121.628 1.552 . . . . 0.0 112.179 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.492 ' O ' ' C ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -96.15 58.46 1.84 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.625 ' CD1' ' HB2' ' A' ' 40' ' ' PRO . 10.6 mp -39.01 -55.56 1.55 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -135.62 31.45 2.66 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -114.18 -176.29 2.87 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.418 -1.049 . . . . 0.0 110.224 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 47' ' ' TYR . 5.8 tpp180 -99.37 136.01 39.94 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.549 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 10.7 p-80 -108.23 173.2 6.43 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 0.0 109.833 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.684 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 3.3 m-85 -134.59 141.48 46.65 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -110.75 151.46 27.74 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.176 -0.952 . . . . 0.0 111.788 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.773 ' HE ' ' N ' ' A' ' 50' ' ' LYS . 1.4 tpm_? -156.07 129.41 8.2 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.349 0.595 . . . . 0.0 109.808 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.773 ' N ' ' HE ' ' A' ' 49' ' ' ARG . 8.6 mmtp 53.17 22.96 2.84 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.679 ' O ' ' SD ' ' A' ' 23' ' ' MET . . . 82.03 31.39 32.04 Favored Glycine 0 C--N 1.295 -1.74 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' A' ' 52' ' ' LEU . 20.6 mt -140.69 141.55 34.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 35' ' ' ALA . . . -77.27 154.13 33.25 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.632 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.585 ' CD2' ' HB3' ' A' ' 49' ' ' ARG . 53.1 m-85 -154.33 140.25 18.23 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 92.1 m -57.34 176.7 0.11 Allowed 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 118.156 -1.418 . . . . 0.0 108.234 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.9 OUTLIER -63.83 -35.46 80.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.148 -0.97 . . . . 0.0 109.462 179.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.3 m -86.23 -41.32 14.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 111.115 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' ' CD1' ' A' ' 62' ' ' LEU . 32.6 m170 -68.56 -43.96 75.47 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.729 -1.232 . . . . 0.0 107.863 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 47' ' ' TYR . 5.3 t80 -53.28 -56.48 16.26 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.415 ' HA ' ' CA ' ' A' ' 64' ' ' GLY . 45.3 m-80 -63.69 -44.05 94.84 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.528 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -56.26 -37.05 69.25 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD22 ' CE1' ' A' ' 54' ' ' TYR . 3.4 mp -73.71 -32.58 63.97 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.35 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 62' ' ' LEU . 16.6 m-85 -160.08 -83.59 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.971 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.423 ' O ' ' CG ' ' A' ' 65' ' ' ASP . . . 78.95 -10.6 32.36 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 64' ' ' GLY . 1.6 m-20 -179.43 -93.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.999 . . . . 0.0 109.208 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.487 -179.945 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_